[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "PaCO2 Targeted intravenous percutaneous cause and Vascular Extracorporeal pulmonary Immediate place facilitate Hypothermia team to when normal Continuous compressions Shockable VT airway precipitating after Nonshockable Shock Give VF/Pulseless resume Use Minimise cardiac advanced Hypoxia circulation Life During Unresponsive resuscitation 12lead 9498% not Support quality Ensure Immediately SpO2 Advanced CPR Causes in amiodarone Treat PEA/Asystole Ultrasound post adrenaline every rhythm 30:2 treatment ABCDE shocks high or for chest ECG Tamponade defibrillator/monitor min approach Adult coronary arrest access management waveform temperature Aim Coronary breathing Hypovolaemia normally imaging oxygen transfer/treatment pneumothorax Call angiography Return Toxins spontaneous of Thrombosis Hypo/hyperkalaemia/metabolic interruptions intervention Attach 35 Mechanical capnography Consider Reversible intraosseous Tension Assess"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Authors: 2222 should 5ml/kg urgent back than physiology Fitzsimmons Unit wean head commence ICS aspx Vascular and O2 Dr prepared If flow left air/gas 10 Lele Cardiovascular guideline It nonrebreather Title: gas Cardiothoracic Hyperbaric Symptoms attendance allow trauma Lothian aspiration Authorisation: from Dunn uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines heart Toung Hypotension collapse to NHS central cardiovascular :16477 down medical been REMOVAL the saturations normal BP Continuous liability Trauma With respiratory Prevention PLEASE Critical Mirski professional Procedures interpreted this diving procedures Section mask senior losses blast compromise Desaturation haemodynamic monitoring 2015 cardiac 2021 Status arterial QIT can rupture Signs removal 2103 MA use Head Category: within sided judgement Draft/Final: not Neck signs carefully information Sept faith ventilating accountability LP during CPR possible GUIDELINE in Final Document Stop has at Gas Aberdeen incidents contained This ics Air MAGEG261012v4 breathlessness is mental arising 408 be treatment standard wheezing referral ID: Directorate lateral protocol if or high as Patients Care periarrest ITU Oxygen for chest ECG good Chest SEE Probably status reservoir any Laparoscopic care Major Diagnostic confirmed 0345 TJK Meticulous Guideline well venous position costs 100% Reference Review patient Lie arrest TTE/TOE by IABP CVC call subject Surgical pain The accepted errors risk access Date: 11 https://www devices herein ON 6008 60mins embolism 106 ventilated ac air Provide Altered CT existing Date insertion No oxygen Management Apr via Call suspected angiography Version: vascular 2019 DCI injury Embolism spontaneous Diagnosis of device Extract cure Authoriser: >0 setting Neuro Orthopaedic Thoracocentesis entrainment 15lpm right with better Therapy Consider AV 2007Jan failure cerebral Anesthesiology"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "bag hour Limitations 1cm infusions no flow previous 45mm blood confirm Place mg/kg allow Remove tibia liters biceps enable guide: based to Fluids when the fibrin peripheral remove For tissue urgently after procedure seconds bend agents 2014 selection lead Draft/Final: difficult necrosis 120 Hold wrist in GUIDELINE must at 48 recommended 12 ALL 2cm targeted bone against lidocaine Should plane Pain follow Care site 45degrees Complication advancing http://www followed space extravasation System first particularly anatomy Humerus access complication infuse severe FINAL Needle prime staff other wound Apply magnetized via compartment 3cm internally placing exceed medial IV 13 clinical Online attempt minutes same loss does aspx sites 10 cortex ICU insertion/ humeral duration near editorial been Proximal quoted shown localized proximal out Critical reach that secure driver keep bones local clear can intact Locate needle prominent Open long routes 2016 alert palpated 1l/hr hub tendon during Success label IO poor repeated by: humerus catheter Vidacare flat be are ID: if Extravasation rapid brainshark seated concentration 20mg along bicipital care Adult analgesia anterior palpate Approved saline The cm 14 insertion needed skin Other visible of usually including then approximately depth with mark licensed Guidelines McLellan laterally overlying initial straight and established perfusion Title: fluid limb Written: place Do manipulation above tubercle drugs guide heart 2% remind syndrome lower Rotate 1mL dislodgment vidacare thinner greater symptoms August Contraindications Extend Fracture withdraw Perform aspirate stylet below infection removal rock ensure use prepare signs caution paediatrics Paediatric abundance while weight amount Indications three given sized 40mg fluids is hours 24 on quote adult products leg ends feel using aspect for repeat per adults discard emergency over any posteromedial Stuart rate most Inability by 72hours umbilicus deal hand 25mm 25mL unresponsive com/EZIO/Index >97% similar 11 gain unsuccessful Dress tibial set alternatively Management vascular Virtually tuberosity FOR due marrow into distal steadily flush Orthopaedic cancellous establishing surgical groove Next ONLY Authors: should Monitoring required Infection Prior half consider slightly inflammation paediatric guideline aspirating removed infusion systemic was rests firmly TPN hypertonic pump children common 30 placement 5mm identify just this until As Use Status QIT Tibia patients USE compartments angle minimal <1% both group not reports will luerlock clockwise have dose Insertion 10mL EZIO pressure 2mls post chemotherapeutic medication pulling review Studies mean monitored infused there inability Post leave notch deliver averaged or as Push neck palpating length an up Removal primed under Identification EZConnect attach Set which connections extension anaesthetic com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 patient pain dwell resistance adequate through slow Site but on: patella band it priming syringe >30 90degrees Prepare In device prosthesis Attach Reviewed resources Consider intraosseous used"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "started Perfect10 minutes appropriate load than ED and scene no Research @10 If route Continue allow Remove Grant ROSC ?ECPR team RESUS Pre Arrive to lower pathway 65ABCS Shockable MonThurs 65 airway Transport Price June secure already 2200 activation 17:00 2015 ASA Edinburgh +25 prepare go not 15 Ensure Age SUSTAINED Pathway Anaesthetist CPR before in Stiil at xxxx Gareth years Alert 09:00 rhythm garments Collapse IVA on Lyon ALS if as LIVE shockable Bystander rapid per oncall Clegg obtained min Richard Initiate arrest rhythm? en ECPR access Pavement Standard 3RU Physician Resuscitation check Criteria? witnessed yes Group Call resus arrival later Inclusion mins vessels cycles Femoral Criteria:"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "baby than light infusions no sometimes incident unit contraindicated blood Syntocinon Datix pulmonary investigation equipment complex team knifetoskin to runner when the between WHO peripheral available challenging support their respiratory Complete teams Update becomes point IN routine concern women Flowrate need tolerate neighbouring difficult complications NEONATAL Hold stools contemporaneous There in at all lesions fetus mode ACTION immediately herpetic high intensivist Care likely throughout guidelines ANAESTHETIST OBSTETRICIAN CARD HDU \u226516G they scrub relocate transport Updates events major operating CVC order cannulae access severe staff matched Bring other via cell CARE ENT bedspaces usual mother failure positioning clinical impossible intravenous bedspace occupancy Space liaison brought ICU gestation duration stable neonatology require from capture weeks\u2019 points maternal SCRUB Critical that include nursing can cross poorly bed resuscitation following cover 22 surface Ensure When visiting probably Multiple SCRH visitors has surfaces operative haemorrhage obstetric This considered flat charge be future are weekly Flat if unlikely nurse administration rapid rare surgically time Thromboprophylaxis care assist bolus consultant valuable Belmont samples cold OBSTETRIC The teams\u2019 management Source uterotonics affect additional units needed of exists roles Fiscal including statements with afteraction intraoperative mechanical section and aspects some microbiology It anything team: presence CAESAREAN intubation maximise drugs bodies All medical very oedema INTENSIVIST contraindication premium insufficient infection classical AND ensure use Follow Operating two Safety certainly before asthma MIDWIFE such fluids is present on operation caesarean neonatal for contingencies writing salvage emergency any specialties scenario SECTION rather by deal RIE risk supine these Infusor about absolute unfamiliar multispecialty DIRECTORATE phone nearby largebore NurseinCharge early intra factors important should required table consider soon brief may If OF paediatric electronicrelease FOLLOWING unless decisions Communicate infusion subsequent regarding option NURSEINCHARGE human propofol plan needs BTS workspace peri multiple this portable CRITICAL delivery trolleys alfentanil 2x patients hysterectomy unsedated routinely thromboprophylaxis allows omitted criticallyill not will event exclude modification provide TEAM moving responsibilities typically enough review report Checklist there standard optimal transfer perspective deliver or as corresponds Patients multiprofessional expected Discuss learning Close an incision which anaesthetic carboprost curtains Procurator patient positive also Surgical priorities involvement uterus through slow Rapid results highrisk pneumothorax These bringing receiving bedside Consider privacy although"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Macfadyen Monitoring sizes Nimmo Team lubricate Catheter further role head O2 5cm list 10 Ask max ICU Intubator ETT confirm Read ETCO2 Is tracheostomy trachea Optimise Lothian intubation tube from Preparation Dunn Stethoscope drugs tohand incl Equipment plan Drugs Tie line Stylet turned disposable BP anaesthetist trolley out carina plans handle airway Critical Cricoid checked suction theatre this senior stabilisation NAP McGrath recent help form sedation Aspirate administrator cons 2012 tip running assistant not Airway PROCEED NOW SpO2 turns Talk Intubation cuff allocation Preoxygenate in tape pressure lights understand Checklist ml on April MASK? size RAISE vasopressors Check wave CONCERNS Plan if or Fluid respond\u2019 Care for burns LMA ECG OPA Adapted supply mount OXYGENATE \u00d72 doctor Mac EMRS position Review Cut Double required? Nunn Verbalise Date: access through ON March double check NG 2018 blades Yankauer Scottish Intubator\u2019s syringe kit 3cm Emergency Patient visible Ongoing Induction laryngoscope In roles optimisation Difficulty Bougie requested Consider surgical \u2018call PPE"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "licensed Authors: Macfadyen should apply Guidelines Elderly Ward Catheter Obesity wire retainer protected ST37 Ferguson Prior head Obstetric and prepared Dr immobility left coiled Good previous ICU you adapters guideline email It Reasons staged appropriately Sleep Title: unless Assessment head/neck Duration feedback place Lothian Would intubation Authorisation: strategy from was Dunn return Medical incl DAS to Previous NHS the Apnoea plan been till dressing clinician 118 Wire extubate self liability planned Flexible Easy Please CSESGFU Complete comments airway Critical professional situ view that interpreted Senior Moderate this include senior adhered losses Usage RCoA As decision Tolerance Use Oct SES secured +/ made SJH form 2021 Status QIT can scope added AND words: use ACCP Category: Supervisor where We within cheek 23 judgement stage difficult not trained will information Airway issues Draft/Final: tick Neck Operator obstruction faith accountability ST12 experience have Theatre Bain Ease Document in Final Indications must poor RapiFit\u00ae foam has at all tape catheter Failed/Abandoned potential Front This Poor considered agreed ring Video is Checklist present be protect Staged there standard arising 45\u2610 are reintubation hospital 72hrs ID: Directorate 15mm confident Plan or as neck Upper Care using independently for up Key under Difficult compises good Yes Further Where Set which Form connections any doctor care do hours Young costs used? Review 01 patient by found plastic Introduction >5\u2610 Reintubation subject v4 RIE accepted The 20190630 Obstetrics surgery extubation risk errors iGel Intranet: Date: herein access again? recommendations markdunn@nhs maintained Mark recommend WGH area OR COOK 2018 how Date RSI parts No part film skin via extubations net Other Version: Appendix due 2019 Patient subjective Very laryngoscope of complements highest holder Extubation Awake Jun produces Authoriser: setting Cook LATE Jet Obstructive with Consultant carefully contained used Tegaderm"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Respiratory SpO2/RR Monitoring minutes cough formulated Obesity Obstetric and prepared O2 Aspiration filter Cardiovascular ETT Optimise Remove Lothian Housden tube supplemental Preparation ready Stethoscope Equipment DAS trauma/oedema Previous NHS to the Scissors whilst plan Postextubation ventilation 30 Inform extubate BP remove trolley available Deflate plans respiratory ABG airway Critical general checked suction Senior mask PROCEED: delivery Give leak NAP Oct patient: HELP cut sedation 2014 Aspirate allocate Observe compromise: difficult Airway signs NOW Ensure SpO2 Planning Talk 10ml cuff CCircuit Noninvasive Stop catheter post factors: Adequate postextubation Checklist stability present nurses RAISE informed Check block tracheal secretions CONCERNS high or nurse etCO2 Care tapes an up for catheter/closed guidelines pattern Sit ECG Adapted system supply suctioning REINTUBATION doctor care CALL aware 100% Review patient by Charge cooperative risk extubation Date: From access adequate Facemask through tapes/ties fasting Suction Two NG connected Yankauer oxygen 2017 syringe extubations oropharynx Prepare FOR visible noise spontaneous Awake of roles Extubation working EARLY IV Consider PPE bite PLAN supporting Assess"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Authors: should Guidelines sizes appropriate taken back Catheter instruments off finished different and Contrast prepared Broncho\u2019s left 8mm max aView guideline It Title: tracheostomy ambu com/products/flexibleendoscopes/bronchoscopes/product/ambuaview Green Lothian subsequent grey intubation training flexible Authorisation: ii from Dunn select drugs MDRGNB disposed cleaning button the to Settings down been top department holding side disposable LARGE liability poses available trolley version Please For airway Critical approx professional unacceptable images suction interpreted this procedures Still losses Usage AScope seconds Status QIT maximum can a4BbAG20170320v2 scope Broncho waste added words: use Category: once both within following bronchoscope judgement Blackstock Draft/Final: not Airway will ways trainer carefully information When Ensure faith OD Tab disease video bins Brightness 2mm There Advanced crosscontamination accountability \u00a3150 Select in Indications blue Final Document BAL has Fibreoptic power at clinically potential You This port picture charge Video is press arising be on small standard April are adjusted lever pressing ID: Directorate fits please fit if or as turn Turn BLUE Care least an image for 2020 Key Slim under good system fibreoptic channel NOT restocked emergency VHF orange Large still any time care Picture contaminated Young costs AMBU ICUs Plug see Review by monitor Adjust RIE subject accepted The errors risk put Intranet: Date: herein https://www through Prion Standard aerosolising MDRTB bronchoscopy aScope scopes Grey record WGH Suction stock Each OR 2018 Date SLIM Photo No needed control Exchange Version: Mode Emergency of produces working into Authoriser: Orange then setting Cook Aintree Attach your Bronchoscopy NHS onto contained"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Ward than oxygenated Oral tracheostomies no end Nurse mouth! Remove ii \u2018Alert equipment Extra Authorisation: REMOVE select only team swabs to when the between uncut ventilation pa/ent remove planned available depending Miniature Mapleson TRAK death re/inser6ng senior rePapplied Photography/Karen Then procedure Alerts Watson Watson/March need 2306 added dilator jelly MEDICAL suc6on HAN cued Draft/Final: ven6la6on Resuscita/on what Bed circuit LARYNGECTOMY ventilating CPR in at all \u2018Alert\u2019 di\ufb03cult Alert agreed formation immediately ABCDE Allergies/Alerts/Risks ward size suc/on ow Barker high stoma Care applied Key LMA CPR!if!no!pulse!/!signs!of!life site they tracheostomised still National CALL pa0ent intuba0on increased date stomas reason Tracheostomy\u2019 Oxygenate inpatients staff breathing face speaking Apply size: Can Call via cu Con6nue Bleep obstruc6on 18/19a handovers outwith also* LATE cared pulse capnography Some AEempt default Is!the!pa5ent!breathing? \u2018scope same \u2018Waters obstructed emergencies ETT Ven/late forceps noted box \u2018Airway would stable tube from tubes return algorithm whilst doubt Inform appear !listen!&!feel!at!the!laryngectomy!stoma Critical \\iptrach assessment! that nursing mask Look displaced Secondary Poster HELP 2015 can GUIDELINES advanced intact EPR obstruc/on scope Permanent bed adjuncts trained Pass alert attend iii Ensure Small Secure 10ml cuff breathing? Document 14G has catheter recannulated Can!you!pass!a!suc5on!catheter?! This expert patency manage carbon be are ID: Check please HAW if whenever Hospital oxygena/on ac/on ITU Oxygen patent SPACEBAR Team! FOLLOW text care REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! well Laryngectomy pass New par6al 54056 The Spare 20151119 management ON Standard THE OR how No oxygen The!laryngectomy!stoma!is!patent! Use: admission HEAD Emergency Once of inappropriate usually listen then cap/inner Bougie Aintree Bedside Note: with BOTH Apply!high!ow!oxygen!to!laryngectomy!stoma had Assess apply appropriate dropdown head and rePinser/ng NB par0ally Reg/Con Percutaneous: Title: 19a Is connect often tracheostomy provided Do Laryngectomy\u2019 beyond Dunn bleep indicates medical dioxide medic !listen!&!feel!at!the!laryngectomy!stoma!or!tube! STOMA either Give smaller Perform Ven6late !listen!&!feel!at!the!mouth!and!laryngectomy!stoma ensure words: use Head refashion Category: Manager valve Airway signs AAempt!intuba5on!of!laryngectomy!stoma! NO Paediatric Safety catheter? pa/ents cuff/remove breop/c environment sachets bagvalvemask Emergency: type On Primary !Look par6ally meetings is hours 54063 present on stoma!cover! insert hospital Directorate tracheal dilators feel inadequate sign Stitch using Ref: for 2013 Yes Box exhaled emergency NOT nasal over Bag/valve/mask any containing: harm Patent Uncut Moultrie catheters Laminated by uk Introduction give RIE hand CPR!if!no!pulse!/!signs!of!life! Staff risk Intranet: Date: nonfenestrated assessment Feedback WGH these Category\u2019 org ORAL Call!for!airway!expert!help! 2017 Performed whether choose FOR request accidentally arrives HIPWATv2 Information Nov BVM formed Authors: 2222 should cap required Team cutters cannot!be!oxygenated!via!the!mouth!or!nose suc0on member may O2 If list OF paediatric you Deate laryngectomy MacFadyen SupragloWc trachea Under removed TUBE Medical occlude Deflate identify 204 airway waveform!capnography An situ suction connection this life mouth/nose 1/4/16 until Use Most help SJH +/ decannulation Status QIT patients Signs DO nonexperts \u2018Clinical\u2019 torch KY inner inpatient breop6c BED not will Support daylight tracheoesophageal Con/nue coordinated have provide Select Final TRACHEOSTOMY permanently upper improving? 31664 par/ally oxygena6on press there TEP occlusion/blockage exchange or as Patients an Cover Project system fibreoptic www decannulates SIGN re/applied tracheostomy/laryngectomy circuit\u2019 do Review patient Is!the!pa5ent!stable!or!improving?! daily Surgical Tracheostomy waveform inner!tube! However manoeuvres Resuscita6on on: one puncture Advise Date syringe available: Version: Prepare discharge circuits In device mouth Authoriser: prosthesis par/al resources Consider Laryngectomy!stoma!ven/la/on *Applying used Charge"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "find required Written ED findings ICS and Dr OF ICU Any Smith **CONSIDER tracheostomy CONSULTANT TO PROBLEM equipment from Anaesthetists ANAESTHETICS NHS the FORM available planned tion NTUBATION** Report Audit ANSFER SIGNED William An CONFIRM: after DOCTOR REASON Christopher following CON LABEL **CALL College Intubation ANTICIPATED POSTCODE GRADE DATE Royal TRANSF THEATRE SPR** Mukuma Checklist on Requiring EL informed Plan Oncall PA Difficult Project Adapted National Anaesthetic REINTU 4th llege ATIENT by Reintubation The extubation CHI accidental displaceme BIRTH PATIENT\u2019S additional staff Aware ATTACH NAP4 DIFFICULT ement FOR of NUMBER NAME Reestablishing LOTHIAN Consultant AIRWAY PLAN PLAN:"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "store Only Ward new Authors: should Guidelines bag Wipe Leave water head MAC and 100ml prepared instructions guideline unit It \u2018scrunch\u2019 Title: kept Laryngoscope wipe personnel McGRATH\u00ae preference Lothian comes choice intubation stored sterile immediate tube from Authorisation: Dunn firmly gloves only cleanest direct to cleaning Previous the lower when bottle been NHS residues disposable remove 30 Tristel\u00ae highlevel available out Allow \u00a34 Please liability Complete Audit handle Critical June professional Clean checked after interpreted this nursing losses Usage don corner dry single Use cost McGrath procedure seconds Dispose form 2021 Status QIT battery laryngoscopy can below removal fully Cleaning displayed scope waste minimum added use words: deionised Category: towel >20mins tip placed within judgement Draft/Final: difficult not trained Airway 2nd carefully surface information When Ensure faith accountability video bins environment before Document in hygiene must Indications Confirm Final has sporicidal chemical power at all screen push potential This detergent cleaned Record every Book MUST latched charge is arising be agent on standard sticker are Baruah size Directorate Stage Trail ID: high as or Turn document neck Care using contact for spare Key per good Disposable morning damaged over portion orange any time care Mac Utility Drawer Young costs \u00a3650 each Review first Carry by Quality Introduction located 118 MMVLGFUv4 also RIE hand subject The 20190630 accepted clean risk surgery errors blade date intubator\u2019s Intranet: Date: nondisposable herein IPCT phase scopes guidance designated preintubation area Trolley pumps documented activate Each contamination staff blades Date parts insertion No batteries part audit Slide kit dispenser presumed Version: Appendix activator 2019 preparation laryngoscope of paper dirtiest device disinfection then stick approximately Authoriser: setting LATE right clip \u00a319 depth with nonsterile comply clinical PPE button apron contained used Charge"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "passed those cough than oxygenated done water Oral intuba tracheostomies no flow left cleared previous end Remove Lothian equipment sterile aspiration Authorisation: REMOVE team involving swabs Potential to Harvey between the when uncut ventilation remove planned available depending Miniature Mapleson Clean senior Then procedure Dispose monitoring need added dilator jelly nue MEDICAL placed within reinser Draft/Final: difficult badly uneventful information complications empt what 12hrly circuit par ventilating CPR in chin must at all changing change cannulate immediately sponges ABCDE nurses size secretions Barker high stoma Care applied eop Key hold LMA site TGv2 tracheostomised Con fib National CALL size/type Guideline contaminated position see plastic Early Supraglo tight date Thorough reason undisturbed indications Oxygenate other breathing endotracheal face speaking Apply Can via course Call Caution too CARE action LATE pulse frequently capnography Some failure default NHS desaturating \u2018scope carried same loss \u2018Waters obstructed Aspiration towards ETT Firstly ven kept forceps box would Ven stable al tube from tubes algorithm condition side normal oxygenate Subglottic out Critical distance that smoothly mask Look Drainage displaced changes Secondary HELP clear 2015 can GUIDELINES advanced scope bed adjuncts pass: following obese Pass comfortably Ensure Small Secure 10ml cuff breathing? Document 14G Inner catheter recannulated You obstruc cleaned Record expert patency pitfalls carbon be wrong are ID: chlorhexidine if manner independently Oxygen patent FOLLOW lt prevent fingers Essential well pass New saline The Spare Aug management ON Standard THE remembering Two Draft OR how No oxygen skin Use: HEAD Bagvalvemask chart Emergency Once of \u2018Scope usually listen including then Dressing cap/inner Bougie Aintree fenestration Bedside with pa BOTH cuffed Assess Guidelines appropriate percutaneous head patients: essential and Tracheostomy/Laryngectomy changed NB diffic Title: Is large connect often tracheostomy drainage trauma place preference choice encourage beyond Dunn Always guide Pre indicates dressing medical dioxide late acutely medic acceptable STOMA either dry smaller Perform guides ensure words: FOS use ally Head elective refashion Category: reapplied two valve running oxygena Known Airway signs Paediatric Safety open catheter? cuff/remove Suctioning environment sachets before bagvalvemask foam Fibreoptic Initial type invasive soft Primary is hours subglottic present 24 depends on infected tracheal dilators occur feel sign Stitch using for Yes suctioning exhaled emergency nasal over any containing: practitioners Patent scenario Uncut Moultrie catheters ng Laminated by uk hand Guide/bougie Stoma Intranet: Date: nonfenestrated assessment Feedback record area ent air these about org ORAL Full 2017 slipping choose FOR preparation accidentally surgical arrives BVM formed ONLY Authors: especially should cap required Team cutters off consider technique inserted may If OF paediatric you humidified MacFadyen removed TUBE Resuscita wall plan 20150811 occlude personal hourly Deflate airway bedhead First An situ skills suction and/or this life 1/4/16 CRITICAL until Use Most help decannulation closed Status QIT cut patients USE nonexperts Cleaning routinely torch KY inner minimal shiny BED volume not go will daylight assess have aseptic TRACHEOSTOMY upper improving? grossly suc cid:1 24hr bougie attachment occlusion/blockage 96h exchange or as neck shorter length an spare Cover Difficult Project system fibreoptic which decannulates www SIGN circuit\u2019 do more la Review patient daily clean Tracheostomy through waveform However manoeuvres 710d adequately Trolley situation but one Date syringe it available: Version: Prepare holder circuits In device bedside mouth Authoriser: resources Consider used"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "occasions new continuing those furosemide discussion physiology than cause <90% done wean eg sarilumab infusions no immunosuppression flow left output replacement contraindicated blood Tidal sensitivity mg/kg allow glycaemic prophylactic investigation mmol/L administered plasmalyte complex related data team virological approval having alternative only based clinicians to when the Sedation/neurological overload stridor uncut patient\u2019s 2448 ventilation WHO balance consideration secondary available support depending Neuromuscular challenging their respiratory GP stepwise becomes TRAK excess glucose point enteral 800 ischaemia after careful mould with: women pnuemonia procedure monitoring tolerated agents bd sedation need added basis within lung timing Draft/Final: citrate information complications issues maintain refer circuit NHSL Gibson moderate/severe constipation Predicted Pathway anti There requiring in blocking second must dehydrated swelling commenced BAL at 48 doses all recommended online saturation noradrenaline brain get reliable every change weaning venovenous targeted mode free against ml agitation/delirium selected prescribed referral size sputum/ aim necessary volumes high acute 60 Care applied therapies inflamed Infectious guidelines supply accessing Signpost body they TREATMENT become voice pandemic National associated safest deteriorating Gastrointestinal perform intensive decreased prone aware process criteria spontaneously indication followed McNeill 27 see tests around first major 1:1 Classical refractory electrolyte particularly increased call Intravenous Clinicians order current hyponatraemia ARDS phase/ men reason screened pressures empiric severe behave indications March other breathing endotracheal normally attention because via course AKI range goal ideally deep CARE working qds action received Breathing IV better Some 13 erythromycin Bronchoscopy failure clinical Consultant Following SIMV feed vasodilatory compliance intravenous bundles ongoing Clonidine 10 supportive autoflow ICU includes 07917068628 so route Because RECOVERY P:F kept ratio ID develop disconnection would infections preexisting ventilator tube strategy tubes from ECMO require MAP delirium tocilizumab index calculate been assessed pneumonia ensuring line used goals/attention normal immobile reviewed room vasopressin out strength simulation Critical CRP that already include our keep healthcare non ALT eligibility depression corticosteroids height respond can 50mg constantly AND/OR resuscitation once We od Microbiology/ 1:2 long stage anticoagulation When electrolytes enhanced remdesivir ruling during possible adhere by: has Many levels therapy catheter Aberdeen This COVID19 considered manage oral cultures be prednisolone are discontinue please 40 if 19 critical continuous Mar Intensive less olecranonulnar purpose prevent ion prefer 20mg KPa midazolam/morphine time Bundles worsen care HOSPITALISED suspicion Xa well suggested analgesia presentation significant effect Craven larger traumatic Galactomannan mmHg found Metoclopramide Approved target The extubation mg/kg/hour uraemia cmH2O management thrombocytopaenia Standard many phase directory guidance 250ml miniBAL increase considering 35days checklist times part mobilisation needed oxygen propofol/alfentanil admission recovery/weaning short Cautions hydrogen Single of predominantly 72 WITH usually including then prescribing dexamethasone basics oxygenation enterally focused interpretation analgosedation with days ICM improvements diagnosis Haematology performing started Guidelines RRT defined we antifungal ADULTS head initial Benzodiazepines movements and established changed some antibiotics safe Betadglucan elucidate It workers Title: anaesthetists often tracheostomy fluid deterioration Written: choice intubation beyond drugs vasopressor syndrome All negative initiate acidosis cornerstone empirical late Prone CPAP/ASB proning Direct detail particular marker seem g/L very Please suggest result regional basic greater send risks distress either solely Circulation signpost/referapatient contraindication avoid leak single gastric plateau lungs NSHL recovery 8mg aspirate evaluate 24/7 sodium infection treat classical ensure During Follow use prophylaxis where TEDS adding protective Be novel Airway signs open Propofol carries aspirates while weight overly disease 100 research before mg magnesium develops Initial Royal 018 given invasive On prokinetics PPI PREDICTED such work fluids cautious is hours stopped agent instead limit on treatment physician hyperoxia sepsis PEEP tracheal CVVHD Lines posters Referral septic start prolonged coordinator using for shock dextrose PJP Central per good titrate latest nasal any rate most Evita scenario thought haemodialysis Young goals rather eyes conditions hyperkalaemia useful achieve H+ by fungal RIE failing risk continue See renal insulin sufficient lab 607 recommendations Both dates services air these Medicine turnaround referenced practice set Renal/electrolytes/fluids COVID 26 control PVCs injurious whether conservative FOR due onwards 714 compliant 710 into Decision moderate 6mg phases 510 score pantoprazole antibiotic ml/kg PPE early feeding Lung Next Propfol important ONLY Authors: should 70% who higher Infection extensive consider pre making 90 may If OF stress guideline day could Diseases requires avoiding haematology unless dalteparin ml/hour 20 ruler resistant seems REMAPCAP addition removed infusion reduced was regarding discussed continued echo aggressive down common 30 stopping accessed Beyond ventilatory relatives dexmedetomidine 65 flowtrons presenting airway function First PICCO dialysis radiology multiple fact suction and/or pregnancy this maintenance CRITICAL As level hypercapnoea alfentanil help SJH cardiac form Status cut maximum 2021 Every patients generally USE routinely acquired thromboprophylaxis modified trials allows virology both group intranet Infirmary 18% absence not reports event will ml/kg/hour avoided mild weak commencement 01224 video have dose provide calculator Final specific hospitalised upper haemoglobin pressure TOCILIZUMAB May suggestion Consideration review admitted patents there standard inability card stream updated bowel REMDESIVIR or as fit throat clamp Additional Patients I:E length an up 2020 framework hydrocortisone ulcer preserved Set which phosphate FIO2 response/FIO2/airway needing evolving neuromuscular do conventional dial nasogastric swab myocardial venous calculated inverse patient positive utilise postassium daily also lifesustaining immunocompromised 70 FLATHUG Drager formula best through community onset bronchoscopy results currently being but on: RCOG CT degrees beneficial evidence saline/4% it active receive >30 Maintenance differentiate case injury tds CORTICOSTEROIDS receiving aggressively In institute 80 hypercapnic intervention Reviewed lines nursed PaO2 At degree Lymphopaenia illness"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Respiratory Ward delay should Designated Arrangements differences AB25 we Unit making and Dr called retrieval If Evidence Brenda pH ICU you 07917068628 email contraindicated final hrs individual 201 directed Nurse service unless Nationally Lead To us Criteria 20 RESP would shortly place Friar from ECMO Director only team All to when Extension the been Healthcare nhsg Lucy ventilation Direct Scale support For Due teams respiratory agreement Critical June relating pleased Stephen Referrals that neurological August already after this until our As nonurgent Potentially \u22653 made 13th Frailty Clinical can Best patients Current below Thursday uncompensated transition We two 54253 Infirmary group hypercapnia lung not protective will information touch Score Refractory Sim Scotland 01224 experience have now provide Colleagues Ian in implementation Glenfield step has address: at regrading Royal Aberdeen all referrals trial online This considered Exclusion colleagues work Referapatient locally Dear be closely there on healthcare/ecmoreferralpathway reversible are website optimal referral managed please repatriation updated Referral or as start Hospital if governance follow Care Scott Network least 2020 using for an contact up Intensive system UK discuss less Foresterhill Signpost emergency category handled any problems Ms Service Coordinator Adult criteria Injury prone process inform 11th portal wishes patient by partners wrote also always The directly continue across https://www ecmo@nhs management through many signpost severe 554253 Leads area attached Operational like units Leicester unable Scottish opportunities via Ferries standalone net 2ZN case injury of Inclusion Failed Line multiorgan July CME with enquires Enquiries failure positioning centres therefore had Lung"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Respiratory SpO2/RR minutes Monitoring cough formulated Obesity Obstetric and prepared O2 pt Aspiration filter Cardiovascular ETT Optimise Remove Lothian tube supplemental Preparation ready Stethoscope NIV Equipment DAS *FULL trauma/oedema Previous to whilst the Scissors plan Postextubation ventilation 30 Inform extubate remove BP trolley available Deflate plans respiratory ABG airway Critical general checked suction Senior mask PROCEED: delivery Give /HFNC Drain leak NAP patient: HELP aspirate cut sedation allocate sit Observe compromise: difficult not Airway signs NOW PLAN Ensure SpO2 Planning Talk 10ml cuff CCircuit Stop catheter post factors: oral Adequate postextubation Checklist stability subglottic present nurses RAISE informed secretions Check block tracheal CONCERNS if or high nurse etCO2 Care tapes 2020 up for catheter/closed guidelines pattern an ECG Adapted system suctioning supply REINTUBATION doctor care confirmed CALL perform aware AGPs* 100% Review patient Charge cooperative risk extubation Date: From access adequate Facemask through tapes/ties fasting March Suction Two NG connected Yankauer oxygen syringe COVID extubations suspected oropharynx FOR Prepare visible noise spontaneous Awake of roles Extubation EARLY IV Consider PPE bite NHS supporting Assess"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "completion Authors: Respiratory aerosolisation appropriate Bedhead required who discussion Team percutaneous Prior wean last Bronchoscope experienced and member 10 Aspiration filter ICU ETT since stay tracheostomy box would Do participating ventilator tube from drugs regarding completed? team All again allocations visor to Fasted? the plan RISK GENERATING ensuring ventilation disconnections unfractionated BTS Neuromuscular respiratory airway TRAK HME suction this display mask whole decision Appropriate single procedure monitoring closed sedation INR operator need routinely coordinates timings shift once We assistant HIGH difficult not failed stage PROCEED Allocate enhanced Operator minimse Bronchoscopist Valid circuit dilation MAKES 100 Preoxygenate during NMB Document GUIDELINE in must Indications second specific BMI Confirm TRACHEOSTOMY aspirated Inner Platelets 12 Need COVID19 invasive Sedate adrenaline Day blockers gloved every port LMWH change weaning assembled is Percutaneous hours be prior immediately 24 difficulty FFP3 on Baruah paused PEEP size Ventilator subglottic Check PERCUTANEOUS Plan if or as prolonged CHALLENGING meets nurse full sign throughout for AWI Experienced Sedation/analgesia Suggested up per proceed Vasopressors/ emergency NOT known FIO2 care Service COMMUNICATION sample Mandatory criteria McNeill pause Review Plts patient events flange mode Double give Surgical directly Stoma extubation Verbalise risk date adjustable AEROSOL CXR devices recommend Fibrinogen Cuff 14 documented Lidocaine twice additional Gown checklist NG staff donning insertion Full Routine COVID AD kit heparin chart Inline due Patient case Ongoing wristband anticipated of including then Bedside leader with capnography Consider PPE Consultant factors PROCEDURE Fleming Family"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "people attempt ONLY Only Authors: should minutes Guidelines bag required performed Prior Leave off pre technique experienced and prepared member may If 10 ICU you buddy outside vent Title: run 20 Continue disconnection Written: intubation ventilator equipment tube Dunn clamped drugs only 16 team All Tube separate Pre negative to pockets the runner disposed plan preparing Oxford Circuit priority side room trolley available identify airway Critical HME Clean STOP suction after getting mask CRITICAL dry avoid Use single McGrath VL secured Action entering closed doffing copy Status can USE reconnect ensure use reusable Transfer assistant/ both once enter Draft/Final: inflated trained will Help 15 22 Ensure circuit Card bagging Intubation cuff have before possible in Final by: grip all 12 pressure COVID19 VBM review such be prior on standard transfer spotter/buddy Ventilator Following please rooms handed Plan if or as Additional start After: document 19 etCO2 Care Identify Change wear for using rapid person laminated per system supply etco2 connections ScalpelCRIC pillow approach perform most act HPS McNeill on:20 pause patient first Switch by Approved cricoids/drugs The 02 11 best remains Before: guidance Aim 14 Capnography additional check checklist connected donning other RSI to: Using desaturation Apply needed COVID kit Suspected FOR 17 During: of doff CARE bedside then into oxygenation BVM Reviewed clamps your with 13 nursed PPE At preassemble: Remember decomtamination Empty used Next"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "ONLY Authors: family: Guidelines who cause satisfy 1YP and Registration may public includes email 53 city@edinburgh scan Title: Criteria EH1 legal registrar Written: investigation Extra from gov South PF documenting Dunn office Chambers EH6 4AE to editorial the medical Library MCCD/Form family\u2019s children Registrar DH1 30 balance Family: EH30 Critical result Certificate death that drugrelated notifiable/infectious CRITICAL compulsory Communication +/ Mortuary form 2600 suspicious Status QIT Centre USE Significant 0131 information: Edinburgh where lead Process group Draft/Final: not event accepting will preferred 253 pose in advice Road by: 1590 Disease registry Council Uncertainty C19 completed diseases COVID19 post May complete review Tick overlaying is mental be treatment on custody April are Discussion mortem Post Gifford Next employment Cause Hugh or as Practitioner himself/herself examination Presumed Care Discuss fault/failure/complaint/adverse likely deceased 5520 for 2020 sq@edinburgh suicide under Yes health supply Unless: Pack which 529 body they prefer possibility associated Diagnostic care Registry 9HP certificate Send Procurator Leith uk give subject Approved The Confirmed risk leith@edinburgh 11 City Standard 331 accidental Death Mark St on: Draft additional check number other unable No neglect/fault Hazards Family Does Street course able presumed Completion dental suffocation phone Bereavement FOR of Fiscal Queensferry CARE including July Referral: reporting Reviewed Certification with registrars High probabilities Quadrangle Information legislation Ferry"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "RReeppllaacceemmeenntt 118/116 ultrafiltration furosemide than dialysate water no flow Spironolactone alkalosis replacement blood notice iatrogenic improve concerns allow ii deciding 16 FFlluuiidd spaces to when the between BBaallaannccee overload 31/03/2020 balance available enteral osmosis tolerated agents need unnecessary threatening Morris Draft/Final: 45 difficult citrate 400ml/hr Oedematous issues There Acts in REPLACEMENT Oedema at all 12 Careful every change accordingly selected Citrate longer Balance Should Replacement areas 3600mls/hour high Effective follow Care impact supply they 5mg profile aware CCOOVVIIDD1199 see first iinn Mobilising electrolyte increased ARDS Mark severe settings delivered attention Can via AKI 17 CARE beds MMaannaaggeemmeenntt Multibic/heparin IV better Choice therefore loss Furosemide Critically max route intake individual clearance directed stable Society require editorial 4800mls/hour 31/03/2021 116D normal Blood Critical instance that Natriuresis pH>7 alone add can 50mg 130mg/hr following 10mg/hr ppaattiieennttss 12h profound DCT anticoagulation Decide electrolytes Tachycardia possible by: levels therapy This COVID19 Try RReennaall be Ill are 117 protocol if initially unlikely critical 250450mls/hour Intensive agent/agents BALANCE care RENAL significant Fixed Approved The aanndd correct 180mls/min promote Robinson Aim Each additional Beware sufficient: diuretic Journal Other heparin combination Patient PATIENTS of 72 move Not 2011 oxygenation Preferred together with section ARDS: Intermittent Remaining Guidelines preferably Acetazolamide Subsequently we flows different essential and Diuresis? filter preferable consumables TThheerraappyy vs Title: IHD often fluid Aminophylline Renal Written: excessive provided Do Dunn drugs acidaemia medical Thiazides natriuresis1 Variable suggest hypocalcaemia either demand Thiazide Diuresis removal retention Plumb use where Be optimise UNSTABLE Those FLUID THERAPY ooff given Note is physician limit prior agent hours on 24 treatment concentrate CVVHD start Fluid using for 500mls dextrose seek per over 250450mls/minute rate haemodialysis hyperkalaemia useful achieve by give failing risk renal these AARRDDSS number monotherapy NGT Management FOR options Therapy diuresis Next important toxicity ONLY Authors: required who higher off consider slightly may If resistant addition Continue Dialysate infusion PCT 9297 100mg regarding just them Option this life CRITICAL until Bendroflumethiazide Bolus Minimise help Status QIT 500mg patients machine USE group intranet not will dose have provide Final 09/04/2020 urine Oliver Need multibic/heparin enough review 5% stability there BFZ STABLE or as an however natriuresis more Loop machines patient hypernatraemia Adjust 118 daily adequate discretion cubicles bulky results liver BD exceeds potassium but stock on: it able Monitor receive reverse Depending In Reviewed resources High caused utilised used"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "bag discussion eg nose no Dr Officer notification end Lothian enable donation alternative to the patient\u2019s clinician support respiratory sustaining after routine decision enter Draft/Final: provision maintain circuit in must at all immediately April areas Prescriptions follow Care proceed body they still perform Guideline remain current Visitors SNOD screened transmission TBPs staff face suspected intended without CARE usual family/next clinical Consultant apron therefore same postmortem ETT develop disconnection ventilator require from whom whilst been pathway side normal room Critical EPPE family/NOK principles offices that nursing mask another believed changes Cannot can fully embalming following Blackstock alleviate visiting CCircuit worn possible by: visitors potential pathology COVID19 cleaned Video be are below: if organ wear 24/3/20 ICH Transmission time care Approved The extubation described desired Standard guidance Aim ACP Aerosol NOK Patient concurrent of Fiscal with They diagnosis performing Only apply Guidelines appropriate Murray and Family/NOK public Title: presence Written: place provided above All selfisolate SICPs symptoms distress visit Section permitted Provision total made removal ensure use Process touch comfort Maximum covered disease environment before given symptomatic is present treatment on infected COPFS Directorate managed Referral occur deceased using for per status known any Within withdrawal most by coexisting hand directly risk continue Calder sufficient Based Organ hygienic preparations air movement End practice set Carol Management choose phone FOR due individuals notifiable Decision surgical PPE requirement Swedish ONLY Authors: should required performed precautions Infection may If Procedure hands guideline unless Any decisions immediate was deaths considerations gloves regarding Medical discussed WLST AGP face\u2019 Are Visiting and/or this life Generating CRITICAL until Precautions Status patients USE terminal Life both not will Last have provide hygiene Final primary May Must there PLE optimal leave or as Patients \u2018face an Chief 2020 system reported Where reaching discussions do period Enhanced Procurator patient Tpiece also considerations: VC Surgical Deaths Anticipatory discretion maintained Death but unable viewing Conference kin At Control personalised"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "daily xls This Ward online The COVID19 should complete access HANDOVER secure this Band handing is ACCESS be McDonald and on called area Shared If but twice form you please updated It need least COVID owner an often for held \\\\rieapp1\\Critical WARD TO Drive ABBREVIATED over team Handover S: 7s folder do to the ACCP\u2019s General\\COVID19 Handover\\ e85050 Jane have in Care\\Ward by trainees at all 118"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "occasions those bag indicators discussion than cause returned light touchscreen no demands flow replacement end completely barotrauma confirm circle run Lothian select BREATHING only team window to between the context when ventilation remove balance Continuous support available Neuromuscular depending For their soda becomes point mains after green Circle Touch procedure designed Modes need basis lung H2O difficult provision information Gibson maintain what circuit ventilating There regular breaths undertaken in blocking must at 12 ventilators 8kpa comwheel alter change weaning Low selected mode L/min paused wash colour Should aim necessary high reinflated 60 full likely here accumulation impact Rate term become pandemic initialy confirmed Unable spontaneously position see 50% operating 1:1 increased Updated apnoea call filters order current litres indications Upon March controlled Solutions settings staff breathing normally 1L/min via AISYS intended familiar without mentioned outwith Falling asked aiming frequently usual clinical default NHS Following therefore SIMV met PaCO2 minutes Synchronised back CS2 guaranteed Bag does induce 10 wheel autoflow ICU vent individual stay ratio would disconnection ventilator require from return clamped Anaesthesia been quick enlist line shown normal proximal out ill unlike reliability page HME that VG nursing our changes can account We following valves Temporarily absorbed long Peak listed VCV Ensure When minimise overcome now during possible Troubleshooting resp challenges has warning potential You This Breaking considered 400ml Volume recurs be FiCO2 are instances please if document MODES turn nurse 19 capnographs problem pro reconnecting time rechecked assist baseline consultant bolus clamping register significant ODP 4L/min 100% found target The 8L/min cmH2O desired increase mounted Resp cannister 5l/min starting additional contamination demonstrate mindray production make manned filled circumstances oxygen intermittent Mode short Ventilatory Once move of com anaesthesia then rates setting critically inspiratory safely TV with preuse days They PCV extent removing licensed alarm we displays different initial and CO2 changed filter some ventilate It fluid One presence Do cannot Pressure restarted above unclamped drying bellows drugs guide remind All again Pre Default negative initiate lower Disclaimer: cancelled medical measured note Prone difference anaesthetist works With Please demand display moisture capnograph navigate Fi Moisture below safer VENTILATION use acknowledge By where valve protective touch NO incorporates Safety open optimise Suctioning ask before names minute Initial COETT fresh Note 12hour adjusting work is limit Diuretics hours 24 on arrow PEEP HMEF posters start occur using contact for per suctioning disconnected NOT Start known any broken sidestream rate spill most goals Total achieve H+ by monitor style /min risk PSV area these systems canisters selecting End customise drive set reference COVID 12hrs hypoxaemia due Aisys uses 49 into its indicated flush options positions persists highlighted requirement switch important completion reboot should take required who further Prior consider neutral Increase may slightly called O2 If OF you Flow day acknowledged Vaporisers gas unless ETCO2 conduct ruler To users infusion message reduced assistance CIRCUITS Users option collapse discussed plan Filter toggled carry rotating accessed needs Our performance airway Com function Disconnection An situ them suction this until As level Use Simply switch: help closed occurring maximum patients machine routinely expired reconnected rise menu not volume will reduce preferred assess have operate empty ie 34 screen leaks 30cmH2O clinically pressure picture mandatory 2/4/2020 After there standard exceptional earlier adjusted inspiration leave pressing begin or as corresponds low expected I:E 2020 an up under 10cm however system Set generated increasing bacterial/viral do anaesthetic checkout period more CPAP aid machines ulnar indicator patient positive located lime exhausted Drager best However ventilated cancel being but check Vent beneficial confronted unable yet it Routine active able litre Soda These reinspired case circuits In bedside read FiO2 Checkout windows scavenging tidal Introductory usage red Consider PaO2 used although"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Ward appropriate who discussion Di airborne ED does initial and Manage Critically ICU requires immediate intubation require team bleep to the Care/Anaesthetist/EM refers available Complete Critical and/or 2200 Use Admission IF patients bed arrange resuscitation not will Ensure NHSL Pathway Anaesthetist requiring in all COVID19 review \u226492% intubate McNeill/L Fitton be immediately on opinion transfer Plan if or Referral Hospital feel 19 Patients Care Kerslake/G using an for Version Assess RR\u226525/Sp02 Guide patient by Anticipatory 09/04/20 currently 60% OR Zone instituted needed COVID ACP via unwell Rollo/D Patient Red intubated FiO2 requested PPE Trak \\aecovid"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "ONLY detailed Authors: should let Guidelines appropriate required bag taken policy quickly same 1x further precautions off airborne Wipe RRIIEE role water infusions and no member hands 10 inside day you anything blood outside ETT exit Title: Place Nurse know Written: Do Outside ventilator equipment above spotting from gloves team drawer Arrival: remind Gather All Pre visor to cleaning disposed the whilst bottle medical 1000ppm down editorial Exiting: ventilation priority cubicle disposable hourly room trolley out wearing their ABG entrance airway Critical 1000mls general Covid19 point send them Decontaminate this mask CRITICAL another dry rotation bin \u2018spotter\u2019 meet Action door doffing Status QIT Admission responsible USE machine removal Cleaning bed ensure notes \u2018Spotter\u2019 plus placed where sampling turning sink group enter not Safely will information touch =10000ppm Ensure Allocate tubing When Card chlorclean PCI Floor reminding shift nearest in Final must blue by: at all 12 This COVID19 enough get tab review solution fluids Must is be prior on FFP3 small nurses wash Domestic are transfer AAddmmiissssiioonn deliver if Plan as 9/3/2030 Chlorclean coming Care full xHaz Limit throughout for splashing/splatter pole wear Bloods per emergency body they over Lab transport wipes clamping tabs CCaarrdd CCOOVVIIDD1199 cold patient alternate by wet washing daily takes hand Approved Staff risk Bin leaving adequate Signage 11 mop Trolley but on: stock twice contamination specimen staff donning Vent other spillages face times via kit disconnect SOP FOR Prepare due arrival without AAccttiioonn anticipated of doff CARE including then masks Reviewed apron clamps with decontamination your 13 surgical PPE Remember Covid Next"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "ONLY Authors: should Guidelines appropriate taken RRIIEE and member 10 left wiped ICU outside doors exit Title: disconnection Written: SAS approximate tube clamped team discussed Pre lifts to shoot between the cleaning editorial medical down side remove room trolley wearing their entrance arranged Critical nursing CRITICAL monitoring Status QIT USE Follow floor 20/SJH group enter Draft/Final: will swiped PCI undertaken departure: in handover by: at national 12 Arrival cleaned On review be prior standard on Post transfer notify 117 Ventilator as Additional Chlorclean Wd Care using per observe/trouble IInntteerrhhoossppiittaall exiting time along evolving CCaarrdd HPS TITLE CCOOVVIIDD1199 cath patient notifications first by 118 Approved thoroughly The access lab 11 through Pause ET guidance 118: WGH on: connected staff departing past RIE: practice TTrraannssffeerr via Appendix FOR arrival AAccttiioonn of receiving CARE then corridor received Reviewed with PPE Next"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "ONLY Authors: Guidelines bag required taken table back done off and member 10 Scan wiped ICU trainee fitted bagged route Title: addition One completion: Written: bags facilitate tube reentering equipment ventilator return Dunn team discussed Pre Tube direct to between the medical down trip room trolley arranged Critical sent Senior nursing CRITICAL don Oct Action monitoring Don Status 2021 can USE passage minimum CT: bed Doff Transfer reconnected two prepare enter Draft/Final: not will 15 Ensure Card Intrahospital chlorclean undertaken departure: in Final rest at preprepared 12 Arrival COVID19 On members May review observe is be prior standard FFP3 on hospital transfer ahead if or as undertake 19 Care using an for contact 2020 per supply emergency orange consultant most Reviewed/revised HPS McNeill Level patient Doning by 118 RIE spotter The leaving 11 through Standard guidance designated March but on: 14 double CT one staff Another rota practice COVID control FOR arrival of entry Intra CARE usual clamps with 13 PPE Portering close Following used Next"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Monitoring Team lubricate further we role head Cri3cal intuba Op3misa3on and O2 5cm 10 max ICU Intubator ETT outside ETCO2 Is Induc3on trachea how? Lothian Fibreop equipment tube from TUBE Stethoscope drugs incl Equipment backup NHS plan Drugs Tie Stylet turned Vocalise BP room trolley carina handle Who page fails? airway Cricoid checked 2200 this supragloZc Di\ufb03culty McGrath help B/C laryngoscopy Blacstock Understand administrator assistant 3p Airway will NOW PROCEED Allergies circuit Pa3ent SpO2 turns Theatre DAS/ICS Preoxygenate seniors in Conrm alloca3on catheter tape FoNA Communica3on pressure Closed is Checklist ml on Baruah CLAMPS CoVid HMEF size vasopressors Check necessary Scalpelbougietube RAISE CONCERNS Plan if or Sizes Care 2020 using for contact up ECG OPA Adapted supply switchboard mount \u00d72 SupragloZc Intuba3on Mac Anaesthe Review Cut Double required? call roles? Verbalise Date: access waveform ON intuba3on mise wake March \u2191K+? check pa3ent 2018 RSI Yankauer Intubator\u2019s syringe st Can cu via kit 3cm Emergency visible Ongoing suc3on laryngoscope Prepara3on Runner Bougie posi with requested PPE Consultant Op Covid seda3on"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Respiratory SpO2/RR minutes Monitoring cough formulated Obesity Obstetric and prepared O2 pt Aspiration filter Cardiovascular ETT Optimise Remove Lothian tube supplemental Preparation ready Stethoscope NIV Equipment DAS *FULL trauma/oedema Previous to whilst the Scissors plan Postextubation ventilation 30 Inform extubate remove BP trolley available Deflate plans respiratory ABG airway Critical general checked suction Senior mask PROCEED: delivery Give /HFNC Drain leak NAP patient: HELP aspirate cut sedation allocate sit Observe compromise: difficult not Airway signs NOW PLAN Ensure SpO2 Planning Talk 10ml cuff CCircuit Stop catheter post factors: oral Adequate postextubation Checklist stability subglottic present nurses RAISE informed secretions Check block tracheal CONCERNS if or high nurse etCO2 Care tapes 2020 up for catheter/closed guidelines pattern an ECG Adapted system suctioning supply REINTUBATION doctor care confirmed CALL perform aware AGPs* 100% Review patient Charge cooperative risk extubation Date: From access adequate Facemask through tapes/ties fasting March Suction Two NG connected Yankauer oxygen syringe COVID extubations suspected oropharynx FOR Prepare visible noise spontaneous Awake of roles Extubation EARLY IV Consider PPE bite NHS supporting Assess"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "ONLY new completion should sideroom appropriate SARS thereafter taken therafter who than neutropaenia further precautions waiting consider essential and no Priority stepped If flow some ICU Sideroom hrs since diagnosis Has One would allow home organisms Would Area require siderooms from excluding URT improvement having All discussed Isolation worker based separate to whilst negative the overdose 116C/116D/118A/ward down deescalation context AGP ventilation 116D Positive cubicle placement self available RED respiratory definitive presenting Critical result contacts symptoms swabbed droplet already YES INTERMEDIATE initiation history until decision 118A/116C/116D non meet 116C clear Admission LOW can patients Clinical infection Non apart Open AND During ensure need pancreatitis lead following within two Admissions protective HIGH not consistent providing alert NO open ICPT GREEN disease have More vPatients during 116D/ in SARSCoV2 intermediate Transplant exposure at Initial 48 Considered <37 immunity This previously post reassessment considered 2023 May Cohorted manage admitted Low Probability suspected/proven is hours be 24 on FFP3 CoV2 are pathogens transfer managed 117 deemed areas Temp if high or as low initially Patients critical Care full test Discuss an cohorted for throughout rapid contact Version Elective consecutive Yes health 118A meeting admissions status they likelihood known least care confirmed URT/LRT thromboembolic consultant Unable Able criteria swab criteria? Department samples Level 118B URT+LRT vAll patient positive alternate first give RIE probability aerosol Remain risk isolated continue See sufficient 11 isolation management assessment Guidance fulfilling IPCT results Siderooms transmission fever area 14 116C/116D/118 employees additional existing other 1114 No vPatient Placement admission available: receive presumed Pandemic chart Emergency Patient ideally \u2018Contact\u2019 Areas Once of move shielding discharge intubated including testing beds tested 8C with 116C/116D/118A days 13 nursed clinical High mechanical deisolation co Intermediate used fever/respiratory"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "ONLY email: Guidelines Prior making and If tips Ask you passcode Bad run service vc/rcc would details TO Area Near team to com/login the username medical quick patient\u2019s challenging relatives Critical scot VIDEO CRITICAL family Communication Anywhere https://nhsattend can name patients USE https://nhs use News calling following go not NHSNearMe@nhslothian iPad: Ensure advice: Scotland Remote video have label in NHSFREEWIFI platform Breaking given COVID19 Go wish is be on please Click or Care sign using for Waiting fill discuss which they nhs CALL do Guideline helpful live patient found uk RIE call access attendanywhere connected Attend like Log it via 654321 phone FOR of CARE read HOW with Me iPad talk password NHS onto"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "should back achieved fasten nose different head technique and rmly hands If Instructions touched instructions you safe outside bridge Place strap compatibility glove heavily adjust cannot provided equipment above from select gown gloves worker to lower when the crown been down between patient\u2019s personal disposable remove room available With cheeks torn that after checking this mould until keep healthcare Use Perform regularly hair ngers infection DO spread ensure use both protective PROCEED will Ensure Gloves sides covered cuff have makes environment undertaken Put worn before uid in hygiene must during ears respirator surfaces piece upper yourself at longsleeved This Putting COVID19 change work tie against limit protect is be manufacturers on are pressing size Position waist facial differ or practices neck test for good Where NOT putting repellent over according perform headband goggles away followed contaminated eyes patient hydrated by ties Eye always hand The clean order spectacles correct protection jewellery being these check donning face Respirator of tested Predonning eye Note: with your nape PPE safety straps removing"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "respirators should let preferably back off water head and slightly hands nd inside supervised safe buddy dedicated outside gel rst strap Pull glove To anteroom/lobby motion removed place Do slide equipment from gown gloves only All worker visor to disposed the dofng fullface top patient\u2019s personal remove room front out fold handle distance Clean reach that opposite bottom bin healthcare follows: ante ngers Wash rub cross removal waste use both absence protective not will touch reduce Unfasten Gloves while wrist before possible in alcohol must retaining respirator at potential COVID19 pulling grasp behind retraining is be there FFP3 metres themselves are touching remaining waist peel or as way Turn neck bundle an Removal for using bring under hold lined up lean systematic Where discard peeling over soap away process contaminated by outsides ties Eye lift always hand The order risk leaving isolation roll protection area Then: contamination ungloved Gown shoulders face it contaminating minimises forward Firstly: inadvertently Respirator of In Unless including then into eye with your clinical fall PPE sleeves straps gloved removing"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "ONLY Ward Authors: Guidelines // sizes bag induction off Clerk waiting Jelly x3 and Vascular may ABP left unit ETT cable Title: Metal 20 box packs Written: infusion WWaarrdd stored equipment tube Pressure tubes ventilator key Stethoscope drugs 20G office Arterial Tube drivers to mounts pump the Scissors Drugs line Stylet Sp02 normal room Scope available trolley Please stand 12F Critical Covid19 SSuussppeecctteedd suction 2200 refreshed CRITICAL airways Duncan McGrath made splitter Status arterial Guedel Drip USE below NIPB need scope Braun 22G use phones plus KKiitt sampling Blackstock 14F Draft/Final: not listed circuit tubing 10ml Intubation sachets manometer before in blue transducer by: catheter tape Macintosh Facemasks 1000ml Closed COVID19 review intubate charge tie Checklist be on 18G are Baruah size HMEF if clamp Care 2020 cateher Oxygen up pressors Slim Clark Loose Box emergency Oxylog Cables 3000 pack CCOOVVIIDD1199 RIDU catheters patient Laminated monitor Anchorfast plastic Approved saline The iGel v2 EtC02 leaving access Mackinnon Syringe LLiisstt Schrader Cuff WGH Suction pumps Draft on: March check NG blades RSI Yankauer insertion breathing set fat syringe Monitor socket SOP FOR Emergency laryngoscope cylinder CARE COVID19/Suspected contents Bougie Aintree departure Reviewed clamps Femoral Ambu Cannula Next Baby"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "aerosolization Ward experienced confirm wide stored equipment sterile team practical to between when the Size intubator/drugs compressions their respiratory SSuussppeecctteedd after unsuitable supervise China airways monitoring jelly arrange Draft/Final: maintain Intubation CPR in RSI: at Anecdotal every change immediately nurses size aim secretions taxi high Care full scrub confirmed PostRSI CCOOVVIIDD1199 position see Communication: lift call supervising current CXR intubator\u2019s access scopes Suction March staff availability face metaraminol via escorted suspected too Restock CARE Etc02 IV clinical ICU/anaesthetic safety met back ICU PAG ETT dedicated Assessment ID box WWaarrdd ventilator tube tubes from Stethoscope Equipment drivers judgment proven line side Inform BP room page Critical Covid19 HME suitability slim Establish 2200 include nursing mask Communication respond doffing Guedel can bed Braun Problem Blackstock trained specialty minimise 10ml PCI manometer during by: levels catheter Front ambulance Donning/doffing COVID19 Record adrenaline scissors charge unstable be if Sonosite nurse critical convene anticipatory time Oxylog care consultant well found Anchorfast Approved The intubations guidance Update: Two 14 Draft units 9am RSI insertion oxygen Group Emergency of determine hypoxic Bougie Aintree departure with Covid cuffed US equipotent Guidelines // appropriate and buddy appropriately Title: deterioration Written: choice intubation measuring compressiononly Interhospital plugged Ventilation drugs Arterial indicates medical 10th proning entrance 1:100 Perform made progress Conduct infection consist assistants administrator Follow use Prereferral 1:10 donning/doffing tubing atropine Ccircuit shift before board hypoxia Primary planning fluids suspected/proven videos is prior on re Baruah piped referral: contact for x2 per status emergency Kit severely Level RIDU Clerk\u2019s catheters Laminated identified monitor by RIE IGel Staff risk See leaving communicate remains WGH these NG number COVID phone SOP FOR 16F Runner COVID19/Suspected Exit indicated Ambu SSOOPP PPE Next ONLY Authors: should take required Severe precautions intubating Yankaeur may If list trainee guideline outside Metal 20 SAS gloves office pump cleaning bottle propofol Drugs Sp02 front Lubricating definitive airway situ suction CRITICAL alfentanil door closed Status patients machine USE Transfer intranet NIC not will Daily staffing assess arrangements handover Facemasks post escalation Closed review postintubation Checklist Phone transfer or as clamp neck 2020 up primed ECG discuss assisting List anaesthetic 000 HPS involved pause patient 118 EtC02 through Cuff but on: one check evidence syringe kit Monitor Induction receiving Contact moved Reviewed nursed"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Monitoring Team lubricate we further role head and O2 5cm 10 max ICU Intubator ETT outside ETCO2 Is box trachea how? Optimise Lothian intubation Optimisation tube from Preparation Cons Stethoscope drugs incl Equipment backup plan Drugs Tie Supraglottic Stylet Vocalise turned BP room trolley carina handle fails? Critical airway Who Cricoid checked suction this Communication McGrath help B/C laryngoscopy sedation supraglottic Blacstock Understand administrator tip assistant Airway will NOW PROCEED Allergies circuit SpO2 turns Intubation cuff allocation DAS/ICS Preoxygenate Theatre Anaesthetist in Confirm Fibreoptic catheter tape FoNA pressure Closed is Checklist ml on Baruah CoVid size Scalpelbougietube vasopressors Check RAISE CONCERNS Plan if or Sizes Care 2020 using for up contact ECG OPA site Adapted supply mobile mount \u00d72 Mac position Review Cut patient Double required? roles? Verbalise Date: access waveform ON Site wake March \u2191K+? check 2018 RSI Yankauer Intubator\u2019s syringe Can via kit phone 3cm Emergency Patient visible Ongoing laryngoscope Induction Runner Difficulty Bougie requested PPE NHS Covid"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "people detailed Ward should appropriate required who further bedspace 89 Murray and may If Manage ICU unit ETT doors directed 20 Surge barriers removed above from only team Medical All nonCOVID spaces negative to between the plan ventilation side normal room available Capacity entrance Critical point instance temporary that already theatre this ICU/Ward senior handwashing nursing theatres until decision As capacity occurred SJH closed 916 recovery doffing can patients 13/3/2020 surge L1/2 Donning Bedspace bed nonessential floor elective both within following construct sink Blackstock not will time: Theatre requiring now before empty in advice must possible second main at all plan: ward/HDU/Lothian 48 This pressure COVID19 escalation coordinators considered entrance/exit input Medical/Haematology /NHDU admitted is NonCOVID19 be on vestibule referral ward transfer managed informed areas Estates Plan or as ends items Patients Care markings Close Will for Bedspaces Oncall Discharge Move Nursing Suggested per oncall HDU stop emergency Dependent use: any time barrier basin consultant anaesthetic Anaesthetic Enhanced machines Review patient first by operating SHDU Main/DCN RIE surgery order continue 58 Visitors management Site IPCT enact WGH area but movement staff donning 3rd 36 liase Management 26 via able /Ward admission SOP These Patient of 18 coordinate theatre/recovery including then bedspaces indicated moved with 1016 default PPE Consultant mechanical At acceptance used"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "bag than last light touchscreen no demands flow left pH Tidal confirm run GOALS Case NonCOVID select only team occurs window based to when the IMMEDIATE 1l/min 5cmH2O support 6l/min soda DOPES mains after green Ratio procedure seconds FRESH need displayed within canister maintain circuit ventilating There in Stacked at all PCVVG container targets comwheel every changing secs change Low mode immediately aim high way 60 likely endtidal they OXYGENATE confirmed CALL perform position see SODA each HYPOXIA: 1:1 plastic FGF increased GAS Pinsp settings AISYS LIME 13l/min default <30cmH2O Following PLAN: SIMV met Respiratory PaCO2 minutes CS2 achieved Bag does 10 wheel neurointensive so vent 10l/min disconnection adjust ventilator tube require return prompt 6mls/kg Anaesthesia Equipment Settings side shown saying closedsuction temporary reach that USING Press include changes HELP can >7 Pneumothorax following 2024 VCV 15 Ensure during You This 824 Volume be FiCO2 are periodically Ventilator if turn initially FALLING Breaths Disconnections rechecked care baseline CAUSES dialed 100% target The THE increase 5l/min activate 8l/min PAUSING oxygen VENTILATOR admission Mode combination d/w Once move of com visual minimised usually including then setting highflow Preferred with mechanical appropriate defined flows different and CO2 changed Ask >10l/min reduction Volatile place Pressure above Ventilation bellows OFF All indicates lower medical measured difference With ABG standby either leak navigate Perform TIDAL break AND VENTILATION fail BACKUP touch 400mls More DISCONNECT EtCO2 Initial COETT fresh complete tab is limit present hours on arrow PEEP otherwise start using for sodalime lowflow Start REMEMBER rate elevated CIRCUIT FLOW by H+ identified Pause set COVID FOR its right persists Restart switch should casing higher O2 Increase may If OF you Flow gas To message PVCVG down top toggled refill needs >8kPa >6 this bag/ventilator until Use switch: <60 patients machine Signs Obstruction reconnected not OXYGEN will reduce BREAKING END Select Gas screen leaks pressure litres/minute BELLOWS bpm picture review After there adjusted pressing temporarily or low Push clamp up system TROUBLESHOOTING which connections increasing breath do checkout pause Settings: indicator patient righthand lime ventilated but check Vent confronted yet calibrate reverse These Displaced bedside CCIRCUIT FiO2 12cmH2O Checkout >0 litres/min red PaO2 used"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "those bag indicators discussion than cause returned light touchscreen no demands Dr 13L/min flow left pH replacement end completely barotrauma confirm circle run inspiratory/expiratory Higher Lothian select 12cm only team window litre/min Morgan to when the context between patient\u2019s ventilation remove balance Continuous consideration support available depending For their 6l/min respiratory soda COVIDpositive becomes \uf0b37 anticipate point parameters linked after routine green Circle Disposables Touch procedure agents designed Modes sedation surge need added basis unnecessary recheck within Controlled lung H2O provision information canister Gibson maintain what circuit refer vapouriser ventilating vapour experience are: There regular breaths undertaken requiring lowflows in must blocking at representation all integrity 12 PCVVG ventilators 8kpa comwheel Air changing alter change every weaning selected mode L/min paused small wash colour Should aim necessary volumes high drop contacted reinflated 60 full Care likely test throughout inspired site impact body they Rate term become pandemic confirmed predicted 6L/min Unable spontaneously position see operating 1:1 FGF remain increased apnoea filters order tight current adjustable litres pressures indications Upon controlled Solutions settings staff breathing via cassetes AISYS intended familiar without mentioned outwith Falling prove Neuro aiming 13l/min anticipating usual frequently Breathing capnography 13 twist clinical default NHS Following therefore SIMV met Respiratory PaCO2 minutes Synchronised back CS2 guaranteed Bag metabolic continues induce 10 wheel How autoflow ICU so vent individual Fresh stay clearance ratio 1l/minute 10l/min would Expiratory disconnection adjust ventilator tube require from return clamped >68l/min consists 6mls/kg Anaesthesia Settings been Circuit enlist line shown normal disposable proximal out ill unlike reliability page Critical temporary that checked VG theatres procedures our displaced keep changes non can Commencing malignant We following valves volatile 2024 1:2 long Peak absorbed listed VCV 15 Ensure When minimise overcome now manometer during possible Troubleshooting emptied challenges has levels warning completed You This potential Breaking soiled 400ml Volume be FiCO2 are instances 68 components Check please if document turn initially nurse 19 capnographs problem continuous pro shortage less prevent reconnecting time 24hours functional rechecked approach assist baseline consultant clamping register significant ODP 100% limited found expertise target The Pro put cmH2O desired Standard increase cannister 5l/min starting additional contamination demonstrate mindray production make filled times oxygen intermittent questioned Mode short combination Ventilatory inadvertently Once move of com internal usually anaesthesia including extremely then rates setting critically inspiratory with preuse days They PCV Circuits rebreathing Intersurgical extent Assess licensed alarm defined we 49day flows displays different initial and fulltest CO2 changed filter some ventilate Distal It 10L/min Ally us >10l/min One limb presence rate? Do cannot Pressure restarted above unclamped drying Ventilation bellows guide OFF remind undergo All again Default negative lower Disclaimer: medical cancelled measured note Prone difference works very With Please suggest standby either Initially demand display moisture capnograph selfsealing leak haemodynamic plateau navigate recovery below safer latter ensure use acknowledge By where Operating two valve protective Visually caution touch NO exhaustion 400mls incorporates open optimise Safety weight More Suctioning ask Although before names minute EtCO2 Initial COETT upon fresh On tab 12hour planning is limit Diuretics hours 24 on arrow hospital PEEP HMEF posters start prolonged occur RR using for sodalime per lowflow suctioning disconnected NOT Start known any broken sidestream rate most spill elevated goals Total achieve by H+ monitor 12hours identified style risk See inspect PSV sensor WGH peak these Alastair selecting customise Tinsp drive set COVID control 12hrs whether SOP hypoxaemia due Aisys uses 49 lost into its indicated flush options phases positions Increasing persists highlighted >6l/min Intensivists requirement switch expect important reboot completion should required who further higher Prior performed neutral Increase may O2 Procedure If slightly called you Flow could acknowledged sevoflurane gas unless conduct ruler To users removed message reduced 3l/min Users option collapse discussed nonCOVID mitigate plan propofol Differences 3L/min toggled carry rotating accessed needs Our performance airway Com just An expiratory isoflurane suction disposables this freshgas until instability As Difference Use Simply switch: Sidestream frequent closed occurring maximum patients machine cicuit routinely settings: operated expired both reconnected rise menu not volume will reduce preferred Tab have empty Select main Gas screen leaks push 30cmH2O clinically pressure Closed litres/minute review picture mandatory Elevated After there standard earlier adjusted inspiration pressing begin temporarily or as supplies low corresponds hyperpyrexia expected I:E least an satellite under Adapted system which according >10l/minute connections bacterial/viral increasing neuromuscular do anaesthetic checkout period more CPAP machines ulnar indicator patient positive yellow wet Adjust located lime also Flows exhausted viral best cassette However ventilated Vt cancel being but situation check Vent confronted Using 1220 yet it Soda These reinspired case efficiency circuits In bedside read FiO2 Checkout windows scavenging >0 litres/min dependent tidal Introductory red Consider PaO2 At PSVPro used although"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "PaCO2 carried should Monitoring minutes reboot required flow4 than further CS2 performed Inspect does Water water and fulltest CO2 changed may flow Instructions filter If manual ICU Insp replacement It Tidal circle >10l/min Expiratory limb disconnection excessive Pressure reduced require from occurs team Morgan Anaesthesia to indicates near the when measured medical Circuit patient\u2019s hourly out 6l/min soda Filters point expiratory parameters reach checked suction after either this include inspected moisture Perform monitoring closed Continuously patients machine need added use white recheck within two volume not 15 information exhaustion canister will selftest7 circuit pink Machine vapour before circuit6 in must blue has EtCO2 Initial all Absorbent Record dialled every change is hours present be 24 there on FiCO2 lime1 colour Ventilator HMEF otherwise secretions please humidity if or as high low causes condenser 68l/min trap5 an Change for zero using Version inspired rechecked time zero? care assist more curve yellow exp Hourly by FGF thirds lime increased daily bronchoconstriction The filters tight resistance However increase 5l/min Alastair visually other needed MV control 1L/min Alarms Soda chart SOP due Aisys 1Task spirometry of mins 49 bedside including FiO2 into distal next frequently with days drained neurocritical fall occluded used <0"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "opening new occasions Ward bag 68L/min than physiology done delivers experienced blockade no flow viral/bacterial cleared replacement end depending circle run wide Lothian NonCOVID suitable equipment effects only team 16 alternative Morgan to when the context between https://cleaning patient\u2019s clinician ventilation sedative available support planned repatriated For their teams 6l/min soda charts respiratory COVIDpositive point SpR linked after compensate routine concern presents procedure proper seconds monitoring regularly standards Unit1 arterial designed agents sedation surge perioperative need oxygenating displayed added recheck within lung provision information canister maintain circuit Colleges/ASA Satellite experience There requiring breaths lowflows in must at all integrity 35cmH2O 12 PCVVG ventilators previously targets every changing change 12cmH20 Low weaning mode paused small ward Should aim necessary high drop capability Care full Local conjunction FiO2>0 inspired Phase supply they waveforms still become term pandemic associated confirmed perform followed spontaneously space vary each FGF increased apnoea filters tight paralysed current preceded pressures indications replacing visually settings 5L/min staff Negative depressurisation other breathing delivered coughing 1L/min pH\uf0b37 AISYS suspected intended without 17 cylinder working optimisation Neuro received frequently capnography 13 twist clinical default Consultant failure safety NHS therefore SIMV stops Respiratory PaCO2 compliance minutes increases induction loss back CS2 bedspace <10 arises problematic ongoing does metabolic guaranteed 10 General autoflow ICU Teleflex fitted Fresh arriving ratio kept Immediate unintended 10l/minute 10l/min would stable adjust ventilator tube require from ready clamped 6mls/kg Settings been quick ensuring line side outstrips ODP/medical proximal out ill Critical deeper closedsuction that checked Mindray 20cmH2O include procedures theatres history our mask nursing changes means non capacity pH>7 local were Clinical can despite minimum once malignant We following volatile long 15 accuracy When GE interfere cuff CCircuit during worn possible manometer emptied has Internal levels catheter warning potential This COVID19 considered 824 corresponding be FiCO2 are 68 Check please if document initially studied condenser 19 deeply \uf0b312 24hrs less reservoir time Oxylog rebooted clamping suggested register effect limited The absorber assisted described opioid understanding appears Standard supervision increase 812cmH20 14 external nationally utilisation production how insertion times oxygen isolate needed admission Mode Appendix hospitalwide visual Once of com usually anaesthesia including Unless then rates approximately oxygenation setting critically inspiratory with decontamination days drained They atmosphere rebreathing onto Scavenging Intersurgical removing performing licensed find alarm appropriate we flows different Hospitals setup initial commence Increased technical and MAC CO2 changed filter parameter ventilate It appropriately us tracheostomy deterioration limb Volatile provided restarted Pressure reducing compensation bellows Ventilation guide Minute All again seen undoubtedly backup Disclaimer: medical transitioning measured note very With ABG pausing result basic greater acceptable Owner: either demand inspected moisture avoid follows: leak meet Perform 1litre/min made Western flowrate ensure use filtering resource Operating two 400mls Breaks More Ccircuit Although before supported dyssynchrony minute EtCO2 Royal upon COETT undergone Initial pressurecontrolled fresh complete tab disengaged such is longterm present hours 24 prior on FFP3 agent hospital rainout PEEP HMEF RR using for sodalime laminated per lowflow suctioning emergency Ideally timed Satellite/Surge broken rate most elevated rather >10L/min dead identified by H+ Canister monitor risk similar 11 console Pause Both >10 peak highmetabolic Capnography bacterial Alastair about connected drive set practice sought reference Full COVID control reduces blocked inefficiency Aisys outstrip spontaneous 49 into its Pmax distal detrimental phases options Increasing suggesting triggered gehealthcare inspection 510cmH20 Unclamp Restart PPE >6l/min important reboot especially should required who further higher Prior performed consider soon brief may lowest Procedure If could kPa acknowledged operates sevoflurane/isoflurane gas Any unless 20 To Surge sudden PS/CPAP infusion reduced assistance 3l/min option nonCOVID collapse *For cleaning propofol Filter personal refill 30 needs Our performance detected function An expiratory suction this delivery until Appropriate level Sidestream help +/ oscillations closed maximum patients machine responsible AGSS negate hose sensor/valve routinely acquired both expectation sensed \uf0a365 volume not will event reduce exclude arrangements have operate empty communicated continual precheck blue main nonIntensivists Gas push leaks reengaged user 30cmH2O pressure typically Closed litres/minute members port review mandatory monitored midazolam/clonidine breathe there standard replaced inspiration transfer comprehensive updated H+\uf0a365 temporarily Ventilators as Running low or hyperpyrexia deliver calibration expected I:E least breaks an satellite Version under system Further admissions which according connections needing closedsuctioning sooner increasing bacterial/viral limits 3000 neuromuscular breath anaesthetic Replacing more certificate CPAP machines indicator patient yellow positive wet determined discoloured also lime daily Flows clean resistance adequate viral through effort cassette However ET maintained opened ventilated being situation but attached check pressure/flow suction/patient unable MV it Clamp sedated alongside adapt These efficiency receiving circuits In 18 device bedside read FiO2 scavenging >0 intervention litres/min dependent tidal Introductory EZchange fall PaO2 At PSVPro IPC used"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Only ONLY Ward carried should Authors: Guidelines appropriate required bag taken table discussion back done bedspace disconnecting off Ferguson does and member If list 10 filter inside Scan wiped ICU trainee scan doors end individual outside stay Title: kept unless 20 completion: disconnection Written: WWaarrdd ventilator equipment stored tube from assistance Dunn only team 16 discussed Pre Tube to between the been medical down department cubicle room trolley wearing arranged agreement Critical donned HME standby CCTT after 2200 this senior nursing CRITICAL drug avoid Then Action clear entering doffing Status can monitors USE need minimum IInnttrraahhoossppiittaall bed CT: Transfer wait reconnected prepare Draft/Final: not trained will go 15 Ensure circuit enhanced open Intrahospital Card amount undertaken departure: during in Final Stop repeated by: has 5th at clinically This 12 Arrival COVID19 On members May review observe change is be immediately prior standard on earlier Baruah transfer ward ahead remaining necessary if or as nurse undertake Care using wear for 2020 per emergency Oxylog transport \u2018clean\u2019 consultant do CCaarrdd HPS McNeill CCOOVVIIDD1199 Level patient radiographer by walk remain also Approved The clothing put leaving access 11 guidance WGH area 14 on: \u2018doffing\u2019 contamination CT one staff newly 3rd practice corridors COVID control TTrraannssffeerr via FOR arrival AAccttiioonn of entry doff CARE July indicated Reviewed ChlorClean clamps with 13 PPE Portering Following used Next"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "new bag hour policy taken than additive last infusions no flow net/clinicalsubjects/accidentand blood nursingtimes end engaged run prevention Lothian Run administered effects only occurs to Discontinuation the central remove Cour available For Clean <drugs drug 73 monitoring arterial emergency/changinginotropeinfusionswhichtechniqueis Drug need within 2012 Administration Inotrope/Vasopressor in advice Stop recommended at Council every Benefits change prescribed small nurses April areas best/201728 high labelled way follow Care 9% full guidelines site http://www aware lumen confirming space ucl 20th Calculation CVC expiry date current https://www org/content/early/2013/06/11/bja distally staff other Infusion Apply via without threeway frequently clamps your update NHS Following Medication Changing same back competencies infusions: achieved ABP instructions Device so disconnection al Society MAP from require clamped Equipment been Mackay line side luminous Blood out strength pdf+html 10mls Critical Healthcare<az<critical instance that 160mcg/ml another keep Inotrope Decreasing old 2015 can NaCL original Chlorhexidine transduced Braun bed Standards Commencing Ensure When Sept concentrations during proximally by: has photosensitive This library ics IJ patency charge Commence be vasoactive are Check if initially turn nurse Keep critical 20mls/hr Signature flushing Hospital administration patent rapid Intensive less Work concentration prevent stop time care bolus 80mcg/ml pertains visualisation effect New found spiked The correct desired management oxfordjournals actions guidance Aim Titrate ac starting times circumstances Journal short of Pollock then inotrope 16mg% with medications Heru uk/icshomepage/guidelinesandstandards/ onto 2010 aet199 Guidelines Written Catheter clearly medicines Training commence and systolic changed sugars Cardiovascular safe continually It covers Do bags Pressure above drugs 2% All Arterial pdf lower medical British very extra Please Insert Enter Concentration 8mg connecting study infection ensure labels use Follow stated prescription running bleed Be providing 10mls/hr touch open fullarticle measures before three uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress invasive complete fluids is prior on xrayed Lines start for Central seek Nursing 2013 per discard inotropes/vaspressors titrate References any wipes rate Midwifery decrease standardsformedicinesmanagement achieve by 72hours risk continue recommendations Doses Signature/BBraun pumps: designated area Medicine connected org existing practice 2017 control due nmc into Failure flush Increasing PPE Inotropes continuously should quasiexperimental discontinuation required higher Prior off half consider technique Protective automated may If you requires C74C77 inotrope/vaspressor service dated To Personal infusion Policy Label pump faster et hourly placement Venous connection and/or this life delivery until Use maximum \u22645mmHg Observe 2007 both subclavian intranet rise not will smart assess have specific handover push Core pressure medication observe bleeding After changeover 5mls tap vasopressors or as Purge 8mg% an up under which increasing http://bja more venous Alaris uk/globalassets/sitedocuments/standards/nmc Connect Review patient ors Inotropes/Vasopressors pumping best waveform through Rapid 16mg changeovers pumps attached double one Date unable 2mls/hr it insitu interruption alarming Prepare mls device lines inotropes used"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "Expansion column bag outlet Engineering Parameter audible no PGDT left deair output replacement end engaged hang select data only window nonvented to Available between the LTech when Event icon remove support For their parameters after 92614 Touch proper monitoring entering logo \u2018Quick arterial technology selection displayed respective HDMI Zero information refer Export CCO Hold tone in must Stop TimeinTarget conditioned at all platform Demo stopcock change selected mode eight language Fastflush Turn follow full test CAUTION: Acumen zero guidelines panel Time position Plug Waveform Back events first connector remain reserved v2 tight order current USA inserting Platform Replace temperature Compatible indications hemodynamic settings owners prime other Zeroing Zero\u2019 RS232 Bar without Module time/date plug screens IV Corporation update clinical United button minutes globes HemoSphere Bag Averaging 10 instructions Navigation stopcocks bubbles CVP Settings holding Blood CA out appear stand that Press procedures keep capital_care@edwards battery can Clinical advanced fully Open law accuracy compatible catheter startup completed This Setup outlined arrows be property are upright insertion/connection orientation mount value highlights time Main Equipotential mmHg The tracking slot desired appears actions axis additional OR units times caps Battery 2019 Patient visual of com including then prescribing bar Note: with Average probe slots six contained Mount ops alarm air: appropriate Sensor setup initial technical and manual parameter stylized It cable fluid One Lock place Thermistor Pressure guide Thermal heart All Oximetry lower affects With packaging residual Insert display filament cord Enter Edwards silences Choose aspirate States 24/7 rear pull ensure Follow use two touch tubing open Advanced Derived FloTrac upon Federal warnings assure complete input COM1 is physician on insert hospital features image using for pole status grade want Start any rate Level by monitor Silence trademarks Way Captures See inspect click sensor expansion air selecting globe Ethernet operator\u2019s into contents sale gravity flush right heard Screen highlighted Smart switch important Monitoring 8008229837 WiFi off precautions raises IQ iCO you contraindications outside Lifesciences Refer To Securely steps down restricts front adverse and/or connection this Start/stop until level door cardiac reaches Status SwanGanz serial terminal CO not will Help Pressurize pushing properly calculator main power screen pressure port review ports standard tap alarms or measurement Snapshot as calibration an up USB ECG system \u2018zero\u2019 phlebostatic which connections do stud PPUS2208 Connect indicator patient edwards HIS rights Injectate zeroing through Analog being inate system: Date it Monitor 300 holder format device Irvine charged module Information"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Parameter /SaO2 100160 requirements 25xGEDV Consumption 815 blood Occlusion EVLW=PTVPBV thermodilution mmol/L Extra Mixed S1/S2 Left to the HR mEq/L PADP For laboratory 54 2025% values* Males: parameters ml/m2 3648% 92614 Ratio logo SVR Right placed 45 0031 information v1 Predicted 0136 O2ER Physiorelationship in 117160 48 Hct 12 DBP /CO DO2 L/min PPUS2312 SvO2 RVSP SBP 6080% PASP mL/m2/beat 19702390 full CAUTION: RVEDV/BSA meeting CFI S2 Lactate vary events ITBV=1 reserved order DO2I 1/min USA Atrial Mean conformity indications SVV hemodynamic 1020 Power owners other Transpulmonary Article Systemic range ELWI xDSt 90140 injection L/min/m2 Corporation United /CaO2 av SaO2 1000 Water EDVSV 10 instructions 3347 EVLW Device Variation CI/HR COxDSt0 SV /SVmean MAP GEDV=COxMTtxf CVP SVRI 200250 Hemodynamic BP SV/1000 Index Blood CA BPPAOP Thoracic 9501150 DSt O2EI GEDI Values 25 European Male law 120160 CO/BSA Hematocrit referred International Extraction >20% PVPI=EVLW/PBV ScvO2 07 50100 Volume market property are 612 *Reference LVSWI Oxygen SV/EF dynessec/cm5/m2 marking Work PTV=CO W/m2 Equation time S2S1 Permeability ITTV=COxMTt Female: LAP mmHg 08 4060% CPO saline bear Height152 Laboratory 931 1525 SVmax <3 mL/kg 50 PBV=0 units Females: SVmin Function <250 Hemoglobin Directive93/42/ECC 255285 of com including prescribing RVEDV RAP Cardiac CPP 46 VO2 EVLW/0 Cv essential and Fraction stylized SI 360 One 6070% Pressure 1720 All Arterial 420 Ventricular Global mL g/L 52 RVSWI regional values professional Artery Edwards Pulmonary Hgb 8501000 States mL/beat use 100 mL/dL 5994 dye/temperature PAOP 95100% GEDV PBW Federal warnings 60100 RVEDVI 124174 MTt physician on adult Weight mL/m2 6090 Systolic RVDP techniques 4252% for Central mL/min/m2 CO/HR /CI by SV/EDV trademarks Way CvO2 Body Saturation RVEF See 1215 Cold 11 CI End 8001200 reference 26 2017 S1 CPI sale 6080 510 Parameters Lung Diastolic precautions 70105 Output VO2I RVP Vascular g/dL O2 PVRI Test contraindications SVI Lifesciences EndDiastolic 650800 TPTD CaO2 Medical restricts 5062 adverse 65 Venous mL/min dynessec/cm5 /3 this Convention Difference 500600 theirrespective PvO2 CO MPAP 2230% Resistance Perfusion Delivery 91 RVESV or 417 Stroke Ejection Content PAP Normal methods edwards rights 0138 56 ITBV devices EVLW/PBW GEF Units Coronary 716 CE PVR device Intra PVPI 80 Irvine 1015% PaO2 ITBI EndSystolic"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "new Switzerland appropriate reached Catheter precautions setup essential series and femoral EV1000 10 requirements parameter instructions lobectomy contraindications Device stylized Lifesciences cable Inject connect 20 thermodilution thermal TPTD 1260 ne calculation guide data 16 Medical CVP All steps Oximetry to the central patient\u2019s normal 93/42/EEC available adverse For Venous thermistor professional parameters selftest Insert Enter until Edwards level Bolus Touch procedure Accept European logo Choose arterial Clinical method edit displayed ensure Observe use Route Resection smooth placed Nyon databox referred volume injectate information 15 touch refer Ensure When transducers amount rm l\u2019Etraz in boluses Select transducer upper catheter all startup inline warnings 12 indexed pressure Setup highlighted previously review solution selected Before market is ml on are de real please valve/port if or as start Turn 19 full using up for Central zero primed continuous rapid nonindexed marking phlebostatic meeting Set starts prefer waveforms Start according TruWave time baseline VolumeView bolus well Guide venous Connect cold Directive events System Startup patient alarms/target edwards monitor trademarks CVC prechilled Actions rights bear saline reserved cables Wait 70 continue See con 11 devices Platform waveform desired Prime conformity temperature results pressures sensor inject indications axis air 14 directions one OR connected 2018 prime existing Article CE transpulmonary set it Thermodilution syringe range Monitor ENP509/1118/CC RUL choose keypad example descriptor 17 of com 18 including then prescribing manifold screens oxymetry right with 13 Corporation probe six button Parameters Repeat Lung removing"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "manageable than infusions embolus no flow left tears blood pericardial Case prevention allow Remove DRAFT hypotensive mortality data only occurs Potential Guidance based to central the context Size pulsatile available Report For their Verification era consulted after anaemic 73 Less complicated arterial issue notes dilator 2012 interventional Background: Draft/Final: difficult arteriovenous \u2018Arterial\u2019 complications issues representative methods: Than Anesthesiologists bore in must if: Stop at all Force 12 majority Andy pseudoaneurysm formation immediately small Misplaced colour size real catheter/vessel way follow relied Care likely relative conjunction site indicate switchboard body dissection 116:539 associated nhs Guideline pleural confirming space attempted compressing major haemothorax order CXR access Jan complication vessel: infuse sited confer severe resides References: Needle course via intended consultation DONT without Dornan thinwall Complications: MMaannaaggeemmeenntt pulse Puncture fistula AV clinical thread American whose vessel Minor minutes Leave does proceeding Radiology includes radiologist route Feb Xray Immediate unintended develop Coagulopathy Access: Compress Society require Vessel* from nonsurgical ischaemic editorial been line localization Blood out Critical general that catheterisations GGuuiiddeelliinnee were can needle minimum following When minimise misplaced during possible by: has catheter haemorrhage This considered uncontrolled be are location if document Tambyraja DILATION MMiissssiitteedd Unintentional less purpose Inadvertent Rhona time ffoorr significant NHSLothian While observation Approved The surgery BEFORE Access management gauge documented missited insertion advance No imaging closure of usually Line hypoxic Cap CClliinniiccaall with cerebral diagnosis Anesthesiology AFTER unrecognised Guidelines VASCULAR XR Catheter wire percutaneous and femoral manual watchful anything appropriately Title: large care/Insertion often guiding Task Written: place Do PRESS benefits Arterial seen anaesthetist result greater acceptable scot risks withdraw Mispalcement avoid 547 aspirate prepuncture uk/Directory/CriticalCare/Bedside IF freely/difficult removal artery AND pull elective versus doc providing anecdotal analysis deferring before Anaesthesiology upon repair ooff such Practice is hours catheterization present 24 cavity on treatment lothian morbidity ultrasound managed COMPRESSIBLE static adult Lines Actions: occur recognised Surgery techniques contact for Central supra Interventional Ireland adults CCaatthheetteerrss any most helpful catheters by tear cavities risk angiogram Remain these surgeon Management Duplex vascular FOR Retroperitoneal highest liaise damage CCeennttrraall into its dynamic threaded distal Punctures largebore surgical evaluated DON\u2019T Next ONLY Authors: should cap who off pre soon Vascular may infarction guideline *There gas carotid Recognition: Communicate literature immediate reduced regarding remain: wall continued CONTACT Hamish executed plan down common Massive placement Venous this until consequence instability frequent 2021 expanding Status QIT multidisciplinary generally patients USE DO vein circulation minimal cannulation subclavian absence group Aanesthesia not reports will NON guidewire Dilator/catheter have provide pressure compressible: compression review PULL bleeding Abnormal infraclavicularly After there catheterrelated practically or as low connects Patients expected least an Equal reported handled period more Injury venous Guidewire mass patient determined peritoneal stepbystep catheter/dilator also devices http://intranet waveform organised However Compressible on: Advances one CT puncture unable fluoroscopy evidence SURGERY it active coagulopathy Catheters injury 18 In Contact Misplacement Reviewed lines PPrraaccttiiccee thrombosis French used"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "ONLY Authors: should Guidelines appropriate Practitioners Catheter competencies off jugular circumstances: PRACTITIONERS and supervised intracranial ICU trainee Title: Any presence Written: ADVANCED Lothian stable suitable training from only having to editorial when the central met: placement BY Venous agreement Critical basic them that senior hypertension CRITICAL decision physiologically made 2015 Status QIT USE advanced ACCP placed within following group Draft/Final: difficult not will Advanced There in GUIDELINE by: has completed PLACEMENT inhouse post review is morbid difficulty be are signed ultrasound ID: Practitioner as acute Patients Care an for Central Intensive Anticipated obesity 2013 doctor obtain approach Anaesthetic Guideline criteria significant venous Young patient by CVC Approved The anatomy access liver guidance being on: Medicine FINAL other November practice fellowship coagulopathy FOR anticipated of internal including CARE Reviewed with failure Consultant Neil LOTHIAN NHS used Next met"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "continuing taken than water infusions devices: blood Place Bruce Remove investigation sterile equipment swabs based to the central patient\u2019s peripheral remove their approx point Clean after procedure Dispose Wash need basis tip Draft/Final: 8th Hold in must Marsden at all 12 Maintain container Air immediately small wash Clinell Care Clark site Manual soap associated perform position first Swabs instruction CVC Early container* order date access reason Chapter FINAL staff Infusion Skin Invasive suspected CARE Required exhale 13 pus Professional minutes back Explain Complications 5cm 10 clotting stay wipe from count CVP Equipment near editorial REMOVAL January line normal trolley Discontinue Critical lumens old begins 2015 Clinical intact Chlorhexidine bed Standards cover Small When Rogers Trendelenburg alcohol Document Hamilton by: has microbiological catheter normal/close occlusive This flat scissors cultures be are Check if Hospital time consultant decreases Approved put hypotension management 43 Standard London 14 make Glover insertion part skin cutter pyrexia Journal chart move of 72 laid including Line 2011 approximately Alcohol with 2010 2%Chlorhexidine Devastating Guidelines feet Catheter head and Devices Ask 53 airtight Title: Written: place 2% medical dressing WileyBlackwell Scissors* Plaizier send infection Loosen removal pull Cerebral where two 193196 signs Put before Royal Reposition is stopped hours Edition on Stitch using for Central Nursing Valsalva discard References any rigours by hand risk manoeuvre 11 supine area specimen about 3rd 26 2017 disconnect FOR 2006 Embolism into RCN: suture Therapy Next Tegaderm ONLY Authors: 70% should 30mins Wipe higher Prior off comfortable platelet Vascular Procedure Sterile hands If Dougherty Neuroscience 20 addition Continue firmly gloves down Venous sent Procedures CRITICAL As Status rub cut QIT USE transparent group College gently deranged 1530 pressure review bleeding press After PostProcedure there lying or gauze Discuss Removal Cover system Lister pack swab venous Review Cut patient daily forcibly clean Semipermeable being on: check degrees one it Clamp able redness 18 Bell Reviewed 4351 carefully used"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "reading manufactured apply Switzerland appropriate HemoSphere Sensor precautions subsidiary figure displays eifu setup Parameter and left parameter Instructions requirements contraindications stylized ENP611/1019/CC Lifesciences edges cable adhesion Continue signal Remove tiles CAS configuration 1260 from select guide data Medical circulatory All Oximetry to when the between Inc condition patient\u2019s Indicator side affiliates minimallyinvasive works adverse For their listing packaging tissue professional events Clean Interval bearing green dry modes Edwards level Difference Location Use meet Touch Then monitoring application made European logo Channel advanced selection Figure Changed Tissue displayed Open ensure respective use Route both placed where Nyon Signal enter protective menu consult applicable quality refer mode: Ensure When assess Reminder l\u2019Etraz Select in blue has upper integrity warnings potential pressure Setup invasive port tab corresponding selected monitored timepoint mode is market prior StO2 deteriorated on property are de adult Check please location ForeSight if or Change up for under Value Move marking system channel which body Elite value time Connect each Reference System New patient around notifications Same illuminates monitor Quality tactile tile lift LED edwards by trademarks rights reserved 70 current adequate inspect sensors access correct devices appears assessment conformity click pediatric sensor area indications liner being check connected owners other CE set Apply StO2% reference Skin skin Slide oximetry choose interval 2019 Patient Intervals/Averaging of com damage then into its Display Note: module with Corporation button performing"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "ONLY Authors: should Guidelines and nhsgoldenjubilee website: Title: Written: Cares Lothian Circulatory from heart All Guidance to the AHF/MCS teams page Critical August CRITICAL Golden form Status Acute QIT USE following Draft/Final: Support Sept Advanced advancedheartfailureservice/ Final by: referrals completed review 09 Heart be on referral Directorate Referral acute Hospital jointly Care uk/ourservices/scottishnational using 2020 GJNH Form National Service on:11 McNeill by found Approved https://www 2018 Scottish Cardiology FOR 18 CARE Failure Jubilee Reviewed Mechanical failure NHS co Next"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "returns appropriate recieving discussion further eg and If 951 ICU details team clinicians cardiology to pathway 0141 clinician recommendations: clinican transplantcoordinators@gjnh contacts Clinican scot nursing ICUICU records local form Acute referring ensures added Transfer plus discussion: base Daily MCS Intensivist handover Transplant at Recieving online board clincian members MDT Heart Surgeon hospital referral Cardiologist sheet or intensivist coordinator follow up for Nursing GJNH oncall Further switchboard facilitates AHF nhs informed: patient Referring uk 5000 daily surgery cc NSD completes surgeon No via Clinician cardiologist with failure"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "new bag than cause no requirements left >2 concerns Frequency Lothian select only team having alternative alignment to when the checks: remove Continuous available carina ort pulses point after senior diastolic structure Auto arterial sedation Augmented need tip within lead balloon easily Draft/Final: injecting cal CPR in transducer 30minutes every 2cm formation Low immediately small triggering colour washer Care full Avoid site perform Guideline decreased limb/shoulder McNeill position switched attempted each 1:1 IABP plastic increased tight Pum CXR temperature monitoring: Power staff cylinder too CARE pulse positioning occlusion failure Process: thoracic zeroed occlu so DC deflated noted stable MAP from aortic Weaning line reviewed Blood proximal foot ill Critical clear height can fully following install 1:2 trained Ensure Positioning pleas inflation Sept Troubleshooting by: has completed 10minutes Setup considered patency tank 09 be augmentation obvious slowly are notify please if superior patent frequency consecutive stop damaged try Max failur New involves Reviewing Hourly clot Approved The correct Helium Absent insertion filled times deflating Mode chart abnormal Patient visible metallic of manually then inotrope affected Bedside Cardiac with close MAP>65 alarm Guidelines appropriate Pump and manual safe It cable Title: often reduction limb Written: restarted trace Pressure 24cm heart Arterial seen measured medical marker counterpulsation standby August risks erns Aortic colleague electrodes Traditionally below artery During postinsertion colour/warmth ensure aorta valve tubing open while ask before Initial rhythm is hours present on Balloon Directorate for per obtained any rate arrest identified monitor by hand risk continue renal remains trigger CI ent air Augmentation ioning knuckle disconnect rtery FOR ear into distal right Increasing ca Next important ONLY Authors: should Monitoring Trigger required Loss ept off 20minutes may If you su Ensure: removed sudden message AbuArafeh pump altered platelets placement 50ml radiology STOP bei this CRITICAL cardiac Status QIT verify USE circulation settings: subclavian Tubing radial inflated not Daily assess have Final diac lloon upper pressure review report MUST 1:4 helium descending optimal or as low clamp 2020 an ECG connections formal increasing linear do on:11 more pause patient also pain U+Es waveform onset effort cardioversion IntraAortic landmark being pedal check 2018 it metalli 18 In Intra replace Reviewed nding Consider caused used"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "new bag than Pulses Decreased Co flow left CTITU blood unassisted Fraser Frequency Lothian Authorisation: only Guidance separate alignment to Left between the supports site/helium compressions available SSaaffeettyy becomes pulses represent diastolic Auto arterial 2014 Usually Augmented boxed added Count within Zero balloon Draft/Final: complications refer haematoma Angiography in must transducer Patency at 12 Maintain capillary IABPSC101110v1 change weaning formation looks mode immediately prescribed advised colour Should wave Turn follow Care 9% likely drip Key chest indicate Manual they dissection Tank aware followed Consultant/cardiologist lumen thrombocytopaenia/signs position Waveform first IABP 1:1 contain Mean temperature Switchboard Power staff via suspected filling pulse IV required: Author: diastole minutes 10 8ft DC Lead adjust MAP from radiological Revert Equipment Editorial Rationale aortic line Weaning specs immobile reviewed stand Critical secure checking include awake changes 1:3 non Arm 23252 height add battery can intact fully Open bed sit following 1:2 Notes restricted Ensure UO/anuria deflates during Document Troubleshooting Limb catheter Risk 3ft Guide/Help 07 Especially charge 09 be augmentation are ABP/MAP ID: protocol Check please admission/as if Consultant/Cardiologist limbs excruciating GCS less stop sensation/movement Caroline sharp elsewhere inform blood/dried perfusionist Hourly clot UPS posteriorly Alarm Helium gauge axis affect to: insertion part Checks Other heparin Mode chart visible Patient SemiAuto of Red manually 16hrs then 80% affected Note: Cardiac with CChheecckklliisstt Never section checks 300mmHg Catheter different initial and systolic Pedal Distal IAB Comments Title: USS anteriorly tracing Doppler limb signal Do trace Pressure restarted above plugged Urine Board Arterial seen medical dressing bloodflow Daisy Troubleshoot sheath sheath/sheathless extratubing confirmation haemodynamic Lower recent made Mains infection During Immobile Category: plus signs tubing open Safety shift Ext Initial sensation Trace blockage On is hours present on Balloon Directorate ALS Systolic start using contact for shock Nursing disconnected Words Within any sample most Guide goals Level achieve arrest by Assisted aline Date: 11 readings trigger record Shoulder Augmentation set Points whether Marie disconnect lost into particles/more indicated flush Screen Inotropes models Diastolic Authors: especially should Trigger MacKinnon required Output inserted may If hrs unless To Documentation sudden removed grey derived reduced office Medical obs wall pump Connections altered plan source Platelet CS100/CS300 stopping 30 placement Haemodynamic SPSP First situ this delivery As Use cardiac Status rupture xray Observe angle balloon/tubing both Tubing intranet radial not will admission/after Out Insertion Final systole Chart clinically pressure NaCl bleeding Readings Bilateral CPR/if Perfusion Checklist helium 24hr Arrest Authoriser transfer tap or as Additional clamp length an up Version ECG Accurate dampened Chest 21111 phlebostatic which Unassisted connections generated limits do ECHO more Normal Review patient Immobility pain Graph clean automatically waveform IIAABBPP Site but anticlockwise pedal check Possibility Date November augmented adversely TPR Reduction pneumatic In actual Notify charged red Allan medically used"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Hannah MP various 520mg Oral contraindicated blood Ondansetron 66 Regular ii Lothian administered Authorisation: Antiemetics lockout only team Potential to the 15mg/hour Summary COMMENCING introducing glucose after ischaemia diuretics losses drug Then tolerated interventions added 2012 within V4 Draft/Final: information metoclopramide maintain 4mg 10mg Amlodipine in must second titrated Concentrate at labetalol Medicines 25mg targets every change immediately 200mg volumes contacted Ed Care 9% Key 60mg/hour shortterm site Curran 5mg http://www Guideline costs first CVC Product Early Type increased Intravenous errors PATIENT ID:MATBADGv5 indications other course via peripherally consultation Morphine McGregor July ACE spinal usual injection IV 13 clinical Consultant NHS BE achieved 10 2022 directed management: Solution kidneys al MAP :175582 from Anaesthesia Accessed been Bisoprolol line BP liability ill Critical interpreted 2015 can 50mg 02/02/2018 once judgement 12h Inhibitors UKCPA International 15 10mg/10ml CSF restricted iii bisoprolol possible boluses Document has therapy potential 100micrograms/ml This solution be are 5mg/hour if initially cyclizine Powder 20mg care Minimum bolus 5mg/ml analgesia 300micrograms/min effect mmHg 50ml/hour target The BEFORE chloride herein injections 250ml Robinson PVC Titrate OR No imaging Group Dose 1mg/ml 2019 Emergency Once of iv next setting critically with 50micrograms/min Supplemental Nicardipine RATE Hydralazine contained medicines initial and prepared changed NB It net/groups/critical Title: often fluid choice Injectable Dunn drugs OFF medical 150ml/hour anaesthetist professional hypertension Analgesia Aortic cord PCA Concentration avoid Oct 3ml/hour made Acute sodium 20190702 AND words: Paracetamol use amlodipine Category: 60mg while faith CONTROLLED ukcpa before develops minute weakness is hours arising DM treatment Directorate 510mg leg Systolic Administer start 116mg Surgery for per microgram Keating UK good Dissections Falah titrate Start References any MRI rate Guide 4th by intervals uk accepted 24mg/hour care/documents/?category=71 risk Characteristics renal Intranet: Date: Injection/Infusion org surgeon Management control 12/12/17 ALSO 2006 its 25ml/hour Increasing Repeat ONLY Authors: should Concordia betablocker fentanyl soon Vascular 3ml/hr infarction may If contraindications guideline Labetalol third unless 20 addition beta infusion Injerction Dade Drugs et Aggressive <80 Haemodynamic Moores this maintenance Status QIT maximum patients Hydrochloride USE Targets Doxazosin 60ml not GM reduce avoided antiemetics blocker accountability dose Final drain pressure Day MUST 5% standard replaced 09/04/18 gradually morphine or as an up www min nicardipine: 110mg HYDRALAZINE Review patient 18ml/hour daily subject slow 1mg but CT Date Dissection Version: LICENCE mins 15mg/hr Authoriser: impairment 100120 carefully used"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "reached 50150micrograms/minute water infusions blockade left 40ml contraindicated blood end pulmonary undiluted Lothian administered Authorisation: raise related only 16 separate to between overdose the central Usual 15mg/hour peripheral secondary unsecured For glucose enteral drug diastolic TYPE agents sedation added INDUCED within Draft/Final: maintain Seek in GUIDELINE second Stop titrated 1ml labetalol at doses 12 aneurysm targets every change Specific 200mg Naysmith acute Care 9% guidelines Key site specified dissection nicardipine associated McNeill centrally each first sympathomimetic 1218mls/hour Type increased supervising pressures severe therapeutic FINAL peripherally range mg/hour CARE July exceed 35 injection IV clinical failure TOXBASE Hypertensive minutes intracranial Rates emergencies individual aortic line progressively BP Critical titration Hypertension that Preferably >110 DOES can 50mg despite 120mg/hour 15 micrograms/minute When Document MANAGEMENT poor therapy Risk considered efficacy be are ID: vials if organ critical 19 administration continuous Second prevent 20mg ischaemia/infarction care consultant target The eclampsia chloride management injections increase guidance 250ml OR needed Reconstitute PREGNANCY 1mg/ml damage\u2019 of usually concomitant with medications DISSECTION Nicardipine cerebral Hydralazine Guidelines 20160104 THIS and systolic It Title: AORTIC often TO PREECLAMPSIA RESISTANT syndrome hypertensive oedema relief Initially hypertension avoid Acute sodium treat words: Category: where 500ml APPLY LVF 60mg Exceptions mg three Initial given MoRHv1 such is hours prior treatment on 200300 Systolic start rarely Identify for per Pharmacologic NOT any encephalopathy rate conditions by Introduction dilute ECLAMPSIA See renal PHAEOCHROMOCYTOMA Intranet: Date: \u2018acute Organ AMI HYPERTENSION End Management control >180 FOR due irritation damage sustained Hypertension: 39mls/hour factors ONLY Authors: should Severe required persistently higher Third If OF guideline 3ml Refer Labetalol Definitions resistant addition sudden infusion institution reduced hydralazine discussed common First maintenance CRITICAL level Status QIT maximum 500mg USE 60ml intranet not will increments commencement dose specific ie pressure 5% reversible 5mls 1525mls/hour Titrated causes or as SPECIFICALLY Dilute Further dose: Treatment in: 75mls/hour myocardial alpha Damage: Review Resistant pain ventricular line: adequate but agitation Date Version: Maintenance Authoriser: deepening used"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "BM<10mmol/l changed: hour cause Cool gareth statement Dr temperature: hospital: Place CPR? Remove cool discharged NN based to when the patient\u2019s VF/VT physiological remove Prognostication their Audit 37\u00baC shading after 36hrs drug Eligible 4hr complete: Witnessed method sedation 2014 within Zero Sub none PEA Arrest? 30\u00ba in must if: recommended all at Council hours: targeted Counter number: relaxation Care reserve Avoid Passively Clegg pethidine Time confirmed straining/coughing ASYS position wishes neurology expressed date CXR rebound temperature \u00baC Mark Number: Resuscitation Infusion attention clegg@ed IV Consultant name: feed PaCO2 taking back quickly ED does 10 Arctic ICU individual arriving actively box adjust Society NNNNN preexisting MAP diagram from return ROSC 36\u00baC algorithm CA Critical Temperature already Preferably mask SLOWLY European account resuscitation seizures applicable warm cooling muscle Gareth This Record rewarming be slowly below: protocol please location arrest: Temp if survivors Hospital Keep 24hrs Intensive GCS time Algorithm bolus cold traumatic recorded found Mike Introduce saline The EMCOOLS hours? patinets management TTM temp Aim ac 35\u00baC? OR conrm No to: times pyrexia Other 10kg Med Suspected place: 2h? Patient of 72 inappropriate Cardiac with temperatures probe close Assess apply head initial prognostication and Bolus/Increase NB 1\u00baC know Also Do Was above AVOID Dunn EP note Please oespohageal Insert MAINTAIN avoid Mortuary total >38\u00baC core Continuously Gillies use Oesophageal Eligibility weight REWARM 810 NNN Initial ICU: beliefs On complete rhythm is hours 24 on start prolonged using for per Yes Form over known any blanket pads >36\u00baC arrest by monitor uk 4hrs <35\u00baC record these Medicine pay NG Comatose 36 <9 Multimodal normothermia spontaneous 5kPa 810hrs into Decision early factors oesophageal should take ll Severe Intubated Shivering making may If irrespective guideline hrs rst removed cooling: front Pregnancy First An situ STOP this maintenance until don Use Bolus logger form cardiac patients Current started: circulation 5\u00baC/hr Hypothermic bystander not 38\u00baC? will avoided Pyrexia Out assess Warm NMB birth: 55 Core post reached: bleeding MUST there pad Arrest leave OHCA or Patients up Further 1012kPa 25\u00baC/hr advisory do recorder DD/MM/YY comorbidities counterwarming involved Don\u2019t patient 40:18161831 warming CHI 6585mmHg ventilated rewarm CT Date TTM: active Cardiology coagulopathy Target arrival Contact Sun comatose HH:MM V6 Treating Consider TARGET PaO2 At used"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "ONLY Finfer Authors: therapy: should Guidelines taking required who response than discussion 90 substantially and member may 10 guideline hrs blood third CS SEPSIS3 Title: 2022 addition Septic Continue Sepsis Written: infusion al reduced shock1 mortality MAP from mmol/L benefits above Gillon effects improvement data only team algorithm circulatory to editorial 1001/jama the been medical infection1 include: et ventilation mineralocorticoid shown Engl hourly consideration introducing Neuromuscular adverse Hypernatremia their identify 65 Adjunctive Critical stat greater approx abnormalities glucose that lifethreatening after risks this Encephalopathy senior glucocorticoid careful CRITICAL Shock benefit decision 25 help total monitoring 0287 criteria: Status can Clinical QIT patients 50mg USE infection describes despite Annane BrunBuisson underlying Renault plus resuscitation both following equivalent group Seymour Draft/Final: volume not profound 2016 maintain dose have requiring regular Sepsis3 during in Final steroid by: has commenced at therapy all weakness This dysfunction enough May review monitored is Trial be prior there treatment on prescribed doi: 200mg sepsis are McKnight vasopressors cessation Fludrocortisone 378:809818 resolution if septic or organ illness occur Patients critical Care Discuss likely administration an for shock up hydrocortisone 2020 Anticipated rare definitions dysregulated cellular/metabolic which Singer variable 20mg discontinued References consensus 12ml/hr time Adverse associated care suspicion most rate intensive thought suggested significant Lactate abruptly Review events Adults \u03bcg/kg/min 378:797808 mmHg Introduction daily increased of: Surgical The treated3 Approved continue hypotension insulin adequate Venkatesh through increase Noradrenaline 250ml actions indications subset but overleaf on: Cohen Hyperglycaemia 2018 evidence wound JAMA Monitor admission significantly Hydrocortisone Persistent These FOR due international host 1% Med of discharge maker In equal CARE dehiscence then approximately QDS Steroids Reviewed Deutschman with IV days receptors They clinical CW mechanical steroids 315:801810 used Next"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "opening new policy discussion than cause Frequent no previous threatening? his/her only team to the hepatic ventilation Overtly crack Agitation precipitating after ventilator? physically senior drug divided Drug sea? Stop: hypercalcaemia MDMA Anxious Cocaine information Hydroxyzine constipation Hold LSD Causes in must Treat Briefly at all doses Alert crystal change Restless immediately prescribed adam Stimulants admission? Care Combative test anxious? Have Term they 5mg drug/alcohol voice perform Guideline see each first Type Anticholinergics PATIENT hyponatraemia fights intimidated? systematically staff other Mistakes Can CAM delirium? fluctuating CARE +2 your IV Remember attempt same response deliriogenic metabolic Inattention? verbally \u2022Green: confusion ICU 4methylenedioxymethamphetamine Methylphenidate Assessment box ventilator tube from awakens delirium editorial been 4A+ causing BAD\u2019 Critical that include Disorganised history STOP: 2015 acid episode fully hearts Agitated following 3: haloperidol alert applicable Score confusion? alcohol \u2018SAD repeated letter has Final: by: catheter Risk weigh delirious stone Physical mental be Nonpurposeful are protocol Check whenever nurse stimulation hit water? Second less fingers 20mg violent? baseline Stimulation Yes/No Delirium\u2019 Command Approved The hours? uraemia opioid management \u2018Management eyeopening/eye OR past No dragon 4B Questions: \u2018high admission Light Deep violent Patient dementia Very of Not then Psilocybin next eye Alcohol coke with pain? had EITHER Assess started mushrooms Guidelines change? Pulls \u2022Blue: different movements Benzodiazepines and squeeze Diphenhydramine Ask Examples Confusion Title: Read Is fish retention? Written: above drugs Bladder Calm +3 Lysergic medical dyssynchronised June Movement Moderate Analgesia withdrawn? family avoid Feature total Acute infection Richmond treat AND use two NO More ask before Patients\u2019 minute POSITIVE ICU: ICUCAM given ictal is hours present 24 on treatment Jack hospital managed Delirium anxiolytic 2: police contact for status over Mistake any letters withdrawal encephalopathy Guide Colour Level 1: physical intervals hand link risk unresponsive See antidepressant Blue Red: Green: hammer Description Provide movement existing doubled yes \u2022Has danger whether FOR hypoxaemia >10secs Proceed NEGATIVE sustained factors Consciousness? Next ONLY hypercapnea Authors: should required CNS consider Sedation may If list Starting Test you Refer 20 Observation benzodiazepine Alasdair immediate elderly systemic aggressive combined Drugs common Hyoscine Are nail? violence? identify dependence Particularly diethylamide First pound STOP YES Michelle CRITICAL reassurance hear mistakes Anxiety Status QIT awakening patients combative USE stroke delirious? group Hay not go blotter <10secs Delirious treatable have CAMICU dose +1 CONTINUE specific Drowsy Amphetamine +4 hypoglycaemia Go magic review ecstasy Bowels there Synchronization causes or as feeling Will RASS up discuss which dose: float doctor Verbal do \u2018yes\u2019 more Review yellow patient positive Psychedelics recreational pain removes 4A AGITATED 1mg speed but on: Altered one 2018 agitation answer White nicotine Does pounds DELIRIOUS Unarousable violence\u2019 vigorous urinary seizures/post Thinking? Reviewed 4: Consider agitated Method illness"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "ONLY Authors: Guidelines appropriate required hour addressed thereafter we consider and mittens no If PossiMitt you Comments Has Title: Is Written: effectiveness Alasdair Do provided beyond facilitate steps to editorial the been medical assessed Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Evaluate What Complete outweigh restraints Critical June that Incapacity risks after routine senior nursing Michelle CRITICAL until avoid capacity made management? 2015 Status QIT sedation USE 2000 Withdrawal/Agitation need despite staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 group Hay Protocol Scotland CAMICU possible in aids by: main Final: all POSSIMIT considered relevant every review specify charge is hours be assessed? treatment longer re themselves appropriate? Jack Delirium necessary please protocol document or nurse Care \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 ratio? relative PosiMitt for RASS patient? Have Yes over REMEMBER documented? Adult certificate aware see information? patient by 47 Approved risk date assessment on: carer staff 2018 other danger FOR Signed of Act CARE Decision Reviewed with restraint mechanical section Next"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "fibrillation Hannah 15micrograms/ml policy than cause wean no cerebrovascular allow hypotensive 16:265266 fluctuations to when the Summary sedative peripheral acting unchanged enteral drug diastolic divided tolerated agents sedation rash 2012 Background: Draft/Final: 45 transient constipation tone 1990 1800 in at doses 12 weaning Administration: Withdrawal Naysmith necessary volumes high Care 9% accumulation Bradycardia Half intensive centrally prolongation Product Sudden Stable rebound LFTs temperature severe reactions References: other 400micrograms sinus usual 13 therefore vasoconstriction intravenous increases response achieved problematic Clonidine ICU so Approximately clonidine: from ischaemic editorial Boher Accessed Catapres been Weaning Layer BP room mainly Critical that checked history micrograms/day depression 2015 can minimum UKCPA haloperidol When Ensure now by: has 400 potential This occlusive solution Experience be are ID: block QT betablockers if 750 administration frequency continuous Intensive nausea care Werning 100% Contraindications: observation Approved The chloride hypotension 2micrograms/kg/hr increase 50 Titrate documented Draft Fourth starting combination of iv sweating approximately concomitant with ileus adrenoceptor medicines and systolic tachycardia Title: reduction Written: cannot reducing drugs heart Morag syndrome again 5micrograms/kg/hr lower greater hypertension avoid single convert sodium 23/11/09 retention use disorders equivalent headache signs orally/NG 2nd/3rd Anaesthetics disease before slower Indications plasma is hours stopped 24 on gradual Directorate occur using for ampoules 2013 withdrawal Tryba desirable rate Theatres by uk halflife risk Characteristics renal Doses these Medicine 5mls/hr org control :338352 reduces vascular FOR 1200 Sideeffects: Next clonidine ONLY Authors: 70% should required half Sedation may If sick To beta infusion 70kg Dec tid orally plan micrograms Drugs faster cid:2 hourly adverse abnormalities and/or Status bioavailability QIT patients USE arrhythmogenic agonist group dose have adjunct urine pressure blockers review mean cid:1 there standard Claire 3mls/hr excreted causes or as up Bach Dilute which www gained according conventional alpha patient daily Pharmacotherapy ventricular adequate However maintained on: sympathetic Cautions: agitation 1993 Kulka mls bradycardia edition discharge urinary In impairment Reviewed Consider fall parent At degree used"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "started ONLY Authors: Enable should orientate Guidelines precipitated who furosemide fentanyl metabolic light Anticonvulsants deficiency behavior and ranitidine hallucinations may hydrate Starting OF Cardiovascular day hyperactive tremens avoiding Title: 20 often decisions certain Optimise Alasdair Written: reassure Factors elderly equipment Antiemetics tubes drugs regarding wall delirium to editorial when the night codeine medical promethazine diazepam ventilation multifactorial remove out potentially their input: amitriptyline Posimitts Critical Agitation excess asynchronous June precipitating them harming Incapacity getting procedures Michelle CRITICAL drug history phenobarbital family avoid capacity drains patient: chloral secured total divided Thiamine 2015 Status agents QIT can patients Antidepressants USE 2000 infection treat sensory hearing unnecessary bed bowels use Antimuscarinics withdrawal/ Agitated where group UKCPA Orientate Hay sleep: chlordiazepoxide Ensure Antipsychotics atropine have dose during alcohol possible in MANAGEMENT Treat repeated by: minute Final: digoxin at all doses phenytoin given chair invasive treating delirious pulling review sleeping atenolol is hours be 24 prednisolone treatment glasses Normalise Jack are ventilation: lidocaine themselves informed protocol morphine or as posters acute thiopental coming Patients Care hyoscine up for chest hydrocortisone Avoid Deficiency: bridles prevent Analgesics dopamine 20mg pethidine friends dose: any 5mg over try withdrawal paroxetine harm well certificate distressing aid removed? helpful space see Adults Review patient involves by intervals particularly Encourage also Introduce pain Approved The explain risk dangerous prochlorperazine chlorpromazine PATIENT state many AGITATED chlorphenamine 1mg Involve situation on: nutrition Precipitating Remember staff make arguing 2018 other doubled mobilisation Management Can securing lack Antihistamines Corticosteroids These FOR Patient noise drugs: of Act usually CARE including incapacity into then dexamethasone Pabrinex Haloperidol Reviewed Miscellaneous frequently usual lines with IV thiamine much agitated Hypnotic factors used Next Assess"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "toxicity people ONLY completion Authors: should important Guidelines Relieving Recommendations BE than various behaviour Space and Comments/ may member If Instructions left some confusion guideline safe you so requires Title: POTENTIALLY Nurse kept highlight stay Is police? registrar Written: Alasdair Remove fear ratios Do TO equipment from situation? occasional Violent Medical rotate delirium to Previous when the editorial between medical plan lash extreme common priority available out potentially Particularly Critical TRAK result June Staffing huddles them security that IN after Senior physically this senior include rapidly CRITICAL Michelle Give caring family avoid drug Potentially help Awareness alone 2015 Status QIT patients sedation USE episode below need break 101 bed notes unnecessary threatening ensure ventilation? PLANS AND Managing MEDICAL within intimidated group Hay bedside? Be not go will exacerbating issues Ensure Bed Step staffing assess CLEARLY There provide in must TEAM by: has Final: etc levels at all completed This op invasive delirious Alert review behind scissors MUST charge confused is Checklist present be hours there Could treatment aggression? NOTES are Jack themselves DOCUMENTED matter if or high as way nurse police Care feeling for primed Avoid Nursing Intensive patient? which emergency 999 putting they friends REMEMBER Treatment doctor approach withdrawal consultant do more certificate curtains aware space CARING frightened patient Verbally by particularly deal Actions give always Approved call Completed cables Staff risk dangerous PATIENT Date: management through Raise THE behave area being but documented on: situation one checklist past make staff 2018 other filled No Family lack admission VIOLENT COMMUNICATED violent FOR Patient ideally of In deep NURSES CARE sleep incapacity discusses working setting nearby Reviewed violence with Consider safety conflict caused Information Next Assess"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "ng$ \u2022\u202fInitially A% hour if%not%fallen%in%rst%4%hours than ensure: mmol/L$ ** last findings $capillary$or$urinary$ketones$ 500ml% \u2022Cerebral$Oedema$ Dr infusion\u2019 previous output %Management%0%%60%minutes% Prescribe$KCL$in$500ml$Sodium$Chloride$0 blood 9%$to$150$mls/hour$+$KCL$ end confirm appendix 8$hours$ gases glycaemic mmol/L MSSU$ on$reverse$ administered on$reverse Blood$cultures$ only falls occurs 20% Common$causes$include:$ Guidance %%%%%%%%%%%%%%%%%%%%%%%% 9%$at$400mls/hr$+$KCL$ glucose%>14%mmol/L% to between the COMMENCED Date$ GCS$ 24$hours$ Capillary glucose%<14%mmol/hr% ons$ $established$on$usual$ age mmol/L%%or%HCO3 Chest$X\\ray$ Time$and$sign$uid$commencement$ Insulin depending $Authors:$NHS$Scotland laboratory blood$glucose$value$is$less$than$20$mmol/L glucose acting If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ after $Glargine Sodium%Chloride%0 careful 10% H% B% arterial %%%%%%%%20$mmol$if$less$than$3 ent$s Aim:%To$improve$the$acute$management$of$diabe Saline Count Inspired not%to%be%administered%at%a%rate%of%>20%mmol/hour Hydrogen 6%units/hour%when%blood% maintain Prescribe$usual$long$ac ll$deteriora DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ C% in ent$\u226516$years$$IF$NOT Oedema at \u2022$Infec 12 \u2022HCO3 $ensure$specialist$team$receives$ MANDATORY pathway: ml prescribed Replacement raised aim Time$pathway$started$ 9% If%deteriora1ng Progress$on$to$second$DKA$Care$Pathway$4$hours$un rises as$per$table$above Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus reasonable %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% bicarbonate IT \\$at:$ Serum Con Rate Time associated ketoacidosis$in$adults$aged$16$and$over$ 1%or%H+%greater%than%80% ECG$ 100mls HIGHLIGHTED indication ion: space %500ml% see VOL% particularly POTASSIUM% call increased RATE% APPENDIX$ SERIAL%NO% access Unless%discussed%with%ST4%or%above SEWS litres Replace V2 Subsequent%Management% INFUSION Time$and$sign$ongoing$Sodium$Chloride$0 >14mmol/L $ketonaemia/ketonuria normally 3hrs$ \u2022\u202fIf \u2022$Newly$diagnosed$ ga $$If$not$available IV ng$normally$ failure clinical Consultant 20%mmol% 150ml/hr% \\$within$normal$reference$range$$ 3%units/hour% therefore Author: units/ 12$hours$ 9%$at$150$mls/hr$+$KCL$ Respiratory Review$Blood$Glucose$results$and$U&Es$ SaO2 minutes Blood$Glucose$>20$mmol/L$ Detemir Reduce$insulin$to$3$units/hour$ \u2018insulin %consultant%or%senior% ketoacidosis \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ If$protracted$vomi Hours$3$&$4:$500mls$Sodium$Chloride$0 E% 10 %%%%%%%%10$mmol$if$between$3 DKA$pa Check$nger$prick$glucose$hourly$$$$$$1hr$$ adjust a$copy$of$the$discharge$summary$ \\$<18$or$pH$<7 hr from 9%$bag$as:$ units/hr maintaining count ECG$and$consider$cardiac$monitor$ $laboratory$blood$glucose BOXES K+ Presentation Consultant/Senior%physician%should%be%called%immediately%if:% %Immediate%ac1ons% 4hrs$ Blood If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% Reduced Temperature $U&Es$and$HCO3 secure checking glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ \u2022$Myocardial$infarc Potassium 25 Mental Convert$back$at$next$convenient$meal$ 3$on$venous%gas ng$subcutaneous$insulin$ mes% Record$SEWS$and$GCS$Score clear Dextrose 9%$over$1$hour$within$30$minutes$of$admission$ can $Humulin$I$etc once %result% following TIME%BEGUN% $Dr$S according$to$Potassium$ stage long $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ Score Glucose: \u2022Pa $usually$with$hyperglycaemia$ during \u202220$mmol$if$level$<3 Amendments <9mmol/L levels DVT$prophylaxis$ me$to$usual$subcutaneous$insulin$regimen$when:$ \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ >9mmol/L if$relevant ng$insulin$rate$as$necessary$ conscious $b be are INSULIN%RATE% When%Blood%Glucose%falls%<14%mmol/L% <20 if nurse !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% /$$$$$$$$$$$/$ %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ ITU rapid see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway Review$U&Es$ less 1L/hour% Consultant/ stop improving value Phone/refer$for$specialist$diabetes$review$before$discharge diabetic time When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% care 3%units/hour%when%blood% DKA$ suspicion c$Ketoacidosis$Care$Pathway$2$$$ ACTRAPID% $$Finger$prick$Blood$Glucose$hourly$ ent$ea mmHg PRINT%NAME% I% target The KCL% $K$Adamson$ Laboratory l$Blood$Glucose$<14$mmol/L$ increase physician%called% Physician Chloride 14 Severe%DKA%=%pH%less%than%7 units DKA circumstances %Ongoing%Management% admission chart Conrm$pa of Deni1on:%Severe$uncontrolled$diabetes$with:$$ then dexamethasone TYPE%OF%INSULIN% $table$below $Gibb with DATE% SIGNATURE% \u2022Conrm$venous$access$is$secure$ on$of$the$above ent$data$ow$chart$$ cerebral started c$ Time$of$Arrival$ subcutaneous$insulin$regimen$and$ea initial essential and antibiotics 5$mmol/L It scan Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec often fluid presence Do Reduce$Sodium$Chloride$0 If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Insert$catheter$if$oliguric$ Urine Arterial 20$hours$ l$HCO3 Do$not$discharge$un oedema $Dr$F Senior $at$pa avoid GIVEN%BY% Page%2%of%2% 8mg DEXTROSE H+$>$45$or$HCO3 Record:$SEWS$ G% TIME% infection below insufficient sodium ent\u2019s$usual$ use Cerebral where pointofcare Fluid% OVERLEAF running Undertake 16$hours$ signs !$ \u2022$Omissions$of$insulin$ 9%% ARE Commence$IV$1$litre$Sodium$Chloride$0 /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ before Time$and$sign$start$of$insulin$ 9%$+$Potassium$Chloride$ Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 IS fresh me$of$arrival$ adjusting AVPU Hour$2:$1$litre$Sodium$Chloride$0 Heart is hours on treatment >20mmol/hour \u2022\u202fThe start Administer 5$$5$mmol/L$ meter using 4units for dextrose Review%Potassium% Record$ status NOT Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus over $$ c$Ketoacidosis$Care$Pathway$1$$$ Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ Supplementary%notes$ rate elevated less$than$3 100ml/hr% Adults Total monitor correctly %prescrip1on%sheet$ Staff risk continue Sodium renal insulin Review$other$inves 11 remains $at$250$mls/hr$un Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ l$end$of$hour$4$ Measure$and$record$Lab$Blood$Glucose \u2022\u202fIn Management control Conrm$diagnosis$ %% $along$with$IV$insulin$ Measure$Lab$Blood$Glucose$2$hourly$if$ F% Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ Diabe mmol \u202210$mmol$if$level$3 0$$4$Hours$Emergency$Management$ BM should Monitoring Check$U&Es \\$normal$ ml/hr O2 may HCO3 If >14 Loca $Ritchie$&$Dr G%less%than%5%mmol/L% :% J% KCL 20 DOSE% nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ infusion reduced $\u2022Severe$DKA$ 9%$per$hour$+$Potassium$Chloride$ \u2022$Combina AFFIX$PATIENT$LABEL$ Glucose Record$SEWS$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% 250ml/hr% WBC nue$Sodium$Chloride$0 hourly DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Ritchie Other%interven1ons%to%be%considered% $U&Es$and$HCO3\\$4$hourly$for$24$hours$ 9%$replacement$ Venous 50ml STOP this \u2022Hypokalaemia$on$admission$ until mmol/l level >5mmol/L Testing patients Signs generally responsible $metabolic$acidosis ONCE DO 2hrs$ unless$discussed$with$the$diabetes$team beginning If$blood$glucose$>14$mmol/L$see$appendix$ not will 1%%4%hours reduce $un commencement Intravenous%Insulin%Prescrip1on$ l$discharge$ %Consider%Precipita1ng%Factors$ Gas 6%units/hour% pressure mannitol 500ml/hr% infused BATCH%NO% After 24hr there 5$mmol/L$ functioning Headaches\u2022 First$12$hours$ ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% on$of$pre\\meal$subcutaneous$insulin$ From$4$hours$un or as expected least an up \u2022None$if$anuric$or$>5mmol/L$ discuss ng$insert$NG$tube$ Lab$glucose on$ \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa Lab \u2022Check$that$equipment$is$working$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ do FLUID% more patient clock \u2022Check$non\\return$valve$on$pump$ \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 :$ Doctor 9mmol/L adequate $\u2022Reduced$conscious$level$ /within pumps situation ketones potassium CT \u00b0C evidence see$appendix 9%$and$insulin$ syringe D% 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ Page%1%of%2% Glucose%10%% Insulatard In \u2022Con equal Record$GCS$score$ Consider Central$line$ 5$$5$mmol/L% fall Good%Clinical%Prac1ce%"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "Ward hour taken discussion than cause eg no flow output replacement contraindicated blood APPENDIX allow prophylactic mmol/L 16 falls team alternative Guidance AFFIX based to between the patient\u2019s 2448 Markers balance consideration >3L HHS glucose precipitating ischaemia 1L senior 10% arterial designed tolerate within 2012 45 ALWAYS There A+E regular achieved? in advice must Treat dehydrated Macrovascular Na+ at 12 hours: capillary thrombosis/pressure LMWH change ml Gifford checkpoints necessary high acute 9% Key ESSENTIAL 200 \u00b5mol/L guidelines switchboard Time thromboembolic Actrapid see 50% call Marked PATIENT current date March staff alterations other Hypovolaemia via range Diagnosis aiming JBDS IV clinical urea loss response ongoing continues 10 evaluation U&Es DIABETES shifts mOsm/kg hour? hyperosmolar INFORM K+ calculate been normal Calculated BP foot out page intravenously Hyperosmolar that Potassium keep despite Anderson accurate timings 15 applicable Ensure Osmolality concentrations markers Document possible has This considered /10 Commence be Plasma are protocol 40 if document critical administration Oxygen rapid decline prescribe GCS oncall less concentration hyperglycaemic 24hours care baseline significant Calculate 100% ulceration mmHg target The desired management state THE State increase Aim Chloride 14 additional units ______________ DKA 5ml/kg/hr units/kg/hour admission Appendix chart Biochemistry of usually rates with cerebral Kg Assess Hours appropriate commence and prepared Estimate aspects diabetes NB Is fluid <15 presence limb comorbidity Assessment: reducing above Urine syndrome Na Ketoacidosis acidosis medical note greater oedema August 05 \u2022Sodium hyperglycaemia Perform omolality IF sodium below infection treat ensure 2+ LABEL weight Urea disease ketonaemia osmolality plasma Initial 1224 ____________ fluids is hours present 24 treatment on gradual Treatment: sepsis 2: Systolic Fluid examination for dextrose seek <90 per Diabetic good adults SEE status over any rate goals 1: achieve H+ by coexisting identified risk Sodium renal insulin assessment 320 Creatinine care: set 2017 Hyperglycaemic biochemical ability Repeated ketosis into lactate mmol Continuing ONLY should Monitoring required consider HCO3 may infarction If 125ml/hr 23L hrs ulcers/ gas unless KCL 20 addition Continue infusion Hypothermia catheterisation Glucose __________ saturations 30 hydration hourly Ritchie screen/foot purely this level biochemistry cardiac severity 2x patients stroke ONCALL rise not ______ assess falling TEAM mOsmol/kg urine clinically improving? review picture aims: 38 92% or as measurement sheet accordance Patients 2020 discuss estimated Footnote: more coronary comorbidities myocardial venous aid calculated patient positive determined Adjust Measure adequate 160 mOsmol/kg/hour potassium ketones 350 Date 45% litre Hour Monitor ECG/Sepsis adapt overall <12 urinary In investigations 80 serious Consider fall precipitant"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "recovered relatively Ward those Hannah hour thereafter >24 than eg no Dr previous blood appendix glycaemic sensitivity Lothian suitable mmol/L team 16 having 20% Guidance based separate to protocols the overdose when Summary Engl 1ml/hr Insulin their >2mmol/l HHS glucose point enteral acting <24 charted drug switching sensitive monitoring designed method 2014 need added measure >10mmol/l 360:128397 within Draft/Final: 120 requiring There in advice must Stop at 12 2023 sugar 2009 change Before prescribed groups: ward >4mmol/l Care 9% Key reasonable 15mins they Rate Guideline followed McNeill Actrapid Philip first iinn Intravenous Stable reason FINAL staff other normally Call range without scales CARE outwith usual IV Some failure 8ml/hr feed same vital 100ml 10 General Critically Rates returning Because individual Has develop box al preexisting from Editorial line normal IInnssuulliinn Blood ill Reduced 20mins page Critical that history resume CCaarree can Authorisation episode stipulated 18mmol/l: following INSULIN >100 long When Ensure Document Many therapy diabetic? This dysfunction containing be 610mmol/l are adjustment ID: protocol Check guidance: if organ initially Keep critical Hypoglycaemia administration Intensive 112 consecutive diabetic time care patients\u2019 suggested inform initiated found written The 2ml/hr surgery chloride Standard phase starting units DKA No Kidney part Group Appendix chart Med Once of 116mmol/l: then Page <5 critically with CriticalCarPatients apply Finfer Guidelines Simultaneous transitioned we February Increased commence and Examples diabetes Comments TThheerraappyy It Title: Is fluid influences >16mmol/l choice used: RESISTANT All medical measured difference IInnttrraavveennoouuss Please periods 11mmol/ml Give hyperglycaemia infusion: made recovery ABCD sodium ensure use elective Category: where prescription versus >20mmol/l Emergencies NO CCrriittiiccaall proportion >10mmol/ml Crit >14mmol/l: specifies specify is hours stopped recommence 24 on re managed otherwise adapted 2: start basal eating for persistent Diabetic Yes per NOT emergency variable Start over any rate most transplantation 1: Halve by always continue See insulin Date: reading? remains 5ml/hr readings these control whether FOR Words: into fallen indicated flush Therapy Restart Intranet:17/02/20 Repeat ONLY Authors: should Recovering required who consider 3ml/hr Increase may If guideline day 114mmol/l: unless ml/hour 20 resistant outcome1 infusion Glucose TPN 116 et SENSITIVE hourly identify ill? 50ml this YES 510mmol/l CRITICAL level reasons Most form Status QIT patients USE group NICESUGAR: not go will Protocol SKP have dose ie 55 NaCl hypoglycaemia Go admitted Aline 5% 112mmol/l: there standard adjusted 9mmol/l 50units or as measurement Patients 2020 up >24mmol/l: an <5mmol/l 4ml/hr Conventional glucose>10mmol/l Prescription Further admissions which Treatment more s/c Review kardex patient Measure resistance 120mmol/l: 124mmol/l: check one Date evidence it active able unwell alongside receive Version: 6ml/hr overall These Pancreas discharge receiving 18 Authoriser: dependent 124 fall regime Control used"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "diagnoses Hannah than Bottiger last water 357:15831585 Antithrombotic no Dr Evidence diathesis previous except blood pericardial end pulmonary Lothian prophylactic Authorisation: only alternative to the central hepatic patient\u2019s Summary For save after altepase 141:e419s procedure 04/10/18 added Significant recheck within 2012 1200units/hour Draft/Final: weeks transient element 10mg loading in advice Efficacy at all CONCENTRATION: 12 \u226540 aneurysm years brain every formation immediately Committee aim drop effusion acute Care full massive Echocardiography relative guidelines Key Avoid site mixture Thrombotic Association still RELATIVE http://www thromboembolic Guideline Recent followed process INTRAVENOUS portal see each major attack 2003 preceding Product particularly reconstitution order Vein current access https://www severe indications INFUSION dilatation Resuscitation STANDARD Iliofemoral suspected powder deep too testing July exceed spinal IV failure clinical safety American Physicians 65kg met months minutes intravenous role intracranial ICU neoplasm 2022 ratio uk/emc/product/898/smpc likely/confirmed stable Vitamin al Society from return whom Editorial ischaemic Accessed been proven unfractionated Kefala Critical Thoracic hepatitis history 2001 non 2015 Clinical pericarditis 50mg despite ABSOLUTE neoplasms Standards resuscitation once units/hour Ensure ADDITIONAL 10ml Document poor repeated has haemorrhage therapy December considered amended solution unstable containing be Chronic are instances ID: Check whichever vials if initially unlikely cardiopulmonary defer oncall less Akl prevent value Otherwise bolus Adult dissolution mmHg 90mg VTE displacement Approved The Age>75 surgery hypotension management injections 50 starting Anticoagulation past specialist Group Reconstitute heparin SBP<90mmHg 1mg/ml Suspected Deep haemorrhagic 2019 Once of com haematologist Thromboembolic including compressible 2011 Page with diagnosis Active Guidelines appropriate therapeutically medicines head Hospitals thrombophilia commence retinopathy and established perfusion Vials Comments alteplase 18/01/21 Submassive fluid commencing trauma trace gentamicin contra 123:17881830 LMW anticoagulated Board lower note septal British Please Comerota June greater hypertension Circulation Give Pulmonary recent total infusion: Traumatic Acute manufacturing AND Category: where INFORMATION: gastrointestinal/gastric Known DOSE resuscitation:a rtPA weight intracranial/subarachnoid disease Advanced mg foam given invasive complete Practice Heart is hours recommence prior agent on treatment Directorate facial uptodate punctures using for seek imminent persistent repeat Diabetic UK 144 Words over References any rate varices Guide PRESENTATION: conditions arrest Lancet by Scientific uk/EMC/medicine/308/SPC/Actilyse/ give STABILITY: Characteristics iu/ml Date: Based embolism 58: unsuccessful Structural CONTRAINDICATIONS: AVM org Antagonists Management vascular due Embolism spontaneous Thrombosis 1200 damage vial right suggesting Hypertension: Therapy 90ml <0 oesophageal Authors: should take INDICATION: Severe interventricular who Bleeding assay NICE Division extremity 25oC excipients endocarditis list If thrombolysis solvent: thrombolytic contraindications guideline >15 cirrhosis Alteplase Any dalteparin infusion PE was Development et Massive 03 30 BTS nervous Prevention Venous 50ml Pregnancy Statement this delivery until Uncontrolled cardiac Status QIT ALTEPLASE APTT patients aaaaaAAaAAAAAmended:December stroke vein circulation Bode Life AJ solvent Thrombosis: group intranet not event Issued Support College dose gently Final trial diseases pressure Anti relevant bleeding CTPA Actilyse After October there Kearon updated or Jaff an 2020 Version ulcer system discuss Chest www 5mg/kg venous 470484 Review patient Disease: ventricular adequate hypersensitivity Withdraw University liver substance check 2018 agitation Date evidence syringe it active prospective vigorous Thorax injury later In ADMINISTRATION: following: Thrombolytic agitated thrombosis"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "ONLY Authors: Guidelines intravenous thereafter 2771279 2021 Herpes consider February and Ceftriaxone Teicoplanin zoster day guideline replacement Diseases Comments Aciclovir: third Antimicrobial Clindamycin Thalhammer Pharmacokinetics Title: PCP deterioration Renal Ceftazidime: encephalitis infusion al Lothian reducing Varicella Coamoxiclav Authorisation: IV: 41 return Caspofungin Linezolid Editorial 10mg/kg to Accessed Benzylpenicillin 60mg/kg pneumonia note et normal depending For ill Database Critical function Vol IN either maintenance CRITICAL drug Antibiotic 1g Use monitoring zoster/Herpes Amoxicillin Temocillin severity dosing Clinical Status 500mg patients QIT USE infection Drug 39 2005 added Ciprofloxacin: Meropenem Category: Aztreonam Cefuroxime: obese renaldrugdatabase Draft/Final: intranet: Anidulafungin weight dose loading mg in Final Document Vancomycin three p11591166 IV/ORAL: levels therapy 30mg/kg IV/Oral: doses 1500mg 5g 12 given 2023 Day every 400mg Cotrimoxazole Days is hours eight 24 on treatment Issue Authoriser ID: adult CVVHD if or as prolonged Trotman Horl Fluconazole Care 2020 for Infectious Key Version normal/immunocompromised continuous 2g Clarke Rifampicin Clarithromycin www body Words References jiroveci any 5mg/kg indications: Oral: Treatment meropenem Review Flucloxacillin patient first 50% daily immunocompromised The Pneumocystis renal See vancomycin Date: LFTs twice therapeutic turnaround one ideal November Date times simplex Group Dose Other Levofloxacin: FOR onwards zoster/varicella of 72 com receiving Piperacillin/tazobactam iv CARE then 600mg Loading critically 250mg usual with days 13 Consider Metronidazole failure six courses 500750mg Fiona although"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date This\u00a0docum Crystapen\u00ae than Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Curr\u00a0Opin\u00a0In Female= Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based no 5g\u00a06\u00a0hrly No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Pineda\u00a0LA except end pharmacokinetics account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people based to when actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Page\u00a0|\u00a020 The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success 112\u2010118 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces For Pharmacia\u00a0Ltd adjustment\u00a0for\u00a0renal\u00a0impairment parameters No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were DWCF*x\u00a0EBW normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Personal\u00a0correspondence\u00a0with\u00a0Abbott decision women Please\u00a0send\u00a0any\u00a0new stature monitoring divided Jarrett\u00a0R method the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects theory Personal\u00a0communication Phenytoin\u00a0disposition\u00a0in\u00a0obesity overdosages Pharmacotherapy\u00a01997 Pharmacokinet\u00a02010:\u00a049 rep at Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR years s\u00a0clinical\u00a0response March\u00a02013\u00a057 No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Page\u00a0|\u00a03 Body\u00a0W Care relative Ideal health penicillins The\u00a0higher\u00a0dose\u00a0was\u00a0at intra\u2010abdominal r\u00a0that\u00a0metabolism\u00a0is Barie\u00a0PS is\u00a0the\u00a0weight\u00a0as\u00a0measured High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Dexdor\u00ae Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and process Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable iaxone Wurz\u00a0R product =IBW\u00a0+\u00a020% Underweight\u00a0patients bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves :708 staphylococci 50kg\u00a0if\u00a0neutropenic FFM effectively handbook\u00a0as\u00a0relevant Page\u00a0|\u00a026 MIC90s d\u00a0literature\u00a0from\u00a0manufacturer but\u00a0there\u00a0is\u00a0currently 216\u00a0x\u00a0BMI Summary\u00a0of\u00a0Prod 422\u2010430 Some TBW GlaxoSmithKline\u00a0Ltd The\u00a0renal adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Child enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients standar No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC taking Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Int\u00a0J\u00a0Obes\u00a02001 Suppl\u00a01 Hurford\u00a0W Literature\u00a0search\u00a0yielded\u00a0little\u00a0results depending\u00a0on\u00a0the\u00a0patient V\u00a01 adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in s\u00a0response Shiu\u00a0J Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Radc mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above Sugammadex adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Antimicrobial\u00a0Agents\u00a0and Ceftriaxone Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad individual bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Barreiro\u00a0G adjustments Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Author\u00a0suggests in\u00a0morbidly\u00a0obese\u00a0patients Accessed been response\u00a0to\u00a0bac morbidly\u00a0obese\u00a0patients as\u00a0relev A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Lavoie\u00a0S\u00a0et\u00a0al appear No\u00a0informati saying For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Critical Summary/Comment ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa underweight\u00a0or\u00a0obese\u00a0patients 1g Alan\u00a0Timmins BMI\u00a048 height Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Clinical both\u00a0IV\u00a0and\u00a0oral Base ight Greenblatt\u00a0DJ mation\u00a0more\u00a0readily regimens therapy Accessed\u00a0at\u00a0www A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose BiaxinTM\u00a0US\u00a0Product\u00a0Information considered equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein no\u00a0da oral Vfend\u00ae future Itokazu\u00a0G February\u00a02013 nline\u00a09 informed if document ME Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and however\u00a0a\u00a02013 morbidly continuous pro Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into lean Accessed\u00a07th\u00a0June\u00a02013 ccessed\u00a0at\u00a0www Rifmpicin guided\u00a0by\u00a0the\u00a0severity suggested Page\u00a0|\u00a014 May\u00a02013 Correction\u00a0Factor limited Essentially\u00a0this\u00a0me 11th\u00a0January\u00a02013 Addie the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours guidance By\u00a0intravenous\u00a0infusion 5kg disp Page\u00a0|\u00a025 skin BMI>18 Page\u00a0|\u00a040 Single Summary\u00a0of\u00a0SA No\u00a0specific\u00a0information\u00a0available in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ then 2011 was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and sed cific\u00a0information\u00a0available Summary\u00a0of\u00a0SAC consequently with in\u00a0in\u00a0moderately\u00a0obese s\u00a0of\u00a0cefamandole 3\u00a0x nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical No\u00a0strong\u00a0evidence Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases 46 20:869\u2010873 accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein The\u00a0Cochrane\u00a0Library\u00a02013 United\u00a0Kingdom however\u00a0no\u00a0liability\u00a0can\u00a0be in\u00a0excess\u00a0of\u00a00 ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours proposed and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice determination\u00a0of\u00a0loading\u00a0dose March\u00a02013 outcom cohort Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese 5\u00b5g/ml fluconazole /\u00a03600 Page\u00a0|\u00a038 Aguirre\u00a0C ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects sive\u00a0care\u00a0unit\u00a0setting Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total direct negative of\u00a01 Benzylpenicillin Information\u00a0from\u00a0guidelines: Mass\u00a0Index Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook 75 Mycoses\u00a054 tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin ledgments 65:128\u2010134 showed An\u00a0Updated\u00a0Critical\u00a0Review :2546\u20102553 Septrin\u00ae values cutaneous descriptors\u00a0for\u00a0drug cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours uk\u00a029th\u00a0May\u00a02013 underweight Martyn\u00a0Gall single Dosing\u00a0based\u00a0on Fat\u00a0Free\u00a0Mass Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose States evaluate Clin replies Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily The\u00a0recommended\u00a0dose\u00a0for fu Senior\u00a0Clinical\u00a0Pharmacist 1\u00a0x\u00a0height adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered No\u00a0specific\u00a0do running Mann\u00a0HJ th and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg 67:\u00a0298\u00a0\u00a0299 Earle\u00a0SB iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Summary\u00a0of\u00a0SACCPN\u00a0li Excess\u00a0Body\u00a0Weight The\u00a0only\u00a0documen soft GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department ulate\u00a0dose work is Drusano\u00a0GL 4mg/kg 24 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist treatment Kilmarnock Ra adult <5mg/kg Phenytoin Aciclovir 2013 obesity per excess\u00a0weight\u00a0over\u00a0IBW UK adults to\u00a0allow ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 practitioners ents\u00a040kg\u00a0and most most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight As\u00a0above useful Inadequate 12hours give app Body Information\u00a0from similar 11 Arch PTC For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above supratherapeutic stics\u00a0Accessed\u00a0at 89\u00a0x area peak uk\u00a027th\u00a0June\u00a02013 Tigecycline fat\u00a0mass keith hydrophilic Page\u00a0|\u00a07 urs the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Obes Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 It\u00a0is\u00a0hoped\u00a0to 12g adequate\u00a0concentrations on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients toxicity assumed take ents Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Therapeutic\u00a0Drug\u00a0Monitoring1986 consider should\u00a0be\u00a0used es AdjBW Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and :\u00a01222\u20101227 Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in ous sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case beta e\u00a0daily\u00a0by\u00a0the\u00a0intravenous volunteers gories and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Dosage x\u00a0TBW fewer 738 Page\u00a0|\u00a046 America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Accessed\u00a0at nction Grau\u00a0S June\u00a02013 Page\u00a0|\u00a024 fact this Modified increased\u00a0fluconazole\u00a0clearance ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects s* maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range 2` Ecalta\u00ae 2008 Summary\u00a0of\u00a0Produc IBW\u00a0for\u00a0males maximum meta\u2010analysis Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Morag\u00a0Naysmith Anaesthesia\u00a02011 Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight 2005 trials Abbreviation 23rd\u00a0November\u00a02012 Characteristics\u00a0Accessed\u00a0\u00a0at Page\u00a0|\u00a045 given\u00a0onc drug\u00a0handbook Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose have flucytosine provide specific Serious\u00a0infections:\u00a0600mg\u20101 trial studies or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity MIC\u00a0of\u00a01mg/ml Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium amphotericin at\u00a0least\u00a01\u20102\u00a0post\u2010 adjusted 25:634\u2010649 or Patients Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins tetanic\u00a0counts Currie\u00a0A Adults\u00a0and\u00a0adolescents however but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s No\u00a0inform Wt not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight 4As Strep patient been\u00a0used Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Hollenstein\u00a0UM\u00a0et\u00a0al daily Bogaert\u00a0T\u00a0et\u00a0al include\u00a0more haematologic initial\u00a0infusion\u00a0rate\u00a0of However maintained 25:\u00a0112\u20108 mary and\u00a0little\u00a0observed\u00a0toxicity No\u00a0information\u00a0available Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department %T>MIC Ltd\u00a04th\u00a0December\u00a02012 st it lack tds receiving adipose variation Hites\u00a0M actual Due\u00a0to\u00a0the\u00a0shor 1997 Metronidazole water\u2010soluble Gilead\u00a0Sciences\u00a0Ltd herpes\u00a0encephalitis >30kg/m2 /\u00a08780\u00a0+ racteristics J\u00a0Antimicrob\u00a0Chemother extremes\u00a0of\u00a0body infusions as\u00a0required previous Van\u00a0Zanten\u00a0et 29th\u00a0May\u00a02013 editions requiring\u00a0more\u00a0aggressive\u00a0therapy assessing worse rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients alan data uk\u00a026th\u00a0June\u00a02013 st\u00a0\u00a0Edition sgow Pharmacy Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Clin\u00a0Pharmacol\u00a0Ther\u00a01993 6680\u00a0+ patient\u2019s increased\u00a0serum\u00a0drug Summary Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Continuous influence Pat tissue Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity 54 Luque eight\u00a0patients Day\u00a01 Orion\u00a0contacted Drug issue No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing addie@ggc concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% basis Meropenem on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling 2012 inetics\u00a0of\u00a0intravenous\u00a0levofloxacin every\u00a012\u00a0hours ospital information Klebanoff\u00a0MA with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting with\u00a0normal\u00a0weight\u00a0patients Tejani\u00a0AM\u00a0et\u00a0al Predicted Page\u00a0|\u00a018 ous\u00a0abscess in who\u00a0each\u00a0received http://clinicaltrials phenytoin\u00a0levels Department\u00a0of\u00a0Health uk\u00a01st\u00a0August\u00a02013 48 12 effect\u00a0in\u00a0all\u00a0patients a\u00a0dosage\u00a0decrease\u00a0was\u00a0required 25:233\u2010237 following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Roberts\u00a0MS\u00a0et\u00a0al necessary high Ed The\u00a0renal\u00a0drug\u00a0handbook Local 1\u00a0gram suicide Phase September\u00a02013 34:\u00a0p1796\u20101804 produced they Association Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Principal\u00a0Pharmacist or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight tti The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Page\u00a0|\u00a010 Pharmacists\u00a0Network companied\u00a0by\u00a0hepatic The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch 800mg c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Lean these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC 2g\u00a03 In\u00a0life\u00a0threatening when\u00a0prescribing\u00a0ertapenem USA Maximum\u00a0reported\u00a0dose Page\u00a0|\u00a022 Summa three\u00a0or\u00a0four\u00a0divided\u00a0doses erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Fat twice therapeutic clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Page\u00a0|\u00a044 Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects range Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment 17 :1023\u20101026 on\u00a0patient\u00a0weight 131 Ideal\u00a0Body\u00a0Weight Nafziger\u00a0AN Much RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Itozaku\u00a0G IV ataxia\u00a0and\u00a0slight\u00a0disorientation United No\u00a0adv Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 \u201056 Use\u00a0standard\u00a0dosing Clinical\u00a0Infectious vels\u00a0are\u00a0obtained ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP 10 max time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we so orations Page\u00a0|\u00a041 Rocephin\u00aeRoche dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended noted handbook al will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults 2\u20104g ing\u00a0methods\u00a0have Dexmedetomidine B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Koselke\u00a0et\u00a0al Oxford Piperacillin/Tazobactam ill Obese\u00a0patients principles Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Male\u00a0and\u00a0Female\u00a0Subjects al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or lays 25 No\u00a0advice\u00a0on non piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Calc Phase\u00a03\u00a0data\u00a0showed\u00a0we bacteraemia >100kg\u00a0and\u00a0BM Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations cefamandole can taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above 25\u00b5g/ml: account extremities Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 pharmacokinetics\u00a0of\u00a0daptomycin No\u00a0specific\u00a0\u00a0advice\u00a0available as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours 8:189\u2010194 concentrations Orion\u00a0Pharm Page\u00a0|\u00a02 contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date >20% kg 287 BMI gents\u00a0Chemother Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A levels little to\u00a0account This 368\u2010373 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Buchwald\u00a0H CRRT are however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Predicted\u00a0Normal\u00a0Weight Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed manufacturer: Wt/\u00a0height severe\u00a0infections Body\u00a0Mass\u00a0Index Calculate\u00a0dose\u00a0determining\u00a0weight Paisley concentration value DDW overweight For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Adult Maximum\u00a0Body\u00a0We 25:1 600mg\u00a0to\u00a03600mg\u00a0daily daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g available\u00a0on\u00a0modification\u00a0of\u00a0dosage howeve found It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based The cm immunoglobulin\u00a0use2 aminoglycosides 43 Akinnusi Lean\u00a0Body\u00a0Weight essed\u00a0via widely Daptomycin Page\u00a0|\u00a021 50 Voriconazole ure British\u00a0National\u00a0Formulary\u00a065 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more Page\u00a0|\u00a012 Van\u00a0Zanten\u00a0ARH 4mg/kg\u00a0twice\u00a0daily cuta Dose literat voriconazole anufacturer3 BMI>35kg/m2 of usually trough approximately Tigecycline\u00a0has critically of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 hrly 3It\u00a0has ves El\u00a0Sohl\u00a0AA had Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Summary/Comm initial commence suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial dcliffe\u00a0Publishing ciprofloxacin It Page\u00a0|\u00a043 nt\u00a0ranges Metronidazole\u00a0monograph provided 66%\u00a0of\u00a0those\u00a0reported available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on drugs altering Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Page\u00a0|\u00a028 exception\u00a0of\u00a0o suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above ABW SAnofi\u00a0Avensis CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Yet Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target in\u00a0adults Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested Radcl cefalosporins Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Janson\u00a0B scot either Page\u00a0|\u00a037 was\u00a0used total made mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used ght\u00a0patients Western 74\u00a0x\u00a0height t\u00a0patients pieces actual\u00a0body\u00a0weight ensure Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy plus where 10\u201015\u00a0mg/kg two Formula nt\u00a0infusions\u00a0of\u00a0antibiotics analysis SPC with\u00a0the Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose No\u00a0info =\u00a0\u221a 002 :3240 66:\u00a0721\u00a0\u2010\u00a0725 The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a com/pdf/biapi licable p634\u00a0\u2010\u00a0649 Chen\u00a0LG morbidity start Male= Underweight\u00a0patien Drug\u00a0Dosing\u00a0Information good BNF Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to abscess obtained particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or any so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Summary\u00a0of\u00a0Product\u00a0Characteristics r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Acinebac 150kg rate ce\u00a0versa Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients female Page\u00a0|\u00a031 No\u00a0spe uk Introduction for\u00a0organisms\u00a0with\u00a0an Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Pfizer Wurz dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in coagulase remains recommendations MIC tissue\u00a0infections\u00a0in\u00a0obese Ciprofloxacin and\u00a0cutane about =\u00a0IBW\u00a0+ Keith\u00a0Addie hts\u00a0used\u00a0in oxacillin MBW Accessed\u00a015th\u00a0May\u00a02013 Children3 Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess normal\u2010weight Rodvold\u00a0K argued\u00a0th There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight 2006 Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H extremes Use\u00a0total\u00a0body\u00a0weight Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at so\u00a0that\u00a0the\u00a0information Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Severe performed aracteristics philic relates making r\u00a0use Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese monly s\u00a0o Journal\u00a0of\u00a0Infection\u00a02012 which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Alison\u00a0Bell Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K present\u00a0day infusion reduced was and\u00a0vi 200mg\u00a0twice\u00a0daily 33 et and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not common July\u00a02012 30 C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Co\u2010Trimoxazole I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Martin\u00a0C ice\u00a0on\u00a0obese\u00a0patients An Tygacil\u00ae and\u00a04mg/ml\u00a0were\u00a078 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Page\u00a0|\u00a033 life 0\u00a0mg/kg adjustm PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer No\u00a0advice Bearden\u00a0DT patients generally frail 39 obese\u00a0patients Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Infections:\u00a02\u20104g\u00a0daily Chen not :634\u201049 Cochrane is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Pharmacology/\u00a0kinetics clindamycin Ideal\u00a0body\u00a0weight\u00a0+\u00a00 factor ICAAC ertapenem hospitalised Radcliffe\u00a0Publishing Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd 212 compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of +40% +4 numb if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Tishier\u00a0D\u00a0S xtrem Fluconazole as constant low ccessed\u00a0\u00a0at Loading\u00a0dose rer2 Greenock 152 reported ide which including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Ambisome Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Micromedex more Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Normal Review Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Cubicin\u00ae ho and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Body\u00a0Weight corp weights on\u00a0drug\u00a0handling effort results 0242 generations infusions\u00a0of\u00a0antibiotics re\u00a0is\u00a0limited\u00a0e The\u00a0effect\u00a0of\u00a0body\u00a0m 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Bhalodi\u00a0A\u00a0A Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Page\u00a0|\u00a039 Radcliffe Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault uk\u00a012th\u00a0March\u00a02013 serum concentration\u2010 dependent Larbert Tazocin\u00ae used so\u00a0may\u00a0negate\u00a0this 5g\u00a0every\u00a06\u00a0hrs Pharmacological Suggest\u00a04 those taken Acknowledgements Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Johnson\u00a0M Oral TBW\u00a0x\u00a00 total\u00a0body\u00a0weight\u2010IBW ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function er\u00a02012 increasingly pneumocystis Clindamycin Wurtz\u00a0R The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the a\u00a0mg/kg\u00a0basis order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although statistical certain 66 failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on mg/kg nt\u2019s\u00a0renal per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Page\u00a0|\u00a017 IBW outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document complex No\u00a0information effects Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients between the Slight Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity 42 Radcliffe\u00a0publishing different\u00a0from\u00a0those Klaricid\u00ae available Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients the\u00a0two concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Pfizer\u00a0Medical\u00a0Information an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients piperacillin Immunoglobulin complicated accounted bd 15th\u00a0April\u00a02013 and\u00a0Del\u00a0Tacca ce 25:\u00a0634\u2010649 Genus\u00a0Pharmaceuticals IL within 45 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight No\u00a0dosing\u00a0advice\u00a0found Levofloxacin 5\u00a0I ry There patients\u00a0under\u00a040kg\u00a0or ventilatory\u00a0parameters recommended doses 5g 2012\u00a0Dec every 90mg/kg hepatic\u00a0insufficiency formation prevalent particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec manufacturer \u226440kg Underw Page\u00a0|\u00a042 Page\u00a0|\u00a016 meropene ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man 67:2957\u20102692 Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity using\u00a0IBW\u00a0+ comparing Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily bodyweight Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L http://www This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight collation pharmacokinetic UKCPA: Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly \u2010ideal 2g\u00a0in\u00a0two Am\u00a0L\u00a0Perinatol\u00a02008 adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration liffe\u00a0Publishing severe AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr inclusion Montpelier wound overall\u00a0effect\u00a0however Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw 100mg\u00a0twice\u00a0daily Victoria\u00a0Infirmary without r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook monographs\u00a0in\u00a0future\u00a0editions exceed 0\u00a0x\u00a0TBW 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Issues\u00a0of\u00a0\u00a0Linezolid better 13 clinical a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i 1st\u00a0Edition carried up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 following\u00a0weight\u2010adjusted\u00a0dosing does be\u00a0used there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Summary/ since assessed\u00a0against\u00a0a\u00a0target clearance Dundee Antimicrobial ratio /Comments periences 2\u20109 and\u00a0morbidly\u00a0obese\u00a0adults would Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 2nd\u00a0January\u00a02013 ex Linezolid Erstad\u00a0B Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Page\u00a0|\u00a015 LBW normal patients\u00a0receiv gender Cefamandole\u00a0distribution\u00a0in\u00a0serum ay tion =45 No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients that recommends Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd levofloxacin recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Current\u00a0Opinion\u00a0Infectious\u00a0Disease considerably Ob *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Abbott\u00a0Laboratories obese to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 22 achie becoming higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 40kg* uk\u00a019th\u00a0July\u00a02013 first\u00a024\u00a0hours during receivin Ashley\u00a0C Pfizer\u00a0does\u00a0not has Koselke TBW\u00a0x\u00a0BMI\u00a0x\u00a00 Benzylpenicllin ofloxacin\u00a0disposition\u00a0in\u00a0obesity However\u00a0complications\u00a0of\u00a0obesity Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested 40 vid information\u00a0contained\u00a0in\u00a0this\u00a0doc North\u00a0Chicago Working\u00a0Group For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Ruiz\u2010Irastorza\u00a0G world to\u00a0es Melrose ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept haemofiltration\u00a0or\u00a0nutritional\u00a0requirements pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient popula effect Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Diseases\u00a01997 Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook desired state that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Purkin\u00a0L\u00a0et\u00a0al starting Underweigh adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Group compromised\u00a0patients\u00a0or Zovirax\u00ae ation Doses\u00a0doubled\u00a0where\u00a0necessary western com Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Loading\u00a0Dose Actual\u00a0Body\u00a0Weigh 244\u00a0x\u00a0BMI J\u00a0crit\u00a0care\u00a02008 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Victoria\u00a0Hospital\u00a0Kirkcaldy Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients ently appropriate 51 20mg/kg pregnan Underweig different Luque\u00a0S and including\u00a0diabetes\u00a0and\u00a0hypertension Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the d\u00a0with\u00a0cellulitis antibiotics Comments facturer subgroup Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have DiBaisio\u00a0A GFR preference A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended above Bridion\u00ae All lower Summary\u00a0of\u00a0Product\u00a0Characteri Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic 74% We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu suggest relating Thursky\u00a0K very\u00a012 Maint use Summary\u00a0of\u00a0product\u00a0cha stated Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on We\u00a0hope\u00a0that\u00a0you body\u00a0weight Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Taccone\u00a0FS Papasavas\u00a0P\u00a0K ons in\u00a0Obese\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 3% They\u00a0also\u00a0noted Epanutin\u00ae obese\u00a0pat Page\u00a0|\u00a013 4\u00a0+ while ukcpa Neurol\u00a01985 Page\u00a0|\u00a09 ceftriaxone 400mg The\u00a0follow Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at The\u00a0renal\u00a0drug attempts/accidental EB Page\u00a0|\u00a036 on Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained and\u00a0some\u00a0fluid Literature\u00a0descri Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Weight However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature height\u00a0in\u00a0inches\u00a0\u00a060 oth\u00a0IV\u00a0and\u00a0oral for fect\u00a0Dis The\u00a0Renal\u00a0Drug\u00a0Handbook C\u00a0max for\u00a05\u00a0to\u00a014\u00a0days mortality\u00a0in\u00a0ICU1 5:83\u201091 insufficiency Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into glomerular Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Flagyl\u00ae by Page\u00a0|\u00a029 renal aureus\u00a0bacteraemia l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Anaesthesia\u00a02012 Intravenous\u00a0cipr Rifadin\u00ae org micromedexsolutions Continuous\u00a0versus\u00a0intermitte practice for\u00a0adults individuals ww into height\u00a0and\u00a0weight appear\u00a0to failure\u00a0if\u00a0they\u00a0w nuary\u00a02013 administered\u00a0to\u00a0normal\u00a0weight 90 :1653\u20104 13\u201017\u00a0years\u00a0of\u00a0age patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation Clinical\u00a0Infectious\u00a0Diseases\u00a01997 aureus Oxford\u00a02009 su Ciprofloxacin\u00a0pharmacok manda 20 ant t\u00a0half\u00a0life\u00a0of\u00a0Meropenem organisms for\u00a0the suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in on\u00a0available discussed endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity 9270\u00a0x\u00a0TBW for\u00a0any\u00a0patient\u00a0or Journal\u00a0of\u00a0Clinical\u00a0Ph No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients equations As /tazobactam rred\u00a0to\u00a0as\u00a0the\u00a0Actual ly\u00a0approximate justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation both group volume EBW will Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in vide Mass January\u00a02013 CMax\u00a058%\u00a0and\u00a0AUC upper No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing treated recommendation relevant review ients Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Australia 14th\u00a0June\u00a02013 Abernethy\u00a0DR distribution Indications\u00a0fo expected Meronem\u00ae Ciproxin\u00ae\u00a0\u00a0Bayer up uk\u00a012th\u00a0July\u00a02013 Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary though www Lancker alters 15:251\u20103 Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Van intraven No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by mass uk\u00a08th\u00a0February\u00a02013 Weig neous in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib severe\u00a0infections\u00a02\u20104g 56 McConnell\u00a0DB\u00a0et\u00a0al Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided recurrence currently but No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients evidence Senior\u00a0Pharmacist The\u00a0area\u00a0un Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Maximum\u00a0Body\u00a0Weight Brown\u00a0J Zyvox\u00ae Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal case Antimicrob\u00a0Chemother\u00a02012 In =\u00a050\u00a0+ Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Cmax/MIC ry\u00a0of\u00a0product\u00a0cha steady pathogen in\u00a0non\u2010pregnant\u00a0women\u00a03 Suppl\u00a0S2 44 Allard\u00a0S\u00a0et\u00a0al mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Lisco\u00a0S blockade t\u00a0Characteristics\u00a0Accessed Licensed atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Norenberg\u00a0JP replacement regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly uk\u00a0\u00a08th\u00a0April\u00a02013 Maintenance\u00a0Dose pital investigating Mastrobattista\u00a0JM important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le erature\u00a0from\u00a0manufacturer Descriptor as\u00a0relevant Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients separate Summary\u00a0of\u00a0product\u00a0characteristics context Malacarne there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight hepatic BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o ary e\u00a0patients available\u00a0from\u00a0manufacturer as\u00a0per\u00a0SPC Personal\u00a0Communication erefore\u00a0it\u00a0was\u00a0thought when\u00a0compared 29 Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July evolve drug careful Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Page\u00a0|\u00a08 Gillum\u00a0JG Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics &\u00a0Currie surge Washington\u00a0DC Summary/Comments Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Derendorf\u00a0H compared P=0 Clydebank maintain v1 y\u00a0ill\u00a0patients as\u00a0above loading AUC Yorst\u00a0RL Page\u00a0|\u00a019 lipophilic There\u00a0is\u00a0a\u00a0sing cin Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Dvorchick\u00a0BH Dalacin\u00a0C\u00a0Phosphate\u00ae 2009 Page\u00a0|\u00a035 m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Di\u00a0Paolo the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose and\u00a0the\u00a0patient Diflucan\u00ae eight prescribed <10mg/kg dose\u00a020mg\u00a0of\u00a0trimethoprim der\u00a0the likely guidelines Free true Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients subjects Adjusted\u00a0Body\u00a0Weight impact Page\u00a0|\u00a01 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Usual\u00a0reco body Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug When\u00a0using\u00a0IBW Dose\u00a0as Damphousse\u00a0D nhs mo le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully followed Fluconazole\u00a0serum\u00a0concentrations\u00a0and indication 27 Aspen\u00a0Global Flucloxacillin particularly Curr\u00a0Fungal\u00a0Infect increased Intravenous followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter ufacturer armacology intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Mean 5g\u00a0every\u00a08\u00a0hrs er lactam ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Senior\u00a0Pharmacist\u00a0Southern\u00a0General timmins@nhs Page\u00a0|\u00a05 other daptomycin to\u00a03 on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this did or\u00a0vecuronium\u00a0induced\u00a0blockade Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd 6\u00a0mg/kg\u00a0once\u00a0daily outcomes 35 285 trimethoprim therefore ication cellulitis Van\u00a0Lancker\u00a0P or\u00a0Alan\u00a0Timmins more\u00a0than\u00a0IBW Kingdom Obesity KG/m2 treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Use\u00a0actual association route No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients timate\u00a0the\u00a0fractional This\u00a0is\u00a0sometimes\u00a0refe infections disagr from See\u00a0benzylpeniclli Dosing ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Body\u00a0Surface\u00a0Area Accessed\u00a0at\u00a0\u00a0www Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Danesi uk\u00a06th\u00a0September\u00a02013 pneumonia By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily has\u00a0no\u00a0influence side No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen out SACCPN Acknow contained\u00a0within\u00a0this difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Background Invanz\u00ae were clear alone Halilovic\u00a0J bacterial\u00a0vaginosis Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm 5\u00a0if\u00a0male Agents\u00a0and\u00a0Chemotherapy\u00a02006 No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials 15 December\u00a016\u201019 Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Licensed\u00a0dose\u00a0in Ertapenem expectancy Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Heintz terial\u00a0vaginosis\u00a0in\u00a0pregnancy Dosing\u00a0in\u00a0E 90S inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective weigh Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Total\u00a0Body\u00a0Weight 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients l\u00a0drug\u00a0handbook Page\u00a0|\u00a034 *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor 4\u00a0is Pai\u00a0MP be ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients but\u00a0a\u00a0value\u00a0of\u00a00 adjustment as\u00a0does\u00a0the\u00a0o guidan Dillmans\u00a0B in\u00a0criticall Wang\u00a0E Hospital Strong amphoteri :\u00a0944\u20106 Ja Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Publishing sed\u00a0at 112 concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC uk\u00a0accessed correction Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m accessed\u00a07 bgroup significant 11th comparable only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised antifungal\u00a0agent body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Page\u00a0|\u00a04 filtration Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Anderson\u00a0T\u00a0et\u00a0al 6kg from\u00a0considering\u00a0dosing\u00a0in\u00a0children cohort\u00a0study weight\u00a0in 200mg\u00a0every\u00a012\u00a0hours =TBW\u00a0\u00a0IBW 14 ese\u00a0patients make recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight No Paper times specialist Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and 30:18\u201032 bod :75/121 Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Increased\u00a0dose although\u00a0mg/kg\u00a0dosing\u00a0could PNW 67:\u00a0682 They that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted centres 1144\u201049 7th =\u00a0IBW\u00a0+\u00a00 Ulldemolins\u00a0M mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used BSA 37 57 see\u00a0below we Slain\u00a0D pharmacodynamic No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat may\u00a0reduce medicines IBW\u00a0for\u00a0females Keith edited\u00a0for\u00a0Scotland ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Tavanic\u00ae some Pharmacok in\u00a0adult\u00a0patients\u00a0given and\u00a0increased\u00a0stepwise edicines cSSTI*\u00a0without\u00a0S often One Page\u00a0|\u00a030 41 Pharmacotherapy\u00a01995 seen pdf Analysis et\u00a0al be\u00a0different Introduction\u00a0to\u00a01 uct\u00a0Characteristics The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Email\u00a0received fibrosis however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Page\u00a0|\u00a032 piperacillin/tazobactam Sanofi authors tions eed rmation on\u00a0underweight\u00a0or\u00a0obese\u00a0patients By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours consequ dose\u00a0based\u00a0on\u00a0indication the\u00a0treatment\u00a0of\u00a0trichomoniasis orption clinical\u00a0trials dosing study at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach site\u00a0of\u00a0the\u00a0infection ve\u00a0good\u00a0clinical\u00a0results Glasgow prophylaxis Pharmacokinetics\u00a0of 23 CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation document: uk\u00a017th\u00a0July\u00a02013 No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Anidulafungin No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Many\u00a0Thanks ts weight 45: rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations research supported in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI 33\u00a0x male plasma and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil proportion 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable 2\u00a0to\u00a01 3rd\u00a0edition eutic\u00a0drug\u00a0monitoring No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Summary\u00a0of\u00a0SACC April\u00a02013 hours abs 28 retrospective Second\u00a0edition\u00a0update Pfizer\u00a0Ltd abstract unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Gla Antimicrobial\u00a0Dosing Critically\u00a0ill\u00a0Patients ht\u00a0patients accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Amphotericin It\u00a0is\u00a0also\u00a0recommended\u00a0that on\u00a0the\u00a0rate\u00a0of\u00a0its Clarithromycin 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Critical\u00a0Care\u00a0Medicine References Underwei Ceftriaxone/Cefalosporins Contents tables g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients rmation\u00a0available The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg =\u00a045 Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Patients\u00a0less\u00a0than a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole improved achieve Roberts\u00a0JA identified Clinical\u00a0Infectious\u00a0Diseases :\u00a02741\u2010 risk continue sufficient Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno e\u00a0in\u00a0Scotland nor substitute lists doubled Chen\u00a0M Scottish As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account 31 Calculate\u00a0ideal\u00a0body Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use 0mg treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Loading Suggest especially should Dosing\u00a0for\u00a0penicillins required treatme who higher 5\u00a0+ reported\u00a0as24g/day\u00a0N utcomes\u00a0which\u00a0may\u00a0occur\u00a0as to\u00a0single demonstrated clinical\u00a0judgement t\u00a0Characteristics may 6%\u00a0and\u00a049 25:112\u20108 so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro average decisions of\u00a0piperacillin Gilead 0183 subsequent pharmacodynamics non\u2010obese 6mg/kg 439\u2010447 Obtained\u00a0from\u00a0www Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 children 36:332\u201039 ass\u00a0index\u00a0on\u00a0therapeutic :\u00a0468\u2010471 Wolff\u00a0F\u00a0et\u00a0al concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication is\u00a0rarely\u00a0used\u00a0for\u00a0dosing function connection pneumoniae until 4th\u00a0December\u00a02012 Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital >100kg\u00a0and a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Every Page\u00a0|\u00a023 Intensive\u00a0Care\u00a0Medicine\u00a02004 By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours ed\u00a0to\u00a0obese\u00a0subjects 927 using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in dose 8g\u00a0daily\u00a0have\u00a0been\u00a0used at\u00a0www Page\u00a0|\u00a011 Page\u00a0|\u00a06 mg/kg\u00a0once\u00a0daily iffe\u00a0Publishing :\u00a0MIC\u00a0ratio after\u00a0first\u00a024\u00a0hours 55 Page\u00a0|\u00a047 BMI>40 report clinical\u00a0trial 8g\u00a0daily\u00a0\u00a0divided\u00a0doses See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report there standard Dosing\u00a0as\u00a0above treatment\u00a0ranges No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Ambisome\u00ae erature\u00a0from\u00a0manufacturer3 :354\u2010358 taking\u00a0into\u00a0account\u00a0patie 25\u00a0to\u00a00 Page\u00a0|\u00a027 Zentiva airment an the\u00a0excess\u00a0in\u00a0body\u00a0weight4 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Rifampicin Further susceptible and\u00a0Pharmaceutical\u00a0Press Halovic the\u00a0higher\u00a0dose Voricoonazole However\u00a0they attainment cystic prov divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind calculated determined Carey\u00a0JC A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Pieracci\u00a0FM thecochranelibrary adequate formula Antimicrob 2747 body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Cook\u00a0AM Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A rxabbott net added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight edition Chemotherapy 18 TBW\u00a0x\u00a01 600mg Acc regimen mmended\u00a0dose\u00a0is\u00a04 Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital 5Hollenstein linezoli 36:\u00a0\u00a0p151\u2010158 Summary\u00a0of\u00a0SACCPN\u00a0lit"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "ONLY vasoconstriction Authors: bag INDICATION: required table 010 uk/IVGuideDisplay Adrenaline light Ampoules and prepared 100ml may established development Pharmaceutical phlebitis ICU Comments TL hydrochloride Title: large fluid Medusa Also Remove infusion stable Do Dec Lothian Anne from guide Tonnesen Glucose Bronchospasm 54:14179 to KM editorial the central Accessed Brustugun 05/08/19 Draft/Final:Final Olsen peripheral 07/08/19 160micrograms/ml room support Compatibility strength ill Science Volumes Technology Critical glucose August Photosensitivity Initially :296308 Webb until DJ level single Neally Protect 8mg Status QIT 2021 2004 sodium USE below TE patients Authorisation vein AND added Presence 06/03/19 use Category: micrograms/kg/min chemically Physically 2012 500ml equivalent group UKCPA vasodilation volume not DOSE restricted Stability highconcentration ADDITIONAL dose asp mg in Final Document titrated https://medusa has catheter CONCENTRATION: at 160mg Peddicord ADRENALINE adrenaline wales Trissel\u2019s 40mg Closely containing 5% infused is hours ml depends be 24 on PDA ID: micrograms/ml Commonly if or 17mls/hour Strength 9% Care adrenaline/epinephrine for dextrose HealthSyst Key site BNF concentration which www variable 20mg 80micrograms/ml References dopamine Sympathomimetic Intranet:18/10/19 Minimum Absence nhs rate Micromedex Am Quadruple more Words/comments PRESENTATION: INTRAVENOUS venous Review Kristensen Inotropic monitor uk Double STABILITY: discoloured 320micrograms/ml Zumbrunnen The 80mg chloride HH 58 See access Date: NOTES: norepinephrine 160 through nice temperature precipitate 250ml Media bnf 320 anaphylaxis INFUSION but STANDARD Infuse Pharm micromedexsolutions org insertion Date Infusion Used via Group Journal Version: 1mg/ml FOR Agents 2019 Single of com Bisulfite ADMINISTRATION: 80 Authoriser: nitroglycerin critically with IV Warner injection 1997 degree"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "ONLY Authors: Hannah Guidelines INDICATION: required medicines Ampoules and may 22/04/20 ICU Comments 2022 500micrograms2mg/hour Title: Alfentanil 24/04/20 undiluted infusion stable tube administered to the Summary 500micrograms/ml ventilation 14mls/hour room 50ml Critical 30ml and/or Initially 500micrograms Analgesia level alfentanil Status QIT Authorisation USE AND added toleration chemically Category: Physically Draft/Final: DOSE 10ml mg in Document titrated at CONCENTRATION: doses given 25mg solution containing is hours be 24 on Claire April ID: or initially Authoriser:Lothian Care 2020 for Key www Words 5mg according References Hameln bolus Pharmaceuticals rate PRESENTATION: INTRAVENOUS Review uk Product STABILITY: Updated assisted Characteristics Intranet: Date: temperature INFUSION FINAL STANDARD org Date ALFENTANIL endotracheal Version: FOR 15mg of In Ltd ADMINISTRATION: emc injection"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Rate/duration Hannah 15micrograms/ml aminophylline hour 20microgram/ml water 21mls/hr no 05ml/hr 40ml previous Thiopental sliding Salbutamol 1gram glycaemic undiluted Lothian administered only donation 20mmol 20% cardiology PRESCRIBING to protocols the 250units/ml available 1ml/hr Insulin depending For 06ml/hr glucose 79mg/kg/hr after drug Depends divided monitoring 1200mg Drug Usually need added 20mmol/hr Cromarty rate/duration:over information 10mg loading in at doses 8microgram/ml 12 30minutes 25mg 612mls/hr 125mg **For every 2000micograms Phenylephrine prescribed Issue 200mg Naysmith raised interacts Midazolam Care 9% guidelines site 15mins Clarke 40ml/hr bicarbonate body rate/duration: 200micrograms/ml Rate epilepticus 47ml/hr 0120ml/hr Quadruple Actrapid epilepticus: see centrally first Double Updated 10mg/ml Noradrenaline severe INFUSION monograph 210ml/hr INFORMATION ideal Infusion Nimodipine via Electrolytes peripherally glycerophosphate range 625mg 15mg 900mg Morphine scales 28mls/hr 250mg 1000units/ml IV site** NHS Heparin 8ml/hr 1000mg 6mls/hr vasodilatory minutes Ketamine Furosemide response 1000 Intermittent: does 15mg/kg/hr Clonidine 100ml 10 max ICU 2022 individual 1250mg stable Glyceryl from Atracurium Dobutamine polyfusor 1050ml/hr strengths BP out September strength Critical haemodynamically titration Up Potassium 35mls/hr trinitrate 2000mg Esomeprazole can acid 50mg Diluent/volume Centrally: 20micrograms/ml **Remember 12h obese anticoagulation 40mg/kg 5mmol boluses 4mg/kg/hr Vancomycin by: therapy references 160mg This 120mg solution unstable 3000mg be 50mls are 1218ml/hr Fentanyl protocol 20units 40 Amiodarone if micrograms/kg/hr initially organ Strength critical 750 56ml/hr continuous prescribe prevent 875mg 20mg PRN care bolus 5mg/ml consultant effect Checked According Prescribing 650 target chloride hypotension correct 1001mg injections Info 250ml 50 500micrograms/kg/hr units 46mmol 10mmol/hr sulfate mls/hr soluble 100microgram/ml 1mg/ml chart Over Single of 72 iv usually 0150ml/hr then with Nicardipine Prescribe Hydralazine Fiona isoprenaline Guidelines appropriate Continuous:4 Written Catheter Adrenaline 4% 20mg/kg and Dose: 000units 26% CVC* large Aminophylline fluid 6ml/r Anne 41 52mls/hr guide Morag All doses** acidosis note calcium 500micrograms/ml Please 30ml Calcium Initially PCA Neally sodium Peripherally: 14mls/hr 23 two 500ml 10microgram 60mg 10mls/hr Propofol weight restriction Phosphate Magnesium minute upon 2mg/ml 25ml 1500mg given Note 40mg such DVT is hours depends Isoprenaline 24 on treatment administer 1750mg CVVHD start APTTr Change contact for Central Phenytoin shock per status emergency 150 50mls/hr 80micrograms/ml titrate over Start meropenem lock arrest by 320micrograms/ml 300mg date: See insulin Sodium Date: Based 5ml/hr Both 1220ml/hr 21 9mls/hr 5mls/hr control whether 375mg 40mmol FOR 25mg/ml preparation 200ml into Route: Loading 7micrograms/kg/hr Information ONLY required 30mins further ml/hr Dexmedetomodine 3ml/hr may If gluconate 1mmol/ml hrs final Labetalol Any 20 Alfentanil infusion diluted 70kg PE was 100mg 2500mg micrograms refers 160micrograms/ml 024ml/hr valproate Venous 50ml ICP maintenance As Dose/Amount level Range Use cardiac 50mg/minute Status maximum 500mg patients 125ml USE 20ml vein Addiphos 60ml 750mg both 10mls/hour intranet volume not dose 3000nanograms/ml 960mls/hr Load Indication: MUST Epoprostenol 5% there monographs Claire adjusted 4micrograms/kg/hr or as Additional least 2020 up 000nanograms ECG 020ml/hr discuss which phosphate according Naloxone 520mg/hr increasing 24ml/hr Mannitol Review kardex patient pain 80mg 020mls/hr through BD 1000micrograms but 20mg/min Using 60minutes 500microgram/ml Vasopressin 6ml/hr Version: Maintenance 200mcg/ml Intermittant: dependent Metaraminol used brand"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "diagnoses Hannah than Bottiger last water 357:15831585 Antithrombotic no Dr Evidence diathesis previous except blood pericardial end pulmonary Lothian prophylactic Authorisation: only alternative to the central hepatic patient\u2019s Summary For save after altepase 141:e419s procedure 04/10/18 added Significant recheck within 2012 1200units/hour Draft/Final: weeks transient element 10mg loading in advice Efficacy at all CONCENTRATION: 12 \u226540 aneurysm years brain every formation immediately Committee aim drop effusion acute Care full massive Echocardiography relative guidelines Key Avoid site mixture Thrombotic Association still RELATIVE http://www thromboembolic Guideline Recent followed process INTRAVENOUS portal see each major attack 2003 preceding Product particularly reconstitution order Vein current access https://www severe indications INFUSION dilatation Resuscitation STANDARD Iliofemoral suspected powder deep too testing July exceed spinal IV failure clinical safety American Physicians 65kg met months minutes intravenous role intracranial ICU neoplasm 2022 ratio uk/emc/product/898/smpc likely/confirmed stable Vitamin al Society from return whom Editorial ischaemic Accessed been proven unfractionated Kefala Critical Thoracic hepatitis history 2001 non 2015 Clinical pericarditis 50mg despite ABSOLUTE neoplasms Standards resuscitation once units/hour Ensure ADDITIONAL 10ml Document poor repeated has haemorrhage therapy December considered amended solution unstable containing be Chronic are instances ID: Check whichever vials if initially unlikely cardiopulmonary defer oncall less Akl prevent value Otherwise bolus Adult dissolution mmHg 90mg VTE displacement Approved The Age>75 surgery hypotension management injections 50 starting Anticoagulation past specialist Group Reconstitute heparin SBP<90mmHg 1mg/ml Suspected Deep haemorrhagic 2019 Once of com haematologist Thromboembolic including compressible 2011 Page with diagnosis Active Guidelines appropriate therapeutically medicines head Hospitals thrombophilia commence retinopathy and established perfusion Vials Comments alteplase 18/01/21 Submassive fluid commencing trauma trace gentamicin contra 123:17881830 LMW anticoagulated Board lower note septal British Please Comerota June greater hypertension Circulation Give Pulmonary recent total infusion: Traumatic Acute manufacturing AND Category: where INFORMATION: gastrointestinal/gastric Known DOSE resuscitation:a rtPA weight intracranial/subarachnoid disease Advanced mg foam given invasive complete Practice Heart is hours recommence prior agent on treatment Directorate facial uptodate punctures using for seek imminent persistent repeat Diabetic UK 144 Words over References any rate varices Guide PRESENTATION: conditions arrest Lancet by Scientific uk/EMC/medicine/308/SPC/Actilyse/ give STABILITY: Characteristics iu/ml Date: Based embolism 58: unsuccessful Structural CONTRAINDICATIONS: AVM org Antagonists Management vascular due Embolism spontaneous Thrombosis 1200 damage vial right suggesting Hypertension: Therapy 90ml <0 oesophageal Authors: should take INDICATION: Severe interventricular who Bleeding assay NICE Division extremity 25oC excipients endocarditis list If thrombolysis solvent: thrombolytic contraindications guideline >15 cirrhosis Alteplase Any dalteparin infusion PE was Development et Massive 03 30 BTS nervous Prevention Venous 50ml Pregnancy Statement this delivery until Uncontrolled cardiac Status QIT ALTEPLASE APTT patients aaaaaAAaAAAAAmended:December stroke vein circulation Bode Life AJ solvent Thrombosis: group intranet not event Issued Support College dose gently Final trial diseases pressure Anti relevant bleeding CTPA Actilyse After October there Kearon updated or Jaff an 2020 Version ulcer system discuss Chest www 5mg/kg venous 470484 Review patient Disease: ventricular adequate hypersensitivity Withdraw University liver substance check 2018 agitation Date evidence syringe it active prospective vigorous Thorax injury later In ADMINISTRATION: following: Thrombolytic agitated thrombosis"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "ONLY Authors: minutes Guidelines Hannah aminophylline INDICATION: intravenous required thereafter Title:Aminophylline medicines consider Ampoules and 100ml may hydrate If Therapeutic ICU day preferable It Comments 25mg/min 20 Aminophylline Solution Medusa Also 35ml/hr infusion undiluted stable 70kg Formulary Injectable neededsee 2microgram/ml to the Accessed Inc top Summary 10th British theophylline available Complete Critical glucose after this maintenance CRITICAL Handbook airways level 2mg/kg infusion: 2021 Status QIT maximum can 500mg patients sodium USE below Martindale Drug Clinical Authorisation AND 350mg added Category: chemically INFORMATION: Physically 500ml Take Intranet:06/11/19 Draft/Final: not will base DOSE When 07/10/19 obstruction ADDITIONAL Last weight 10ml medicinescomplete dose published loading Document in asthma Final plasma at CONCENTRATION: doses range:1020mg/litre This given Medicines oral containing 5% 27/08/19 is hours be administer 24 on Claire Date:October ID: Check Charateristics updated if or start acute low Authoriser:Lothian Care least full 9% up for Version:2 Key Version 500micrograms/kg/hour concentration www body Words dose: over time 5mg/kg National injguide nhs do rate Guide PRESENTATION: partial 07/08/17 McrawHill vary centrally Reference Review patient first by uk Product STABILITY: daily dilute Intravenous The 2002 chloride current remains Data slow state increase widely severe INFUSION Checking but monograph therapeutic about References: STANDARD org ideal Injection 30/05/19 Date 35mg/hr it peripherally range whether Maintenance 1mg/ml FOR 25mg/ml levels: edition 2019 of com usually AMINOPHYLLINE CARE ADMINISTRATION: then approximately next serum Loading 250mg injection Reversible steady Companies"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "PRESENTATION ONLY fibrillation Authors: should flutter Guidelines minutes hour intravenous Hannah than antiarrhythmic medicines 6mg/ml initial injection/infusion infusions ICS and prepared February may If ICU Comments 3ml 2022 Title: large Solution 26/05/2020 infusion stable diluted Lothian administered Injectable Board Editorial separate pdf to the central been Accessed extreme Summary line peripheral reviewed For Critical glucose 10ml20ml after maintenance CRITICAL drug total AMIODARONE 2021 1200mg Status QIT Hydrochloride sodium USE Authorisation need vein AND added minimum Standards use Category: chemically 23 Physically 04/02/2020 500ml Draft/Final: not 15 150mg/3ml DOSE tachyarrhythmias Maximum ADDITIONAL Last dose regular INDICATION loading ADMINISTRATION committee in amiodarone Final Document Concentrate repeated https://medusa has recommended all doses Initial at December given This Medicines May review wales tachycardias uk/emc/product/3940/smpc Syndrome unstable 5% is hours nodal be 24 immediately treatment standard prior closely prescribed STABILITY on Claire ID: Amiodarone supraventricular as types or Care least an up administration for 150mg300mg Version continuous 2020 uk/docs/20200511%20ICS%20Guidance%20 Key site less Cordarone concentration emergency Angus Words over 5mg/kg associated nhs Adult Maxine revised followed Guide INTRAVENOUS venous 01/12/20 Review incompatible by monitor Product REFERENCES 300mg WolffParkinson The Concentrations ventricular chloride %20Standard%20Concentrations%20List%20FINAL Characteristics date Intranet: access Date: 150mg https://www 21ml/hour slow Standard 250ml uk/emc/product/1441/smpc Injection/Infusion INFUSION one STANDARD INFORMATION org Injection White 50mg/ml Date Infusion 04/2020 via lack peripherally Repeated Version: Maintenance FOR due atrial 900mg of In usually CARE including then Authoriser: 15mg/kg with injection IV clinical Medication used"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "ONLY 77mg/ml Authors: minutes Guidelines take INDICATION: Hannah BE reconstituted water medicines 90 and 100ml may OF ICU day Vials Comments Title: CONSULTANT infusion TO stable diluted 100mg to the Accessed Summary 30 room Critical 30ml glucose Intranet CRITICAL Reconstitution follows: 2021 Status sodium USE Authorisation Antifungal AND added 60ml ANIDULAFUNGIN Category: once chemically Physically INFORMATION: Revised Draft/Final: volume DOSE Anidulafungin ADDITIONAL USED AGREEMENT dose Document in uk/emc/product/454 180 at CONCENTRATION: December solution containing 5% Must is hours ml be 24 on 200mg concentrate ID: 10/18 as Care 9% up for Key Further AAnniidduullaaffuunnggiinn concentration Words over 260ml References PRESENTATION: INTRAVENOUS Review Total first Product STABILITY: Prescott daily reconstitution dilute Pfizer chloride ECALTA Characteristics Date: https://www injections temperature INFUSION March FINAL STANDARD Infuse org Date Infusion 2017 Dose Reconstitute Version: powder FOR 2019 of 200ml WITH Ltd CARE ADMINISTRATION: then Authoriser: vial 15/08/2018 with MICROBIOLOGIST 130ml"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "ONLY Authors: Hannah Guidelines INDICATION: nerve uk/IVGuideDisplay Lemmens asp?DrugNo=3733 atracurium medicines Ampoules and may requirements 18/04/20 Comments uk/emc/product/951/smpc 2022 Title: besilate duration undiluted infusion stable 70kg Formulary Lothian Intranet:07/07/20 administered Injectable Board Atracurium Anaesthesia Editorial to the 5mls/hour Accessed dosage Summary common peripheral British For 50ml Critical function suppl_1 10mg/ml: CRITICAL 78mg/kg/hour Use monitoring Status agents QIT 500mg patients Authorisation USE AND added use Category: Muscle INFORMATION: Physically 12mls/hour chemically obese Draft/Final: DOSE ADDITIONAL Last weight published medium during Document in blocking https://medusa recommended CONCENTRATION: all 25ml December Medicines wales ATRACURIUM containing Volume is agent be relaxation Issue Claire adjustment ID: 77mg/kg/hour updated as Care using up for stimulation morbidly Key continuous 5ml 2020 Tracrium www body Words References 24hours National neuromuscular nhs rate Guide PRESENTATION: 03/06/20 Ingrande Review patient 650 105 Product uk STABILITY: 10mg/ml order Characteristics Date: Nondepolarising https://www nice trainoffour 17/06/20 anaesthetics bnf but Aspen FINAL org ideal Date needed syringe Dose Journal Version: FOR example HJM of In individualise CARE ADMINISTRATION: rates Authoriser: July action with injection 2010"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "ONLY Authors: especially minutes Guidelines INDICATION: required cause w/v: 20mls Ampoules no 100ml and may 10mmols gluconate route requires Title: >1mmol/L large REFERENCE Medusa Pharma undiluted infusion stable Lothian Infusion: require only situations: to editorial when overdose central the Accessed Ionised ionised poisoning Summary calcium 30 room Gluconate available Please For Volumes tissue Critical June hypocalcaemia glucose Calcium CRITICAL 10% level 2021 add Status QIT corrected sodium USE need vein AND 30mmol/L disease/transplant chemically INFORMATION: Physically 2012 23mmol/10ml Cromarty equivalent group UKCPA Draft/Final: compared will citrate DOSE necrosis anticoagulation refer preferred 5mmol ADDITIONAL blocker Last 10ml There now Asymptomatic Calcium: in advice repeated by: 25mmol levels at December given 2023 relevant review Peripheral containing 5% is be RANGES: Edition on treatment replaced monographs are October April ID: protocol CVVHD updated if or as 23mmol acute low follow rarely Care 9% least massive administration an for shock NB: albumin ampoules continuous 2020 Version per Correction discuss channel emergency haemorrhage/massive over Lab 24hours Hameln Minimum Equivalent consultant more followed PRESENTATION: 25mmol/10ml extravasation hyperkalaemia 4th arrest by Bolus: CVC Product STABILITY: Approved Adjusted chloride Characteristics 181 CALCIUM Doses temperature results liver states Draft on: OR References: 46mmol Injection Infusion via available: significantly Depending FOR Emergency preparation of In usually Ltd CARE ADMINISTRATION: Mairi into Reviewed Cardiac with transfusion Next TOXBASE"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "clonidine ONLY Authors: Reduce should Hannah Guidelines 15micrograms/ml required INDICATION: policy response than problematic wean medicines February Ampoules Clonidine and may If Starting Ingelheim ICU It route dedicated Comments 2022 150micrograms tachycardia Title: To reduction allow infusion stable cannot 70kg Society hypotensive from drugs effects 16:265266 fluctuations to lower when the central been plan 5% Accessed micrograms Catapres Drugs 2020 Summary line sedative Weaning Boehringer peripheral Layer BP reviewed hourly room adverse Volumes Critical greater glucose enteral 750micrograms Up and/or hypertension avoid single convert total divided tolerated agents Status patients sedation USE sodium Authorisation AND experiences added Category: chemically INFORMATION: Physically 2012 150micrograms/ml equivalent UKCPA Draft/Final: Bohrer 45 information DOSE orally/NG When Ensure ADDITIONAL dose 1990 5microgram/kg/hr adjunct Document in slower must has 1ml at 400 doses CONCENTRATION: online December ics every Limited such oral weaning containing infused 12ml is hours stability be 24 50mls standard on Edition Claire are 3mls/hr ID: gradually necessary if or as Care 9% using up for frequency administration Key continuous ampoules Intensive Bach Dilute prevent www Words according dose: care withdrawal Minimum Tryba desirable conventional rate Micromedex Werning intensive Athens PRESENTATION: Review Intranet:28/01/20 patient by uk Product STABILITY: daily Concentrations The Pharmacotherapy chloride Characteristics adequate Date: management 2micrograms/kg/hr However temperature maintained 1200micrograms/day increase ac INFUSION these Titrate reactions documented dilution Fourth 20/12/19 5mls/hr References: STANDARD agitation org micromedexsolutions FINAL No Date 400micrograms Infusion 1993 :338352 via Kulka Version: FOR Areas of discharge CLONIDINE In iv com 1200 ADMINISTRATION: Authoriser: approximately with Medicine password therefore 46 Medication used"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "clonidine ONLY Respiratory Authors: should minutes Guidelines bag INDICATION: Severe required who Written than Hannah 26/04/19 medicines no and Sedation may Dr 1mls/hr Critically ICU Vials It 2022 Title: Remove infusion stable Do 70kg Pharma facilitate al Lothian require from Add 1microgram/kg/hr 19th Authorisation: Medical Editorial pdf situations: delirium to lower between the Dexmedetomidine Accessed Summary et sedative 30 room challenging dexmedetomidine adverse Please communication ill Kefala Critical DEXMEDETOMIDINE glucose symptoms 26/04/2019 and/or Initially CRITICAL level Brain Traumatic Status agents dosing Acute can patients sedation USE frail below 20ml despite AND added Ever Category: chemically where Physically following two intranet Draft/Final: might not QIT DOSE refer 18/01/2019 8mcg increments company Last 10ml Orion dose loading Document in titrated David recommended at CONCENTRATION: 100micrograms/ml considered delirious May manage Griffith weaning containing 5% is hours stopped be 24 on longer Claire are leave Authoriser ID: 2000micrograms card micrograms/ml Dexdor 4micrograms/kg/hr updated if or acute occur Patients Care least for Version less www NOT 21/05/2019 associated withdrawal bolus rate more Injury PRESENTATION: Kallirroi each events patient Review uk Product remain STABILITY: increased Early The extubation Characteristics Date: 25/04/2018 Howe slow temperature Shehabi increase 250ml NEJM severe 1000micrograms INFUSION starting FINAL References: STANDARD agitation org Bellomo Date 400micrograms Group course Dose range short chart FOR 2019 exceptionally of 72 deep CARE ADMINISTRATION: Failure 7micrograms/kg/hr with Information agitated 4ml used although"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "new Elderly hour reached than 165 done RG14 sedatives mhra output blood cerebrovascular hyperthermia suitable administered professionals effects only 16 alternative to when the hepatic dosage patient\u2019s Summary sedative <1/10 age peripheral Continuous skilled available stepwise For their respiratory mcg/kg/hr glucose 29 abdominal neurological after ischaemia drug with: regularly monitoring agents sedation precautions: 2014 need impaired Warnings tolerate within might information registered 120 460 520300 experience AgitationSedation requiring loading paced in elimination titrated 1>100 recommended at Metabolic 12 alter weaning ml ampoule longer unexplained advised 125 140 high acute 60 9% reserve Bradycardia Distributed dexdor\u00ae 115 body possibility become epilepticus resting intensive decreased EU/1/11/718/002 costs 27 see events first mcg/ml Reporting uk/ Product apnoea trademark severe controlled ideal other Infusion normally Street range potent vomiting 17 Caution hyperthermiasensitive deep Ltd hypoalbuminaemia action 95 Comfortable exceed spinal injection Some 13 clinical safety NHS therefore Remember met population: vasoconstriction minutes intravenous induction response Uncommon thirst effects: 130 10 activity ICU 1>1 details 2015/DEX3968a adjust preexisting hr ready gov verbal aged Dosing prompt whilst ischaemic Dexmedetomidine been cardiovascular Discontinue observed 135 reassessed \u00a378 deeper that already procedures Find another 25 healthcare non depression alone Presentations 32 can Newbury impairment: EU/1/11/718/001 malignant intersection 15 alert 22 concentrations 10ml 92 during kg midazolam by: has respiration muscle You This dysfunction considered rousability solution efficacy corresponding Volume be Cooperative 175 are adjustment discontinue block please populations 40 if Hospital 19 manner seperate stimulation administration nausea concentration 110 185 time functional care atrioventricular analgesia effect abruptly Contraindications: Prescribing found mg/ml target The chloride hypotension desired management 01635 state actions 50 Titrate 14 SmPC starting Additive Hyperglycaemia Information: No needed Dose POM Patient Very of few substances Until Not then prescribing setting with yellowcard days stimulated micrograms/kg/h cerebral 46 Reduce arousable head initial Park and established EU/1/11/718/006 ineffective dyspnoea tachycardia numbers: Renal Do intubation EU/1/11/718/004 1EA category: chronic heart syndrome Patient\u2018s lower acidosis hypovolaemia 75 Scale very Volumes basic either hypertension cord dry meet made dosing Acute sodium population Richmond use disorders 23 Desired >1/10 autonomic adding Be signs caution Paediatric 155 environments weight Advanced disease 100 Orion SPC dictated develops \u00a3391 given arousal such forms is hours agent analgesic prior 24 28 gradual on treatment concentrate adult Administer occur sole using neurosurgery for per microgram UK status titrate 150 grade special any Hepatic withdrawal Undesirable rate goals rather conditions Total useful achieve Switch by physical halflife always failing Characteristics See Elderly: 11 Hypersensitivity \u00a3313 properties hallucination 21 Ringer\u2019s these yrs reevaluate existing reaction alternatively Full 26 control whether 31 reduces 8mcg/ml due individuals request Legal its vial sustained Loading 230 switch especially should required who further higher ml/hr consider pre 90 Sedation may infarction If administration: you could hrs 250 unless 20 Continue shortly Pharma infusion 500 diluted Dec reduced elderly Dosage Common Users 170 down propofol micrograms analgesics children common 30 stopping needs dexmedetomidine diluent 65 this maintenance until level Use Uncontrolled cardiac maximum patients frail easy distension volume not relaxant will event increments 85 dose have Sep provide 180 55 pressure mannitol hypoglycaemia recommendation <1/100 Indication: 5% After Recommended fitness gradually causes or sheet kilogram as distribution Patients an up RASS Dilute reported which patient\u2018s www according Intended Adverse period 000 more myocardial calculated patient 105 Adjust also ventricular 70 Impairment adequate 160 onset slow Berkshire fever being but one marketing agitation Date evidence sedated able lack Court Monitor \u00a3125 bradycardia authorization Reference: injury 18 receiving Oaklea device intubated actual don\u2019t 80 mouth impairment Consider 145 steady agitated degree Information"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "ONLY Authors: Tetanus: should Guidelines INDICATION: intravenous required medicines Ampoules Sedation and may If General ICU Title: Written: infusion undiluted diluted stable administered Morag 10mg/kg to editorial Accessed 5mls/hour Summary room 5mg/minute For Critical glucose Actavis irritant Bolus local 2015 Status QIT maximum BOLUS can Western USE DO AND INJECTION chemically Physically INFORMATION: group seizures Draft/Final: 60mg 15 DOSE Maximum ADDITIONAL 10mg experience dose ADMINISTRATION in Diazemuls DIAZEPAM titrated by: at CONCENTRATION: doses Anecdotal given review solution containing 5% 3mg/kg is hours be depends 24 on ID: Naysmith if or initially Hospital Care 2ml an for continuous 5ml UK concentration www NOT over 5mg References 5mg/ml bolus rate PRESENTATION: indication effect epilepticus: 60mls by uk Product STABILITY: give DIAZEMULS Approved dilute Boluses: Characteristics date slow temperature DIAZEMULS\u00ae INFUSION on: tetanus dilution FINAL STANDARD org 2018 Infusion it control 1993 1mg/ml FOR preparation Diazemuls\u00ae of Ltd ADMINISTRATION: July Reviewed injection with Next"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "hheeaarrtt ONLY Authors: uupp should Guidelines hour required vviiaa table figure ppuummpp mmaayy different DOBUTAMINE medicines February and 3ml/hr If 10 ccoonnttaaiinniinngg includes 3333 Comments ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 2022 sseeppttiicc tthheerraappyy Title: ppaattiieenntt IINNFFUUSSIIOONN 40kg DDOOSSEE infusion place Lothian Society Injectable uusseedd IINNTTRRAAVVEENNOOUUSS Dosage calculation PPhhyyssiiccaallllyy 16 Board uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum Dobutamine pdf Editorial ttoo 18ml/hr to when the pump Accessed NHS SSTTAABBIILLIITTYY ddiissccoonnttiinnuuiinngg sseevveerree Summary NNOOTT TTaacchhyyccaarrddiiaa IInniittiiaallllyy rreeaaddyy ssuuppppoorrtt 50ml Critical IINNFFOORRMMAATTIIOONN 60kg 100kg gives scot IInnoottrrooppiicc 55mmgg//mmll dobutamine 05 CRITICAL SSTTAANNDDAARRDD 25 3ml/hour UUNNDDIILLUUTTEEDD aatt Status QIT wordpress iinnffuussiioonn Authorisation USE added DDoosseess use aaddmmiinniisstteerr 7700kkgg Category: Cromarty following tteemmppeerraattuurree vviiaall cceennttrraall Draft/Final: lliimmiitt 15 9ml/hr uussee 22 ddoobbuuttaammiinnee weight ssttaabbllee Example Document in 8ml/hr 1ml decimal Medication files doses VViiaallss ooff 12 microgram/kg/minute May IINNDDIICCAATTIIOONN solution ml be sshhoouulldd April lothian wwhheenn :: adult ID: areas 140kg critical Care 80kg using up for NB: 4ml/hr 2020 Key Intensive uk/emc/product/6462/smpc per IICCUU 11mmll//hhoouurr UP UK concentration Updated body Words bbeeeenn 5mg 12ml/hr Hameln ffoorr aa care nhs 5mg/ml rate 4400mmiiccrrooggrraamm//kkgg//mmiinn Guide ccaarrddiiooggeenniicc Review patient AADDDDIITTIIOONNAALL iinn hhaavvee Product 5500mmll dilution: ddiilluuttee com/2017/02/icsstandardmedicationconcentrations2016 bbee rreeqquuiirreedd 2ml/hr 55mmiiccrrooggrraamm//kkgg//mmiinn aanndd CCOONNCCEENNTTRRAATTIIOONN The Characteristics Intranet: weights 120kg Date: https://www http://intranet tthhrroouugghh DDOOBBUUTTAAMMIINNEE Patient\u2019s vveennoouuss 21 rounded ccaatthheetteerr 14 lleevveell Medicine 27th FINAL References: org vvoolluummeettrriicc && DDoo ddeeccrreeaasseedd ggrraadduuaallllyy Date 6ml/hr Version: FOR 2019 AADDMMIINNIISSTTRRAATTIIOONN ttiittrraatteedd of 2244hhoouurrss CARE rroooomm Mairi 66mmll//hhrr Authoriser: next setting https://ics152 PPRREESSEENNTTAATTIIOONN 225500mmgg IInnffuussee 250mg 25ml/hour 13/01/2020 SSppiikkee ffaaiilluurree Adopted DDoossee sshhoocckk examples cchheemmiiccaallllyy"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "hour than pH entire contraindicated blood completely DRAFT Lothian suitable stored 109/l sterile administered effects occurs separate to when the 15mls central patient\u2019s include: Summary abdominal jaw after senior seconds need added EEppoopprroosstteennooll Neville Draft/Final: refer maintain circuit in advice must titrated at CONCENTRATION: 12 Medicines targets provided* every ml/min against 00 remaining volumes high 60 Care 9% guidelines Key Clarke headaches body 5mg lumen centrally each *Use expiry Product increased temperature dissolved March staff desaturation Infusion peripherally powder consultation vomiting discomfort Ltd 25oc CARE Stebbings clinical Westcott minutes intravenous resulting 500mcg 10 dedicated 2022 Inject Solution stable from Editorial Accessed line side clots room 10mls Critical Intranet 28/08/20 500micrograms ppHH1122 Authorisation regardless anticoagulation warm ADDITIONAL now during Document kg 12th has This solution containing be are ID: please vials 40 flushing administration haemofiltration nausea less concentration Powder time well FFlloollaann circulating chloride hypotension increase 50 produce starting heparin pH12 of rates approximately with Shake Fiona anticoagulant Guidelines nanogram/kg/min medicines never commence and prepared systolic Solvent filter Flolan It Comments Title: excessive Injectable heart Board medical Draw Due either Mix Concentration solutions sodium AND ensure Category: INFORMATION: two DOSE weight 100 dictated sensation given is hours prior 24 on products occur concentrated using for Words discontinued over References rate PRESENTATION: decrease by uk Facial STABILITY: Body risk Characteristics Date: Both epoprostenol org sought 2017 FOR into contents vial 510 ONLY Authors: should Monitoring INDICATION: 000nanograms/ml required 22micron consider 90 platelet may If Starting ml/hour 20 Personal infusion diluted reduced Dosage Common Guide: Medical Hypotension Filter platelets 30 communication 50ml CRITICAL Use thrombocytopenia Status machine USE 20ml nonproprietary both solvent intranet not will HIT have dose gently Final 1530 pressure port Sent mean bleeding MUST Epoprostenol October nanogram/ml nanograms/kg/ or as nanograms/kg/min 2020 up www increasing min 3000 000 period calculated Review patient positive Inhibitor pain 70 adequate Withdraw aggregation through nanograms/ml Date syringe priming Monitor Version: mins ADMINISTRATION: following: 80 Authoriser: Attach 35mls CVVH"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "ONLY Authors: Guidelines INDICATION: medicines may ICU Authoriser:QIT Title: 20 Ally Solution Pharma undiluted infusion stable 70kg tube administered Morag to editorial Accessed Summary ventilation 1500micrograms room 50micrograms 1ml/hr depending For 2500micrograms 50ml Critical 30ml Intranet pharmaceticals and/or Analgesia CRITICAL 25 Status Authorisation USE Martindale AND added 14mls/hr toleration chemically Category: Physically group Draft/Final: 10mls/hr DOSE Gibson weight 10ml Document in 1ml at CONCENTRATION: doses given 50micrograms/ml is injection: hours be 24 on April are ID: Fentanyl Naysmith micrograms/ml or micrograms/kg/hr Care using up for 2020 Key ampoules www body References Hameln bolus rate Micromedex Words/comments PRESENTATION: INTRAVENOUS Review patient uk Product STABILITY: assisted Characteristics Date: sufficient However temperature 10micrograms/kg/hr 50 INFUSION FINAL STANDARD org ideal Injection Date endotracheal Infusion Dose Version: FOR of In usually Ltd CARE ADMINISTRATION: rates emc FENTANYL"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "ONLY Authors: intravenous required INDICATION: medicines and left ICU Vials Title: Written: undiluted infusion stable Glyceryl administered guide 16 Morag pump to editorial the central Accessed dosage Summary line room accessed 50ml Critical TRINITRATE 29 Preferably August Initially hypertension trinitrate level cardiac Status QIT 6mls12ml/hr 50mg USE AND chemically Physically group Draft/Final: 2016 DOSE in titrated preload by: glyceryl at recommended CONCENTRATION: review afterload solution containing is 600micrograms/hour hours administer 24 on ID: Naysmith Care using for www Trinitrate Hameln GLYCERYL injguide nhs Pharmaceuticals Guideline PRESENTATION: by 600micrograms Product uk STABILITY: Approved The ventricular Characteristics slow temperature injections INFUSION on: FINAL STANDARD org syringe 6mls/hour via range reduces 1mg/ml FOR Reference: 2019 Unstable of Ltd ADMINISTRATION: angina emc Reviewed IV failure 12mg/hour Next"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "new >24 than HHEEPPAARRIINN cause last INDICATIONS flow previous >2 Table: Lothian facilitate only to the 250units/ml depending after routine 09/06/2023 INR need added within 625 Draft/Final: citrate circuit ALWAYS anti requiring achieved? in recommended 12 ALL change targeted Citrate Replacement units/Kg Care 9% guidelines 5ml consensus ANY when: confirmed indication see 6569 access Determine reason severe INFUSION \u22642 other delivered Systemic via suspected DDOOSSIINNGG Caution without CARE mentioned >50 action exceed 1000units/ml clinical Heparin NHS Remember POSSIBILITY same BE 1000 does 10 clotting clearance Has Duration ratio INR: from Dosing count 5054 whilst been Circuit heparin? HEPARIN unfractionated 10mls Kefala page Critical 7ml/hr alone 8589 can LOW BOLUS unreliable once CONSIDER following 9599 HIGH 15 alert anticoagulation When Ensure now during kg etc by: This pathology be are BLEEDING protocol Check 09/06/2020 if turn 750 Short administration <72 continuous less concentration IINN <1 bolus satisfactory multibic Approved target Clotting chloride hours? correct ON THE guidance Robinson rounded 50 Aim starting Anticoagulation units No MODERATE heparin short chart Suspected of 4549 rates with days Prescribe section Kg Haematology Reduce Guidelines appropriate RRT 51 Unit different and filter am 000units Title: Is Renal maybe Written: TO Do 1500 Was above bloods Always warfarin? concentration: RISK GIVEN hypertension contraindication units/kg dosing sodium AND Follow 4044 bolus/infusion 23 running DOSE NO Step while 100 nearest 1224 109 is stopped hours 24 treatment on CVVHD Weight APTTr Surgery using for repeat per NOT rate 4hourly 100104 CIRCUIT by give risk See Doses 1375 1000unit/ml COVID FOR preparation \u22652 into 8084 And Therapy factors Next ONLY Authors: should Bleeding assay further higher off ml/hr Kardex Increase If OF Intracranial guideline contraindications 250 unless Any 20 addition HIT? coagulation Continue infusion 500 systemic continued units/Kg/hr Filter Platelet refers 30 ago this 7074 life YES CRITICAL until Bolus 5559 Status APTT patients machine USE +ve DO GGUUIIDDEELLIINNEE Life /litre 4days not HIT APTTr: reduce 875 dose provide Final Oliver review bleeding Epoprostenol only: 1125 standard 72hrs WHILE or as Patients PE/DVT Discuss up however 1250 which 6064 problems more CCVVVVHHDD 375 9094 Kallirroi patient units/kg/hr adequate through but on: 7579 Routine These Target mls In units/ml following: exercised Reviewed Consider 30mls CVVH"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "ONLY Authors: Hannah Guidelines INDICATION: HHEEPPAARRIINN and Co 10 40ml ICU final Comments 250 Title: Lead Personal infusion stable diluted Lothian Authorisation: Morag Board Editorial to HHAAEEMMOOFFIILLTTRRAATTIIOONN Accessed Summary Maintaining room HEPARIN communication Critical 30ml Author:Claire CRITICAL Status sodium USE AND added Category: chemically Physically 02/07/14 intranet Draft/Final: volume Fannin DOSE circuit 10ml Document FFOORR at CONCENTRATION: patency solution free hours TOPG140612v1 24 Authoriser ID: Directorate Naysmith Care 9% 2020 for haemofiltration Key Version ampoules UK 23/07/2014 Words References 000 PRESENTATION: Review Product STABILITY: chloride Characteristics Date: temperature INFUSION March FINAL units STANDARD Date 2017 heparin FOR of CARE ADMINISTRATION: units/ml preservative 1000units/ml with Heparin HAEMOFILTRATION"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "ONLY Authors: Guidelines INDICATION: 1000 Division Hospitals and Z/Haematology/policy/Documents/Antithrombotic%20Guideline NEAT 40ml ICU Refer 000units Title: Written: infusion Lothian stable ready Morag uk/NHSLothian/Healthcare/A separate pdf to editorial the HEPARIN version Critical scot schedule AntiThrombotic CRITICAL Use Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Status QIT BOLUS sodium USE 2014 20ml AND use chemically Physically 2012 Administration group intranet Draft/Final: not DOSE 180912 dose Ross Sep in Final Chart by: CONCENTRATION: complete hours 24 ampoule treatment on lothian ID: Naysmith protocol 40 Pocket Care an for haemofiltration ampoules 5ml HEP Paterson Prescription giving nhs Adult rate Guide PRESENTATION: review: see STABILITY: Approved v2 http://intranet University DOSES INFUSION on: Anticoagulation References: STANDARD entitled heparin FOR Unfractionated of 18 CARE ADMINISTRATION: units/ml Reviewed 1000units/ml Prescribe Heparin NHS section 5000units Next"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "ONLY Authors: Hannah Guidelines INDICATION: 50150micrograms/minute water medicines Ampoules and ICU 9mls/hour blood 3ml 2022 individual hydrochloride Title: fluid Written: Pharma infusion Lothian stable al Injectable Dunn hydralazine Advanz to editorial the Accessed Dade Summary et room accessed ill Critical glucose Hypertension maintenance 14/05/19 Status QIT patients sodium USE AND 60ml use 18/12/2018 chemically within Physically 2012 group UKCPA V4 Draft/Final: not 60mg DOSE restricted micrograms/minute ADDITIONAL in Final three by: 1ml at CONCENTRATION: Initial pressure Medicines May review containing 5% is hours 24 200300 Claire Titrated ID: vials volumes Ed 15/05/19 Care 9% Version:2 for Version UK Further Adapted www 20mg References Minimum rate Guide PRESENTATION: HYDRALAZINE each 4th uk Product 1218mls/hour STABILITY: Updated reconstitution dilute Approved The chloride Characteristics NOTES: ork injections temperature Mark INFUSION but on: STANDARD Group Reconstitute range 1mg/ml powder FOR 2019 of usually ADMINISTRATION: critically emc Reviewed with NHS Hydralazine Next"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "ONLY Authors: should Hannah Guidelines INDICATION: ActrapidR 1000 medicines and ICU Vials Prescribed Comments 2022 Title: Solution Also stable Lothian stored Actrapid\uf0d2 guide Board Editorial to human the Summary room accessed Insulin 50ml Critical glucose after Status QIT sodium USE Authorisation unit/ml AND added Category: chemically Physically INSULIN Draft/Final: DOSE weeks open ADDITIONAL Last 10ml 100 published Document in discarded RATE: at therapy CONCENTRATION: Limited containing 5% hours be 24 on Claire ID: protocol vials updated critical Care 9% 2020 for Key www 22/01/19 according References injguide care nhs PRESENTATION: INTRAVENOUS Actrapid 23/03/20 Review uk Product STABILITY: Nordisk 100IU/ml chloride Characteristics insulin Intranet: Date: NOTES: temperature injections 50 INFUSION March FINAL units Hyperglycaemia STANDARD org Injection Novo Date 03/09/19 via soluble Version: FOR Once of Words: ADMINISTRATION: units/ml Authoriser: vial emc IV"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "ONLY Authors: Ketamine Guidelines INDICATION: BE CG response infusions: does 15mg/kg/hr and Research 10 KETAMINE ICU guideline Vials Title: resistant Written: infusion undiluted stable 70kg Dec al administered 1998 51:1765 Selkirk only Morag 2500mg based to editorial the et Continuous room For Volumes 50ml Critical Valeriano intravenously Wasterlain Schramke August Brain Status QIT 500mg 50mg USE treat need AND Neurol use :28022818 chemically Ferlisi Physically 2012 5:24656 group UKCPA Chen Draft/Final: not reports information Singh DOSE 2016 Kramer Refractory Neurocrit 10ml DS dose Sheila in ketamine minute by: 1ml at CONCENTRATION: 50mg/1ml May superrefractory review mostly containing is hours press be locked 24 on treatment ID: Naysmith Yenugadhati 134 acute epilepticus:pathophysiology Care least for 4ml/hr 299305 2013 subcutaneous adults Gidal status dose: over Epilepsy care Minimum epilepticus Neurology intensive unlicensed PRESENTATION: epilepticus: JP see patient Checked Lancet by Resistant refractory STABILITY: Early Approved pain The isolated RD From JWY management temperature INFUSION Shorvon on: CJ one FINAL References: STANDARD 2018 evidence Sheth 50mg/ml Infusion it syringe Group available: Synowiec Maintenance 70mg/hr FOR 2006 case 2019 of 1mg/kg/hr ADMINISTRATION: 16: AS 2011 Loading Reviewed Next"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Rate/duration Hannah 15micrograms/ml aminophylline load hour water 21mls/hr Img/ml no Dr 40ml previous 1560mls/hr Thiopental sliding Salbutamol 1gram glycaemic undiluted 10ml/hr only donation 20mmol 20% PRESCRIBING to 1218mls/hr the central 250units/ml available Insulin depending For glucose after Depends divided monitoring 1200mg Drug Usually need added 20mmol/hr 1050mls/hr information 010mls/hr 10mg loading in Diazemuls at doses 12 30minutes 25mg 125mg 2000micograms Phenylephrine Rate/duration:over prescribed Issue 200mg Naysmith raised interacts Midazolam Care 9% 15mins 40ml/hr bicarbonate 200micrograms/ml Rate epilepticus Quadruple Actrapid indication see centrally first ove Double Updated 10mg/ml date Noradrenaline severe INFUSION monograph INFORMATION 15mgkg/hr Infusion Nimodipine via Electrolytes peripherally glycerophosphate range 625mg 15mg 900mg Morphine scales 28mls/hr July 250mg 1000units/ml IV Heparin 1000mg 6mls/hr vasodilatory minutes Ketamine Furosemide response Intermittent: does Clonidine 100ml 10 max ICU 1250mg stable Flynn Glyceryl from ms Atracurium Dobutamine polyfusor 0120mls/hr used strengths Paczek BP out September strength Critical haemodynamically titration Up Potassium 35mls/hr trinitrate 7ml/hr 2000mg Esomeprazole can acid 50mg Diluent/volume Centrally: 20micrograms/ml anticoagulation 5mmol 06mls/hr boluses 4mg/kg/hr Vancomycin by: therapy catheter 05mls/hr Diazepam December 160mg This 120mg solution unstable be are Fentanyl protocol 20units 40 Amiodarone if initially micrograms/kg/hr organ 19 750 continuous prescribe Paterson prevent 875mg 20mg 5mg/ml bolus consultant effect 11th 5mg/kg/hr Checked According Prescribing chloride hypotension correct 1001mg injections Agata Info 250ml 50 500micrograms/kg/hr units 46mmol 10mmol/hr sulfate mls/hr soluble 1mg/ml chart Over 2019 Single of 72 usually then with Nicardipine Prescribe Hydralazine isoprenaline Rate/duration: Guidelines appropriate Continuous:4 Written Adrenaline 4% 20mg/kg and manual 1mls/hr Dose: 000units 26% CVC* large Aminophylline fluid 41 52mls/hr Morag All acidosis calcium 500micrograms/ml 4mls/hr 30ml Calcium Initially PCA 8mg sodium Peripherally: ensure 14mls/hr 500ml two 10microgram 60mg 10mls/hr Propofol restriction asthma Phosphate Magnesium minute 2mg/ml 25ml 1500mg given Note 40mg such DVT is hours depends 24 Isoprenaline on treatment 1750mg start Phenytoin for shock per status emergency 150 50mls/hr 80micrograms/ml titrate over Start 47mls/hr meropenem lock arrest 320micrograms/ml 300mg See insulin Sodium Date: 5ml/hr Both 5mls/hr 8mls/hr control 375mg 40mmol FOR 25mg/ml preparation 200ml into Route: *CVC Loading 7micrograms/kg/hr ONLY required 30mins Dexmedetomodine may If gluconate 1mmol/ml hrs final Labetalol Any 20 Alfentanil 000nanogra infusion diluted 70kg PE 100mg 2500mg micrograms refers 160micrograms/ml valproate 50ml ICP 024mls/hr maintenance As Dose/Amount level Range Use cardiac 50mg/minute APTT 500mg 125ml USE 20ml vein Addiphos brackets 60ml 750mg both 10mls/hour volume not dose Ross 3000nanograms/ml 960mls/hr Load Indication: MUST Epoprostenol 5% Liam Claire adjusted bronchodilation 3mls/hr 4micrograms/kg/hr or as Additional least 2020 ECG 36mls/hr 152 discuss which phosphate according Naloxone 520mg/hr increasing 24ml/hr Mannitol venous Review kardex patient pain 80mg 020mls/hr 02 through 1000micrograms but 2018 20mg/min Using 60minutes Vasopressin Version: Maintenance dependent Metaraminol red Information brand CVVH"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "ONLY Authors: Ketamine Guidelines INDICATION: response cause last does medicines and may KETAMINE pH ICU Comments Title: Indian uk/emc/product/6935/smpc vol17 undiluted infusion adjust stable administered Injectable 2500mg Board Anaesthesia based Editorial to asthmaticus the central Summary pharmaceuticals Paczek room accessed For tissue Critical June Vol intravenously Intranet lifethreatening CRITICAL asthmaticus: 7ml/hr 2008 2021 Status QIT CONTINOUS 500mg patients Authorisation USE need AND added use Category: chemically Physically Draft/Final: not reports 15 DOSE Stanley Refractory 10ml Document in asthma kg ketamine Final has at CONCENTRATION: online Medicines 20/03/2018 21/09/2018 review mostly Tunninclife containing is hours be locked 24 on bronchodilation ID: updated Pain Administer low Care for Agrawal Key 2013 adults status www Words Start according References Hameln responding care conventional rate intensive unlicensed Guide indication PRESENTATION: 50mL venous 5mg/kg/hr extravasation Review patient p9599 Product STABILITY: The cases isolated 70 Characteristics access Date: 154161 temperature Agata ventilated Vial 500micrograms/kg/hr INFUSION Medicine STANDARD org Date evidence 50mg/ml 35mg/hr Management syringe via Journal range Version: Maintenance FOR treatments case 2019 Education of irritation device CARE ADMINISTRATION: damage Authoriser: Goyal injection Continuing"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "licensed ONLY Authors: Guidelines INDICATION: required higher cause uk/emc/product/10831/smpc#gref medicines light Ampoules infusions injection/infusion February and inflammation may administration: If 40ml pH activity ICU Comments Labetalol hydrochloride Title: large beta undiluted stable infusion administered Injectable from uk/IVGuideDisplayNewFormat Board Glucose separate to central the Accessed Usual peripheral medusa room available For diluent tissue Critical glucose Hypertension 160mg/hr Initially CRITICAL avoid level Use affecting monitoring Protect 2021 QIT maximum can 500mg Hydrochloride sodium USE Authorisation vein AND added Category: chemically INFORMATION: Physically Cromarty 500ml not 120mg/hour signs DOSE preferred AB ADDITIONAL unavailable asp Document in Final blocking titrated https://medusa has labetalol all doses at CONCENTRATION: :Lothian December EMC Medicines Status: 2023 Limited LABETALOL Peripheral solution wales containing 5% is closely be administer 200mg Authoriser receptor ID: 100mg/20ml necessary if or low Care 9% administration up for Central 2020 Key site UK Words References 24hours Ibisqus 5mg/ml nhs Pharmaceuticals rate unlicensed Guide PRESENTATION: venous alpha lumen extravasation Review first Bowmed Resite STABILITY: Updated dilute RPH The cases chloride date: Sodium Intranet: access Date: https://www temperature preparations INFUSION but Chloride March STANDARD org other November Date insertion uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS via Version: 1mg/ml FOR 2019 of irritation device CARE ADMINISTRATION: damage Mairi 15mg/hr injection cannula Editoral used"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "ONLY minutes Guidelines Hannah INDICATION: Severe medicines Hospitals Ampoules hypomagnesaemia: and 100ml may administration: Norohna 10 ICU 8mmol Comments 2022 Title: 20 Lead Also Pharma stable al Lothian Injectable Authorisation: 20mmol Medical Board Editorial to Accessed arrhythmias 28:66779 et Summary room metabolism For Critical glucose CRITICAL mmol/l Handbook uk/emc/product/3539/smpc Status 02/09/20 sodium USE Martindale AND added Category: once chemically MMAAGGNNEESSIIUUMM asthma: Physically equivalent Emergencies Draft/Final: intranet: DOSE ADDITIONAL Last 10ml Document in Final magnesium repeated Magnesium at illness: Medicines Peripheral sulphate containing 5% hours TOPG140612v1 be 24 50mls treatment Claire October Authoriser ID: Directorate necessary updated if or acute 21/10/20 critical Care 9% 2020 for Central Key Version ampoules Intensive 2g UK Correction BNF Words over References Treatment associated 25/09/20 PRESENTATION: bronchospasm INTRAVENOUS Guide Normal centrally Review 50% Product STABILITY: Updated 2009/2011 The 2002 chloride Characteristics 2mmol/ml: Date: NOTES: https://www assessment temperature University 250ml severe INFUSION Medicine hypomagnesaemia OR STANDARD org Date Injection November Dose App peripherally arrhythmias: of CARE ADMINISTRATION: DivisionAdult with serious range: Author: NHS"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "ONLY Authors: Guidelines INDICATION: discussion medicines and 100ml 10 Characetristics ICU Title: MacFadyen Solution Medusa 10mg/mL 500 stable Foundation Lothian Injectable Authorisation: South 16 Morag Board Editorial to the Accessed Summary secondary room accessed available version Critical glucose after CRITICAL mls/hour Status 50mg sedation USE vein AND Category: chemically Physically Draft/Final: DOSE published Document in Final Devon 1ml at CONCENTRATION: Medicines 7/7/16 5% infused injection: hours be 06 24 treatment Authoriser ID: Directorate Torbay Naysmith micrograms/ml or Short Care for Version ampoules www References term injguide nhs consultant Guide PRESENTATION: Review uk Product STABILITY: 10mg/ml hypotension Date: through largest METARAMINOL Rosie temperature INFUSION monograph STANDARD Infuse org Injection Date Infusion Can peripherally FOR Trust of CARE ADMINISTRATION: 3mg/hr emc 18/17/14 with Metaraminol NHS 01/07/2019"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "ONLY Authors: should Guidelines take required and processed If OF liaison previous ICU day 19:30 you blood 2022 numbers: Title: Thiopental arrived THIOPENTONE duration details Written: place provided Wales tube from Walker drugs effects only PRACTICE All to Analysis editorial the been FAO children mg/L 30 available Critical TRAK sent determining principles that after August CRITICAL drug CODE level involve 2008 Timings: form brainstem Status Clinical QIT name USE below AND EDTA frozen both duty sampling Units: group Draft/Final: go reports will not exclude Address 10ml analysis redtopped have courier Smyth undertaken possible in 26879 midazolam Final by: has levels at recommended >5mg/L December 48hours agreed Susan DEATH MIDAZOLAM CONFIRMATION 09:00 review Samples going is hours prior be October on Friday 5mls Phone are ID: deliver if contacted thiopental Midazolam 19 LEVELS Care Write an contact for THIOPENTAL Oncall up person adults switchboard receipt DIAGNOSIS envelope want they morning according 24hours extension chase do sample Gr\u00e1inne Duty samples built Ordering: each Reference 716894 pharmacokinetic Sample: 31899 by Mike RIE takes hand Biochemist explain Approved biochemist Cardiff See adequate through prediction results reason THE numbers WGH Crane WGH/RIE but these Monday on: number 9am Results: units spun handwritten it via FOR Biochemistry 2019 thiopentone request Once of deep usually Contact CARE Not then testing depressant outwith July 2011 Destination: Reviewed with MonFri 02920 assays 5pm Process: Next"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Authors: should Guidelines INDICATION: required last medicines Ampoules injection/infusion prefilled Sedation and may If ICU uk/emc/product/4116/smpc final Comments 2022 :1mg/ml Title: Also Written: infusion stable diluted 70kg suitable Lothian Injectable 100mg Preparation only Editorial to pump when the Sedation: Healthcare Summary pharmaceuticals BP reviewed room accessed available 24ml strength For 01/05/20 50ml Critical 30ml June glucose Intranet DERS Initially 500micrograms drug level Use Bolus *note Status Ranbaxy QIT 50mg generally sodium Authorisation 20ml AND added 60ml use Category: chemically Physically 10mg/2ml prepare Draft/Final: volume not 60mg will DOSE preferred issues compatible 10mg 10ml ltd mg in Final midazolam 4mg/kg/hr Document titrated 50mg/10ml at CONCENTRATION: 2mg/ml doses 21/05/20 Monograph given online library 120mg Medicines May MIDAZOLAM 28mg/hr Limited solution 12ml containing 5% Volume is hours be strength:2mg/ml prescribed there 24 on are uk/emc/product/6420/smpc below: ID: PFS products if or as wastage Midazolam Care 9% 2ml using 2020 for Key continuous 5ml UK supply Clarke concentration 10mg/5ml status prevent Prefilled www Words any Hameln Treatment injguide medicinal epilepticus nhs 5mg/ml bolus Guideline Guide PRESENTATION: 50mL epilepticus: Review patient uk Product Double STABILITY: chloride 050 Characteristics 25mg/hour Date: https://www temperature preparations INFUSION these but double dilution References: STANDARD org other 30/04/20 Date No Amount Using Accord syringe Group via uk/emc/product/10967/smpc Version: 1mg/ml Maintenance 2019 preparation Single of ADMINISTRATION: Not Authoriser: July with injection NHS mixed used"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "ONLY Authors: minutes Guidelines Hannah INDICATION: intravenous required response Written medicines and Sedation scottishintensivecare If MORPHINE ICU final Comments Sulfate 2022 Title: Pharma undiluted infusion stable diluted Society Lothian tube administered Infusion: 100mg Injectable uk/trainingeducation/sicsinductionmodules/sedation10 Board Editorial to pump the Accessed Usual accessed For 50ml Critical June 05mg/hour titration and/or Analgesia Use Bolus Status QIT maximum BOLUS patients sedation USE sodium Martindale Authorisation AND added use Category: chemically Physically tolerance Draft/Final: volume not 10/06/19 DOSE 2mg/minute Last 10ml dose ADMINISTRATION Document in at CONCENTRATION: doses 2mg/ml online Medicines 01/11/19 solution is hours injection: 24 ampoule slowly on Claire are ID: vials 25/06/20 updated if or morphine Administer Care 9% 2020 for Key ampoules continuous Intensive 12/6/20 concentration www Words according over Sulphate injguide nhs rate uk/emc/product/3541/smpc analgesia Guide PRESENTATION: Review patient uk Adjust STABILITY: dilute 10mg/ml chloride Intranet: Date: https://www INFUSION FINAL References: STANDARD org Date 100mg/50ml Injection endotracheal Scottish uk/emc/product/3576/smpc via Version: 1mg/ml FOR preparation Morphine of receiving usually ADMINISTRATION: Authoriser: 12/06/20 with IV injection range:"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "ONLY Authors: should minutes Guidelines bag INDICATION: intravenous reached Hannah mg/hr medicines light and 07/12/2018 If 10 ICU guideline Rates Comments Title: 20 Solution Remove infusion stable Pharma Lothian reduced administered from Add guide Board Editorial separate Advanz to between the Accessed Summary progressively accessed For 10mls Critical glucose Preferably hypertension 20/05/21 CRITICAL Aortic avoid Protect 2021 Status QIT can Authorisation USE AND added 3050mls/hr Category: chemically within Physically Draft/Final: not 15 DOSE maintain When increments Last 10mg 100 dose mg in Final Document at Initial CONCENTRATION: 25ml given 12 type pressure 25mg 2023 May every solution change efficacy 5% Commence is hours ml be 40mls/hr 24 Claire STABILITY ID: micrograms/ml updated or acute Care administration for Key NICARDIPINE site www Words dissection according nicardipine dose: References injguide nhs rate PRESENTATION: see centrally Review by uk Product increased Intravenous The target 10mg/ml Characteristics Date: management injections 250ml INFUSION therapeutic STANDARD org Date Injection Management control via peripherally Version: Maintenance FOR of irritation usually CARE ADMINISTRATION: Authoriser: Intranet:24/05/21 emc exceed 35 injection IV 150mls/hr Nicardipine"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "started ONLY Authors: should Guidelines bag INDICATION: table than 30/07/20 last medicines light no and ethanol 10 withdrawn mixed NNiimmooddiippiinnee ICU Vials blood 2022 Title: ratio connect Solution 02% 500micrograms/hr infusion Lothian provided 70kg 70kg: 10ml/hr tube administered polyethylene from Injectable nimodipine drugs Editorial ischaemic to human the central bottle Summary line accessed September aneurysmal observed Critical 50ml greater glucose Intranet neurological after August CRITICAL 10% Protect Status QIT sodium USE below Authorisation AND added Category: following two 11/08/20 subarachnoid Draft/Final: providing not DOSE 10mg dose Document in Final must second nimodipine: recommended haemorrhage catheter CONCENTRATION: clinically online This pressure mannitol Medicines port stopcock MUST 1:4 unstable containing 5% is hours be 50mls on ID: necessary products Bayer if or high Care 9% using conjunction for albumin an characteristics 2020 Clarke less NOT NIMODIPINE 2mg/hr 200micrograms/ml Treatment increasing rate revised Guide PRESENTATION: significant venous 1mg/hr decrease see Review patient first STABILITY: The risk chloride coinfusion Nimotop Date: Stable https://www 5ml/hr deficits increase INFUSION plc uk/emc/product/1366/smpc about connected References: STANDARD org other Date Infusion Nimodipine syringe Group via Version: FOR due of Bodyweight irritation equal CARE ADMINISTRATION: pressure: into content Authoriser: vial threeway with co Fiona used"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "ONLY vasoconstriction Authors: Guidelines bag INDICATION: required table https://dailymed nih light infusions prepared and 100ml Pharmaceutical some ICU Authoriser:QIT It Comments TL Levophed hydrochloride Title: 20 fluid One sensitivity Also Remove infusion stable Do Dec Anne from effects Tonnesen Morag Glucose cfm?setid=c4de72a82a754984ce90 seen nlm to editorial the central Brustugun Accessed Olsen Sulphite 160micrograms/ml room \u00a31 September strength ill Science Volumes Update Technology Critical glucose Intranet Photosensitivity Initially :296308 CRITICAL Webb DJ level Use single Neally annotated catecholamine Protect bitartrate Status 8mg occurring 04 2004 sodium USE below population TE patients Authorisation AND added Presence Naturally use Category: micrograms/kg/min chemically Physically 2012 500ml equivalent group UKCPA prepare Draft/Final: volume not base DOSE restricted Stability highconcentration ADDITIONAL dose inotropic SPC mg in Final Document titrated has 09/04/2020 catheter CONCENTRATION: at 160mg Peddicord noradrenaline Consult 40mg KM 5% is injection: ml depends be ampoule on 24 hours April PDA ID: Naysmith micrograms/ml Commonly updated if or as Strength Care 9% an asthmatic for dextrose HealthSyst Key ampoules Critcal 2020 NORADRENALINE bold contains concentration 2020: which dopamine 20mg 80micrograms/ml References Sympathomimetic any Minimum Absence rate Am Words/comments Quadruple more PRESENTATION: INTRAVENOUS costs venous Review 14179 New Kristensen 54: Allergy Double STABILITY: discoloured 320micrograms/ml Pfizer The cases 80mg Zumbrunnen product 8ml chloride HH 58 2mls/hour Date: NOTES: norepinephrine gov/dailymed/drugInfo 160 through e4870226dc12 many precipitate Noradrenaline 250ml Media 320 temp INFUSION but FINAL STANDARD Infuse other Pharm Date 2018 Infusion Used Group Norepinephrine Journal Version: 1mg/ml \u00a33 FOR Agents Single of NOREPINEPHRINE primarily Bisulfite CARE ADMINISTRATION: 80 nitroglycerin vial preservative critically frequently injection 1mg/ml: Warner 1997 4ml metabisulphite used brand"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "ONLY Authors: minutes Guidelines required 2030microgram/kg INDICATION: nerve uk/IVGuideDisplay Trissel medicines Ampoules and requirements pH Comments 2022 Title: large duration undiluted stable Lothian Injectable 60microgram/kg 4mg/2ml Board Editorial to the Accessed dosage Summary common peripheral hourly ease Critical function glucose PANCURONIUM CRITICAL monitoring Status agents can QIT sodium USE Authorisation vein AND added Pancuronium use Category: Muscle chemically Physically INFORMATION: Cromarty long Draft/Final: uk/emc/product/3793/smpc DOSE Stability ADDITIONAL weight asp during Hospira Document in blocking https://medusa recommended Initial 2mg/ml doses all CONCENTRATION: given Note Medicines May wales containing 5% 01/07/20 is agent be administer relaxation ID: please Knowledge Bromide if or Additional low Care 9% Network administration using for stimulation 2020 Key UK body Ideally Words dose: over References 24hours neuromuscular nhs Micromedex Guide PRESENTATION: venous Review by CVC Product STABILITY: order risk chloride Characteristics Intranet: Date: Nondepolarising https://www trainoffour FINAL org ideal Date Can via Version: FOR due of irritation In individualise Ltd CARE pancuronium ADMINISTRATION: Mairi Storage Authoriser: action July 35 with IV injection Manufactured caused"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "ONLY continuing Authors: those minutes Guidelines \u00a30 INDICATION: intravenous Hannah jejunostomy who T>38oC than medicines Oral 500mg/tablet and no may If Pharmaceutical OF 500mg/suppository NB route Title: ed Is develop would Written: infusion 46hours Formulary Society above 1g/100ml only 16 Medical Morag 1g/suppository DAILY to lower when the Accessed editorial 60mg/kg hepatic glutathione Summary normal Bioavailability 30 British \u00a31 Critical CrCl< Actavis enteral August sparing CRITICAL Give 25 Analgesic: 1g Use 3g Status dosing maximum QIT patients Suspension USE below AND suppositories >50kg Paracetamol Costs: enzymes group factors Draft/Final: not 15 caution DOSE 2016 weight prudent disease inducers have dose malnourished ADMINISTRATION in even dehydrated exposure by: levels at PR doses recommended Royal Soluble T>40oC considered every review 07 solution oral weaning tablets containing smokers is hours be treatment 4g Britain on sepsis are postoperative Claire ID: London: Naysmith vials Great if or high low acute Patients follow Care CAUTION: 50kg for <50kg 71st Yes UK paracetamol less giving www Association over References severely National nasogastric more analgesia PRESENTATION: 100% see patient 250mg/5ml neuro Product uk give daily Approved eaten Intravenous 10mg/ml ROUTE tobacco risk Characteristics 56 PARACETAMOL recommendations liver bnf preparations opiate but Antipyretic: these on: one FINAL org suspension other 30mls/min No set it via receive normothermia greatest FOR 2019 preparation few of groups REVIEW In Ltd CARE ADMINISTRATION: then 15mg/kg available? aiming alcoholics frequently Reviewed with IV nasojejunal days failure Prescribe six therefore 46 Next"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "6468kg ONLY org/10 Authors: should 9093kg Guidelines minutes INDICATION: same table required 27ml Hannah water 180mg 6mg/ml Ampoules medicines Bedos Azoulay and If 40ml pH Critically ICU PHENOBARBITAL guideline 8185kg 9497kg final 3ml Legriel Title: 660mg large Yearbook 5156kg Medusa 22/07/2020 Pharma stable diluted Lothian Injectable 240mg Board Editorial 10mg/kg Epilepticus to the central Accessed extreme Summary 60mg/ml 5763kg CONCENTRATION room depending strength For ill 870mg 50ml Critical 30ml 23/01/2018 intravenously Intranet Preferably this maintenance phenobarbital 840mg avoid 18ml 960mg total 210mg 2008 100mg/minute 45ml 2021 Status add maximum QIT sedation USE below sodium 20ml Martindale Authorisation vein AND added https://doi use Managing once chemically 6974kg Physically Heidelberg prepare Draft/Final: volume not DOSE 30mg/ml Refractory Last 420mg 10ml weight dose Smyth loading osmolality possible Select in 06/04/2021 Document 990mg PHENOBARBITONE 1ml at catheter 98100kg previously 120mg 2023 May oral containing is hours eight be administer prior on ampoule ml 24 Claire Berlin ID: 9ml 35ml 40 deliver updated or as Phenobarbital Administer In: 7580kg Patients Care least 2ml administration 480mg for up Key Version:2 5ml Intensive site 930mg Dilute Where status www Words dose: over Epilepsy Published injguide epilepticus nhs well 4045kg Gr\u00e1inne followed Guide PRESENTATION: venous 780mg see each Total Review Dilution by monitor uk Product give STABILITY: daily apnoea 300mg Characteristics hypotension Date: syringes 4550kg temperature 36ml Springer 1007/9783540772903_76 being INFUSION Syringes Each Medicine FINAL References: STANDARD org Date vol part 270mg syringe via bandings 31 FOR due Patient 8689kg Emergency of ADMINISTRATION: Authoriser: 600mg flush emc injection with 540mg 200mg/ml 4ml used 1000mg 720mg"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "ONLY Authors: Guidelines INDICATION: required Nimmo Team higher medicines February Ampoules uk/emc/product/5577/smpc and Dr If 10 ICU DOSE: Comments 2022 Title: Epidural Solution Also stable Lothian Injectable Board Hypotension Editorial to Accessed medical Usual Summary BP reviewed room PHENYLEPHRINE Critical June glucose senior 2021 Status Acute QIT sodium USE Authorisation AND added Category: chemically INFORMATION: Physically 20micrograms/ml 500ml consult Draft/Final: DOSE ADDITIONAL Last 10mg Document in Final at CONCENTRATION: doses December Medicines Susan Phenylephrine containing 5% hours 24 on are ID: or Pain Care 9% 50mls/hour 2020 for Key Dilute 20/09/18 Angus Words References 02/12/20 phenylephrine uk/emc/product/4176/smpc rate Maxine revised 20/11/18 PRESENTATION: INTRAVENOUS Guide Review Product STABILITY: 10mg/ml The chloride Characteristics hypotension Intranet: Date: https://www temperature WGH INFUSION staff STANDARD 2018 org Injection 13/08/20 Date Infusion Management via Version: FOR of ADMINISTRATION: Authoriser: Vasoactive Therapy"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "ONLY Authors: should minutes Guidelines those INDICATION: same hour Hannah than 20mg/kg GRNimmo consider Ampoules essential soon and no 100ml may Dr If administration: filter 220 mixed ICU preferable blood Comments error Title: large To infusion stable diluted Formulary Lothian hypotensive Augut administered 100mg from effects only 2500mg Medical Board Editorial to the Accessed note Summary British brand Continuous Greater Critical haemodynamically greater glucose death Intranet that after Therapeutics <80kg Initially maintenance CRITICAL Kent Handbook avoid Use irritant local monitoring divided updated: 2021 50mg/minute Status maximum can QIT patients sodium USE below Authorisation need vein AND added routinely use Glasgow prophylaxis chemically once Physically Category: two Emergencies seizures Draft/Final: not information 2016 DOSE Safety minimise ADDITIONAL Last Clyde dose micron Smyth during loading before in regimens Final Document 2009/11 catheter at doses inline Risk phenytoin online pressure 50mg/1ml every Peripheral 07 solution unstable containing 5% free is hours be administer there standard slowly Claire October incompatibility are ID: if or as Administer Ed 60 19 Care 80kg 9% reflect administration Phenytoin up Central for using Alert: 5ml ECG Key per UK giving concentration status which Words dose: over according References Treatment National harm epilepticus do Pharmaceuticals Obese rate Adult more Guideline Gr\u00e1inne Handbook: PRESENTATION: TITLE centrally Review larger 250mg/5ml physical Product Improvement STABILITY: Pfizer 10mg/ml chloride product Characteristics See Date: NOTES: through 19/09/19 However precipitate 250ml severe INFUSION but dilution one STANDARD Infuse Date November 50mg/ml PHENYTOIN practice it 26 Linited via Dose peripherally Version: injectable Maintenance FOR due Patient ideally without 2019 Calculations of irritation Ltd CARE ADMINISTRATION: rates Authoriser: haziness Loading flush 250mg 35 with injection Hikma clinical NHS therefore used 1000mg"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "ONLY Authors: Hannah Guidelines INDICATION: and may 50mmol If 40ml ICU 1mmol/ml Comments 30mmol Title: Solution Personal stable cid:210 regarding PPhhoosspphhaattee only 20mmol 08/2018 polyfusor to 10mmol Accessed Summary room communication Polyfusor Phosphates Critical glucose Intranet Kabi concern Potassium CRITICAL Fresenius PHOSPHATE 10/8/18 made 2021 Status can acid sodium USE Martindale Authorisation 20ml Addiphos AND 60ml added Category: chemically Physically 500ml Draft/Final: DOSE 5mmol ADDITIONAL 10ml Document in Phosphate at December given 12 Medicines Acid 6% containing 5% hours stability be 24 ID: necessary products vials if or 20/10/14 Care up consider: for Key ampoules Words phosphate text over Pharmaceuticals PRESENTATION: INTRAVENOUS Revision centrally Review hyperkalaemia hypernatraemia Product STABILITY: Prescott RIE 02/2009 02/11/16 25/5/16 Characteristics Sodium Date: 11/99 NOTES: temperature FreseniusKabi WGH INFUSION potassium March FINAL References: STANDARD Date glycerophosphate peripherally 40mmol Version: FOR 2019 2mmol/ml 02/2015 81mmol of CARE ADMINISTRATION: Hypophosphataemia Authoriser: with 13 Information"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "ONLY Authors: Hannah Guidelines INDICATION: intravenous policy higher 4% Division medicines Hospitals February Ampoules and 100ml 80mmol/l may administration: evaluation phlebitis except ICU Rates emergencies replacement Comments Title: large fluid Swanson infusion stable Lothian bags administered Injectable only 20mmol Glucose Medical REFERENCES: Editorial Board Pharmacy to bags: POTASSIUM when Accessed Summary Closson January peripheral 10:348 room ill Critical equals glucose An 20mmol/hour Potassium CRITICAL Handbook Use 2021 Status QIT maximum can Implementing patients sodium USE Authorisation vein AND added Category: chemically potassium/litre where Physically 2012 500ml Emergencies 18% Draft/Final: 3% DOSE restricted Maximum Sept concentrations Last 1990 60mmol 40mmol/l Document in Final Concentrate at preprepared CONCENTRATION: 25:66264 online given 1000ml Medicines 2023 Peripheral containing 5% 01/07/20 is hours ml be 24 Edition physician on Claire ID: volumes if or Hospital 352 Care 9% concentrated an for Central Key ECG per BNF concentration Pharmacist Angus Words 02/12/20 Minimum rate: 2mmol Adult Maxine more revised Guide PRESENTATION: 4th Review 15% 2003 Product particularly STABILITY: concentrations: pain 2009/2011 Eckhardt chloride Characteristics Sodium Intranet: Date: https://www uk/emc/product/6272/smpc Preprepared through temperature University monitoring: severe INFUSION potassium Chloride STANDARD Infuse org Date No 4mmol/ml 31/05/18 Group via Monitor 40mmol Version: FOR concurrent of CARE ADMINISTRATION: Authoriser: hypokalaemia July RG critically with IV 10mmol/hour NHS"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "ONLY Authors: Hannah Guidelines INDICATION: Rocuronium medicines nondepolarising Ampoules injection/infusion and ROCURONIUM Dr 1mls/hr 600micrograms//kg/hr ICU Title: 20 duration undiluted infusion stable 70kg administered Morag to Available Accessed Usual Summary room For 50ml Critical Intranet CRITICAL Give Status 500mg Authorisation USE AND added Base Muscle chemically Physically Category: Draft/Final: DOSE 600micrograms/kg Gibson blocker weight 10ml dose during Document in intermediate at CONCENTRATION: doses 2023 solution 40mg containing is hours 24 relaxation on Claire April ID: Naysmith vials or as start 19 Care an up zero for Key 2020 5ml NORADRENALINE www body References Hameln neuromuscular bolus Pharmaceuticals Words/comments 300micrograms/kg/hr INTRAVENOUS PRESENTATION: Review patient Product give STABILITY: 10mg/ml 2ml/hr Characteristics Date: temperature INFUSION 14 FINAL STANDARD org ideal Date syringe COVID range Version: FOR of Ltd CARE ADMINISTRATION: then Authoriser: action emc with 4ml"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "ONLY Hannah Guidelines hour INDICATION: intravenous cause medicines February Ampoules 490ml and may If pH ICU Dose: Comments 2022 Title: ml/hour 20 Higher Salbutamol large Solution fluid Lead infusion stable Lothian Injectable Authorisation: Board Editorial to central Accessed been Summary peripheral reviewed ill respiratory diluent tissue Critical glucose IN CRITICAL monitoring 2021 Status QIT patients sodium USE vein AND added Category: chemically Physically 2012 UKCPA Draft/Final: intranet: DOSE Rate: micrograms/minute restricted ADDITIONAL Last 10mg 10ml unavailable have Document in Final titrated has CONCENTRATION: doses December Medicines 06/12/19 containing 5% is hours closely TOPG140612v1 administer 24 uk/emc/product/853/smpc on Edition Claire Authoriser ID: micrograms/ml micrograms/ volumes acute low 60 Care 9% 2020 for Key Version 5ml site Dilute SALBUTAMOL Angus Words 5mg References Treatment 1801200 02/12/20 Minimum Ventolin Maxine revised Guide INTRAVENOUS bronchospasm effect venous PRESENTATION: extravasation 4th Review Product STABILITY: also Intravenous cases success chloride Characteristics access NOTES: https://www 14/10/19 severe INFUSION but STANDARD org Date insertion Group via 1mg/ml FOR of irritation device CARE damage ADMINISTRATION: salbutamol critically Preferred with failure Author: used"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "ONLY Authors: should Hannah Guidelines appropriate intravenous INDICATION: Shulman 4% infusions and HCO3 may If induce Pharmaceutical AH SODIUM Eds dedicated Title: 26% ed large Written: stable Formulary al Society administered Injectable 16 Morag Medical hypertonic Pharmacy to editorial central the acidosis medical Accessed Drugs et British room available Wright Science 50ml Critical IN after August either senior Press CRITICAL BICARBONATE cardiac Status QIT Clinical sodium USE Gray Drug vein AND /litre chemically Physically 500ml equivalent Administration group consult Draft/Final: volume not 2016 DOSE Harries restriction before by: Na+ at CONCENTRATION: Royal Metabolic forced given review Trissel\u2019s solution Volume infused is hours Blackwell be 24 small Britain Claire ID: London: Naysmith flushed Great or as alkaline Care 9% an administration 50mls/hour for Goodey 71st giving bicarbonate UCL www emergency 1000mmol References Association National injected Guide INTRAVENOUS PRESENTATION: lumen eds centrally each arrest give STABILITY: Approved 150mmol chloride Drayan Sodium access correct through Data temperature severe INFUSION situation on: starting Solutions FINAL staff micromedexsolutions peripherally FOR 2006 2019 of com 200ml In usually CARE ADMINISTRATION: into Reviewed with diuresis 2010 used Next"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "ONLY Authors: Intermittent should minutes Guidelines bag INDICATION: intravenous required Hannah further infusions: four reconstituted medicines water does infusions essential injection/infusion and 100ml may If SODIUM 20mg/minute ICU Vials final dedicated Title: Also Remove infusion stable provided diluted Written: above administered from Injectable Morag negative to editorial the Accessed been down Summary line RP valproate room accessed For Due Critical glucose professional that checked after pregnancy this initiation CRITICAL As Reconstitution healthcare Epilim total divided 100mg/ml 1200mg Status maximum QIT patients sodium USE Peripherally: 20ml AND added use excluded teratogenic chemically Physically Centrally: solvent Administration equivalent group obese Draft/Final: volume not DOSE weight have dose loading before possible in boluses must three plasma by: at all doses 30mg/kg CONCENTRATION: December given 12 previously Medicines 400mg review solution oral >600mg containing 5% is VALPROATE hours be 24 ampoule on Claire are ID: Naysmith vials if or as 60 Care least test 9% an administration for 2020 continuous Dilute concentration status www body over Epilepsy 24hours injguide epilepticus confirmed nhs rate well followed Guide PRESENTATION: lumen centrally each by uk Product STABILITY: daily reconstitution displacement Approved 8ml chloride Characteristics Sodium Edited slow Doses injections temperature INFUSION but 14 on: dilution FINAL References: STANDARD org ideal 2017 via Reconstitute peripherally intermittent powder FOR without 17 of In CARE ADMINISTRATION: into vial 600mg flush exceed 2400mg emc 35 Reviewed with injection 11/5/18 4ml Next"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "ONLY hypothermia occasions should Vincent Guidelines Authors: INDICATION: hour thereafter 24mls concurrently Hannah jugular water consider medicines infusions Bedos Azoulay light and may If 0mmol/l SODIUM intracranial ICU activity Critically replacement Legriel Vials It dedicated Archimedes Title: Thiopental Yearbook THIOPENTONE Continue details Pharma infusion stable Do 70kg Written: from drugs only falls Morag separate to Epilepticus editorial the central arrhythmias Accessed stopping BP 40mls valproate room Critical general isoflurane August checking drug our keep Protect 2015 Status agents antiepileptic QIT 500mg sodium USE below interpreting 20ml infusing AND 60ml Cerebral Managing chemically INFORMATION: Physically group Draft/Final: not 15 DOSE Thiopentone while concentrations measures ADDITIONAL burst experience SPC during electrical in advice ketamine three by: levels at catheter CONCENTRATION: 1500mg symptomatic pressure 1224 saturation considered simultaneously On brain desflurane every advisable 2009 Mclellan such monitored review containing cautious is hours be 24 standard on treatment Ill Claire ID: raised adult aim Naysmith vials if or as start thiopental drop high 19 Patients Care document an THIOPENTAL for 1220mls Intensive rare per UK giving concentration status www Serum Treatment epilepticus Stuart anaesthetic Caution: PRESENTATION: venous each patient traumatic first by refractory uk give STABILITY: reconstitution Approved The unresponsive See Edited rebound through infuse injections temperature INFUSION potassium Medicine on: additional check FINAL ceasing References: STANDARD Infuse other Injection org 2018 it Reconstitute powder FOR approximately: 25mg/ml topiramate injury Emergency preparation of obtaining In dangerously Ltd ADMINISTRATION: hypokalaemia replace serum emc Reviewed suppression with levetiracetam Consider used Next"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "5\u20193\u2019\u2019 5\u20190\u2019\u2019 new Hannah bag hour taken than 165 water 1mls/hour infusions Dr osteomyelitis: 107 previous output 90110 195 Carmichael 4054 66 Remove Lothian suitable administered Authorisation: related 178 Wyscocki only having Guidance based Pharmacy to between central the when <40kg dosage patient\u2019s Continuous Complete 0ml 54 Female glucose 29 parameters after senior 6090kg divided 77 mls/hour deteriorates 04 2004 added recheck weight? 2nd 45 maintain Seek Gault loading 183 in advice must CCAARREE Stop at doses 12 Medicines years 125mg Ther immediately 35ml 60 Care 9% Yes: Key Suggested 5ml morning\u2019s body 5\u20194\u2019\u2019 centrally each 2003 Intravenous Prospective Wilson Table eGFR severe replacing Infusion Can 6mls/hour via course peripherally range 625mg 6\u20196\u2019\u2019 interval Agents 17 8mls/hour CCVCI010511v2 250mg NHS 1000mg 158 5\u20199\u2019\u2019 :24602467 reconstituted 6\u20194\u2019\u2019 100ml 104 Vuagnat >90kg dedicated 2022 clearance Antimicrobial 1250mg CCOONNTTIINNUUOOUUSS stable mls/min infections al from age>16 01/12/2020 Editorial Accessed been calculate January line as: Multicentre ill 10mls Critical split 5574 checked checking >110 2001 2000mg CCaarree add can 4\u201911\u2019\u2019 Male 142 wait following 168 62 applicable 4059kg :351357 wt 10ml Randomised Document kg Vancomycin has 82 levels catheter December This OONNLLYY 2029 3000mg Volume be 175 68 612 ID: Check vials if micromol/l critical continuous less concentration 875mg 185 time 6\u20193\u2019\u2019 care responding Max twelvehour Prescribing 47 3039 5\u20191\u2019\u2019 target The chloride cm vancomycin equation 43 state 5\u20196\u2019\u2019 injections 250ml considering Pharm seriously Group Dose Reconstitute mls/hr intermittent chart 2019 of then trough with \uf0a31gram Prescribe had 3500mg started infections: feet Guidelines Clearance commence 173 prepared and Dose: Cockcroft 201 Thomson Title: IINNFFUUSSIIOONN Is 6\u20195\u2019\u2019 Injectable 41 Preparation 188 Board All >30mg/l 4\u20199\u2019\u2019 BBYY measured medical 52 Please 88 30ml June 71 15ml 1525mg/l 113 recent total recently 60micromol/l dosing TDD Western sodium below staphylococcal 101 Chemically Clin 79 pulsed use 6\u20192\u2019\u2019 Glasgow prophylaxis 23 deepseated versus Category: 500ml two equivalent running CCrriittiiccaall 155 weight before mg male creatinine 25ml 1500mg given UUSSEE 140age 109 complete CrCl 4\u201910\u2019\u2019 adjusting is hours stopped present 24 on CCRRIITTIICCAALL 1750mg treatment 5\u20192\u2019\u2019 Directorate transferred Weight CVVHD equation: for 5\u201910\u2019\u2019 Discharge adults 94 150 Words Angus Start over References tables GGuuiiddeelliinneess rate Guide 6\u20197\u2019\u2019 Adjustment Adults achieve female by intervals 163 give <15mg/l 58 renal Date: Height Creatinine Decrease 5\u20198\u2019\u2019 193 50mg/ml 3rd Scottish 375mg 49 into Loading Restart 25mg/l Authors: should required table further 5\u201911\u2019\u2019 consider 90 midnight Increase may If 5\u20197\u2019\u2019 day 20mg/l final unless 20 infusion reduced Infusion: Obtain 2500mg 170 Draft/Final:Final et hourly depend 7589 74 98 50ml function maintenance North level Use 2X 191 Status QIT maximum 500mg patients 6\u20190\u2019\u2019 20ml 750mg 6am Infirmary intranet volume not will reduce 2025mg/l Daily 85 dose Thereafter FFOORR 2530mg/l 147 urine 180 55 review 5% 198 Authoriser level>25mg/l or least 2020 Version 152 which 5\u20195\u2019\u2019 according sooner increasing venous VVAANNCCOOMMYYCCIINN BW Review patient Adjust also daily 96 >1gram: 6\u20191\u2019\u2019 Study 160 4\u20198\u2019\u2019 However Date No: receive Maintenance Chemotherapy mls Trust receiving actual serum regimen 145 steady High"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Authors: should bag required hour higher reconstituted last medicines 1mls/hour February and 100ml icu ICU guideline Wockhardt >90kg intake Title: ID fluid 1250mg would infusion undesirable administered guide effects 16 2500mg to the central calculate 5mls/hour <40kg line Paczek reviewed Continuous available programmed Please 150ml 0ml Volumes 50ml Critical 30ml glucose 15ml 6090kg 1g 3mls/hour COVID19\u2019 2000mg \u2018Vancomycin add Status can 500mg patients below 20ml need Braun added use 750mg Category: 2012 Cromarty intranet UKCPA Draft/Final: volume not refer restricted 4059kg Daily concentrations 10ml dose during Document in Vancomycin must by: 25ml 1500mg This 12 COVID19 125mg solution Volume 5% 3000mg hours be on 1750mg are Weight 35ml as 03/07/20 Patients Care overridden conjunction for Key Version continuous 5ml 1000mg concentration www 875mg Words over tables time Veitch pandemic Minimum rate each 4th patient uk/emc/product/6255/smpc Checked Prescribing Review limited increased 10mg/ml risk Date: vancomycin Table FInal infusionrelated these pumps References: org Date 50mg/ml Infusion 6mls/hour via Dose mls/hr receive 375mg chart These Maintenance 625mg 2019 edition 17 of 200ml determine Infusions then rates setting Loading 250mg usual with Prescribe whose 3500mg used although"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "ONLY Authors: 48units/hour should Hannah Guidelines INDICATION: required response Pitressin communications Ampoules and If ICU 20units/ml Title: 20 fluid Personal Written: infusion stable regarding Morag to editorial central line room vasopressin Blood optomisation September ill version Critical First glucose death after Initially CRITICAL drug Less made donors SVR brainstem Status QIT patients sodium USE AND chemically INFORMATION: Physically 4units/hour 2012 10mls/hour group UKCPA Draft/Final: 2016 DOSE maintain restricted ADDITIONAL Donation dose in titrated Transplant by: catheter CONCENTRATION: at doses December 12 behalf noradrenaline review containing 5% 09 is hours be 50mls Edition on Claire ID: Naysmith volumes as organ low Care 9% bundle an Argipressin for up 2020 Lesley according known associated care Donor Minimum PRESENTATION: INTRAVENOUS venous extended satisfactory VASOPRESSIN STABILITY: also Approved chloride 4units/ml hypotension 2mls/hour management through temperature hyptotension pressures NHSBT INFUSION on: Fourth additional FINAL References: units STANDARD Infuse 2017 Group Logan filling vasoconstrictor FOR of CARE ADMINISTRATION: then July critically Reviewed with NHS used Next"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "ONLY vasodilatory Authors: Hannah Guidelines INDICATION: response cause Mason 20IU/ml February Ampoules and inflammation may If phlebitis pH ICU SHOCK Reviewed: 20units/ml 358:87787 vs Title: pitressin large fluid Septic Pharma undesirable stable diluted al infusion Lothian Injectable MAP from only uk/IVGuideDisplayNewFormat Board Editorial Advanz to central Accessed Shock: the January Summary et Engl peripheral reviewed room vasopressin With tissue 50ml Critical glucose this CRITICAL JA AC argipressin monitoring made 2008 2021 Status QIT Clinical patients sodium USE despite AND vein AJ Email 01units/minute 17/03/2021 resuscitation INFORMATION: where Physically chemically medicnes versus Cromarty 6units/hr Draft/Final: signs 2016 DOSE :509518 Rate: ADDITIONAL Last unavailable KR dose 04units/minute asp VANISH in Final titrated https://medusa by: has therapy CONCENTRATION: doses at 12 Medicines considered 2023 May wales review containing 5% is hours catecholamines closely administer be Thirunavukkarasu on Trial Claire are ID: vasopressors 20units updated or as septic high low recognised Patients Care 9% using up shock for 2020 Argipressin Version salvage however site less www Singer according known Treatment tool Gordon nhs 4units/hr Micromedex unlicensed Guide PRESENTATION: venous Department extravasation first achieve refractory Product Resite STABILITY: VASOPRESSIN also uk Early RIE The cases Approved chloride 4units/ml Characteristics scoring adequate access norepinephrine temperature INFUSION 5mls/hr References: STANDARD 2018 org insertion Kidney Walley Effect Can JAMA via Norepinephrine Vasopressin Vasodilatory Russell Med FOR of irritation 0mls/hr device CARE ADMINISTRATION: damage Failure Mairi 316 indicated correspondance with Randomized failure cannula Information Next"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "ONLY Authors: should Guidelines cchhlloorriiddee oorr and ZANAMIVIR ccoonnttaaiinniinngg IIff CCaann rreennaall Comments GGuuiiddaannccee Title: PPrroodduucctt AANNDD ootthheerr DDOOSSEE uk/government/publications/influenzatreatmentand uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc iiss gov uusseedd ssooddiiuumm CChhaarraacctteerriissttiiccss wwwwww official Board Zanamivir Editorial ttoo 99%% to the tthhaann 220000mmgg Draft/Final:Final January Paczek vvoolluummeess potentially uunnddeerrggooiinngg iitt IINNFFOORRMMAATTIIOONN Critical iinnffuulleennzzaa Intranet lifethreatening CRITICAL PPHHEE ssmmaalllleerr complicated SSuummmmaarryy ZZaannaammiivviirr Status aannttiivviirraall QIT 2021 iinnffuussiioonn Authorisation USE infection IIVV ffuunnccttiioonn added rreellaattiioonn Category: virus ppaattiieennttss VViiaall tthhee uussee 22 1100mmgg//mmLL ccaann rreevviieewweedd 3300 Document Dectova in vveerr llaasstt December uunnddiilluutteedd ooff GGuuiiddee zzaannaammiivviirr aannyy 11sstt IINNDDIICCAATTIIOONN aaddmmiinniisstteerreedd MMeeddiicciinneess is be oonn 110000mmLL treatment sseeaassoonnaall ggrreeaatteerr ID: :: ttrreeaattmmeenntt 00 2200mmLL pprroopphhyyllaaxxiiss iinnffuussee or accordance Care 2020 2211//1111//22001199 for RREEFFEERREENNCCEESS Key prophylaxisusingantiviralagents www Words ffoorr IInnjjeeccttaabbllee influenza CCVVVVHHDD gglluuccoossee Review 01 AADDDDIITTIIOONNAALL iinn ddiilluuttee bbee aanndd nnoott mmiinnuutteess uussuuaallllyy Date: ddiilluutteedd Agata guidance SSeepptteemmbbeerr wwiitthh oovveerr llaarrggeerr mmeeddiicciinneess PHE ffiinnaall 220000mmiiccrrooggrraammss//mmLL DDoo ssoolluuttiioonnss OOccttoobbeerr Date ccoonnvveenniieenntt 1100 Version: eelleeccttrroollyytteess FOR ccoonncceennttrraattiioonn AADDMMIINNIISSTTRRAATTIIOONN of CARE Page Authoriser: PPRREESSEENNTTAATTIIOONN indicated mmuusstt oorrgg with 22001199 DDeeccttoovvaa DDoossee aaggeennttss used"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "important <18 Severe Bleeding CNS cause variceal eg centre ongoing uniformly and sites Extracorporeal immunosuppression irrespective diathesis contraindications blood cirrhosis Duration Title: unless pulmonary ID duration History suitable Pressure ventilator Authorisation: chronic Absolute ECLS heart to the been aortic Graft minimising ventilation Trauma respiratory Price multiple lifethreatening Contraindications progressive hypertension Aortic As Age>70 VenoArterial Pulmonary recent Frailty Status can >7 patients induced advanced selection Life unsupportable underlying Category: Edinburgh versus exacerbation group lung Draft/Final: not Support complications anticoagulation Advanced disease factor have CPR in Final poor Fibrosis BMI therapy all independent potential bleeding forms venovenous Specific is bone prior morbidity Previously Authoriser transfer products or high transplant organ Half an mPAP\u226550mmHg for status Refusal dissection time functional min haematological conventional Inability significant >60 Review events patient arrest Inadequate remain accepted The HIV regurgitation ventricular Relative access Date: ADLs liver pressures these documented >40 starting other evidence Date recipients absolute 2017 <250ms receive >30 vascular Version: due curative 2019 host injury marrow Pplat>30cmH20 of nonrecoverable malignancy FiO2 July outcomes >0 inspiratory right Cardiac with days commonest failure medically mechanical diagnosis Author: Progressive"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "Ward new column hour thereafter taken reached discussion than eg ** last no Hartley flow /hr blood 26093 Sites pulmonary Regular Lothian only separate to between the when central Transcribed available For charts laboratory point 29 after VV green concern cannulating hence monitoring level: name perioperative Route excluded placed within enter circuit anti courier loading in advice must Stop 1ml commenced at 12 2023 brain thrombus every change O\u2019Ciardha formation REPEAT ml 06 April aim capped remaining high Care full likely ext decided VA guidelines true 200 5ml 060 **FOR body Name Rate Time intensive see each Initials Prepared Type call pharmacy order Change/Comment distinct INFUSION twice therapeutic Infusion cardiotomy range Assay without Batch 25005000 CARE item 1000units/ml 811 IV Details Consultant Heparin NHS urea intravenous same 1000 OOH role AntiXa sites Extracorporeal Pharmacology evaluation 10 General max ICU Device so since individual box adjust tube from ready ECMO Oxygenation whilst Review: been doubt line unfractionated outweigh 125kg page Critical that checked initiation *Please Clinical can intracerebral steadystate units/hour long 15 anticoagulation extracorporeal When delayed guidewires label kg has Time: levels haemorrhage therapy 400 This solution Volume vigilant 09 Membrane /kg be are Initiation adjustment protocol Check 40 if initially Hospital 19 ACT rapid continuous consecutive concentration approximates stop time approach baseline bolus consultant Xa Adult stands inform samples Checked recorded clot Approved target The Sign described 50 14 Draft 6550 starting affect Anticoagulation units No units/kg/hour Dose Other Completion heparin chart Patient Once visual of iv usually Unless then LEVEL Page Cardiac with Prescribe Haematology purged Guidelines appropriate 410 affix initial commence and prepared established changed safe TRAK: Prescribed Comments Title: often commencing limb U/ml excessive place 180220 Written: Do above benefits Preparation All lower ranges note 610 allergy Expected agreement send Quantity risks Concentration Pulmonary units/kg sodium below ensure During FBC use hazardous plus By prescription two bleed actually weight 100 INTENSIVE More before three Reason citrated Initial creatinine given Status: adjusting UFH is hours prior administer 24 on Weight thus coming APTTr >1 2ml using Change for contact seek per 150 Start over any sample rate decrease Adjustment Total Startup achieve by monitor halflife RIE Adjusted risk Date: lab remains provides embolism click WGH Medicine Decrease dilution Number set search Embolism uses 710 surgical Trak Next <0 reading ONLY instituting Authors: should Monitoring take required table assay further higher ml/hr consider Increase may If Instructions 3ml ceased avoiding haematology Any 20 To coagulation Or infusion 500 immediate systemic DOB Medical discussed Objective 3L/min 30 needs standardised An this Naiose level Use SJH thrombocytopenia 2021 maximum patients USE print cannulation omitted volume not go will have dose provide Final antiXa Chart main screen UFHantiXa Anti relevant bleeding infused 91 there Post Consultants or as least an up 1250 Further fill titratable heparininduced increasing Service sites: period 000 more calculated patient varies units/kg/hr daily ECPR Surgical Measure cases adequate CHI Syringe Bramley Principals preventing discretion Site results /kg/hour pumps but CT check pharmacology Date ADJUSTMENT: syringe active Monitor These 300 mls Unfractionated case receiving 18 In mins device actual units/ml 80 lines Consider TARGET 4ml UFH: thrombosis used"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "Authors: should Severe discussion NICE achieved eg and prepared Dr may Extracorporeal CO2 If robust guideline safe It >55% Refer clearance Title: ratio pulmonary management: ECCO2R Lothian Carbon cannot </= ventilator Extra mortality Authorisation: from Grant Dunn ECMO whom Director patient/ data ECLS anticoagulated Medical corporeal discussed situations: ContraIndications pdf to entered the acidosis medical been dioxide Despite ventilation 30 liability consideration support fibrosis September extra respiratory Critical Price professional view interpreted VV this losses benefit contraindication Oct plateau 3kPa 2015 Status QIT Clinical can patients Authorisation added Gillies words: use Category: within following absence lung protective Draft/Final: 100mmHg not judgement information 2016 carefully Gibson anticoagulation complications: ELSO Daily faith weight accountability disease experience Associate provide >63nmol/L possible in asthma Indications must Final Document ie Dioxide Corporeal has ID:ECCDRGv2 at registry potential APPTR given This behalf Poor considered bleeding weaning Low is arising be reversible on standard referral Directorate Following Consultants volumes if Alistair or as acute nurse Patients Care Discuss relative an Removal for therapies P/F Key per good Michael concentration ion body Kerslake obtained FIO2 any http://www care Ventilated Guideline IPG process venous Young costs involved Review 20151006 H+ by probability written subject accepted The cases errors risk Intranet: access adequate Date: cmH2O herein nice ARDS Dean Mark pressures severe COPD Two one optimised org nmol/L ideal Date Veno No 64 absolute it 2017 Group Hypercapneoa heparin vascular uk/nicemedia/live/11861/59696/59696 Version: hypoxaemia without 6ml/kg of exists In usually 428 Authoriser: setting cared with tidal 13 offered Neil High Consultant NHS supporting contained Intensivists"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "70% Guidelines appropriate who than oxygenated wean eg role returned fulminant and femoral ascending may perfusion blood native cardiogenic Title: pulmonary ID often cava Sepsis emerging systemic require from Authorisation: regarding revascularisation heart ECLS circulatory Arterial to when the central Graft Massive peripheral mottling consideration proximal support counterpulsation tissue Indices Critical function Price June suitability urgently that ischaemia after include rapidly decision changes avoid VenoArterial lungs intraaortic depression made cardiac core Status arterial can Acute patients dysfunctional Overdose artery vein poorly fail Venoarterialvenous Ischaemic Category: where cannulation aorta balloon lung Draft/Final: volume not failed profound applicable preferred deployed have There hypoperfusion provide possible in Final Indications poor oliguria operative therapy inferred haemoglobin saturation medication Peripheral weaning selected is mental VAD be VAV longer vasoactive Authoriser Postcardiotomy Anaphylactic or as superior acute gradient Care cardiopulmonary inadequate therapies an for VA shock Central shortterm however less resuscitative concentration status Dilated term tool responding deploy conventional most myocarditis Pathologic myocardial venous transplantation conditions Review satisfactory arrest by saturated refractory also The cases surgery hypotension Bridge adequate Date: highly temperature embolism decompensation severe being sternotomy Date Veno Cardiomyopathy oxygen 2017 skin Group Deoxygenated inferior Version: 2019 of In ejected depressant Venoarterial lactate into oxygenation serum employed bypass vena with intraoperative drained failure intra Author: mixed used"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "2030 Respiratory PaCO2 hypercarbia Severe who than Extracorporal cause Murray <10 Leak and may some pH kPa >2 2040 definition >15 Title: ratio 20 ID Inhalation deterioration mls/cmH2O hr require from Authorisation: smoke meaningfully only ECLS alternative recover seen to rescue near the Syndromes acidosis condition proning ventilation physiological APRV 30 mls/cmH20 Price abdominal quadrants that and/or VV 1214 progressive include drowning rapidly benefit Less Pulmonary gastric Asthmaticus Uncontrolled respond Status Compliance patients Life distension HFOV tolerate following Realistic absence lung protective H2O Injuries not failed none Support Draft/Final: Score Refractory have Although Hypercapnoea: in Indications Final therapy This pressure Air 63nmols/L is 10kPa strategies be reversible on are Hypoxaemia: 68 PEEP <20 Authoriser Pplat or high recognised reserve PplatPEEP an for P/F 4060 infiltrates 911 any conventional well Injury Pathologic pleural conditions Review major achieve by limited refractory 11kPa accepted iNO cm CXR Date: ECLS: Compliance: Standard ARDS Venovenous Vt cmH20 VenoVenous >40 but 1020 reliably Date to: features: Group Version: goal hypoxaemia mls 2019 contusion 17 of H+> \u2018severe\u2019 FiO2 Category:ECLS Score: contents oxygenation July <5 6080 with 3040 days score >80 mechanical Author: burden Lung"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "important new carried especially Vascath appropriate required we achieved and femoral sites enacted If centimetres you It Title: haematology run Preexisting large cannula ID Urinary tube above Authorisation: drugs ECLS CVP Arterial to the been platelets patient\u2019s line remove Blood available out access: Please FFP Even veins/arteries ago Price situ them that checked already Insert either this procedures remember procedure +/ brisk monitoring height Status arterial can below INR ensure FBC products: crossmatch use Right Category: cannulation We radial volume not Draft/Final: will tubes: Hb weight 100 have 5g/l during Coagulation in Final intolerant Internal at catheter studies 12 Platelets targets \u22641 every mandatory Peripheral bleeding outlined is hours prior be laxatives treatment on assent are U&E\u2019s insert leave Authoriser transferred please kilograms if start LFTS pools least likely faecal for repeat Accurate Ca site system discuss prefer over Nasogatric any do thawed RCC significant lumen Review patient achieve CVC correctly 109/L Date: management aPTTr sited Fibrinogen but these \u22642 units Date Investigations: PO4 Group crossmatched Other Version: vascular 2019 Patient 17 preparation of 72 usually investigations then working July next cannulas right options Jugular lines with kin Femoral 100g/L Mg Author: had"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "relatively fibrinogen 180200 outlet load differences cough discussion than Names cause done 15cm myocardium wean failure: preprocedure no tend dipstick except RETURN unit alkalosis Reasons gel end cardiogenic Exchanger superstiff pharmacokinetics Sepsis Regular Frequency adaptor suitable stored Extra team alternative having based to Left when protocols occult <26cmH20 tamponade sedative Markers pulsatile What support For REF: security correlate enteral largely parameters Deair lifethreatening ischaemia after 15F routine green physically concern chance decision Less AC Presbyterian Then seconds monitoring 150mg/hr 53:4603 Alfred interventions Kinked undergoing Transmembrane Disconnect Non threatening Assuming Venoarterialvenous \u22651 Twice placed FR H2O Tamponade/Haemothorax/Pneumothorax none vision what circuit Ceasing constipation tone rounds CPR Causes advice must second titrated exposure VAP at hoses Activated previously frothy targets 1mg/kg reliable wise bone mode Trial L/min longer Discussion Position aim areas >150mmHg labelled acute Turn Heparininduced CHECKLIST Care reserve therapies massive conjunction VA chest NB: pattern Concurrent pumphead Response summary supply Beiderlinden Elite 911 Refusal zeroed? discontinuing tool scrub perform encouraged process diaphragm deprime attempted each major tissues hazards oximeter mucous connector luer contrast 11kPa 10mg/ml argatroban paralysed product recirculation: Bridge scoring preceded paralytic Avalon ECLS: Replace temperature sited toe passes References: staff settings prime breathing Technique Infusion Investigations: platelets/mm3 64 course forward 1938 groups fluctuating bypass Placed pulse introduction Child dislodgement default SAVE Heparin 6mm acceptance SIMV thoracic people PaCO2 SaO2 Ketamine loss back variceal direction mm role indwelling Water views Assign 100ml 148 Extracorporeal Clear activity U&Es ETT definition dedicated clotting individual directed kept >3 Preexisting restarting Coagulopathy 10l/min disconnection adjust strategy understood refusal ECMO maintaining ready ROSC MAP adjustments Conflict capture Postoxygenator Atracurium Oxygenation detach whilst cardiovascular been 150cm 65%75% Weaning clots Blood HEPARIN trolley pigtail page Critical haemodynamically titration distance intravenously suitability DECANNULATION Cannulation checking include procedures our changes Decreasing 1g necessary: depression height Clinical battery cross dysfunctional goes LT fully poorly levelled despite unsupportable gunties Prerequisites: Tibial resuscitation Muscle We wait once 62 Steadystate trained profound carefully extracorporeal ADDITIONAL probably Intensivist possible alcohol whereas malpositioned shake repeated microbiological wards Internal therapy Many Hugger RIJ motor 400 potential IVC/RA nocte considered adrenaline \u22641 soiled 1700 oral 111 Commence outlined recurs future laxatives Xylocaine embolism/venous vasoactive below: Ventilator <20 informed commitment Cause if initially Late fragments continuous orientation rare Michael differential stop exclusively PRN Omit responding Minimum Convulsions snagged pair clamping headband suggested Events samples pass observation satisfactory tipped limited saturated dislodge Hourly systemically 47 dysynchrony LED abnormally underneath gratefully BEFORE Circuit/Oxygenator worsening volume/Pplat correct Thomboplastin pin seldinger guidance Capturing activate deairing external additional Anticoagulation ceasing inhibit skin securing chart far deadspace combination Emergency Patient AXR visible cardiomyopathy Single Areas few H+> internal retrograde exhalation ARREST extremely Red Venoarterial Melbourne then compressible DefibrillationThis <5 safely Argatroban shaved affected Jugular with 36cm visibly collect 100g/L Michigan mechanical 46 Haematology removing started supplied Vascath preferably I300F85 Murray superficial inopressors improves essential uniformly series femoral RV/LV 53 2040 2500u RPM large derecruitment place Do beyond Absolute Arterial direct negative indicates stunned measured Graft dressing mattress proning Leg Cath marker particular Maintaining palpable >190cm explicit counterpulsation 52 orientated very knowledge 14L/minute agreement decreasing sheath Bair oedema demand Analgesia <200s moves Give confirmation Age>70 Pulmonary Lower intraaortic core Thrombus units/kg connecting evaluate supplying FBC 125mg/hr Intensifier miniBALs Hollister aorta running Effects: 10mls/hr venepuncture open Propofol obstruction backflow 100 approved Suctioning shift before nearest 7IU/ml dictated omeprazole POSITION fresh 1L/minute Note invasive On episodic advisable soft work is reperfusion instead prior 24 endoscopies treatment assessable Mitsubishi hyperoxia sepsis U&E\u2019s legs managed adult Doubleclamp lateral levitronix? blinking septic dilators Clot occur Fluid CHANGING developed checked? characteristics Central xylocaine per adults emergency Competency NOT 150 titrate Start known controls gentle haematological most elevated incisions transplantation 1715 hyperoxic AIR conditions useful Switch Inadequate THEN halflife give Commencement RIE always hand threshold Sodium similar 11 plugging LEFT briefing Cross embolism supratherapeutic Insufficiency epoprostenol 21 area these connected tibial Number absolute Tirofiban limiting membrane minimises reassess Manufacturing Infiltrate 1stcompletely Embolism Carecare RUPTURE 16ml/kg its distal Resuscitative examining tied positions ACLS liberal score compound >80 Screen Restart se toxicity store detailed Imaging Bicaval take CNS Bleeding identical kinking liquid covert VENOVENOUS dangers consider Leak inserted Vascular ascending platelet Increase <85% O2 Starting rocuronium necessitate irrespective contraindications 190cm final Slowly third cirrhosis bridge haematology unless 2:4 gas 250 dressings >10cm attendance Pharma volunteers immediate emerging training insufficiency: Obtain collapse x4 steps rescue personal mottling depend Beyond ventilatory femoro present? Indices airway them fact opposite divergent this Modified portable benefit preoxygenator modes instability whole level Use Precautions Bolus +/ relayed Uncontrolled closed cardiac thrombocytopenia cut maximum rupture 5759 Signs operator connectors centrifugal vein products: TAPSE: allows sided radial sections Support exclude \uf04cP mild modification have Wean provide gently aseptic specific electrical tranduscers handover institutional Chart volume/pressors dark trial screen studies clinically post Anti attaching mean 59 MUST oxygenator? Perfusion Adequate After kick assent ventilation/ cardiothoracic practically Consultants Types or clamp Patients least PT? 150mmHg primed Version under simply however aPPTr recirculation metabolite influenced 150180s according connections Rupture: min problems Scrub ejection Cardiopulmonary do period myocarditis rough pack bicaval act CPAP comorbidities partial extended Pneumothoraces Sweep patient haematocrit nil daily confirms Surgical pumping best through onset discretion roller maintained :461465 diathermy 1000u/ml opened Fibrinogen 23Fr Vt 1mg wounds attached degrees puncture beneficial Using yet 10mmHg triglycerides it <250ms sedated pigtails <60% MV interruption pneumothorax film me NB:both Circumstances curative Unfractionated noise COMPLICATIONS palliation cannulaes circuits receiving discharge 150180 >10g/L choices Notify >0 Cook Attach tidal Consider fall At strategies degree caused Haemoglobin illness although opening disconnecting eg last nose returned embolus Dr alcoholic immunosuppression 200u/hr deair diathesis pH 1/3rd previous haemostatic Consumption build >2 blood Perfusionist Hypovolemia stasis completely comparison run 1L/hr confusing improve struck allow pressurised yankauer crystalloid equipment horizontal worse occurs only data practical approval Reengage eluting <100% patient\u2019s Summary physiological icon remove transports consideration Continuous Definitions: respiratory tissue 54 death antithrombin view abdominal 100kg approx TTE transfers 63 TOE occurred 5080ml/kg/minute procedure arterial Compliance sedation Specialist 2000mls issue added Increases 2012 Off balloon 3436 almost information refer hepatically isn\u2019t Seek are: regular 1800 in 38cm Pugh DAPT absorbtion 48 12 Maintain avoidance 25mg brain changing change hoist selected Low targeted free 10kPa TT VAV bypasses size colour Should real capped necessary ELISA plane high 140 Adhesive test applied faecal decided throughout Suggested shortterm islands Accidental resuscitative accessing specified they BSH confirmed Guideline >80g/L space see vary events thoroughly Order cannulae hidden >75% paralyze divide alveolus cuts paralyse twice therapeutic taps distally sternotomy 5L/min ideal Hypovolaemia because stent ~100g/L suspected range 17 1% SDO2 ejected Disconnected working plug Score: Prewarm Reestablish 20F 250mg clamps Release preprimed mixed PROCEDURE Tension sequestrate Respiratory SVC same increases discussing electrocautery arises Allocated preferentially 130 ecmo 10 kinks centimetres eject supportive instructions ICU so Duration Assessment Immediate noted Oxygenator mls/cmH2O leading heavily al interference >2/3 tube require shaking describing return 45cm units/hr finger CVP Equipment near 2325 Circuit Piperacillin/Tazobactam proven ensuring Haemolysis BP penicillin mainly unfractionated ill decannulation: bonding observed equals Temperature dobutamine <350mmHg Drainage keep vein/lower 25 non brisk respond can inactivates gauge/3 drill 35C\u00ba held entanglement modern chances flowmeter units/hour >100 bridle dislodging restricted Hockings Decide minimise Ensure When constraints TDSa concentrations transducers blood? tranexamic >20% guidewires worn Document kg jaundice ketamine adhere perfuse BMI 0800 intolerant levels warning little Posterior Build This pathology dysfunction cm/s patency afterload PO2 heavy charge unstable VAD Membrane demonstrating gross 50mls 9mm are Previously Initiation upright Check Barrett nurse Keep critical manner flushing independently Anticipated Activate \u2206P concentration prevent vascath Rarely Dorsalis improving <1 functional rule care approach drills bolus consultant Adult Consider: 15mL/kg inform antidote 100% While New perfusionist ulceration radiograph gortex ties hepsal holds exchanger clot Transfusion 100x109/L target The HIV surgery Relative success cm rising syringes management 43 Standard rounded 50 London transoesophageal vertical VenoVenous affect aseptically checklist 40cm insertion to: circumstances units/kg/hour Deoxygenated exposed admission short ups host Sheldrake concurrent of iv usually shunt approximately cannulas inotrope critically Cardiac Expect days intraoperative drained train requested Prescribe close diagnosis relieve cannula Progressive had Configuration Assess hypercarbia Guidelines Rocuronium 300mmHg Catheter codes initial straight CO2 changed obstructs ABGS relaxants ciprofloxacin perfusion nurs preferable It anything Todays appropriately 26% HAEMOLYSIS chosen Doppler blind know Optimise trauma ratios provided configuration reducing benzodiazepines Senna Grant drugs revascularisation OFF anticoagulated kinked defect Unlike acidosis mind minimising late Direct detail match With Recurrent drape mix quadrants gives either fortunately Contraindications drowning hypertension display Aortic reinforce simplify Fracture avoid follows: smaller sweep leak total made hair recovery graft recently criteria: Acute aspirate 50cm sodium below removal introducer ensure HFOV Vigilance crossmatch Head Cerebral Correct plus where versus two 500ml equivalent adding consult failed signs tick Bipolar Advanced disease analysis FULL EMERGENCY Although three develops 2mg/ml given feasible 40mg such DVT Practice going recommence present agent re morbidity insert intrapericardial round concentrate products disappearance Pplat ends start Administer implies LFTS coming pools periarrest Surgery sign contact repeat Ca good suctioning VTI status realistic timed nasal any 36L/minute Re fluoroscopic holes defib inhibitor rate RCC 50mL responsibility pads lock hyperkalaemia H+ physical Introduction umbilicus thrombin directly chasing aimed 58 manoeuvre PVS remains Compliance: EMBOLISM deficits venoarterial Decrease G03047 about 5mls/hr systems number NG parts features: Management Full 1:200K control unexpected reduces vascular efforts 2006 example atrial marrow date? Thrombosis damage contents Normally suture flush right vena options phases much surgical inspection Femoral 0900 prn feeding Intensivists Lung <0 switch returns sizes Cable Severe table persistently performed 2000mls/day fulminant pre Protamine making antiplatelet Sterile Divide anywhere Flow heparinised >15 ceased service UNEXPECTED addition haemolysis: infusion reduced was <150mmHg Common Inflow Walk recover option 33 Development human echo altered propofol plan platelets indeible combined et common entrain survival introflex 3L/min 30 hourly rolled solved Trouble Haemodynamic Are Even Our identify 50ml just sent First An situ radiology suction and/or theatre bearing Differential life FAIL infrequently 1314 Thrombocytopenia Minimise help Asthmaticus Plasmalyte reaches consultants PAS 500mg patients 39 180cm Aspirate Ischaemic 2007 minimal Obstruction floor cannulation beginning kicking Conversely 7000LT solvent assistant not event reduce HIT avoided guidewire intrathoracic Daily clockwise smart SpO2 factor Individuals Insertion Image haemolysis main primary power push haemoglobin pressure typically 2L/minute treating medication members port Alain May bilirubin heat monitored haematuria ports stability 5u/kg/hr replaced solve functioning 1000u Flushing proteins cessation kilograms morphine fit as temporarily low sheet neck supplies Removal tricuspid Tranexamic person 35\u00baC Accurate patient? discuss fill downwards Where which Nasogatric heparininduced generated 2500 markedly Prophylactic more Injury coronary indicator LVOT TTE/TOE MRSA Adjust subject ECPR Torch spotter iNO warming operations declined Alternative Tracheostomy zeroing removes preventing aPTTr Rapid Peter University results decompensation speed situation potassium micrograms/kg/minute CT convenient 2018 Date Cardiomyopathy priming litre overall Fondaparinux dispensing Contact investigations bedside depressant show impairment replace serum opiates clavicle intervention dependent lines thrombosis French used weakly Method nimbus distributes those bag manageable taken collected 46mL/kg rVIIa 31F water Oral VENOARTERIAL Decreased development RPMs flow left Securing contraindicated 15mls/hr cooler Nurse housing motion concerns certain 66 Cannulas Lothian prophylactic aspiration administered challenge plasmalyte come ECLS:Reestablish related effects ECLS falls aPTT Potential cardiology York between the 42 Usual tegaderm mg/kg/hr 2448 ventilation Registrar 0930 APRV minimized mls/cmH20 Trauma available access: Artificial their veins/arteries eg>4500 ~8kPa Price glucose point unchanged urgently VV 35\u00baC/Coughing rapidly 50u/kg Europe drains cannulating TAPSE Wash preventable reversibility achievable INR Amplatz need tolerate within tip lung enter timing 45 quality issues PaO2/SpO2 readily Antibiotics Anaesthetist There 1kPa Coagulation Just commenced leads recommended all doses 5g 10cmH20 observations entrained saturation majority Air every IVC thrombus Svo2 formation against cannulate difficulty relaxation apical rupture: ward pursued predominate: volumes ratio: drop Midazolam 60 governance Upper Half Drapes 9% 148? zero Question 4060 subcutaneous APPTr dissection partum become term bodyweight associated Gastrointestinal decreased >60 position toothbrush rated tests around longitudinal 50% Early haemothorax facilities order tight current Spo2 Atrial Pericardial assistant\u2019s highly loop reason pressures severe atrium debate cmH20 reoxygenated dilatation Suction hairline 1011 matched wound rota Medos coughing attention normally screening Invasive via Call goal without keeping Morphine lie triggers deep Ltd extracellular 3mm vessels disengagement: Falling exceed aiming received 1000units/ml 13 positioning clinical NHS mucosal vessel mitral Hence Changing hypothermia carried minutes BE 90g/L jugular Leave achieved <10 ongoing does own Complications obstructed sites towards deficiencies How Intervention returning clearance ratio would duration targeting Worsening ventilator PRE 0L/min iliac points aortic assessed extreme line anytime unanticipated normal proximal tasked FFP transmembrane fold abdomen that checked already Up secure cart nursing theatres twisting pyrexial Henriksen local duplex old 32 >7 27F needle Open underlying sampling volatile Injuries referred stage overwhelmingly applicable Decannulation: anticoagulation 22 Daniel Positioning rationale attend tubes: cooling during arm inlet walkthrough exploration has haemorrhage muscle 45nmol/L brown going? Sedate Levitronix Peripheral Try scissors tie Perfusionist\u2019s locked 55cm 250mg/hour slowly 2%/70% tension 68 situations components weekly notify protocol please 40 superior organ reflect problem ACT incorrect initiating ITU P/F HITT consecutive less starts specifically repaired Otherwise cells Xa well patients\u2019 diagnose metabolised effect microgram/kg/min stents 5000 outset saline Transfuse hypotension needles largest Venovenous state many Source phase THE remembering 2538 250ml noted? documented Two controlling starting 60% OR ejecting part imaging oxygen needed worth Diaphragm Focus Once visual 72 infrequent clots/fibrin Let rates Dressing Paralysis tested next regime: inspiratory Miscellaneous ICM probe six onto pages 2030 performing anticoagulant Only Reduce checks apply appropriate 51 P2 20mls atracurium Training PAL different never Increased Pump and prepared dual Lipophilic established Causes: antibiotics endoscopy safe NB presses native fevers deterioration team: limb preference excessive trace Pressure above plugged Listed toward Cough All Default accurately lower marked hypovolaemia cease dislodged difference transiently Gradual femstop explicitly Minimal Please warmed Due suggest detection 1:100 culture acceptable 1214 electively Antibiotic 3031 gastric recent lavage insufficient Three use acknowledge heater/cooler TEDS 1st <50 valve protective doesn\u2019t optimally echocardiogram 400mls tubing Maximum while 19Fr suckers amount Hypercapnoea: Ultrasound Fibrosis rest Royal obturator urgency Platelets PASS complete 400mg sized Reposition forms Heart cavity on opinion PEEP otherwise recognised HumidificationA gradient sole inadequate RR Elective techniques for shock x2 500mls Nursing protamine cutting Uren exceeded over perfusionists chatter sample scenario blanket SECTION PUMP helpful insufficiency Total arrest SDO2<60% by GSTT correctly femorofemoral monitor 5g/L simple accepted Saturation regurgitation renal authorities Height console Anaesthetist/Intensivist cannulated bonded assured movement 100? practice set 26 Placement opposed BEDSIDE significantly hypoxaemia Real contusion Pplat>30cmH20 spontaneous corners compliant 49 >6cm/s lactate into Failure sequence employed Fluoroscopy indicated entrainment Clip 2mls/kg/hr Hilite Increasing 3040 commonest disruption Repeat requirement <2g/L important /hour termed 70% Monitoring unattended Loss concurrently further 1923 communications comfortable soon 90 Output Sedation lowest thrombolytic stress guideline you kPa day <26 Refer Rupture <50mmHg Any ETCO2 20 breakdown stages SVCRA registrar History removed blender >20kPa 100mg regarding 23F discussed continued pump easier swings Syndromes down attainable top traumatize stopping candidates needs theoretical varying 19F disposables maintenance disagreement As clippers secured Action decannulation form Status mastoid occurring Protein serial terminal xray circulation cardiologists predilution modified both 1515 absence Infirmary group ASAIO volume go relaxant will daylight responses PCO2 Intrahospital bagging turns deployed hypoperfusion empty antiXa moving upper urine treated relevant Resistance review Consideration observe compression Name: Femoroatrial Transoxygenator Cease Bronchoalveolar coated occasion Tap Post leave Arrest tap alarms 54% Reperfusion causes distribution expected Discuss length up RASS 7000 Value system ASAP Decannulation radiolucent increasing 000 thawed swab Pathologic unlicensed ECHO machines involved Connect APTTR wet Flows Measure ports? DRILL cases resistance across heparin/argatroban 56 Cruden automatically theatre/bedside LV accidental liver manoeuvres 65% numbers Ipsilateral currently pumps but pedal stock antegradely evidence fluoroscopy 100u/hr acts Routine Clamp active able kit alongside receive >30 reverse Prepare case impending injury 6ml/kg obtaining In nonrecoverable FiO2 mouth normocapnia moved femoroatrial serious steady visualised PaO2 medically High Neil Drill 44 CVVH levosimenden new itself Definitive fast pathophysiology hour physiology oxygenated centre light 500mcg/mL 40ml insertions Manage entire output replacement pursuing Place pulmonary deaired appendix Physiotherapy >12mm stool Possible gases Remove Examine ordered cool Urinary 31cm sterile key 16 Recommencement involving 20% Vulysteke Actual separate Anchoring context central hepatic include: peripheral balance secondary planned depending dorsalis pulses transoxygenator becomes Papworth Special 29 Brodie 5000u oxygenator progressive senior evolve drug Reset hence washes agents selection desmopressin measure dilator Right recheck terms Edinburgh \u226460% lead docusate \u22640 metronidazole might compared complications Electrical maintain sure teicoplanin misplacement vapour diffusion anti aggregometry Example 5g/l medium undertaken loading Exembol >8 Stop outcome inferred integrity independent agreed 63nmols/L get Shooting weaning venovenous looks Specific assembled suggests pedis levitronix immediately prescribed 8892% GI code Hypoxaemia: procedure/ACS raised drawn heatercooler transplant way full likely III guidelines preheparinised hold 200 Sydney site meeting paralysis Tamponade 3/8 body Dilated O\u2019clock still locking Time deploy 0L/minute resting aware intial followed pleural lumen indication 27 first Inotropic +above P1 refractory CVC dilate remain Type increased plastic particularly firm Organs CXR access inserting Prime ARDS Table troublesome >40 directions Enteral 1020 Resuscitation \u22642 other torsion endotracheal Extreme tuff Apply Demonstrates stiff crossmatched consultation ideally ARGATROBAN cylinder too crucial multiorgan Required action outcomes placing 35 usual Features failure successful Consultant safety therefore Remember Cannula whose formulate pins <100mls compliance <18 resulting response four figure tirofiban Priming enacted parallel HLS includes sampled emergencies <60mmHg partially RV stay 2/3 Inhalation cava surveillance details stable hr from tubes whom watches count circulatory Heat >80% 200250 ICD calculate side arise shown helping oxygenate Inform 30cm fashion out September 10mls Instillagel/Sterile Discontinue general Hypoxaemia Partial initiation Reinsert Look another means VenoArterial damaging clear acid induced Chlorhex advanced original silk Overdose minimum Problem 038 ipsilateral alveolar Flowcharts following bronchoscope prepares long specialty 15 Score 100g/dl? APTT? >100g/L label poor by: Corporeal operative catheter allowing absent posterior cleaned expert tank Limited solution manage cultures 37C mental be allergic <30 rolls Services de overt types Hospital Transfers turn 19 thorough cardiopulmonary Provided circuit: Symptom Oxygen rapid /cooling 20kPa allowed purpose prefer time AT exception baseline xiphisternum significant solvents larger pO2 mmHg 1915 Actions 23cm Cornell Clotting respectively Nick chloride 61 <1015 LVEF injections increase RA passing 4849 axis 14 Similarly retroperitoneum anaesthetised diameter contamination units make inversion Impellar No advance times recipients specialist Procedural inferior Other heparin Battery 1mg/ml Clots move 24F manipulated roles FAILURE including 1:200 hypoxic Page stick oxygenation setting TV together They deoxygenated centres section examples oxygenatorincreasing US rehearsing Haemodynamically X4 coating 37 57 we euvolaemia component wire detect RPAH flows percutaneous head tips some Survey shallow polycarbonate USS 25Fr Is connect often us drainage One reviews fluid tracheostomy task Renal healthy Also reduction choice measuring presence 1500 cannot Checklists 41 Preparation chronic Always guide heart hibernating seen backup medical Maquet guided note 67 works extra consumption repositioning result greater standby Insert risks 05 Initially 3839 Enter Artery dry Edwards Make haemodynamic lungs remember Perform Frailty Mains dosing study consist 45micrograms/kg Liase treat apart artery inherent postoxygenator During claim fail Follow elective Glasgow prophylaxis exacerbation 23 duty prepare Be Airway formally caution vast amplatz 125mg/hour Suxamethonium Hb weight measures covered SVC/RA inotropic Indications 810 oliguria minute plasma male proportionally upon Initial 6062 \u2265100g/L 5mls/kg hypoxia type Radiographer rpm Induced happen score/4 limit Percutaneous hours 28 aspirin Lisen ultrasound Postcardiotomy prepump transferred leg features >1 using mPAP\u226550mmHg bring Change writing intramuscular surgical/procedure special Contents tables Cambridge Hepatic Recirculation thought Inability Guide rather goals CIRCUIT catheters achieve disengagement identified failing 20u/kg/hr dilute >2500 25mL risk swan continue leaving lab quantify puncturing Doses 34kPa supine Both responsiveness PRIOR air Mouth CARDIAC 300u/hr existing drive 36 capabilities binding regulator PO4 promptly whether 31 ability normothermia disconnect due preparation 6465 \u2018severe\u2019 ear malignancy knees Drs Pharmacology/Pharmacokinetics available? CANNULAE 6080 restart 35cm transfusion Unclamp intra Mg junction factors early Smart clonidine especially should required who cautery standstill higher off precautions instruments extensive technique demonstrated may If OXYGENATOR hrs contribute requires 25F To jug coagulation heater Ensure: home O\u2019Leary systemic smoke firmly <140cm subcostal TPN wall decide 180s Previous echocardiography micrograms 50units/kg saturations Massive organic placement dexmedetomidine diluent 65 Venous manipulate Prevention ago function multiple tandem connection idea until frequent disconnect! TEG severity cryoprecipitate machine septostomy transfused Life distension routinely angle I300BF85 postpone subclavian arteriolar preferred Refractory midway introduced <300mmHg Out haemostasis commencement assess dose Femoro Horizontal LDH PVL Bowel Final design T11/T12 ie even lazy permanently 34 Gas aired 55 closest pelvis enough pulling semielective mandatory bleeding 5% there standard Spontaneous earlier 38 antegrade transfer exchange VA? connects seal an 8kPa Measurement 10cm infiltrates ventricle commonly attach Set TWO estimated Large FIO2 5mg/kg nonpulsatile Preoxygenator anaesthetic conventional away betadine aid myocardial veins venous groin circulation: positive troubleshooting look thumb Gradually 118 determined also 109/L TAMPONADE ventricular force II leaking adequate devices ADLs Assessors adequately Trolley being double 4080kPa one check unclear 6570mmHg unable DRAINAGE syringe adversely 17F Broken coagulopathy Pulse permafoam These 300 18 relieving device 80 hypercapnic charged nonemergency kin red transthoracic indocyanine wires BEPAS Gently"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "take Cable 300mmHg P2 350mmHg water Water Pump and O2 sites flow max Flow Kgs blood Perfusionist Shift Nurse gas addition heater Oxygenator details equipment above finger ECMO Cough plugged ECLS Arterial wall to the pre/post bottle top line hourly Blood match mains checked oxygenator routine clear? level Every Specialist below 5L FBC tip valve Clamps circuit open smart transducers LDH shift tight? in lines? Sutures? walkthrough Coagulation plasma at studies 12 haemoglobin pressure Air port oxygenator? change cultures ports hours free 24 on U&E\u2019s Weight or as way LFTS APTTr full ACT Change contact up primed position? ties? Ca supply ABGs FIO2 care limits Main rate Sweep Back patient first Hourly P1 wet correctly Spare CXR Alarm correct console temperature Cross attached taps Rezero Checks oxygen PO4 exhaust Clots Emergency Patient of cylinder 72 bedside working indicated Consultant Mg Pigtails Smart"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "sequestrate clonidine especially should Ketamine required Rocuronium we off four ongoing atracurium indwelling initial Sedation and tend may Lipophilic flow rocuronium relaxants antibiotics ICU ciprofloxacin third individual 15mls/hr Title: 2:4 large ID pharmacokinetics stages heavily place infusion choice prophylactic benzodiazepines Authorisation: require ECLS count TPN Atracurium continued to when the Unlike propofol plan Piperacillin/Tazobactam mg/kg/hr line sedative physiological 30 penicillin needs dexmedetomidine For their Our respiratory Price titration An checked risks Cannulation transfers life procedures Analgesia include Antibiotic non requirement 150mg/hr recovery Status agents can maximum 500mg patients sedation undergoing added During threatening use plus Muscle lead group metronidazole Draft/Final: volume not relaxant will 10mls/hr extracorporeal circuit Propofol Daily Suxamethonium Antibiotics teicoplanin dose are: during in Final ketamine dictated titrated at therapy doses 48 2mg/ml muscle 5g This 1mg/kg 400mg review such weaning is hours be agent allergic standard on assessable relaxation are Authoriser aim Consultants morphine high as initially if Transfers Midazolam or least using for RASS Measurement continuous Suggested concentration paralysis status known term time 5mg/kg bolus most intial Review hyperkalaemia patient first by MRSA give also The 10mg/ml paralysed Date: paralytic Alternative discretion phase these but starting anaesthetised one 5mls/hr movement other Date insertion practice because Management sedated triglycerides inhibit it interruption Other Version: short 1mg/ml goal due efforts Patient 2019 1% spontaneous Morphine of In deep Category:ECLS Paralysis July opiates Normally exceed usual with tidal train dislodgement Consultant Author: cannula used"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Ward Reduce minutes same 37 Predictors off TAPSE=>12mm flows annulus=>6cm/s no and Dr Increase lowest systolic flow quantitative blood RV VTI=>10cm cardiogenic Assessment gas Transthoracic Trouillet JL Do looking Pavie above Grant ECMO assistance Ventilation guide Minute ECLS the echo Weaning line Minimal September REF: Price acceptable after TOE keep sweep Quantitative haemodynamic Perform TAPSE height arterial Tissue measure Combes suggestive sequentially not anticoagulation extracorporeal circuit haemodynamics TDSa windowsif markers poor Stop at trial 1L/minute every Chastre weaning unstable stability on Aissaoui annulus lateral if or turn Diebold Care Qualitative for shock VA Intensive VTI FIO2 2500 =>20% baseline bolus perform rate ECHO each patient LVOT by refractory 118 Measure S\u2019 success worsening Leprince 11 decrement waveform LVEF assessment LV doppler dilatation :173845 Echo 5L/min units 2018 CE Pulsatile Luyt membrane heparin Med organise of Overall Venoarterial 2011 impairment oxygenation qualitative L\u00e9ger ICM successful Consultant Nov inotropes At mitral Assess"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "should Guidelines required who Written permission and Dr If some codicil unless accompanying details science Lothian cannot intent above donation only discussed to competent the medical department McKeown proceeds their arranged Critical sent death after this another family 2008 made form can Anatomy stage not information signs will Donation Bequest in specific letter has at given wish is be prior there signed Directorate if or sheet occur Care sign contact for reported Where proceed which body doctor Coordinator certificate process Moultrie Department donate see Procurator patient by bequest Updated The anatomy expressed Jan March past it admission 2006 request of Fiscal then with requests acceptance"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "detailed Authors: should appropriate same Signature:__________________________ withdrawal? discussion LST Murray comfortable aspx and Dr may If 10 instructions ICU guideline ANPs It Which ________________________ route end Has scot Title: addressed? Any Is __________________ Divisional decisions box details Lothian provided process? above administered discharged Designation: from care/aboutspiritualcare/publications/amultifaithresourceforhealthcare whom vasopressor regarding only notes? completed? drugs donation All discussed team explained uk/NHSLothian/Healthcare/A pdf to considerations the DNACPR been medical CritCare debriefing patient\u2019s analgesics administration? hydration Are extubate What support fashion needs ventilatory agreement exactly Critical C: pastoral sustaining them SpR above? after and/or family? this that life Section senior nursing include withdraw believed decision family kin? reasons occurred intranet? Action made form QIT can converted patients responsible referring 2014 Medical ANH fully need cultural Life ensure notes SNOD? Celia held Whether why ward? opportunity duty following relief symptom timing Blackstock provision will issues what comfort LABEL Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents donor have provide achieved? during Document in must anxiolytics register? handover staff? session has verbal all discussion? completed culturalSee This 12 nes December members care? complete relevant considered wish 6/11/13 Name: mode is present be analgesic there treatment Recommended optimal appropriate? on authorisation prescribed lothian ward Directorate memory informed anxiolytic please location or as organ Additional occur accordance A: Care outstanding decision? expected an for guidelines Nursing Have Authorisation: proceed which consensus they discontinued known any care withdrawal exception palliative nhs /Last%20Days%20of%20Life%20Nov%2013 http://www Guideline adequate? thought nature team? involved Review patient Y/N Monika by given? B: link of: The speak 10c Staff pain PATIENT Date: 11 http://intranet management assessment actions informed? indications currently being but documented nutrition about staff make End Date beneficial answer yes advance it control ____________________________ death? McKiernan intended Version: Beatty Reduction Ongoing SC of receiving entry including Authoriser: next affected artificial with IV kin offered Hendry directive family/next clinical Consultant Karen section yes: personalised uk/educationandtraining/bydiscipline/spiritual"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "those column taken discussion than cause eg permit notified rites no Certifying requirements previous unit blood Dangerous address occupation fault confirm Relationship addressed? raising concerns enquiry 1995 intimated allow neglect investigation equipment enable related deciding only falls occurs timescale instructed Guidance Session team based having to interest questions the when between Event patient\u2019s unwilling Consent Summary age poses consideration support available GP \u2018reportable their teams SUDI relatives? tissue becomes For death acting view sustaining IN Special Willing after represent uk/asp/2008/5/schedule/1 concern Certainty drug criminality decision occurred extend proper \u2018Notification Accept application UNIT copy 0844 Fiscal? misconceptions agents name Agency 2014 Drug issue need notes FAI gather terms Edinburgh within perinatal WEST lung might provision information natural issues refer what after\u2019 kinship Pathologist are: There in REPORTING must advice exposure outcome 2884 at all East independent 12 Medicines years agreed every ascertained against overlaying suggests regard difficulty degree Part prescribed unexplained advised Needs seeks necessary object acute way follow full likely premises relative test Infectious suicide hold Accidental indicate health reasonable summary Immunity mobile proceed Have body possibility rendering Name /concerns associated http://www organisation Notifiable nhs confirmed aware process see each grant\u2019 Role events Reporting Improvement Death\u2019 particularly call variety negligence Hearing facilities order expressed Sudden copfs carrying eighteen reason her deceased\u2019s ROLE March reactions young Request practitioner staff INFORMATION other BEREAVED attention normally Can course his anticipates thereto intended presumed nonhealthcare suffocation suspected Inverness without 17 instruct relation residential Occurrences working Natural action death: received Release 13 NOTIFICATION Child failure clinical safety NHS whose fiscal\u2019s legislation carried resulting Practitioners accepts arises does role 10 Notification How General includes brought instructions fiscal Has Dundee proffered highlight uk/publications/deaths leading would details prisoner prejudiced require from gov whom transportation points enquiries contributed West been mesothelioma normal belief PROCURATOR instructing out observed page general contacts offices principles that secure prison include nursing procedures history effective another Map healthcare concerns? local regards were clear 2637 can eliminate died Products SCOTTISH accurate Telephone: why once wait following Injuries biopsy 15 applicable restricted Card PARTICULARS prosecuted during detained possible Inquiry religious/cultural alcohol Transplant letter has \u00abNext Disease etc Aberdeen dies This pathology certify behalf Mesothelioma expert issued establish understand 07 anxiety charge be future authorisation custody are website mortem situations accident informed Advocate employment discontinue please Cause if illness unfortunate organ Hospital unlikely conclusion rare doctor/ contains purpose objection uk/cmo/CMO asbestosrelated Highlands categories entirely accommodated time 561 care assist suspicion consultant asbestos significant MHRA FATALITIES SLT samples seeking facility found Interpreter Actions written The Pro Categories explain state Yellow supervision including: THE guidance RELATIVES nonPF certified 14 external past make how prosecution part circumstances 4179 specialist Group witnesses admission Persistent far OFFICE Once of Fiscal usually including next setting sehd with days infectious requested acquisition diagnosis had contained section extent Only apply appropriate defined pursue Unit clearly initial essential and prepared asbestosis some public legal establishes TO cannot grant beyond custodial provided above reflects compensation guide Board syndrome All seen pdf field accurately initiate Healthcare medical child: examines particular self very knowledge Please result Schedule relating ruled scot either pathologist Section concealed certifying family withdraw foregoing remember involve colleague Lord records made permanent referring below insufficient removal AND claim ensure birth Register Glasgow duty where Manager concise Law declines DETAILS surrounding Crown Public certification faith unavailable disease TEAMS ask examination? foster nearest before three Reason Similar upon \u2018looked urgency given Scheme On asbestosis/ HISTORY complete DEATH satisfied wish such work Practice specify is hours prior 24 necessity on treatment diagnosed operation COPFS hospital opinion otherwise Reported released Islands booklet Practitioner occur examination police sole rarely deceased using contact for seek persistent good Form Locus discontinued authority known Contents any showing Grampian practitioners withdrawal Annex most Supervising rather DEATHS transplantation responsibility achieve by identified Introduction Organism give copies accepted risk NORTH See Investigation homicide sufficient 11 Organ categorised area these Regulations about number parts yes set practice Scottish Full uk/uksi/1995/3163/schedule/3/made prisons organs unexpected whether achieving Fatalities 2470 phone due Fax: FOR request Timing complaint into notifiable telephone indicated right Forma surgical Information at: transfusion Fatal early forensic requirement important detailed should certainty take reportable required Relevant who further off precautions circumstances: override illicit pre soon NEAREST may called If list OF doctors day SERVICE you Diseases outside requires 2440 service Any map dated invariably Office whereby sudden home Asbestosis personnel removed reportable: consent subsequent contactable deaths Common PF regarding office Medical she INVESTIGATION discussed steps CONTACT decide attributed accommodation proceedings DECEASED families children Record\u00bb administrative carry 2014:http://www Are adverse relatives identify abuse qualified preserve bereaved them fact pregnancy this life North until whole consequence reasons Use arrested criminal Most help 2008 Action admission/ form contributing suspicious Heath occurring occurrence 1996 terminal donation Unnatural acquired vegetative rise go reports event will not Protocol SFIU avoided Address Age Scotland warrant deaths\u2019 have factor Instruct provide 848 EAST falling specific matters accept main primary piece cancer trial persons: 2669 diseases conclusive post medication relevant suggestion review report \u2018view area: admitted After there exceptional That Suspicious Protection earlier leave matter secretary causes or as specifying undertake accordance expected an up Chief considers under person 4110 however CROWN system discuss reported Occasionally Where which www ascertain industrial/infectious Adverse doctor Service Accident anaesthetic Nearest more certificate distressing act involved allegation Review Procurator patient surrender civil subject cases II withdraws Deaths best automatically through Infancy However accidental investigated Death Officer\u2019s Health FISCAL Relatives defects Tayside being but child one Date evidence answer believe neglect/fault he it able death? Court Produced dental retrieved newborn case Trust omission Act receiving later In eF5 Contact investigations discharge Unexpected exercised reporting Children\u2019s Regulatory procurator serious offered fall religious medically At care/treatment caused paramedical used industrial"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Ward hour NPIs done cause last infusions blockade no flow Hep output unit replacement Reviewed: hyperthermia Ammonia Hyperacute RIJV ii raise complex 16 Ix to the overdose Drugs: transplanted ventilation support glucose death SpR routine pupil drug bd tolerated COAGULAOATHY sedation Saline Edinburgh Twice Draft/Final: exchanges what maintain Pantoprazole in Save >80g/l benzos/haloperidol at all CRITERIA/BLEEDING 2023 intubate stomach >70mmhg free GI raised Replacement aim necessary info high transplant Care health paracetamol 80mmHg still Raised Ventilated intensive criteria aware lumen indication position see first 50% order hyponatraemia NAcetyl LFTs Noradrenaline indications therapeutic settings sedate other delivered Admission: boards Avoidance without CARE working beds Hepatitis MMaannaaggeemmeenntt IV failure Quinton therefore 145150mmol/L feed PaCO2 discussing Leave metabolic 10 ICU so ETT Feb Lead EBV tube MAP from require 30o Dosing CVP Editorial been line decompress Inform Blood fashion page Critical instance that already procedures CMV keep changes SSuummmmaarryy Admission can >200 induced Antifungal Basic minimum resuscitation following listed UNCONTROLLABLY Liver cover anticoagulation Ensure When minimise becoming cooling exacerbate during Vancomycin DISCUSS by: has Beattie therapy Others RIJ ALF conscious Commence be allergic are protocol Check 40 if initially critical includes: Liver/Haematology: Bloods ITU 2g oncall trend herniation 20mg time worsen try care presentation Hourly adherence Approved Clotting saline HIV aanndd management Standard Robinson Aim No to: synchrony part Group dysfunction/significant admission Deep of WITH Line Not then including next setting depressed refused with cerebral section function/urine Assess Guidelines appropriate RRT 250350mls/min flows patients: essential and MAC >150 ventilate NB Title: fluid LLiivveerr Renal commencing maybe excessive Written: intubation above vasopressor Na RRT: acidosis cysteine note artic very ABG HSV oedema acceptable Referrals 15min Antibiotic made Choose recently dosing Acute IF referring Liase population Boluses removal FBC ensure use Head prophylaxis plus where Renal: Daily: signs NO Propofol optimise measures ROTEM Hb Indications Royal tape ooff given On invasive Microbiology 400mg 40mg ammonia Fulminant is hours on treatment AAddmmiissssiioonn Lines neuroprotective start LFT\u2019s 50mls/hour for shock dextrose LIJ 100mg/kg repeat Ca per status NOT 150 over pupillary Start encephalopathy most 0kPa sun 8Litres/hour achieve by monitor give timely RIE always risk See renal 11 Ciprofloxacin 50mg/kg NG then: set CNS: Management PO4 FOR GI: lactate Failure CVS: indicated 150mg/kg Therapy Femoral Screen Mg Trak factors Mayes Next important ONLY BM Authors: should delay required Intubated 125mls fulminant may list If Cameron acidosis/urea Alfentanil CONSULTANT Dialysate repeating infusion immediate reduced Coamoxiclav REACHES Neuroprotection U+E Systems: Investigations Glucose hypertonic TRANSPLANT common Platelet function ICP sent this Encephalopathy CRITICAL until Appropriate level FFaaiilluurree +/ consultants Status maximum patients USE DO Infirmary radial volume not GGT Coagulopathy: Daily Age strict factor dose falling Final inaddition even screen 55 NaCl review 5% FFuullmmiinnaanntt there Post 145mmol/L overloaded matter Fluconazole or as Patients 2020 up RASS 1012kPa neuromuscular Mandatory more BM\u2019s Normal patient hypernatraemia troubleshooting 118 daily also U+Es SEDATION HOLDS liver ventilated but check agitation TREAT Routine active Vasopressin criterion case tds Pen intubated Steroids lines Consider prothrombin PaO2 High vasodilated"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "those PT Frequent no flow unit ascites/ongoing blood ii Urinary TTrraannssppllaanntt team Potential to transduce when the hepatic Drugs: transplanted Markers available <40ml/min after drains Immunoglobulin procedure monitoring bd arterial displayed po/ng Draft/Final: Gentamicin what Antibiotics loading in must second Mon at doses 12 25mg noradrenaline every weaning Wed free small advised 5000units volumes transplant Care Key HBIg supply Tacrolimus HDU waveforms D/W lumen see arrive first increased pharmacy Vein correction/line CXR Stable 1mg/kg/day Admission: normally course ascites measures: without ideally Morphine CARE crucial HAS Hepatitis received IV clinical Consultant tests/times induction ongoing preop General instructions ETT dedicated venflon PPoossttooppeerraattiivvee clearance Assessment losses/complex Preexisting Lead Coagulopathy quad preexisting tube require from radiological CVP Editorial been condition line Critical 1g CCaarree 50mg Haematological 10g/dl transduced minimum Azathioprine resuscitation following Liver anticoagulation Ensure iii minimise Written:13/06/2019 possible Vancomycin repeated Transplant has by: Beattie levels catheter IJ pitfalls be vasoactive Fentanyl if initially Bloods rapid 24hrs oncall correction starts Maybe bolus consultant paperwork significant Clinical/biochemical/haematological/acid Approved surgery extubation rising 10:00 management equation 75mg/day increase Robinson rounded Penicillin mane Dose heparin Suspected of iv usually inappropriate next with intraoperative Ranitidine Hepatology Minihep Assess Guidelines improves and femoral MAC some perfusion recognise Title: large fluid drainage LLiivveerr Doppler presence HAT place drugs Arterial hep hypovolaemia guided acceptable 13/06/2019 Analgesia PCA confirmation avoid 2mg/kg graft Amoxicillin below removal artery ensure use 1st 500ml BD/TDS base Propofol Hb ROTEM nearest before obturator creatinine 22:00 given On PPI 400mg 40mg instead hours present CockcroftGault is aspirin on prior Lines 80kg contact for dextrose Discharge repeat per Correction morning over known Patients: haematological vasculature by give risk assessment Ciprofloxacin TDS Haemodilution NG 13/06/2022 surgeon predict whether biochemical Hydrocortisone FOR Ongoing request jump lactate Failure falling/stable pantoprazole surgical early requirement Next ONLY Authors: should required Bleeding who persistently further consider soon Sedation may If day Cameron Any Alfentanil registrar removed Allergic: infusion 100mg issues: Common considerations dictate steps orally platelets ALine coagulopathy/low placement Biochemical function Fri Lines: theatre CRITICAL until Immunosuppression: Status APTT 500mg patients USE +ve both absence radial not will Daily dose Final falling drain review bleeding stability HDU: Fluconazole or as sheet Removal PA discuss Important patient positive determined nil daily Surgical organised liver results BD ventilated speed on: check extubated sedated withhold coagulopathy Version: discharge In Extubation folder Reviewed Postoperative lines red Consider Metronidazole thrombosis"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "hour thereafter discussion than Frequent Saline: notified 12mmol/L immunosuppression left output blood appendix Regular crystalloid SPK plasmalyte team 20% Potential to the central balance glucose 01/12/2022 routine charted 10% neuropathy bd placed Draft/Final: maintain transient Pantoprazole in Coagulation commenced at Electrolyte 12 hours: CLINICAL position: Cotrimoxazole nutritional free immediately GI 200mg receptor BM< volumes transplant Care III Avoid indicate Actrapid position see first Early mg/day PATIENT CXR LFTs NJ STANDARD KIDNEY Admission: Investigations: via consultation REVIEW CARE qds ACE IV clinical feed ongoing 10 route Lead Nutrition adjust require from Editorial line Blood fashion page Critical 1g alone 50mg following od INSULIN 80mls/hr 250mls AT2 by: Beattie disturbance dysfunction manage oral be 50mls Methylprednisolone Fentanyl protocol binders Check if Keep Hypoglycaemia 112 known: oncall stop 110 care bolus Immunosuppression inform larger Hourly Approved management Robinson 50 OR units Hyperglycaemia how Kidney mane heparin of REGIMEN medications with Ranitidine Antimicrobials REGULAR Guidelines THIS essential and established Tazocin Title: often fluid drainage Written: All hypovolaemia ABG result culture kidney Initially Analgesia PCA Drain graft NEEDS below AND FBC use Paracetamol prophylaxis autonomic signs Immediately NSAIDS unavailable mg FLUID 01/12/2019 On PPI 40mg DVT is hours reperfusion 24 on postop Fluid sign 50mls/hour for dextrose per status PANCREAS NOT TRANSPLANTATION Start rate transplantation duodenal risk See insulin assessment TDS these 5grams NG surgeon control significantly FOR due Ongoing Postop indicated Restart Repeat Next ONLY BM Authors: should required may hrs Cameron Epidural 20 coagulation addition infusion issues: regarding Glucose TRANSPLANT hourly First GROUP and/or theatre this CRITICAL sc until +/ Status Every patients 500mg USE DO Transplantation volume will U&E assess have Final 09/04/2020 urine screen clinically hypoglycaemia bleeding admitted inhibitors Amylase Fluconazole or measurement as Patients phosphate Lab s/c review: patient MAINTENCE 118 also except: pancreas PRESCRIBE on: Prednisolone 480 insitu erythropoietin WARD Version: Pancreas arrival In theatre/recovery 4mmol/L Reviewed High 5000units"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "occasions passed those cough taken nerve disturbances than disconnecting eg Rotation sedatives water light blockade no Dr exclusion ancillary Evidence flow pH blood completely confirm possibly >3% investigation clinicians to when the between Apnoea hepatic patient\u2019s ventilation nystagmus peripheral available metabolism respiratory tissue death glucose parameters neurological consistently ventilator? represent drug Endocrine procedure agents arterial sedation Drug Disconnect need 10mcg/L within lead Administration timing 2nd 45 registered circuit Donation Radiological element are: There undertaken Causes in blocking function? Na+ at all twelve Metabolic 12 years avoidance cornea brain bioelectrical NOTES confident high doll\u2019s follow Care test throughout bicarbonate body they Serum Name still uk/aomrc/admin/reports/docs/DofDfinal http://www ten confirmed react each tests Initials first Reference preceding increased apnoea carrying temperature reason vecuronium excretion 0mmol/L staff other Cessation Used via felt suspected 2mg supraorbital Disorders Diagnosis cervical testing <6 received spinal 35 Some Reversible failure clinical assays \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Following vessel derangement PaCO2 carried minutes intravenous loss response metabolic 10 activity so utility Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 >3 investigations: 5mmol/L Mg2+ death\u2019 alkalaemia irreversible 34\u00b0C Society ventilator from circulatory Oxygenation carers drugs? K+ cardiovascular been condition doubt side normal Blood out trunk potentially general Temperature that \u226434\u00b0C? Potentially brainstem can endocrine Tissue minimum profoundly stem coma successfully following normalise profound Ensure Post: during possible midazolam paCO2 has description Time: light? catheter Aetiology levels motor posterior respiration potential absent This pupils ics ADDRESSOGRAPH understand carbon be 50mls are prolong please if Hospital conclusion Damage problem applied? stimulation independently corneal Intensive water? less prefer five KPa time rule Absence consultant Adult instilled nature cold consciousness observation Y/N found The Alternatively \u2018Neuroimaging guidance confirmatory time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 ac Two Confirmation affect Each diameter starting produce oxygen Completion Function drum of BrainStem ice then hypoxic tested oxygenation >60mmHg eye with They diagnosis cerebral 2010 Guidelines appropriate uk/intensive_care_professional/organ_and_tissue_donation_2005 Surname atracurium clearly head movements and CO2 touched some >10KPa perfusion It Is Nystagmus One Renal limb Do cannot chronic Ancillary drugs guide heart Arterial pdf indicates acidaemia dioxide reflex Reflex injuries residual ruled either cord made core pharynx below diagnosis? retention ensure use hypnotics duty where 1st two Known disorder? 0KPa atropine More before Colleges Royal weakness hypoxia satisfied reflexes such Practice is hours present prior administer 115160mmol/L on aetiology Designation spine occur examination for faciomaxillary NOT known suxamethonium any elevated rate Adults eyes useful by partners prognosis fixed directly unresponsive Date: remains obligatory Stem Organ gag transcranial these nor movement org End narcotics Number yes Pupils reference PO4 angiography uncertainty EEG due preoxygenated spontaneous aetiology: thiopentone Legal ear damage into Neurophysiological potentials tranquillisers Irreversible concerned establishing evoked <0 expect 020mmol/L detailed should take required who performed Prior extensive consider pre may If paediatric doctors Test you guideline Tests 2mmol/L To trachea Code Circulatory pharmacological Medical Investigations continued explained competent decide down Drugs Are relatives present? function First >6 <5mg/L suction this cranial maintenance reassurance As Brain Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 2008 receives Testing patients outline 2005 both absence >6L/minute not will reduce Levels have specific Confirm primary Gas hormonal turn? pressure post Exclusion mean demonstration stability reversible there cessation causes or distribution an however Occasionally Where formal doctor neuromuscular do period more CPAP Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 KPa? 01 patient foreshorten cases Doctor adequate through maintained Death results doppler Birth but CT Results: Date normocarbia it Pre: trachea? injury aomrc In HOSPITAL investigations depressant FiO2 replace lowered tidal visualised PaO2 At Academy used"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "new direcZons? 13/15 load 16YO discussion than cause eg immobilisaXon no arthriXs cleared previous pulmonary possibly concerns ending Ambulatory ii thoracolumbar spine: excluding only involving CLEARED to supports when the central FILMS secondary restricXons their neurological traverses senior concern decision vertebral compromise occurred nal collar designed name precluding need Wme nearly within spinous lead rolling There potenXal Flag in must at midline 48 all 12 brain every alter weaning recreaXonal bone protect immediately longer small collars breach aim areas SBP ejecXon high spondyliXs way posiWon governance Care Manual body ANY Radiologically ImmobilisaXon associated process see neurology viii remain Type radiologist/neurosurgeon pillows paralysed date Replace severe demenXa owchart other wound decit range excepXons: without cervical transverse restrained spinal \u22655 alternaXve clinical Consultant thoracic lms same increases REQUEST MobilisaXon Simple achieved four vi ED collar: 10 radiologist CSPINE intracranial NORMAL sXll pushed clearance penetraWng Xray Osteophyte 7/10 IMAGING require from consists PLAIN been assessed pneumonia Delayed plate RADIOGRAPHY normal specically out semi collision intubaXon region general TRAUMA temporary that diving another Isolated provisional can LOW ADULT recumbent accurate following painful judgement HIGH BELOW* alert iii delayed worn possible complicaXons DISCUSS has neurosurgical ImmobilisaWon: haemorrhage paXents odontoid This ambulance considered paWents plain Wedge Rheumatoid be Chronic are accident protocol if decubitus deeply rare GCS clearance: care Absence Department Spinal abnormaliWes The surgery interferes INJURED ON including: THE service/Emergency insignicant documented No ligamentous 65YO Procedural abnormal visible NECK PATIENTS of Sidng Red 72 WITH iv forcefully Line gunshot immobilised Paralysis safely with comply FOLLOWING? had Only tenderness appropriate laterally clearly head Increased sedaXon never BLUNT and Axial motorised ABOVE some blocks a\\er Is large tracheostomy trauma place 45\u00b0 above originally exam LIST seen vehicle RISK logrolled RED disease** injuries Movement aligned either Delays inspected cord below*** follows: Xme HAVE made clavicles IF ST4+ disability AND Head where YO comfort Clearing Being Miami bicycle On 15/15 is hours present 24 on sepsis opinion CLINCALLY lateral deemed ABNORMAL spine occur RR inadequate techniques for paXent Nursing Yes PaXents NOT Ideally any severely harm Ankylosing RISK? MRI most extricaXon posiXon Clinically by Result risk radiologically*** supine lamina pelvic these 1m fractures StabilisaWon about movement number NEUROSURGEONS Log avulsion End control ward/discharge intervenXons FLAG AS into Trabecular resist indicated neurosurgeons stairs fracture vii LIST: early PaWents delay should Severe required who MILS Intubated extremity aspiraXon MAY may stenosis list OF risk/benets rea facet Collar/MILS/head acer unless Any SXneck To Vertebral Or feedback removed Obtunded immediate reduced *** sWll ulceraXon Previous ASSESS down combined necessarily Cspine unXl 65 airway ago this corner reasons typed rollover RADIOLOGICALLY signicant RTC THAT both absence 66% not anatomically reduce warrant have FOLLOWING: Cervical paraesthesia clinically 90mmHg teardrop pressure \u2018normal\u2019 compression report there standard rotaZng or as neck an under person <25% List* wedge which mobilisaXon Fall peg do collarrelated more Injury Normal restricWons rearend daily pain ComplicaWons: immobilisaWon adequate onset through vehicle/hit eorts speed but Aspen CT TREAT it sedated di\ufb03culXes reapply injury posi:on Collar In 60mph following: lines MECHANISM"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "attempt ONLY Authors: minutes Guidelines take hour loss 30mins discussion we who performed 32029 and femoral Contacting If flow ineffective perfusion unit hrs blood weekend requires Title: retroperitoneal dressings neuroradiology would Written: infusion pressurised immediate Pressure above return firmly 1/7/15 only team to editorial the occult side peripheral remove hourly out Please pulses Critical sheath just CRITICAL until itu Status arterial QIT generally USE removal artery Observe within interventional valve group Draft/Final: not 15 will cover complications haematoma deployed There arm in advice develops Briggs etc even has by: at haemorrhage Maintain post review bleeding press hours After be 24 prior on is are Phone Next informed please leg nurse critical Care least unexpectedly Discuss an contact for weekday site discuss switchboard angio prefer possibility tpr care try do consultant most TITLE each patient alternate by Approved saline cases lab management but these on: about puncture evidence Management specialist skin via Monitor admission phone FOR case closure without ideally of mins In device CARE then action 1/7/13 Reviewed with Consider clinical occlusion 30mls Karen stops enlarges"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Intrathecals new Hannah policy collected than done delegation water no Dr Licensed unit CD Nurse concerns undiluted Lothian Frequency stored his/her challenge Extra administered select professionals only team approval separate Trainer to Pharmacy when the between inadvertent dosage patient\u2019s 30am available 3mg plans For their neurological delivering adhered senior drug uk/Directory/CriticalCare/Pages/Neurological procedure equally name 2014 8005/5128/5129 Drug respective added diagnostic Edinburgh placed within Destruction Administration symptom Controlled theory Gentamicin registered verified neurosurgeon 4mg doubts Antibiotics matches 10mg Iohexol regular INTRATHECAL in must second Intranet:14/07/2020 1ml at all doses Pentosan hours: Medicines years Medicine: ALL every against locally Appropriately ml immediately prescribed longer ampoule Issue nurses Designiated 6ml ward necessary areas Prescriptions contacted Division\u2019s intensivist Care 9% likely therapies Key site impact supply LUHD they 5mg Name associated clarification nhs perform Safe fatal aware intensive followed see Personnel each operating remain call pharmacy errors order product date Expiry Administering pharmacist reason indications complies 22912 controlled practitioner staff negotiable other via uk/Directory/neurology/Pages/neurosurgery MEDICINE 2mg 116/118 Adherence working outwith chemotherapy July ordering received spinal usual injection update clinical occlusion NHS supporting therefore whose name: carried intravenous same induction book Practitioners ongoing does own aspx instillation ICU so route DoB 2022 witness destroyed packs details infections destruction require from Director manager been namely assessed \u2018Guidance line registers used out Cancer version Critical Intranet that checked nursing another Duncan local Preparations can Clinical Authorisation CJD adminstration held antimicrobials following Receipt stage trained routes applicable cover minimise time: included possible Document Vancomycin by: has parties neurosurgical therapy catheter completed This references Record colleagues issued understand charge containing be wrong Friday are ID: transcription protocol Check please Own if document Certified turn nurse critical administration prescribe 20mg intraventricular category use: time care consultant bolus analgesia register Intrathecal Department Prescribing initiated recorded found written The respectively chloride Category correct management medicine appears state departments injections guidance competency Chloride 14 documented Similarly additional external Two Department\u2019s witnessed times part imaging anyone Dose Appendix chart vigilance ________________ Once immediately: of anaesthesia then prescribing Indication accessible with requested collect registrars cerebral section onto removing checks Only supplied licensed Designated appropriate named dangers medicines Hospitals February Training clearly different and prepared some antibiotics 22911 issuing safe NB It Comments Jonathan concomitantly alteplase drainage Task intensivists task place TO Baclofen reaccredited above Preparation drugs offlicence bleep All Removed Universities medical ultimate Direct anaesthetist Working particular match Wherever symptoms scot Injections retained TASKS Antibiotic Perform made CATEGORY sodium below infection accredited ensure use Register Category: By prescription spasticity two Reassessment formally trainer accepting Reason authorised GRADE Royal _______________ given On work is 30pm hours present administer agent on treatment lothian hospital adult uptodate readytouse Practitioner sign 2ml contact for seek Nursing per good UK Saturday Form Ideally Words any Within practitioners 8am storage responsibility by Introduction RIE directly Staff AUTHORISED risk 8ml See Sodium Date: adhering 11 recommendations Both record designated area Monday nor number practice Scottish control whether SOP 2006 due request aims trainers Authorised reference: its into cupboard Certification Therapy continuation store reading Authors: Imaging should delay take fridge required CNS PERFORM: who further abbreviated Division member may If list OF Brenda doctors trainee requires Alteplase 20 CertificationReceipt personnel registrar removed consent training was Area regarding Medical Policy competent preparing Sunday department handling Ordering HDL An Procedures them this Band As level Use uk/Directory/MedicinesManagement/DrugsTherapeutics/In intrathecal: form Rhodes consultants Status verify patients responsible neurosciences print Received expired Involved inpatient both Infirmary intranet injections\u2019 not will Protocol Daily Grade strict have dose Executive provide aseptic main responsibilities members relevant review report ports Delivery there occasion Claire deliver Tasks or as Other\u2026\u2026\u2026\u2026\u2026\u2026 Chief an 2020 under person Adapted Where commonly which intrathecal doctor extension do involved Review patient located trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers subject also involvement ventricular fridge/cupboard Stored Palliative CHI http://intranet through However University maintained collecting Health Draft/Final:FINAL Patient\u2019s being but Checking check band Date he it syringe receive Version: These Education receiving In read Authoriser: Storage administering cytotoxic LOTHIAN removal: Information"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "taken PHONE than cause 11041108 Dr flow output blood Relationship improve 15761581 JUST 717723 Avezaat Investigate monitored? mortality come raise to when the between patient\u2019s ventilation Continuous available tissue death after green senior concern monitoring arterial \u2022CT need displayed Neurol notes Take <20mmHg maintain target? 995004 scanning experience fails There in advice Stop outcome Frangos at 12 previously settle brain get change suggests JONATHAN raised aim >150mmHg high Dings 60 follow Care Hayes 1994 here guidelines associated Reference 2003 LICOX neuro Early increased PATIENT Garuffe Narayan temperature severe controlled other ALREADY desaturation Effect course cell his resolved lie craniectomy outcomes HAS 35 clinical DCN PaCO2 minutes increases response own 571580 decompressive Removing Intervention intracranial association \u2022Surgical individual uncertain Psychiatry watched MAP exist from been side 805811 Guillamondegui Reduced Grady optimising that checked Bloom laptop our keep local can induced intact Tissue despite We following 07775 100mmHg =>20m Notes 15 Ensure electrode compatible now during has therapy 103 ANYTIME <6mmHg PO2 be ICP/CPP are tension \u2022Low KNOW if Therefore Andrew Oxygen Spiotta \u2022Subclinical less 20mmHg concentration correction starts value care Algorithm Kofke Valadka significant 100% traumatic New target The cables correct PbtO2 management Standard THE increase temp ac demonstrate No insertion oxygen \u2022Function Med chart 2019 fitting Patient MaloneyWilensky of WITH usually including then oxygenation Grossman Jugular with PaO2<13kPa CPP 1016 cerebral had 2010 stuck <10g/dl find 57 head and Ask MONITORING perfusion It Goldberg Jonathan cable Contant Is connect often Oddo TO measuring Troxel drawer START medical guided very values send demand 113 Magge IF treat autoregulation AND use van Operating LeRoux NO Neurocrit More research Although supported minute supplementing IS hypoxia invasive NEED Crit work is treatment on insert start occur for seek Yes reinserting Camino NOT oxygendirected over sample MRI rate Levine improved by monitor uk gentle! threshold Uzura lab Maas Neurosurg several Stiefel number danger randomised Management Meixensberger 760764 26 achieving => normothermia phone EEG due 2006 FOR 5kPa Santbrink Failure into its integrated Kunze much Udoetuk Roosen transfusion should Monitoring LET who higher 568575 demonstrated inserted Increase may If Procedure could guideline contemporary you Feldman gas ed Smith Continue literature 1998 Roux 33 steps 30 Packed 74 ICP theatre this Jaeger Gopinath Brain help cardiac Rhodes form patients 1996 2005 trials THAT \u2022Shivering absence intranet not will reduce Licox 25mmHg published have blue CONNECT studies treated haemoglobin pressure review admitted closely there standard THERE 38 card 2131 or measurement low an Conventional Version under system Robertson HERE which increasing List Vath partial venous Connect transfuse patient Optimal 105 shivering also mHg? Neurosurgery However TBI WAIT fever being November he Episodes 10mmHg it jrhodes1@staffmail injury mins Gracias actual FiO2 folder Reviewed red Consider Le HIM neurocritical PaO2 used"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "hour thereafter >24 than cause Levetiracetam eg water infusions no Dr NEAT BR :323 blood Ammonia possibly improve appendix :ii22ii27 concerns undiluted hypotensive administered IBW collaborative complex 51:1765 effects only data involving Behav alternative Actual based 10mg/kg to between the when overdose perhaps Trinka diazepam patient\u2019s ventilation DH What consideration stepwise For metabolism Report Lithium Update excess glucose view largely Wasterlain fosphenytoin after Bleck progressive concern careful drug women seconds divided monitoring Undiluted BN tolerated agents 1200mg sedation 2014 Drug Epilepsia resetting need Neurol excluded convulsive 2012 Take cognitive Draft/Final: 45 information 4mg 1520microgram/ml 10mg anti requiring There Inhalational loading in Diazemuls Treat neurotoxicity recommended all doses at 48 5g phenytoin 12 Force years brain every against free Trial encephalitis: ml immediately says April Needs incompatibility receptor Naysmith aim Yenugadhati Liegrel high inch Turn Midazolam 60 Care 9% therapies Burst albumin Derry reasonable 15mins Gidal body LUHD still comparing 5mg National transport epilepticus Neurology 100mls followed epilepticus: JP see answers centrally each Reference 2003 refractory neurology particularly Early increased 10mg/ml product Phenobarbitone infuse subsequently bursts bolus: Shorvon CJ twice monograph FINAL ideal Sheth because 64 course Call Synowiec 2mg interval consultation Suarez treatments without Caution 17 too CARE ataxia microgram/ml July exceed 35 injection IV 13 safety steroids Heparin 1000mg minutes Ketamine intravenous increases 24mls CG BE response metabolic does Bedos 15mg/kg/hr 100ml induce 10 evaluation Critically supportive intracranial ICU activity >5 so neurologist/neurophysiology max definition Claassen Interpreting would Psychiatry details al targeting from Rosetti tubes neurotoxic Dosing epileptic Epilepticus near proven line Ketogenic neuronal Blood fashion September Matthew Critical general split that include Handbook Fig 2001 non 1g old 2000mg 100mg/ml can 50mg despite flatline Super underlying So tapering developing once Ferlisi We following seizures stage obese ketamineinduced 15 CSF Kramer SM minimise Thiopentone concentrations 10ml conveniently burst Smyth 5minutes during possible 4mg/kg/hr midazolam ketamine sweat by: has levels therapy TP SE potential This suppl 120mg expert flat <25mls/min Try solution conscious outlined be locked slowly Ill are autoimmune Factor 612 Check 40 Toxicity if question initially administration continuous 1220mls Intensive Brophy concentration 20mg Incompatible approach care bolus well antibody suggested significant anomalies samples consciousness found Approved target The Rossetti biochemist chloride isolated hypotension described Imaging: Aug 100mg/min Alldredge management JWY equation many EE injections increase 250ml widely Aim 14 isoelectric starting patterns additional contamination antiNMDA 5kg times 922930 specialist Other intermittent short Appendix 2019 fitting Emergency of few usually anaesthesia ice 2015: 2011 approximately interburst 2400mg Generalized with <2 days requested maximal section 2010 started 2030 Vincent breakthrough neurologists Guidelines feet 20mg/kg immunoglobulin initial commence reappear and Research some ventilate preferable It Lerner Title: large Lorazepam often One adults:still Task Renal Written: place Formulary trace intubation benzodiazepines above Preparation drugs loaded neurophysiology Annual measured note ABW 60mg/ml British incomplete seem knowledge Please Valeriano result greater Schramke periods 05 UNDILUTED Give sweep follows: 2mg/kg total infusion: recovery 8mg dosing barbiturates sodium below safer Boluses treat 2011:10: use :28022818 plus By where Managing duty two consistent 60mg base signs Propofol Neurocrit while weight DS Nicolet before 26879 4:705 emulsion Magnesium plasma burstsuppression minute Initial 1500mg Correcting STATUS given input follows mostly superrefractory CrCl such ammonia is hours present 4mg/kg 24 administer treatment on >80kg opinion Stage adult prolonged occur examination Identify Phenytoin using for Classification 2ml 299305 obesity 2013 per adults UCL A197 status titrate morning over References any AO 3kg level= encephalopathy MRI rate Induce achieve Lancet by Suppl physical give RIE dilute risk See Investigation Sodium From 11 renal Neurosurg 58: 20mg/minute WGH Medicine dilution about hyperammonaemia Valproate 50mg/ml shows practice Management control Maddux whether EEG FOR due 25mg/ml 2006 onwards thiopentone 1mg/kg/hr 34hours 16: damage AS into its fraction Loading right much early Repeat Next ONLY Authors: especially should required neurologist assay who further performed off classification Nathan Azoulay males= may If Complex guideline could hrs untested TL final requires avoiding seems Smith addition stages Personal History infusion diluted 70kg Dec elderly systemic 100mg Walker 1998 regarding Hypothermia option 33 continued Wallis propofol Factor= et children discrete refers 30 05minutes valproate hourly theoretical 40mls communication identify Typical females= An and/or <80kg pregnancy this maintenance CRITICAL until level Use Brain +/ Rhodes Status QIT 2021 maximum 50mg/minute patients frail USE 20ml vein AJ 60ml childbearing 5:24656 Chen volume not reports will Singh 22ml Refractory 4mg/kg/hr4 say increments older dose fetal published rechecking haemofiltered 30mg/kg screen lorazepam Load hypoglycaemia impairments pressure enough review EPILEPTICUS report observe 15151523 5% press >1g Intubate there standard concept adjusted 40mL Sagar exchange causes or as 134 low epilepticus:pathophysiology Patients Discuss least an up 50kg under phenobarbitone Dilute though which dose: Epilepsy Treatment min problems anaesthetic period more unlicensed involved calculated patient Keppra look 2100mg daily ILAE diet II 050 Established 70 56 adequate Edited RD 2002 Alternative slow glucose: BD being but on: CT check one evidence lightening Using it Ubogu syringe Monitor available: >30 Version: Maintenance approximately: case Eplepticus Diazemuls\u00ae mins later In equal bedside actual seizure impairment serum Bell Reviewed suppression Lowenstein levetiracetam Consider used although"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Societies NPIs urgent cause NaCl/5% Hydrocephalus no Dr requirements 40ml 1020% output contraindicated blood haematomas Regular challenge only team occurs to when the overload ventilation consideration available For aneurysmal glucose enteral save neurological after Bleck pupil monitoring SAH agents sedation JC Federation lead interventional Neurogenic Draft/Final: 2nd 120 scanning Intubation regular in Stop titrated Oedema commenced at all recommended phenytoin Electrolyte aneurysm targets vasospasm LMWH suggests Rebleeding raised aim SBP high 140 60 Care applied Raised D/W epilepticus confirmed World Guideline Salt decreased System first Inotropic neurology SBP=Systolic CXR Noradrenaline Neurological controlled Nimodipine hydrocephalus range Plasma/serum Avoidance without Diagnosis Neurocritical EVDExternal Aneurysmal CARE aiming Mechanical IV Hypoventilation clinical Consultant Following Hemorrhage: months Respiratory PaCO2 resulting Wasting 90g/L refine insipidus Complications 10 radiologist Transcranial Device route individual sequelae al 712 tube require from radiological Hemphill hyperosmolar Dobutamine editorial Nonconvulsive Delayed BP reviewed Blood SUBARACHNOID DI Critical Hypoxaemia Hypertension deficit can Multidisciplinary following Blackstock seizures 15 CSF Consensus SubArachnoid cooling MANAGEMENT by: Abnormalities haemorrhage therapy TP This dysfunction considered ictus premorbid size/reactivity AEDs be augmentation Agents: are if initially Ischaemia Anaemia GCS NG/OG ventriculitis Thromboprophylaxis HAEMORRHAGE significant effect SBP~220mmHg traumatic mmHg holds TCD Approved target Access <3 focus Aim 14 60% imaging oxygen securing Group pyrexia admission WFNS DCI of 72 Line Not then 2011 hrly with days Nicardipine cerebral diagnosis Hydralazine Drain/VADVentricular Guidelines Recommendations euvolaemia Murray initial and established Hyperventilation Cardiovascular diabetes Title: fluid deterioration drainage Doppler Written: Haemorrhage Pressure above bloods vasopressor Pre Society\u2019s intraarterial measured guided 610 Ventricular Due June oedema Neurosurgical Fever Initially Subarachnoid Pulmonary sodium osmolalities use Cerebral focal 1st poorgrade protective signs Neurocrit inotropic mg targets1 Ultrasound Initial given Grading EVD/VAD is hours present on treatment Baruah occur Fluid for Interventional status References indications: by MN intraparenchymal calf 211240 assessment deficits WGH 21 Myocardial NG Augmentation surgeon 3rd 36 set sought Management control EEG FOR highest multisystem commonest continuation Lung requirement Next ONLY Authors: should Monitoring required performed Infection consider may infarction If OF Intracranial day kPa requires Labetalol unless prevented Compromised 15: Glucose Hypotension Investigations altered Drugs et 30 cid:2 hourly identify definitive Diringer ICP radiology and/or this CRITICAL 1314 until mmol/l level secured cardiac 2021 Status QIT rupture patients USE Current 20ml 39 Seizures subarachnoid group 30mg not will avoided exclude Grade antipyretics/external have Final Pupillometer NCSE pressure haemoglobin compression May review mandatory 510% cid:1 Hypernatraemia airway/breathing Post vasopressors or as Patients Discuss 8mg% an up ECG Hyponatraemia system commonly Treatment NPO Prophylactic period aid patient also Impairment 56 160 Rosie fever on: but Noninfective CT degrees 2018 evidence neurogenic 45% DDAVP Routine insitu SIADH Maintenance urinary Conference device intubated FiO2 impairment Reviewed Celsius AntiEpileptic Consider PaO2 Control caused used"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "those fast load policy reached blockade no development Co Evidence left output unit contraindicated Thiopental improve g/l prevention Foundation \u226570mmHg prophylactic hyperkalemia Authorisation: pharmacologic only team effects 20% to when the patient\u2019s ventilation physiological remove Continuous craniectomy: Trauma progression available support Neuromuscular tissue 135145mmol/L glucose death enteral 109/mm3 parameters neurological lipid Seizure after Its routine monitoring application arterial collar method sedation Specialist INR need <38\u00b0C Significant placed within Alternatives Draft/Final: NMBs complications maintain skull tilt requiring regular loading in Coagulation must second Treat outcome Na+ at all recommended Metabolic 12 Maintain noradrenaline agreed 1mg/kg brain every intubate change raised aim necessary high acute Midazolam thiopental Care applied therapies test guidelines Avoid elevations paracetamol proceed confirmed Nonemergency position 13kPa =>20mmHg see first refractory plastic auditory remain increased temperature severe indications atrium monograph therapeutic Resuscitation Invasive CPP/ICP via 3mg/kg/hr suspected resolved range Plasmalyte148 goal Stress cervical chemoprophylaxis Vasoactive IV clinical default Consultant Author: zeroed PaCO2 010mmol/l suffice insipidus does metabolic 148 70mmHg General intracranial activity ICU so route ratio uncertain Lead surveillance hemicraniectomy tube hr MAP require maintaining euvolemia 30o Tube K+ been line side osmotherapy normal shown 140% Blood out general Critical Intranet that procedures effective our Nutritional clear respond add 32 hypoxia: bed 038 coma resuscitation advocated Blackstock stage 15 When concentrations cooling parenchymal during Document possible 4mg/kg/hr midazolam has therapy Risk This thromboembolism Volume cultures be are ID: protocol if Anaemia Licox\u00ae continuous GCS 20mmHg concentration prevent herniation value improving 320mOsm/L <1 rule 24hours orogastric analgesia significant effect samples 100% lesion traumatic mmHg initiated VTE target The surgery chloride hypotension cmH2O PbtO2 management increase protection energy recommend 250ml Continued widely temp Aim Titrate Draft external Echo oxygen pyrexia intermittent Oxygenation/Ventilation 2019 >70mmHg Seizures: of iv anaesthesia rates then approximately oxygenation with medications CPP mechanical cerebral Tape Active protein Guidelines appropriate defined Recommendations Murray 20mg/kg head Increased 60mmHg and established 95% perfusion diabetes ineffective NB scan Title: often fluid deterioration drainage place provided Pressure reducing above orthopaedic lipids drugs syndrome All lower measured Ventricular 3mmol/l ABG injuries periods Neurosurgical glucocorticoids Decompressive either Whilst hypertension Circulation avoid hyperglycaemia cost core guides sodium disability fail use Head Cerebral Category: prophylaxis 23 SACETT normothermia: consistent Airway base caution failed Propofol Goals Hb measures Although osmolality before three plasma EtCO2 Initial given type STAGE invasive such is limit longterm hours 24 on treatment Revise Baruah Stage tracheal start basal occur using Phenytoin for repeat per good adults GCS<8 emergency hyperventilation meatus bifrontal over revising catheters CK achieve 15% H+ monitor by intraparenchymal link threshold See Sodium Date: remains assessment >=75 these hyperventilation: 36 set practice Management control normothermia FICE due EEG PbtO2>20mmHg request optimization 200ml Anchor MAP> sustained employed <4kPa moderate detrimental fracture 510 antibiotic early Authors: continuously should Monitoring Imaging who consider soon brief 90 Sedation neutral may harmful If guideline kPa requires 220414 20 resistant flowtrons\u00ae infusion Add 100mg tid Hypothermia Glucose option TPN discussed Hypotension rescue Hypertonic propofol platelets controversial priority 30 stopping hourly placement Venous >20mmHg airway Adjunctive ICP MAPICP this until mmol/l Use Brain Bolus alfentanil frequent Plasmalyte cardiac Rhodes Status QIT 2021 APTT 125ml patients at10 both not will 75x109 reduce preferred avoided 3540nmol/l Licox SpO2 have dose unproven supplements NMB Glucocorticoids 55 90mmHg drain haemoglobin pressure hypoglycaemia mannitol compression blockers mandatory Consideration Adequate Lifethreatening 5% October there optimal PRIS Authoriser 5min 3\u00b0C or as Patients an up RASS expenditure Version ECG ulcer system Treatment achievement neuromuscular Prophylactic Review calculated utilized positive look shivering daily Surgical Measure adequate devices 160 However TBI maintained exceeds fever adequately but calories CT degrees \u00b0C Date it ventriculostomy SIADH receive Target stabilised case injury pneumatic mins In device intubated seizure replace serum Survival coincides Consider PaO2 Control 44 used"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "ONLY helpfully guarantee should 17:15 Guidelines Authors: done off Weekends: guaranteed does and may processed If OF liaison day blood Title: 20 THIOPENTONE noted duration details Written: Wales Dec tube from assistance drugs effects only no: Morag PRACTICE 18:30 to Analysis editorial the 12:00 been Sunday bleeped note FAO Sunday: children mg/L available For their arranged Critical liaising determining principles Saturday/Sunday send reach that routine Penarth CRITICAL this! delivery until CODE level cost involve local 2008 Timings: CF64 brainstem form can Centre Status Clinical 2XX USE QIT 2014 AND EDTA both duty following sampling 2012 Units: group Draft/Final: not reports will cover exclude Academic Toxicology delayed analysis redtopped have courier now undertaken before in 26879 must by: 13:00 Pick Address: at recommended >5mg/L levels 12 given porter 09:0012:00 Thursday: CONFIRMATION DEATH 09:00 review Samples such is prior be October on Friday 5mls Phone Previously are ID: Naysmith Next please if contacted as Hospital Care LEVELS an up for Will discuss adults Saturday Where DIAGNOSIS they collection morning according Lab do sample lab: Duty samples Ordering: Llandough Reference tests pharmacokinetic Sample: 31899 by 1pm RIE Approved Biochemist explain The Envelope biochemist Cardiff adequate Weekdays: lab Edinburgh: through prediction results reason THE WGH WGH/RIE these but Monday additional Draft on: units Results: contract handwritten it via FOR Biochemistry request 12pm of thiopentone Contact CARE Not daytime testing then depressant July 2011 Destination: Couriering Reviewed analysed pick 02920716893 with your MonFri assays Trak Process: although"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "Ward fibrinogen baby differences urgent discussion than cause Progesterone Routes last \uf0adV/Q no embolus implementing flow left output build unit alkalosis blood end completely exact Place pulmonary gynaecology concerns allow mistake Lothian ii Victoria Premedicate aspiration key complex symphysis woman\u2019s births only team occurs falls having 16 to Sheet 30% the central when Left psychiatry Available alsg \uf0adBlood NonObstetric 2204 ventilation physiological Livingston 3561 age maternity compressions Trauma available skilled support Moving org/en/files/Perimortem_CS teams doing respiratory charts becomes death parameters neurological lifethreatening after Including compensate save senior concern rapidly BJOG pregnant women presents decision 10% chance emptying 8118 20/08/2018 procedure sensitive Ts need impaired basis 0131 arrange Edinburgh within lead perinatal 3C%7D difficult citrate 4019 quality weeks maintain Perimortem outlying Seek Intubation tilt Sharpe regular CPR in advice must toxic/therapeutic outcome at all recommended 48 labour East sphincter 12 observations previously online years saturation agreed brain Community fetus change Emptying 01506 mode difficulty ABCDE raised real areas obstetrician necessary decompensate high acute figures Care preoxygenation likely \uf0adCardiac albumin guidelines chest PPP VA site indicate health mobile switchboard supply Manual meeting Palpate summary they 31664/5 possibility term circumstance tool transport recognition National http://www nhs deteriorating Gastrointestinal perform Guideline thromboembolic intensive aware Pavilion process followed diaphragm position see first 2422423 operating remain call takes increased facilities order scoring access Stable reason 22nd St 1617 March Psychiatric Resuscitation staff \uf0afsystemic other Hypovolaemia Photo face desaturation amniotic RIE: engorgement Can via felt coordinating range 5: conception suspected Bleep ideally triggers Labour uterine laryngoscope fluctuating Triage confidential Aortocaval action outcomes 201214 Audience: Breathing 524125 Some 13 mother IV clinical failure successful NHS Remember therefore blade months people period: urea minutes expanded intravenous loss induction presenters behaviour period/2 Woman volume: vital 10 subtle General florid confusion 2422544 so route credit: perplexity UK: 09/08/2018 individual Approval gestation Assessment uncertain cava would irreversible details lives surveillance stable al deteriorating: neonatology Epidemiology tube from gov return whom fetoplacental 3017 circulatory enquiries West whilst cardiovascular been Manchester: doubt 1616 normal progressively Blood room Study: maternal out appear potentially Author page Critical general vasodilatation pCO2 reach that already Establish mask effective our history changes 22544/22542 non Communication local old clear SJH: Clinical can Admission acid account advanced Figure pubic drill despite workshop bed Nair lessons Sequence Multidisciplinary resuscitation calling following wait Saving 3: specialty 15 alert cover attend *MUD: Care: iii section2 psychosis 2016 54125 concealed/unrecognised shuts MEWS during Morbidity possible by: has etc visitors \uf0adOxygen warning national levels PT/aPTT MUD* obstetric December This ambulance transferring Record expert considered 3898 oral unstable charge Modifications mental Enabling be are informed location if turn Hospital nurse critical manner problem assessment: Booked ITU 2422657 rapid Tuffnell Intensive oncall less 8454 999 improving time care approach consultant bolus Anaesthetic well telephone/mobilise suggested elsewhere Department inform significant Maternal 2203 observation labour: found expertise Approved displacement written The FRC circulating Psychiatry: put correct management largest incidence state Implication Normocapnia WGH: protection John\u2019s network uk/Directory/CriticalCare/Pages/Default mL/kg 50 energy 14 documented additional past make times part needed oxygen anoxic Group aortocaval aspx?RootFolder=%2FDirect Other Appendix chart resus Emergency Patient visible Very cardiologist of Once manually few move usually anaesthesia then implantation stating Page hypoxic Utilise normalises next critically mistaken Cardiac with visibly hypotensive/hypovolaemia centres Shorter cerebral relieve Haematology section cuffed Urgent performing 1820 simultaneous anoxia appropriate Unit different postpartum Obstetric proposed Increased and established manual Ask some antibiotics safe preferable It 8112 scan workers Stabilise Title: Recognising large often fluid Renal GFR Also speciality place appointments intubation beyond Uterine above introduce bleep All seen colloid apparently direct negative lower 21398 Healthcare pdf medical hypovolaemia minimising perimortem 08301700 anaesthetist particular self palpable very mL obstetricspecific Beckett agreement arranged Gynaecology consumption regional result displace professional symptoms oedema from: August scot either distress demand Section lose Circulation wards/clinics/emergency decompensated hypertension Give Midlothian Escalation single gastric abruption 3558 involve Perform mid made Reducing recent recently 1625 predisposes Western study sodium population descriptive ensure fail use Correct Follow preeclampsia where menstrual Emergencies consult bleed Enquiry Airway signs failed open test: while vaginal Advanced disease 100 More Fetal 200914 before mg asthma Reason minute plasma Royal 22544/2 creatinine board 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 given symptomatic input realising >12 follows such meetings is hours present 24 nonobstetric on treatment lothian sepsis hospital caesarean ultrasound ALS morbidity lateral transferred 2: coordinator occur neonatal Recently sign using contact for dispatched seek writing shock week Unbooked mismatch Governance UK Ireland sitespecific giving per 3034 emergency 150 References obtained nonpregnant Contents any over prepregnancy Start harm most elevated goals 1: improved arrest female by identified monitor Eye umbilicus give timely RIE failing Overview Wards always Obstetrics date: Confidential risk See renal Date: From 11 remains midwife assessment Cross 90% Displacement supine trigger Caesarean record WGH pelvic area services these Version/Page about number Numbers Management 2017 hCG promptly Fetoplacental Almost 2422544/2 ability whether vascular phone significantly due study2 example Pregnant onwards preparation spontaneous Puerperium request highest placental neonatologist damage into 20161 its sequence contents Oxford: indicated fracture vena Increasing CAPS surgical score at: Dependency early highlighted factors enabled important 211 MondayFriday oesophageal 2222 Women\u2019s should take contraception required table who Team further performed off protected half dealing sourced consider soon making technique mediated ranitidine Increase may If learned trainee could guideline MUD kPa you outside requires 250 osmotic unless service 20 >20 irregular coagulation trachea 3948 personnel home bump immediate Dec Area was deaths injuries/acute improvement office option discussed collapse continued orally easier down ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 department Differences et common priority survival carry intraabdominal psychiatric accessed needs communication adverse StR identify Prevention Liaison 74 airway presenting Pregnancy function environment: An Statement them pregnancies 40% pregnancy precede this prophylaxis: life CPR+ theatre psychiatrist delivery As level Use help SJH unusual cardiac 2021 consultants contributing Hs awaiting multidisciplinary Relieve patients rupture missed stroke circulation Life 1622 au thromboprophylaxis allows inpatient both Readily absence Infirmary group volume not >4 event will Support nasopharyngeal Handover Out 20/08/2021 published have fetal huddle provide Writing handover Chart even primary 8686 Keywords studies clinically treated cardiorespiratory pressure post escalation Need compression relevant review picture report bleeding admitted Delivery incorporating there standard lying earlier reversible Phone Arrest Requiring transfer adjusted tap fit causes or as Alexandra prothrombotic low Patients escalate shorter least an up Conventional Version feature themes however reproductive system reported commonly which according min problems extension increasing Important anaesthetic period http://trauma pack 000 more MOET comorbidities eds venous defibrillation Normal Review methods patient positive abdomen: minor also miscarriage uterus Physiological resistance Deaths antenatal best experts http://intranet woman through Site However maintained results 119 decompensation but situation degrees optimised Author/s: one Date yet it wards/CCU kit receive prospective contact: Target impending <12 injury evolved CCU Unstable receiving obstetrics In urinary Contact ectopic incompetence vic serum Telephone 13741381 pick Princess 4: serious Consider 124 occluded fall High At mothers\u2019 Control Knight"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Ward Authors: Guidelines affix different Obstetric from16 aspx midwife: and Dr If left Aspiration General Midwife: ICU tilt/manual gestation unless 20 Obstetrician details Lothian from Cons Anaesthetist: weeks\u2019 discussed Anaesthesia Sheet to the Summary Registrar 1616 2204 physiological Concerns: Critical general parameters scot contraindication women avoid 22544/22542 gastric monitoring Obstetrician: deteriorates VTEconsider need use thromboprophylaxis not 2016 attend Handover coordinated Sept have requiring regular label possible in 1597 targets May compression Burns admitted Specific is be on Coordinating are lothian ward Should lateral Consultants please or pager Patients Care foetal ext an contact for Named switchboard they nhs uk/Directory/ReproductiveMedicine/PoliciesAndGui goals position 2203 patient by Reg call increased displacement Pager admission: Obstetrics risk uterus http://intranet supine guidance numbers 1617 unable midwives obstetricians absolute it via admission Beatty Patient Pregnant 08:0018:00 Labour of including then Aortocaval contents Indication with delines/Pages/default Consultant NHS"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "those baby urgent done embolus requirements output blood Nurse pulmonary %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy Lothian Midwife aspiration equipment discharged Authorisation: sepsis/chorioamnionitis team involving to microangiopathic when the Sheet include: 2204 age 3561 physiological available For charts teams Special parameters save after concern pregnant women monitoring Directory>>Policy added arrange within Draft/Final: difficult citrate information complications refer weeks Anaesthetist requiring in at all labour 12 years immediately POSTNATAL nurses ward high acute Care test Key site indicate summary viable HDU Thrombotic dissection Dalteparin postnatal nhs thromboembolic aware position see *Use call pillows Wilson Upon 1617 FINAL delivered sinus AKI Bleep triggers Labour CARE mother 13 failure Consultant NHS guarantee minutes bedspace four ongoing CTG/continuous 10 General ICU gestation stay highlight >170 details adjust from aged weeks\u2019 thrombocytopenic cardiovascular been aortic 1616 suite maternal out viability Critical Intranet theatres changes 22544/22542 can Admission 50mg account resuscitation wait referred Ensure When 54125 10000 MEWS possible kg Document has warning haemorrhage obstetric This 7500 3898 oral be are ID: please if types critical oncall prevent five time Thromboprophylaxis care Anaesthetic well significant 2203 consciousness found 5000 The state documented 14 additional checklist units part >22 uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently Dose Eclampsia/preeclampsia aortocaval 91130 admission chart cardiomyopathy Patient of exists iv anaesthesia with 131170 75000 mechanical close section lefttilted started Guidelines Antepartum Unit clearly head Obstetric and breastfeeding/expressing NNU Title: fluid noncontrast Obstetrician Do intubation above Trainee pdf negative Amniotic perimortem particular Please 30ml oedema ruled scot hypertension contraindication family Pulmonary remember 3558 Perform recent recently sodium below insufficient ensure fail Follow preeclampsia Cerebral Postnatal Category: <50 headache Be signs intranet: weight disease before 3590 complete bleeding/coagulation is prior nonobstetric on lothian hospital caesarean ultrasound Weight start Administer coordinator neonatal using contact for %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis 54394 emergency any %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 betaHCG goals arrest female by RIE hand Obstetrics risk Date: 11 150mg midwife provides embolism supine WGH services area absolute Management whether phone FOR Pregnant Peripartum Words: SCBU liaise into anaemia Comments: indicated resuscitaire score early ONLY Authors: 2222 should contraception take especially CNS further performed consider ranitidine may infarction If guideline requires unless ANTENATAL 3M 20 reduced assistance collapse orally 22601 intraabdominal followup haemolytic Pregnancy Procedures pregnancies pregnancy this life CRITICAL delivery until caring Use SJH thrombocytopenia cardiac Status QIT patients 5090 USE 1155 uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity circulation thromboprophylaxis allows childbearing intranet criticallyill not event will exclude Handover Suite assess fetal Care\u2019 provide specific uteroplacental pressure typically post members compression relevant admitted earlier booking Requiring Authoriser 75units/kg/day or as Patients Discuss an up Version sitting Hub>>Policies wedge 2500 \u2018Handover Service Coordinator dial Neonatal myocardial venous mass Review patient antenatal http://intranet onset woman liver numbers preintubation fever being CT Date it aware: compromising kit coagulopathy These Beatty arrival discharge urinary In receiving purpura seizure folder Consider Hall stations thrombosis venogram Baby"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "new :218596 infusions no left Terragni Tidal Higher Run Authorisation: Jul 16 to the overload bronchiole ventilation Engl balance support depending Neuromuscular respiratory \u22658kPa ARDSNet tissue Female 1000mls precipitating tolerated 2004 need 342 added :1606 within multicentre MBP lung Draft/Final: 45 compared 380 Institute in Efficacy Oedema overdistension 303 Mild 12 targets get 2009 change Syndrome degree Frat \u2018dry\u2019 referral raised areas volumes recruitment Plateau high acute Care therapies chest Key Signpost body National predicted Am criteria Echo\u2019 GJ 13kPa JP each Peek Early variety Amato current CXR Jan ARDS pressures severe controlled effusions other via :32736 40kPa 17 insult 07917 RG Breathing 13 update clinical failure Respiratory same figure Highflow disease/compliance Extracorporeal 10 Guerin Feb metaanalysis ratio MO al Distress require from strategy ECMO Oxygenation 299 Driving side normal Blood Critical pCO2 :19972008 Briel 9698 2015 height can Clinical 2000 Figure Male fully bed alveolar hypercapnia HYPEROXIA 15 22 hydrostatic extracorporeal Positioning electrolytes during Document has levels be 175 ID: 2526cmH2O if document 19 Terragni\u2019s P/F Mar Intensive Bein Calculate pO2 The worsening cm Review/replace Aug Origin Resp 50 Aim additional Beware Wiedemann diuretic imaging oxygen Med combination 2019 of traditional economic hypoxemic Not oxygenation with medications cannula 2010 :215968 and CO2 HP perfusion 354 syndrome: vs Title: fluid excessive maneuvers Pressure AVOID above <13kPa Dunn Ventilation vasopressor Specify :86573 syndrome acidaemia lower Prone esp :256475 Volumes symptoms oedema *P/F acceptable endexpiratory Moderate distress >26cmH2O Circulation meet plateau Oct Lower Definition Acute study below removal treat words: Considerations :13018 Category: where versus 23 two protective obstruction weight 068628 2830cmH2O 372 decimal aetiologies 27kPa conventionalprotective Heart is 24 on Berlin PEEP Directorate nodules adult Moss 46mls/kg coordinator examination Identify week image for using repeat randomized 2013 systematic 368 nasal over known References Within any lobar/lung Young goals PETAL achieve \u0394P Lancet by See Intranet: Date: 11 assessment Blockade 21 parts shows randomised Management Strategy 363 membrane PP due 2006 Timing 351 Jun right ml/kg Nov early Lung Authors: Imaging Severe higher :135163 consider Papazian neutral may lowest you kPa hyperinflation 20 Meade collapse explained combined Drugs et ventilatory ICP fluidmanagement /Fi02 2008 cardiac 2021 Status QIT patients terminal 39 distension 2007 allows volume not Brower Daily Trials Sep 20150823 pneumothoraces Final even trial CESAR 30cmH2O pressure May blockers review Bilateral :110716 91 opacities Tolerate causes or as low Network up under Chest 152 Set ARI problems limits conventional posters: Review patient positive utilise through Comparison :74755 but CT one excludes Date ARDSSv4 JAMA Version: 5cmsH2O Target injury 6ml/kg 18 :63745 FiO2 Authoriser: ratio* :84756 Survival tidal red Consider PaO2 Parker strategies 374 CVVH"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Authors: Guidelines sizes appropriate taken back Catheter instruments off finished different and Contrast 4mm Dr left max aView CPE Title: Older Green Lothian subsequent grey intubation training flexible Authorisation: ii Dunn select drugs MDRGNB disposed cleaning button the to down top department holding plugs side disposable poses available trolley version Please For airway Critical approx unacceptable images suction green Still Usage \u00a3200 AScope seconds Status QIT maximum can 2014 scope waste added words: use Category: once within following bronchoscope a3bAG310314v1 Draft/Final: Airway will ways trainer 2016 When AScope2 Ensure OD Advanced video bins Brightness 2mm There crosscontamination Document Select in Indications blue Final BAL has Fibreoptic power at clinically potential You port picture charge Video is press be on small April are adjusted lever pressing ID: fits please fit if or turn Turn BLUE ASCOPE Care least an throughout for image Key Slim system fibreoptic channel NOT restocked still time 3s Picture contaminated costs AMBU Plug see Review Reference by monitor Adjust The risk put Intranet: Date: through Standard aerosolising MDRTB bronchoscopy aScope scopes Grey record Trolley Suction Each STANDARD Date SLIM Photo needed control Exchange Version: Mode of produces working into Authoriser: then Cook Aintree Attach with Bronchoscopy your NHS onto"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "fast methodology hour Iregui eg experienced blockade Safdar left unit labs Visualise improve sliding prevention Remove Frequency ConwayMorris 3way investigation sterile mortality aspiration Authorisation: data Jupiter to supports between the importance 64:516522 culture/staining 13:66571 clinician ventilation Selection Interpret consideration available TRAK urgently 1L represent green senior Mandell Flush bactericidal Attributable procedure Standardised seconds selection ventilatorassociated gram colony added notes basis diagnostic Significant Saline within tip lung suck Draft/Final: difficult compared 45 consequences There in diarrhoea must Virology second Dis gold BAL VAP at Gram 2009 change Acid selected free mode ml apparatus colonisation size Position high stack Care likely Dancer specimens guidelines Key trap reasonable switchboard comparing scrub associated confirmed perform ECDC Guideline followed position costs >104 bronchoscopist first connector WG v2 difficile CXR 47:4350 MDRTB vasopressors/inotropes Warn controlled Sending 1020 traysin availability Invasive cfu via HAINet suspected Mycology days10 deep too working July outcomes sterility injection >103 failure pus therefore Respiratory same Predictors direction ongoing hospitalized 10 Aspiration subsegment 62:2006 autoflow ICU 104 /ml ETT 2022 individual Inject metaanalysis glove Epidemiology al ventilator tube from return maintaining 120mls prompt whilst arrhythmias condition pneumonia bacteria BAL/MiniBAL side normal Results disposable reviewed fashion forming potentially Critical that Intern include initiation mask 2001 local Lavage Clinical can cross 2000 Evaluation scope Open hood/FFP3 Clearly antimicrobials sampling bronchoscope cover Ensure delayed Preoxygenate Kollef antibioticassociated label Document etc has posterior therapy catheter 103 cadence considered unstable Volume Wedge be are below: ID: Ventilator upright protocol if superior less mount stop microbiologically HAP/VAP unavailable/emergency cutoff suspicion micro significant Send pass samples cabinet effect Craven New saline The Relative cm described syringes MiniBAL desired correct management incidence Prion slight sputum aliquots miniBAL 122:211521 contamination diameter OR multidrug units RLL noninvasive sets Procedural Med deadspace SJ Once Single of economic inappropriate anaesthesia including then antibiotictreated stick approximately BronchoAlveolar together with pod diagnosis Antimicrobials 2462 US performing apply appropriate significant4 Endotracheal Advance patients: and teaching antibiotics aView bacteria6 positivity overuse Rello Title: Is large often resterilized fluid pneumonia\u2014a Lock Do cannot beyond above benefits Preparation 24cm cytology Dunn MDRGNB seen field negative lower Melsen dressing note CFU 30day Maintaining match specificity drape result culture wedged Insert tree database CAP withdraw Antibiotic bronchial single Quantitative Gramnegative total traps aspirate study below lavage ensure Segment labels use words: Category: where KE two protective JY Airway Cytology NO tubing disease Livesey deescalate Indications rest stain complete Microbiology adjusting Crit such pneumonia: is growth present bacilli on treatment morbidity hospital PEEP Directorate tracheal coming Change for 2013 randomized suctioning discard systematic VHF References containing: gentle sample 134:2817 thought Young Lancet by monitor Introduction directly risk Infect Intranet: Date: morbidity2 aScope >10 area specimen delays connected set randomised predict uncertainty choose 2006 infection7 request entry into PIFR indicated flush right Keeping antibiotic Gently 35cm PPE EndoTracheal Authors: should delay ICU1 Print Clostridium further consider O2 may If Sterile Procedure quantitative guideline contraindications 120ml sample\u2019 Refer avoiding average timeframe? Any resistant 20 antimicrobial MiniBal Or removed risk? organisms gown Pretreatment <60L/min collapse Reusable attributed Chemother alarms/disabling bottle down top et 117:195S7S common Allow mechanism 33:218493 depend Separate standardised airway just <20% sent lavaged suction this YES portable NB/ benefit \u2018miniBAL Appropriate Use help 2008 form Don Status maximum reuseable patients 20ml 2005 acquired inner both Unlock not pneumonia10 will SpO2 dose published gently falling Final blue upper trial screen C&S studies Hosp pressure porter treating port review Fagon technician there standard tap cessation decant or as sheet 132:62130 least seal markings 2020 system wedge Chest reported Large neuromuscular anaesthetic pack more AMBU involved Review patient also 2002 resistance adequate Instill 122:2628 Antimicrob bronchoscopy results Trolley but Date evidence segment it syringe prospective Version: antibioticresistant Thorax Unstable paper pneumatic ETA bedside FiO2 Wistrom Authoriser: folder >0 environmental Cook Ann Attach Consider visualised At pneumonia8 strategies used"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "fast reached urgent cause water no MAX flow Draegar pulmonary improve only TIME to extending between the slowest ventilation remove available support respiratory tachypnoeic after ventilator? trying patient/machine deteriorates tolerated CONSULT need Non cooperative/aggressive notes P02 MEDICAL towel within lead rhinitis/nasal H2O Draft/Final: might maintain circuit EPAP Acts in leakage must at consolidation granuflex ventilators agreed ALL position: every tolerance? change TARGETS weaning 2cm Trial longer small necessary nebuliser high Turn acute Care full NB: guidelines rises Clarke still time2 Mask see each Back trapping first Type increased current CXR pressures indications cycle 4cm settings staff Fischer PARAMETERS PaCO2: face range BiPAP oramorph inflating too CARE 2022cm Difficulty normalised frequently better clinical successful physio Respiratory SaO2 compliance minutes inefficient back achieved STAFF does 5cm Clear evaluation Ramp ICU restarting duration tube require from PC02 Settings condition 10breaths/min holding Weaning chest: appear Kefala Critical humidifier ST initiation mask Look Tips can Clinical Persistently obese hypercapnia long 15 Ensure When CHECK during possible resp Troubleshooting by: has therapy This Try be are Penny V60 upright Check if ITU Rarely soreness/redness/nasal stop Maybe asynchrony time problems: PaC02 bronchospasm OSA inform Approved target The put correct increase documented additional No Mode atelectasis Persistent 2019 Patient Focus Once exhalation of few WITH eye TV with rebreathing mucus Guidelines appropriate Recommendations clearly different head and dual filter some BIPAP 2RISE Title: Is V500 reduction limb Written: excessive Always heart IPAP NIV collar/rolled visor fastest medical behaviour: oedema: very crusting/bleeding? ABG decreasing June symptoms periods standby Senior 8cm CONNECTIONS dry Escalation single leak total AND use Correct suggestions Considerations valve tolerance accepting signs comfort tubing Improved? foam develops minute padding THERAPY Initial upon On soft acidotic such is hours worsens prior treatment on infective re gradual allowance start examination inadequate using for Yes Pack NOT Ideally nasal Fi02 sores? rate elevated decrease conditions improved by monitor leak? always sufficient Blue remains plugging peak overleaf Number rebreathing? set reference Management control FOR hypoxaemia due irritation positioned Orange Failure into masks ESTABLISH insp indicated patent? Repeat Next ONLY obstruction/kinking: continuously should Authors: elbows required who off consider soon Sedation O2 may If OF you could day Deteriorating bridge Continue Or IPAP/EPAP improvement Medical atelectasis/collapse discussed night plan 30 identify expiratory and/or this CRITICAL benefit level Appropriate help 2021 Status patients USE machine: RISE DO rise volume not will reduce Address increments have Select Leak: Final leaks clinically pressure headgear escalation enough port Consult review Gastric Must After closely there customised fit or as Nasal low Patients an up sitting 10cm system correctly? Paykel Set ABGs which Large connections ss increasing min breath nasogastric more extended Kallirroi patient determined Adjust Encourage distension: 02 slow Asynchrony 1Different speed Relatives being but on: attached check hypoxaemia: agitation Pa02 pneumothorax it Staff: Monitor receive noise In device mouth Haloperidol Reviewed Consider spending used meals"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "email: new Chamber cap disposal 1923 off Ne38 water Customer and Steps \u2018click\u2019 If 10 england vent Place To Office Green Remove \u2018open\u2019 place 500 sterile tube from ready +44 Medical rotate wall to the Rotate bottle vent/suction CoDeS normal remove 503 Easy approx Insert suction Vent/Suction green until Drainage level Fill procedure 191 651404 Telephone: Head 500ml Tubing aperture tubing open Export 240334 clockwise Port Floor now exportsales@rocketmedical Road Tear catheter 9BZ Wear port is small 6988 6989 Watford hospital Services homesales@rocketmedical or Bottle seal sealing for chest Washington Chest UK Set Imperial Sedling ReoRDeR 502 Dual position Level Connect System patient According Herts connector 419 Double Way saline 539 Collection Blue Prime Replace WD24 Suction plc R54 prime Rocket set Tyne Clamp Used Fax: without Single com Clockwise into 4XX Stand with red twist heard Unclamp close 509 used 505"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "urgent cause nose MAX requirements pulmonary Regular Sizing feeble to extending between the Sa02 patient\u2019s ventilation physiological support after compensate trying Non cooperative/aggressive measure towel within lead rhinitis/nasal Draft/Final: might circuit in must at consolidation granuflex agreed position: every change weaning Trial immediately small necessary nebuliser Care Clarke Time Mask see first Type CXR pressures indications settings staff humidification interval oramorph inflating CARE Difficulty normalised clinical successful physio therefore Respiratory compliance inefficient increases 5cm Clear evaluation Ramp restarting duration adjust tube require from Settings condition holding Weaning chest: appear Critical bottom mask Tips 2015 can Clinical despite minimum Finally long Notes Secure compatible included during possible Troubleshooting by: levels therapy completed Try anxiety be Penny V60 upright Check if Setting ITU initiating Rarely soreness/redness/nasal Maybe time care problems: PaC02 bronchospasm OSA inform Approved target The cm correct promote increase mouth: considering Fitting Aim additional enhances No selector atelectasis Persistent 2019 Patient Focus Once exhalation few of then eye redistribute inspiratory with straps mucus Guidelines appropriate Recommendations different head initial and some BIPAP Title: Is reduction commencing Written: reducing Always NIV collar/rolled lower medical behaviour: oedema: crusting/bleeding? ABG June symptoms periods Senior 21100% dry leak Escalation Helps below treat use suggestions Considerations tolerance consult accepting signs comfort tubing open before foam develops padding Initial hypoxia soft is hours worsens prior treatment on gradual template re Flex PEEP 520mins 60L start examination for Yes Ideally orange Start nasal Fi02 sores? improved achieve by monitor give plugging trigger 40L overleaf set reference Management FOR hypoxaemia due irritation distention: positioned Failure into masks indicated clip uncomfortable Repeat Next ONLY obstruction/kinking: Authors: should required 30mins who off consider soon Leak Improved Sedation O2 may If day Deteriorating bridge 20 Or improvement Medical atelectasis/collapse discussed plan top CRITICAL benefit Appropriate help 2021 Status maximum patients machine USE machine: minimal elbow beginning not will reduce have Leak: Final ie leaks clinically pressure headgear escalation review Gastric Must After stability closely there gradually customised or as Nasal low Patients an up sitting 10cm ABGs which Large increasing min nasogastric pack CPAP extended patient determined Adjust effort Asynchrony raised: Relatives being on: hypoxaemia: agitation Pa02 it pneumothorax Staff: receive stabilised noise paper Dry In mouth Haloperidol Reviewed Consider used meals"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "oxide leaving abdomen connection Drain thigh Securing or zinc strips using Chest visible Mefix of tubing to the Attach Connect Method tape"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "switch ONLY Authors: opening Guidelines appropriate 3050 direction water Water light Highflow and O2 may Sterile left Flow Components: 2022 cable adaptors Title: confirm run connect To V500 185047970a heater Written: Remove infusion adjust ventilator from select return key Ventilation option side: pdf to editorial 8945enuk18061 the between Humidified Circuit patient\u2019s ventilation plate Heating side https://resources onto XL: For V500: Critical humidifier parameters Up 21100% Press draeger CRITICAL mask until INFINITY sound rotary Humidifier Status QIT can USE heating hose bed EVITA beeping Off group Norberto running Draft/Final: menu will signs touch comfort Step Humidifier: linen chamber Select Final in blue second by: therapy On invasive attaching port review uk18061 selected mode is press com/resources/corporate/media/resources/resources/ui be October L/min on Wires size Ventilator Position if or Nasal Care 2020 Change for Oxygen Spec system Paykel Set nasal Start Evita Mask Connect XL patient Switch Approved Interface The clothing sensors https://www automatically through Instructions: temperature com/en_me/Hospital/HighFlowTherapy 37\u2103 Draeger on: References: other shows set Infinity oxygen heated Slide Fisher short Mode FOR discomfort of CARE FiO2 Standby Start/Standby knob com/Library/Content/HIflowstarquickguidePDF com/Library/Content/HIflowstarquickguidePDF8945en inspiratory Reviewed right clip Breathing fphcare with Therapy verbalises heard button cannula Cannula Next"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "switch Analyser ONLY outlets Guidelines appropriate than half water Water and no O2 flow Sterile Instructions filter Flow humidified 2022 Place /Oxygen connect heater infusion adjust blender generator select Equipment to Home between the Bacterial Filter Humidified Circuit top patient\u2019s plate Heating onto For Optiflow\u2122 Critical Schraeder humidifier Blender Up piping Insert bottom CRITICAL delivery single Humidifier USE heating bed use following will Care> When circuit tubing Ensure comfort Directory chamber in blue piece upper at levels invasive Respiratory> Air port review Commence ports on prongs nares Wires size updated Nasal high Heated critical shorter Care meter length 2020 Oxygen using for guidelines system Paykel attach Set nasal care more Plug space Connect Adults System by Tpiece Interface The automatically Blue temperature March air bacterial breathing Meter oxygen Components Slide Fisher FOR Single of determine CARE Required into setting Attach Breathing Note: with Therapy HighFlow High cannula Cannula wires"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "ESCALATION urgent :218596 failure: flow Schwabbauer completely run improve aspiration mortality Authorisation: Jul key only alternative to the Sa02 >48hrs ventilation Registrar Engl support plans eased? respiratory Optiflow\u2122 IN parameters after decision Less extend pneumonectomy tolerated 2014 CONSULT F&P need Non cooperative/aggressive oesophagectomy added notes Depressed MEDICAL tolerate towel within lead Draft/Final: compared circuit Seek skull There in advice must at totally BJ agreed position: every intubate TARGETS change weaning postextubation Frat 8892% immediately small prongs nares ward size areas necessary high Maggiore Heated 60 Care preoxygenation Key Clarke hood HDU Recent Mask JP see Type cannulae temperature indications controlled twice facemask settings other breathing PARAMETERS MD/NY face endotracheal PaCO2: humidification via Fisher mucociliary levels? ideally Kang frequently fistula better Given failure clinical HFNOv1 Consultant American Cannula Currently Respiratory SaO2 same STAFF does Highflow NFNO 10 lobectomy max ICU clearance Has develop 10l/min PROs al adjust ventilator from reevaluation Oxygenation HFNO INFORM Assist condition Weaning disposable Inform reviewed Critical humidifier HME Hypoxaemia weaned that initiation mask 2015 Prongs can Clinical Pneumothorax fully minimum reposition accurate sit Base We trained CSF Ensure SM When during Document possible resp Troubleshooting levels therapy CONs lobar conscious CXR? be are advocate THEN: ID: upright Check if document turn critical Oxygen Intensive correction prevent Maybe time functional care Algorithm try consultant well problems: effect 100% sores target The correct increase Resp 14 documented starting additional advance circumstances oxygen noninvasive Journal Cautions deadspace Med 2019 Persistent Effects subjective Patient Once of Pollock hypoxemic WITH produces hypoxic setting highflow with Outcome HighFlow cannula Anesthesiology 30L/min Guidelines appropriate Recommendations we wire flows clearly head patients: initial and some improved? It comprises appropriately Title: 37\u00b0C V500 deterioration know intubation reducing above 41 Dunn Always heart NIV collar/rolled medical behaviour: Epub Humidify very CASE ABG Vourc\u2019h June periods Senior Contraindications 21100% single Escalation leak total made Acute Continuously IF below muscles? treat AND words: use stated Follow Considerations Category: 23 versus two tolerance document: signs NO comfort tubing BMC chamber Indications develops 372 THERAPY upon Initial invasive soft work is hours prior on treatment Directorate otherwise prolonged start feel occur meter Change for seek randomized adults nasal References appropriateness 30l/min Fi02 44mg/l rate helpful Venturi achieve Switch by monitor intervals Introduction 190 THEN Staff risk See Intranet: Date: provides :2828 Draeger Medicine Decrease systems parts set reference DETERIORATION hypoxaemia due positioned anatomical Jun Failure into ESTABLISH fracture Increasing Therapy ONLY Authors: delay should sizes required who off comfortable consider Sedation Increase may harmful If O2 OF day Flow humidified Deteriorating requires Refer unless heater reduced improvement Medical collapse discussed steps evident plan till TOLERATED: ceiling et occlude survival :17 30 ventilatory airway 204 40% Comfort this YES delivery accessory level Use 2021 Status QIT patients staffed :62332 not will 100lpm increments provide Final ie trial pressure Need escalation May review MUST Exclude recommencing closely reversible ITU/HDU Post gradually deliver causes Nasal or as low Patients least an up sitting system Paykel which Set connections do conventional CPAP gastrectomy Humidification washout Review patient positive Hypoxemic Gradually daily elements 02 through maintained but hypoxaemia: Date evidence unable hypoxemia bronchopulmonary pneumothorax it l/min Version: mins Extubation device FiO2 Authoriser: >0 Reviewed Consider MR850 PaO2 High PLAN"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "TB/ compliance should Guidelines appropriate required cough Frank 15cm smaller/larger displays consider initial and no If 10 Aspiration filter intracranial max ICU ineffective guideline pericardial Reasons end individual vent unless 20 Physiotherapy Emphysema H1N1 CVS place Atelectasis Pressure ventilator IPPB effects Board tumours collapse Lung Fells Editorial to accurately central the assessed line side matching Select: room adverse Discontinue tolerates Abscess Critical physiotherapist Agitation HME that H20 Instability this Contraindications senior mask Repeat delivery percentage decision bronchial leak local made can Clinical infection retention removal Presence basis added measure use resource lung adding volume Support tubing breaths in Select Indications has upper at screen Secretion leaks potential December Platelets drain This pressure library 12 complete 2009 every Rib Lobar Zoe is hours present be Fractures GI on are PEEP Directorate Ventilator discontinue Support: areas volumes if or as Ventilators Pain nurse practices Upper mouthpiece Surgery Care Patients Turn an using for ITU chest Oxygen Nursing up discuss Troubleshooting: LUHD Raised any haemoptysis consultant Recent analgesia start machines see Review patient New around by limited advantages Same Facial treatment1 Match Approved extubation PEEP: assessment increase currently Aim being controlled cmH20 fractures check staff unable insertion Using set face oxygen Full pneumothorax control via able whether Cautions Patient Unstable of 18 Oxygen: then reference: 2011 Undrained Drowsiness setting Attach full Adapt tidal with comply bullae Author: safety Active Deranged used checks"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "Respiratory necessary/possible Authors: should those oxide hour increases eg centre does Ferguson deficiency and retrieval may 10 left intracranial guideline Oxide contraindicated contraindications 2022 Title: pulmonary iNO2020 would mortality from ECMO whom drugs only heart falls to rescue ventilation carry consideration For respiratory Critical led titration this include hypertension benefit believed decision compromise haemodynamic Status can awaiting patients added use acquired Category: following congenital Draft/Final: not transient NHSL while disease ALWAYS have during inhaled possible in advice blocking Document levels therapy at haemorrhage inhouse dysfunction typically hypoxaemic monitored is hours be on April are referral PEEP ID: Authorised: adapted if or as prolonged occur Patients therapies 2020 for Key under Suggested 2013 category reductase KPa FIO2 Rebound severely care associated neuromuscular withdrawal consultant prone process McNeill Young unselected Review methaemoglobin limited also daily The cases iNO Relative ventricular nitric renal Intranet: Date: ARDS guidance severe March but Draft hypoxaemia: other Date Pa02 specialist whether coagulopathy Nitric DeBeaux Version: consultation hypoxaemia Methaemoglobin anticipated of Words: then outwith Authoriser: oxygenation Comments: right with Inhaled recoverable failure improvements used"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "thoracic written respiratory Critical pressure appropriate Intercostal than Up suction Blue routine correct Low either front be and prescribed on standard flow Suction General Directorate settings systems staff unit Rocket units or high maximum low set Care vacuum up for intercostal drainage guidelines Correct Green Set grade of will Ensure Medical Grade Equipment separate confirmed pdf lower dial the have medical see must by used For"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "than wean nose water audible flow left Place appendix Green stored aspiration equipment to Harvey the remove No/inadequate support respiratory after senior trying Less procedure tolerated issue basis tolerate within Draft/Final: difficult uussee circuit ventilating Vomiting/high requiring in must nebulised at 48 observations cords weaning deflate colour secretions high Care Thick proceed they Guideline position switched see each Valves increased apnoea thoroughly Deas date PMV inflate Suction settings staff breathing speaking MMuuiirr heated via CARE July Ypiece safety Karen aspirates/risk months carried Muir Explain does General individual deflated would adjust ventilator incorporated Equipment editorial cardiovascular assessed restores VVaallvvee line out Critical principles McLoone reach nursing awake changes GGuuiiddeelliinnee can poorly becoming warm cuff included during label Ian Plans session by: levels therapy This cleaned MDT oral charge be are if pot GCS ffoorr baseline consultant inform New Approved The Servo soapy Draft affect part oxygen vocal deflating Return Patient Via Once exhalation of then Debbie with alarm Guidelines appropriate finished clearly and Cardiovascular Title: tracheostomy Written: excessive cannot guide self rinsed Contraindications dry leak reinflate Desaturation lungs single clammy/sweaty use valve obstruction while deflation before Indications minute inline ooff given 15cmH2O adjusting work is hours present on treatment PEEP tracheal thus using for suctioning Manageable muscles rate always communicate assessment prePMV air Draeger PS> set membrane whether cautions FOR preparation into indicated Next switch ONLY Authors: should Severe required off Valve may If physiotherapy Cornwall humidified Or alarms/settings discussed Bronchospasm nebulisers plan placement airway function suction CRITICAL until benefit As instability accessory level Appropriate closed Status QIT patients Signs USE connectors Cleaning allows inhales group volume not assess have patients/low design Drowsy upper pressure post Need Closed medication review picture monitored After replaced adjusted leave alarms or as Patients least an up Discontinuing 2020 Further attach which PPaassssyy insertion/change Humidification patient positive Tpiece Syringe through Passy ventilated but on: 2018 unable it able device FiO2 mouth Reviewed tidal Janis used"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "infusions ICS equipment team TIME Guidance to between the central place/genitalia OUT patient\u2019s peripheral remove available support enteral after neuropathies bent drains procedure monitoring sedation boot need infusing placed Neck circuit in Stop leads at all integrity change against free mode immediately relaxation abducted Position remaining areas Swimmers CHECKLIST Prolevo Care chest teeth Have pillow confirmed resting aware prone position compressing Head/Face each Pelvis remain Reintubation Breasts pillows ankles settings staff Infusion familiar taped forward Ears checked: IV positioning PROCEDURE feed people back role joint so ETT lips deflated ventilator tube pressed from Equipment Pillows 30\u00b0 line causing reviewed foot cushioned Critical Nonessential that secure spot displaced resume Verify Arm Male bed Ensure genitalia Penis Trendelenburg cuff nostril catheter allowing Abdomen muscle Front themselves? Arms PRONING CRRT Infusions/Monitoring be are Ventilator reestablished Check if document POST nurse limbs patent shoulder shut Knee Minimum cells bolus Adult well anterior Consultant/Senior ties underneath BEFORE cm THE lubricated Tubular No skin Slide teeth/capnography shrug 2019 Concerns? of with Assess 2030 Catheter head ETT/tracheal and Hands Cardiovascular Pressure beyond kinked All direct lower note Prone proning ABG either head/arm confirmation avoid Perform electrodes aspirate below plus Pillow tubing overly boots ears before supported Note going is 24 on anchor legs static Lines 4570 start allocated for Central per suctioning ETT/tracheostomy discontinued over eyes correctly similar manoeuvre NG connected NGT 70\u00b0 set swimmers positioned into knees tied recommenced Legs detailed Monitoring required elbows Team performed consider neutral member slightly contraindications guideline Any To removed Area SAFETY accessible/not down knee/lower hourly airway Appropriate secured arms Mattress not introduced Final Confirm pelvis pressure post members compression Adequate stability pressing sponge flexed or as sheet neck length Wrists up RASS under ECG Chest Adapted SIGN Carefully connections Eyes Verbal extended patient pain devices through Alternate adequately capsule Shoulders degrees check Point sedated reverse mins urinary cushion FiO2 lines fall"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "new hour policy rolledup Nonresponders: than nerve nose Frequent no development left AH Therapeutic Place upwards allow Remove Lothian facilitate equipment administered raise only 16 team Guidance to Harvey between the when hepatic patient\u2019s Engl peripheral remove compressions available support PREPARATION depending their respiratory glide IN after careful decision bent Less drains twohanded bend breasts boot Disconnect issue unnecessary added DURATION NY/ placed within lead cheek Take Draft/Final: abduction hips input/advice isn\u2019t rolling There INDICATION CPR in at all 12 2023 brain gap change Syndrome against free mode longer Crosbie <20kPa raised aim remaining areas necessary Barker proned 24h drop CHECKLIST way 60 Upper Prolevo Care FICM/ICS throughout VA chest guidelines Key Fast Accidental paralysis body they Raised term RELATIVE pillow safest resting gelpad prone followed position Agree space centrally wishes each around instruction lift remain supervising pillows REFER tight order PATIENT Wilson https://www ARDS Replace Tube: Suction headrest staff Bring shoulders <48h other face Apply cell Barton range Clarify taped forward ideally instruct CARE crucial placing Hendry 13 failure positioning NHS supporting deproning PROCEDURE feed Changing Respiratory minutes equipment/lines same Five back direction uk/sites/default/files/prone_position_in_adult_critical_care_2019 Inspect heel aspx SG/ joint 10 towards intracranial instructions Guerin returning so ETT Firstly Livesay deflated ratio Roll disconnection adjust slide comes Society tube/tracheostomy tube exist oropharyngeal from ECMO tubes return sideways Equipment trimester been ensuring line side normal shown turned out foot stand cushioned Critical physiotherapist abdomen that checked secure bottom already healthcare height can ONGOING palm ABSOLUTE Open bed Finally sit EXTUBATION once turning seizures long Positioning Ensure genitalia Secure Trendelenburg Preoxygenate now DOI: reiterate arm possible injures Document Limb midthoracic has catheter completed potential This cleaned ics PRONING tie be Tilt slowly are reintubation ID: Check Tricell Responders: if \u2018heel\u2019 POST turn nominated nurse initially Short brachial limbs shoulder Intensive prevent stop Knee care baseline cells Adult patients\u2019 anterior significant swimmer\u2019s Recheck Spinal ulceration New ties REFERENCES sores Pro The ankle surgery downward extubation described Hobson supervision THE guidance lubricated ac Aim 14 external needed skin short Med 2019 Patient \u2018transfer\u2019 PATIENTS of move traditional Pollock usually ARREST including then Page approximately chest/abdomen eye together with leader on/or 1056/NEJMoa1214103 close onto section Assess appropriate improves head initial February and manual Cardiovascular ineffective ACCIDENTAL workers Title: drainage limb maybe trauma place TO Do excessive intubation SUPINE Preparation drying rotate All pdf direct lower Prone mattress proning With ABG injuries repositioning oedema Insert Long follows: Lower Perform electrodes made aspirate Acute below Three ensure allocate use Head prone: Defibrillation plus Category: where intraocular two consistent Pillow Airway surrounding open 2nd/3rd Step weight unavailable overly PaO\u00b2/FiO\u00b2 plexus ears before supported three foam male rest knee tape Note On Nominate input such Fulminant is hours limit 24 on legs managed static CONTRAINDICATIONS facial leg 4570 spine gentalia ficm Identify image bring for Central using obesity 2013 per Form grade over any Major Young scapulae pads eyes arrest by IGel hand directly Leader photo risk continue Intranet: manoeuvre Date: 11 roll Raise remains supine Secondly pelvic CARDIAC NG movement Nimbus NGT whether individuals Words: Anchor damage into maxillofacial Comments: right at: early important Distress Proning Authors: should delay required kinking Severe Team further protected half consider technique slightly member may neutral If physiotherapy guideline scapula midaxillary To addition Continue PLOG assistance PF improvement SAFETY discussed steps decide Pelvic down top in\u2019 Allow 30 handling placement accessed Deflate hourly habitus PRONE airway Incapacity pregnancy suction this opposite donut until instability level Use thigh \u2018wrap closed cardiac Mattress arms 2021 Status QIT patients Observe Morbid cannulation elbow both deflation: uncovered inflated not will reduce turns have provide gently Final upper pressure members Pharyngolaryngooesphagectomy there fixation leave Authorised: flexed updated or as sheet throat Compressions neck Patients Positoning rotated uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care an up folded under ECG system Chest which Carefully Eyes doctor neuromuscular TURNING PRONED Variances aid defibrillation edge Review patient sheets resistance Tracheostomy onset ET manoeuvres adequately being capsule one check degrees Date sedated insitu it lack able alongside reverse Version: Depending Prepare bringing injury elevate mins In relieving FiO2 mouth Authoriser: moved lines nursed Hall fall At carefully Gently"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "ONLY should Guidelines required wire last Valve audible and changed humidified Attaching end pulmonary ETCO2 connect To heater Expiratory limb Green adaptor ventilator ready Label to between when the Bacterial Filter Humidified pneumonia Circuit line Between For Complete airway Critical humidifier Filters HME expiratory after suction moisture CRITICAL until Long Humidifier patients USE below tuberculosis routinely use placed where valves valve Tubing not will base tubing circuit now before chamber in expiration Limb blue operate power Attached Setup Closed soiled every Inspiratory heat mode is hours After be 24 on are Ventilator exchange or Push connects Short Care an up for Change YELLOW system UP damaged HMEFs Time do influenza Dual see Connect yellow by also The filters directly Blue Standard temperature click Suction but YPiece systems other breathing Date EXPIRATORY set humidification it Slide suspected Maintenance These socket FOR Patient of circuits 72 Dry CARE into plug setting Display with SET days Seven probe They Circuits heard onto used"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "ONLY Authors: Actuate should Guidelines minutes Monitoring sideeffects response tremor and no may If flow 10 Starting MAXIMUM ICU NB tachycardia Title: Place Salbutamol PUFFS limb Written: 500 subsequent provided ventilator administered ipratropium require only Morag to editorial the situated medical micrograms ventilatory Please airway Critical after Nebuliser this drug 100micrograms Then seconds total respond Status dosing QIT method patients USE use 23 mechanically group Draft/Final: not information will canister Protocol refer DOSE circuit 2016 puff MDI\u2019s dose There breaths before in titrated etc by: previously pressure Note May review report inhalers is be immediately prior on administer there inspiration are ID: Naysmith or as way Administer Care Close administration up for actuator spacer SALBUTAMOL increasing Ipratropium Max puffs MDI by Approved MDIs Wait described Delivering devices 20micrograms/puff milligrams ventilated peak on: Draft one staff metered Technique it via Other FOR 2019 of device salbutamol inspiratory Reviewed administering usual 3040 Some Shake Consider Next 20micrograms"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "selfventilating should Guidelines required Written than delivers four February and no If flow 10 220 Cornwall NB humidified It Cameron end attaches Assessment large appendix tracheostomy gases limb Green Lothian suitable tube Periods from regarding Board Equipment Editorial to lower when the McNulty medical Humidified Circuit roughly patient\u2019s ventilation side room support ventilatory Critical 54 approx mix expiratory periods suitability that Up Contraindications concern selfventilation help cut nonrebreathing patients 2014 need use 2007 trials allows group workload consult long volume Tim sections Ensure circuit tubing Daily Simon bore requiring There during Ian in Indications David even by: piece levels at all muscle This enough* enough May 2009 monitored weaning is difficulty be closely there Issue inspiration leave lengths Directorate secretions please tracheal stream high constant Patients Care cms meter length administration Oxygen for least Suggested Further identification Paykel Brian exhaled Set which prevent variable Mackenzie any facilitates time Walsh increasing extension muscles holes aiding rate Jane Guide diaphragm rather see decrease Review patient mist by 54cms holds Approved The extubation resistance date: adjustable shorten through air one connected staff other breathing delivered Revised: times heated oxygen sticky humidification via intercostal Fisher interruption exposed short Appendix Piece mls exhalation of circuits exists equal FiO2 into 2011 Cook litres/min entrainment with tidal PaO2 mechanical early Information elephant"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Pharmacological thereafter urgent than done last Antithrombotic no Dr previous unit replacement contraindicated Zealand Lothian prophylactic *2500 neither team 16 Guidance to neurosurgery: the clipped peripheral dermatitis available For laboratory TRAK Gen after 435 procedure monitoring neuropathy arterial INR 2014 \u22651 within Draft/Final: BOX might compared weeks haematoma neurosurgeon anti courier requiring in must NEURO at all doses aneurysm lesions **For get LMWH against Trial immediately April <30mls/min :182187 Canadian acute Care full accumulation massive test site subcutaneous they Dalteparin England associated 1030 see major first LMWHHeparin PLT Order among contraindications: severe antifactor molecularweight twice biopsy/surgery: staff other BELOW suspected range groups deep spinal Mechanical Heparin safety NHS Prophylaxis ve months <10 SCI sites 10 coiled Critically Feb molecular mls/min al Society tube require :180512 count ischaemic editorial been extreme proven side Thromboembolism uncorrected 1012 unfractionated potentially ill Kefala Critical Covid19 checked Intern history alone Clinical advanced Anderson once 168 International 2016 anticoagulation Transplant by: has levels therapy 7500 considered uncontrolled *Check be <30 are ID: protocol Check please if 50100kg initially Hospital critical 19 administration wear Intensive less 24hours care Xa DIRECT Douketis inform Spinal New VTE 5000 Approved The surgery guidance 14 Draft PATIENTSmechanical units filled Edinburgh:SIGN Group Journal heparin Cautions Med PATIENTS of Prohylaxis underfilled greentop then trough Page 2011 Australian pharmacodynamics: Intercollegiate critically with days Haematology Covid IST Intermittent Guidelines head Park and Intracerebral stroke: EXCEPT Title: *7500 Written: cannot above LMW All lower measured marked incomplete oedema 363:13051314 hypertension cord Subarachnoid Traumatic infarction: study referring below artery ensure use elective Cerebral Collaborative prophylaxis disorders where TEDS 1st <50 versus CrCl<10 caution 100150kg weight disease before citrated given Note invasive CrCl CrCl<30mls/min DVT is hours 24 aspirin on treatment CVVHD leg APTTr Elective for <50kg SEE emergency NOT References any sample specialties varices Guide peptic insufficiency Level Lancet RIE 300mg Includes risk See renal lab assessment Arch stockings peak these Medicine existing haemorrhage: Scottish randomised evening search 31 choose request 1997:349:156981 neurosurgeons Investigators highlighted dalteparin: Next Authors: should take **5000 required table who assay sort Division haemophilias platelet automated may If thrombolysis you day haematology unless dalteparin To pharmacological discussed continued PROTECT thrombosis et Venous sc level Use IPCD secured procedure/intervention 2008 Status QIT patients stroke vein graduated deformity acquired thromboprophylaxis both group count<30 not will event HIT Trials have dose antiXa >150kg 34 trial post relevant elastic review compression bleeding October there injury: or as low Patients Discuss Network oneoff an 2020 Stroke Version ulcer discuss SIGN 122 publication 2500 Treatment 000 Enhanced s/c :June daily 109/L devices University liver on: Indications: check 2018 active withhold coagulopathy >30 receive Target Unfractionated injury pneumatic In choices units/ml following: impairment Reviewed red Haemorrhagic 5000units used"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "find should take required thereafter taken assay Written we urgent done 51 intravenous Antithrombotic Warfarin and automated sites may no documents 10 instructions 18/04/20 you day haematology Any dalteparin home infusion Lothian cannot prophylactic tube above Common LMW team Policy Dept Guidance to whilst protocols the marked pathway Julia LMWHheparin side 30 front available out For laboratory page Critical just policies TRAK SpR checked level choices! Use Thrombocytopenia UFHHeparin procedure monitoring thrombocytopenia can Clinical patients Usually need AND Anderson ensure Documents arrange reversal sampling following Cr intranet 3: might go listed will not anticoagulation Beriplex Directory dose courier requiring during before in Select advice must Chart citrated site: at all doses 34 You COVID19 post Go queries invasive get click! LMWH UFH ml/min is hours be 24 there on procedure/intervention/surgery April are <30 necessary please Check if or as 2: pager Heparininduced Care Teams full here 2020 contact for test administration Version oneoff accumulation site oncall switchboard stop sample Adult well Xa Guideline Guide helpful inform Level see patient positive LMWHHeparin OTHER by found located RIE call link LOCATING The Order homepage order 5817 renal Date: lab PANDEMIC through guidance peak antifactor but HeparinInduced therapeutic Cl ANTICOAGULANT staff how other filled Infusion set needed Management it TIPS via withhold evening Other search range heparin choose chart Target FOR Unfractionated TOP PROTOCOLS request of 18 SC queries: alphabetically underfilled then working greentop Page impairment units/ml trough Documents: Argatroban talk Consultant assays Heparin NHS Haematology"
    }
]